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Abstract 
___________________________________________________________________________ 
Healthcare systems, especially those within resource-limited countries, are facing increasing 
pressures, which can, in part, be attributed to the struggles of balancing resource inventories, 
while still providing clinical care of high quality. Pharmacovigilance (PV), a system developed 
to ensure universal drug safety, constitutes one component of healthcare systems globally. PV 
systems in resource-limited countries are struggling to operate both efficiently and effectively, 
while continuously maintaining and ensuring universal drug safety. These PV systems are 
burdened by the lack of expertise and knowledge to (i) prioritise the challenges faced daily; (ii) 
identify the root causes of these challenges; and (iii) determine how these root causes of the 
challenges can be addressed by technology.  
In this research, these three requirements are addressed. First, a systematic review is conducted 
to identify 15 challenges that are experienced in PV systems, especially those in resource-
limited countries. These 15 challenges (referred to as the PV challenge landscape in this 
research) are prioritised with the use of: a PV system and PV challenge landscape matrix 
developed in this research and input from several subject matter experts. Seven challenges are 
regarded as priority, namely: culture, partnerships, transparency, insufficient resources, 
country-specific factors, technical capacity, and adverse drug-reaction under-reporting. 
Second, an investigation into several translation techniques is conducted in order to determine 
which technique(s) is appropriate to be used to translate these challenges from a strategic to an 
operational level, and to identify the root causes of the challenges. The value chain analysis and 
the 5Why method, in combination with fishbone diagrams, are considered to be appropriate 
techniques. Following the implementation of these techniques, the identified root causes are 
once again prioritised based on inputs from SMEs in order to maintain focus on the root causes 
that have the most significant impact on PV systems whilst ensuring that the scope of the 
research remains feasible. It is concluded that 14 of the identified root causes should be 
prioritised for further investigation in this research. 
Third, literature is reviewed to identify an appropriate technology selection framework that can 
be used to assess the technology landscape with regards to it being implemented in PV to 
address the root causes identified in this research. The technology selection framework 
developed by Chan & Kaufman (2010) is considered an appropriate framework, since it 
incorporates many elements one can associate with PV. 15 technologies that could potentially 
be used to address the most prominent root causes of the PV challenge landscape are identified 
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with the use of grey literature and a focus group. With the use of Chan & Kaufman's (2010) 
technology selection framework, these technologies are assessed in order to determine which 
technologies are feasible to be implemented in PV. It is concluded that 13 of the originally 
identified technologies are feasible for addressing the prioritised root causes of the PV 
challenge landscape. Subsequently, a link between the 14 prioritised root causes of the 
prioritised PV challenge landscape and the 13 technologies is established, where it is described 
how each root cause can potentially be addressed by one or more of the 13 technologies. 
This research significantly contributes to the PV system by identifying opportunities to utilise 
technology to address the root causes of some of the most prominent challenges in PV. 
Additionally, this research makes a methodological contribution by proposing a combination 
of techniques that can be used to: scan and prioritise the challenge landscape in PV, prioritise 
and identify the root causes of the challenges experienced in PV, and identify and assess 
potential solutions that can be used to address these root causes.  
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Opsomming 
___________________________________________________________________________ 
Gesondheidsorgstelsels, veral dié in hulpbronbeprekte lande, ondervind toenemende druk wat 
gedeeltelik toegeskryf kan word aan die stryd om hulpbronvoorrade te balanseer, en 
terselfdertyd hoë kwaliteit kliniese sorg te verskaf. Pharmacovigilance (PV), ‘n sisteem wat 
ontwikkel is om universele dwelmsveiligheid te verseker, vorm een komponent van 
gesondheidsorgstelsels wêreldwyd. PV stelsels in hulpbronbeperkte lande sukkel om 
doeltreffend en effektief te funksioneer, en terselfdertyd universele dwelmsveiligheid te 
handhaaf. Hierdie PV stelsels word belas deur die gebrek aan kundigheid en kennis om (i) die 
uitdagings wat daagliks aan die dag lê, te prioritiseer; (ii) die kernoorsake van hierdie uitdagings 
te identifiseer; en (iii) te bepaal hoe hierdie kernoorsake van die uitdagings deur tegnologie 
aangespreek kan word. 
In hierdie navorsing word hierdie drie vereistes aangespreek. Eerstens word 'n sistematiese 
oorsig gedoen om 15 uitdagings wat in PV stelsels ervaar word, veral in die hulpbron-beperkte 
lande, te identifiseer. Hierdie 15 uitdagings (verwys na as die PV-uitdagingslandskap in hierdie 
navorsing) word geprioritiseer deur gebruik te maak van 'n PV stelsel en PV-
uitdagingslandskapmatriks wat ontwikkel is in hierdie navorsing en insette van verskeie 
vakkundiges. Sewe uitdagings word as prioriteit beskou, naamlik: kultuur, vennootskappe, 
deursigtigheid, onvoldoende hulpbronne, landspesifieke faktore, tegniese kapasiteit en nadelige 
dwelmreaksie onderverslagdoening. 
Tweedens word 'n ondersoek na verskeie translasie tegnieke gedoen om te bepaal watter 
tegniek(e) gepas is om hierdie uitdagings van strategiese tot operasionele vlak te transleer, en 
om die kernoorsake van die uitdagings te identifiseer. Die waardekettinganalise en die 
5Hoekom-metode, in kombinasie met visgraatdiagramme, word as toepaslike tegnieke beskou. 
Na aanleiding van die implementering van hierdie tegnieke word die geïdentifiseerde 
kernoorsake weer geprioritiseer op grond van insette van vakkundiges om fokus te handhaaf op 
die kernoorsake wat die grootste impak op PV stelsels het, terwyl dit verseker word dat die 
omvang van die navorsing uitvoerbaar is. Daar word tot die gevolgtrekking gekom dat 14 van 
die geïdentifiseerde kernoorsake prioriteit vir verdere ondersoek in hierdie navorsing moet 
word. 
Derdens word literatuur hersien om 'n gepaste tegnologie seleksie raamwerk te identifiseer wat 
gebruik kan word om die tegnologie landskap te assesseer met betrekking tot die 
implementering daarvan in PV om die kernoorsake wat in hierdie navorsing geïdentifiseer is, 
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aan te spreek. Die tegnologie seleksie raamwerk wat deur Chan & Kaufman (2010) ontwikkel 
is word beskou as 'n toepaslike raamwerk, aangesien dit baie elemente bevat wat mens met PV 
kan assosieer. 15 tegnologieë wat potensieel gebruik kan word om die belangrikste kernoorsake 
van die PV-uitdagingslandskap aan te spreek, word geïdentifiseer met die gebruik van grys 
literatuur en 'n fokusgroep. Met die gebruik van Chan & Kaufman (2010) se tegnologie seleksie 
raamwerk, word hierdie tegnologieë geassesseer om te bepaal watter tegnologie moontlik is om 
in PV geïmplementeer te word. Daar word tot die gevolgtrekking gekom dat 13 van die 
oorspronklik geïdentifiseerde tegnologieë haalbaar is om die geprioritiseerde kernoorsake van 
die PV-uitdagingslandskap aan te spreek. Vervolgens word 'n skakel tussen die 14 
geprioritiseerde hoofoorsake van die geprioritiseerde PV-uitdagingslandskap en die 13 
tegnologieë gevestig. Daar word beskryf hoe elke oorsaak moontlik deur een of meer van die 
13 tegnologieë aangespreek kan word. 
Hierdie navorsing dra aansienlik by tot die PV-stelsel deur geleenthede te identifiseer om 
tegnologie te gebruik om die kernoorsake van sommige van die prominentste uitdagings in PV 
aan te spreek. Daarbenewens maak hierdie navorsing 'n metodologiese bydrae deur 'n 
kombinasie van tegnieke voor te stel wat gebruik kan word om: die uitdagings landskap in PV 
te ondersoek en te prioritiseer, die kernoorsake van die uitdagings in PV te prioritiseer en te 
identifiseer, en moontlike oplossings te identifiseer en te assesseer wat gebruik kan word om 
hierdie oorsake aan te spreek. 
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Chapter 1: Research background 
___________________________________________________________________________ 
This introductory chapter provides the background for the thesis. It also provides the research 
rationale, problem statement, research aim and objectives, limitations and assumptions, 
validation strategy, key terminologies, and the research methodology. 
1.1. Background 
The Thalidomide disaster of the 1960s (Toklu & Uysal, 2008; Isah et al., 2012) has been 
described as the largest man-made medical disaster in history (Vargesson, 2015). The disaster 
led to nearly 10 000 babies worldwide being born with extremity defects (Wang et al. 2009). 
Speculation followed on the true nature of these defects and who was to be held responsible 
(De Abajo, 2005). To this day, survivors of the tragedy are compensated by both government 
and the original manufacturers of the drug. However, the survivors still live with the 
consequences (Vargesson, 2015). Various researchers, including Wang et al. (2009); Stolk 
(2012); Klausen & Parle (2015) concur that this disaster made the need for drug safety 
monitoring and surveillance to prevent a tragedy of similar stature occurring in the future, 
apparent. 
Subsequently, pharmacovigilance (PV) was introduced to the healthcare environment in the late 
1960’s (De Abajo, 2005). During this time, the World Health Organisation (WHO) unveiled 
the WHO Programme for International Drug Monitoring, an organisation consisting of multiple 
international partners aimed at international monitoring and surveillance of new and existing 
drugs (World Health Organization, 2002). PV enjoys much attention in this programme, now 
co-ordinated by the Uppsala Monitoring Centre (UMC) (World Health Organization, 2002). 
1.2. Contextualisation 
The WHO defines PV as the “science and activities relating to the detection, assessment, 
understanding and prevention of adverse effects or any other possible drug-related problems” 
(World Health Organization, 2002). Adverse drug reactions (ADRs) or adverse drug events 
(ADEs), which describe the unintentional and unpredicted reactions to, or side-effects of new 
or existing drugs, are regularly associated with PV (World Health Organization, 2014). When 
such unpredicted reactions or side effects occur, the ideal is that it is reported to the appropriate 
authorities. Depending on the degree of severity of the reaction, the report is either terminated 
at the national level, or sent on to the UMC (Strengthening Pharmaceutical Systems, 2009). 
This reporting process is illustrated in Figure 1. 
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In Figure 1, PV systems are described from a systems perspective. It is an illustration relating 
to people, functions, structures, and expected outcome and impact. People are categorised as 
being either reporters or evaluators. Reporters are those who report ADRs (or suspected ADRs) 
to the relevant authorities, known as the evaluators. Evaluators largely consist of various 
healthcare professionals who could do the necessary analysis to identify and categorise ADRs 
from the data that is reported (Strengthening Pharmaceutical Systems (SPS) 2009).  
Forming part of the processes are the functions associated with PV, from ADR reporting to 
analysis and implementation of solutions. Critical to the effective and efficient operation of 
these processes are the structures and bodies involved including PV organisations, medical 
infrastructures and networks, regulatory bodies, product manufacturers and the media. These 
structures, as well as the people involved, are essential in providing the necessary resources and 
managing the overall PV system.  
The people, functions and structure’s elements are said to be the building blocks of a PV system, 
each dependent on the other. To be both efficient and effective, the elements of the system must 
interact and share resources to contribute to the ultimate goal of PV: preventing medicine-
Figure 1: Illustration of PV system. (Reproduced from Strengthening Pharmaceutical Systems 
(SPS) (2009)). 
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related problems and associated reduced morbidity and mortality (Strengthening 
Pharmaceutical Systems, 2009).  
Other perspectives of PV also exist. Holm, Snape, Murray-Smith, Talbot, Taylor, and Sorme  
(2013) refer to eco-pharmacovigilance (EPV), a developing science aimed at addressing the 
environmental impact of pharmaceutical products within a PV context. Environmental 
pharmacology is a popular alternative to the term EPV (Rahman & Khan 2015), other 
alternative terms include: eco-pharmacology; environmental pharmacology; pharmaco-
environmentology; and eco-pharmacostewardship (Isah et al., 2012). 
PV is also regularly viewed from both a supply– and value chain perspective. According to 
Beninger (2017), effective and efficient PV requires close collaboration across its supply chain. 
Beninger (2017) makes specific reference to the manufacturing industry relating to PV and 
categorises the pharmaceutical supply chain into upstream sourcing of materials, manufacturing 
of products and the downstream distribution process. The importance of supply chain 
management (SCM) is also emphasised by Cohn et al. (2017) who provide a case study where 
poor SCM led to falsified medicines entering the Kenyan pharmaceutical supply chain.  
On the other hand, operating within the stages of a supply chain, Heinrich (2015) describes the 
importance of pharmaceutical value chains. Heinrich (2015) specifically refers to the 
importance of resource management and the essential role it plays within the constrained 
resource environment in which PV operates. Cognizant (2012) also highlights the importance 
of business process management (BPM) in PV. Due to the large scope of PV, many processes 
are required for a PV system to function properly i.e. here BPM is essential in ensuring that 
these processes are managed properly.  
There is agreement in literature that the contemporary scope of PV is considerably larger than 
that of the 1960s system (Olsson et al. 2010; Isah et al. 2012; Aljadhey et al. 2015). Generally, 
the scope of PV includes monitoring efforts related to product quality, medication errors and 
previously known or unknown ADRs (Strengthening Pharmaceutical Systems (SPS) 2009). 
Additionally, the WHO also includes the interaction of medicines, counterfeit medicines, lack 
of efficacy, and the abuse and misuse of medicines in the scope of their PV definition (World 
Health Organization, 2014).  
The increasing scope of PV systems has increased the complexity and number of challenges 
faced within the PV landscape (Edwards, 2017; Pan, 2014). Consequently, there has been an 
increase in challenges such as the under-reporting of ADRs, ineffective culture, lack of 
transparency, and the lack of sufficient resources. Pan (2014) also states that increased pressure 
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is put on new technological developments that are intended to counter the challenges in the PV 
landscape. The WHO describes how the inter-relatedness of the various stages in a PV system 
cause challenges that exist within the PV landscape to have a system-wide impact (World 
Health Organization, 2002).  
The under-reporting of ADRs is an example of a prominent PV challenge that has a system-
wide impact. PV systems are initiated by ADR reports, serving as the line of communication 
between PV authorities and the people experiencing certain ADRs (Varallo et al. 2014). Due 
to the integrated global nature of PV monitoring (as managed by the UMC), the impact of a 
challenge, such as under-reporting of ADRs, can also stretch beyond a specific PV system to 
the global PV monitoring level. 
1.3. Rationale of the research 
The lack of sufficient post-market drug surveillance prior to the Thalidomide incident, 
discussed in Section 1.2, led to the severity of this tragedy. Since then, PV has grown and 
contributed to much safer drug usage. The PV industry has developed relatively rapidly, 
pursuing improved post-market drug surveillance. This development has led to great success as 
the positive impact of PV on human society is evident. However, this significant growth in PV 
has also given rise to new challenges burdening modern PV systems, leading to increasing 
pressure experienced in PV systems, especially those within resource-limited settings. 
Moreover, many of these challenges are discussed on a high level of abstraction in literature 
where it is not entirely evident what the effect on these challenges are. Especially for PV 
systems that operate in resource-limited settings where a consortium of challenges are 
experienced on a daily basis, it is of utmost importance that the core effect of these challenges 
be known, which will make is much easier to address these challenges. 
Additionally, there is also a limited number of studies that investigate the possible impact of 
the existing technology landscape on PV systems. Access to technology is becoming less of an 
obstacle, meaning more PV systems in resource-limited countries have the opportunity to 
investigate and implement technologies in order to address the challenges it faces. 
1.4. Problem statement 
Though PV is an essential aspect of ensuring drug safety, the PV system is a component of the 
healthcare system that is frequently poorly understood by healthcare workers and patients alike 
and is therefore not prioritised. PV activities are co-ordinated by the WHO to enable global 
monitoring to identify potential drug safety related challenges. The PV system therefore forms 
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a complex network that is dependent on information supplied by individual healthcare workers 
and patients to enable monitoring at a global scale. The PV system faces a significant number 
of challenges, some of which could, potentially, be addressed through the application of 
technology. Moreover, there is a lack of appropriate strategies in PV to address the challenges 
faced daily. This research is concerned with: (i) which strategies can be used in PV to 
understand the challenges faced daily, and (ii) the question of which technologies could be 
leveraged to address some of the most significant root causes of challenges in the global PV 
system. 
1.5. Research aim and objectives 
The aim of this research project is to contribute towards improved PV systems, through the 
identification of technologies that hold the potential to address some of the challenges faced by 
PV systems. This will be achieved by first identifying, prioritising, and translating the existing 
PV challenge landscape which will provide clarity on the true effect of the PV challenge 
landscape on the PV system. Once the true effects, or problems, of the prioritised PV challenge 
landscape are identified, the possible impact of the technology landscape on the PV challenge 
landscape can be assessed. The research objectives that will support the achievement of the 
research aim include: 
i. Conduct a comprehensive literature review to: 
a. Comprehensively understand the various sub-systems of which PV systems are 
comprised of, 
b. Identify and understand the challenges faced in the PV industry; 
ii. Prioritise the PV challenge landscape to allow for more in-depth research: 
a. Clearly define and understand the prioritised PV challenge landscape; 
iii. Develop a translation strategy that can be used to translate the prioritised PV challenge 
landscape, by doing the following: 
a. Investigate the methodologies that can be used to translate challenges from a 
high level of abstraction to a lower level, 
b. Select appropriate methodologies that can be used for this translation process 
and describe how each will be used, 
c. Implement the translation strategy to identify root causes to the prioritised PV 
challenges landscape, 
d. Validate and prioritise the root causes with SMEs to determine which root 
causes should be the focus point of this research; 
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iv. Investigate the technology landscape to: 
a. Identify a technology selection framework that is applicable for implementation 
within the PV context, 
b. Identify several technologies that can possibly be implemented within PV; 
v. Implement the selected technology selection framework to assess the prioritised root 
causes and the technology landscape: 
a. Establish the link between the technology landscape and the prioritised root 
causes by describing how the technologies can be used to address these issues. 
1.6. Limitations and assumptions of the research 
This research project is limited due to the vast challenge landscape of PV. Many challenges 
exist that are both related to one another and unique to the context of the PV system. In addition 
to identifying the overarching challenges, focus is shifted towards challenges that have the most 
significant impact on PV. This allows for more in-depth research to be completed in finding 
solutions to the challenges. It is possible that other researchers may deem some of the other 
challenges that does not form part of the prioritised challenges as priority. However, the 
prioritised challenges are validated by SMEs, and therefore form the core of the research that 
follows thereafter.  
Additionally, the research is also done in a general context regarding PV systems i.e. no specific 
PV system within a specific country is considered in isolation. The assumption made is that a 
general approach to identify and prioritise the PV challenge landscape will include a significant 
portion of the challenges faced by PV systems in specific countries. 
1.7. Key terminologies 
There are several key terminologies that should be explained in order to provide clarity on the 
meaning of these terminologies in this research. These terminologies are: PV system; partners; 
and technology. 
1.7.1. Pharmacovigilance system 
With specific reference to the entire thesis document, the phrase “PV system” is used 
interchangeably. In some instances, it is used to represent PV in general, or all PV systems 
across the globe. It is also sometimes used to represent a specific country’s PV system. The 
intended meaning of the PV system, in this research, depends on the context in which it is used. 
Additionally, the phrase is used to refer to PV as a system that is constructed from of various 
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processes or sub-systems. In all cases where it is used, it is clear which of the two intended 
meanings of a PV system is used. 
1.7.2. Partners 
With specific reference to Sections 2.8.3 and 3.5, partners represent both those who operate 
within PV (those directly associated and affected by PV operations), as well as those who 
operate outside the scope of PV i.e. those who are not directly influenced by the operations of 
PV, but hold the potential to affect PV. For example, partners who operate within PV include 
healthcare workers, the UMC, and the WHO. Partners who operate outside the scope of PV 
include non-profit organisations and national governments. Both these partners have the 
potential to influence the operation of PV in a country. 
1.7.3. Technology 
With specific reference to the identification of candidate technologies in Section 5.5.1, it is 
important to clarify how technology is defined in this research, since some might not regard 
some of the technologies identified as actual technologies.  
There are several definitions of technology, making it difficult to determine what can be defined 
as technology and what not. Some may define technology as either tangible (mobile phones, 
computers, etc.) or intangible (software) items, whereas other may have a broader definition. 
Dusek (2008) argues that technology can be defined amongst four categories, namely: 
hardware, rules, applied science, and systems, each defining technology differently. From these 
categories, both Tiles & Oberdiek (1999) and Dusek (2008) concludes that anything we use in 
our daily lives to make our lives easier and to improve the effectiveness and efficiency of our 
daily activities, can be regarded as technology. For example, in a healthcare system (public– or 
private healthcare system), we use hardware (asthma inhaler) that have been developed by 
applied sciences (research in laboratories and clinical trials) according to certain rules 
(prescriptions) to improve our lives (treat asthma). 
Using this definition of technology enables a much wider spectrum of technologies to be 
identified and considered in this research.  
1.8. Validation strategy 
Validation plays a significant role in this research. The research is firmly grounded in literature 
with supplementary, practical knowledge gained from consulting SMEs. These experts provide 
an additional perspective, filling the gaps found between literature and the real world. 
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Consequently, two types of validation strategies, namely informal– and formal, structured 
validation, are used at strategic points in this research. 
The process for informal, structured validation is as follows: SMEs are contacted via email, 
requesting their assistance with the research. Upon indication of their willingness, they are 
provided with an informal, summarised version of whichever part of the research is under 
investigation. They are requested to read through the document, and provide feedback in the 
form of notes, email, or telecommunication sessions, whichever method they prefer. 
The formal, structured validation process is similar to the informal, structured validation 
process, except for the nature and format of the information that is made available to the SMEs. 
SMEs are provided with a formal document that contains considerably more information than 
that used during the informal, structured validation process. As a result, this validation process 
takes longer to complete. However, this allows the SMEs to spend more time and thought on 
the provided information, allowing them to provide more in-depth feedback. 
1.9. Research methodology 
This research consists of three sections (refer to Figure 2), namely: PV, the technology 
landscape, and the combination of PV and the technology landscape. Each of these sections 
consist of different subsections. In PV, two subsections exist: the PV challenge landscape, and 
the PV system. In the technology landscape, the two subsections are the technology landscape, 
and the technology selection framework landscape. Lastly, the combination of PV and the 
technology landscape consists of a combination between all the subsections that have been 
identified here. In Figure 2, these sections and subsections are graphically depicted. Each of the 
subsections are investigated separately, where-after they are combined to marry PV and the 
technology landscape. The tools and validation strategies used during each subsection are also 
shown in Figure 2. 
1.9.1. The pharmacovigilance system 
Indicated in green in Figure 2, the PV system section consists of two stages. Firstly, PV is 
investigated to clearly define and understand what PV is, by making use of a literature review. 
Included in this stage is the definition of PV as a system, consisting of several parts. The second 
stage is also completed with the use of a literature review. The previously defined PV system 
is dissected to clearly distinguish between the different parts of a PV system, and define the 
activities associated with each of these parts. 
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1.9.2. The pharmacovigilance challenge landscape 
Indicated in blue in Figure 2, the PV challenge landscape section consists of three stages. 
Firstly, a systematic review is conducted to identify the challenges that exist in PV, by making 
use of literature, grey literature, and SMEs. An informal, structured validation is then used to 
validate the overview of the PV challenge landscape. This is a reiterative process, meaning 
changes are made throughout the process based on the feedback from the validation process. 
This stage is followed by the prioritisation of the PV challenge landscape which relies on inputs 
from SMEs and a matrix that is developed in this research. Similarly, an informal, structured 
validation strategy is used to validate the prioritisation of the PV challenge landscape. This is 
also a reiterative process, similar to the previous stage. The last stage in this section is the 
definition and understanding of the prioritised PV challenge landscape, which is achieved with 
the use of a literature review. 
1.9.3. The technology selection framework landscape 
Indicated in purple in Figure 2, the technology selection framework landscape section that 
consists of three stages, each completed with the use of a literature review. Firstly, the 
technology selection framework landscape is investigated to identify candidate frameworks that 
are applicable to this research. With the use of predefined criteria, all of which are identified 
and described in the research, the most appropriate framework is chosen, after which it is clearly 
defined to understand how the framework should be implemented. 
1.9.4. The technology landscape 
The technology landscape section consists of two stages, the first of which is the identification 
of candidate technologies that can be used to address the PV challenge landscape. Given that 
this landscape is so large, two sources are used, namely: grey literature and a focus group. This 
stage is proceeded by defining the technologies, describing the exact meaning and scope of 
each. This process is completed with the use of a literature review. The technology landscape 
is shown in orange in Figure 2. 
1.9.5. Combining pharmacovigilance and the technology landscape 
The marriage of the stages in the PV and technology landscape section is indicated in red in 
Figure 2. Initiated with the combination of the stages in the PV section, an investigation is 
launched into the translation methodology landscape to identify which methodology can be 
used to translate the PV challenge landscape. This process is achieved with the use of a literature 
review. Implementing the selected translation methodology, the PV challenge landscape is 
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translated to identify root causes to the overarching challenges. Proceeding the translation 
process, the root causes are prioritised with the assistance of SMEs. This stage also incorporates 
an informal, structured validation, which is used to make necessary changes to the prioritised 
root causes. Once the root causes are prioritised, each are defined and described to create a 
better understanding of the exact meaning of each. This is achieved with the use of a literature 
review.  
The stages in the technology landscape section are merged into the stage where the selected 
technology selection framework is used to assess the technology landscape and determine 
which technologies are feasible for implementation in PV. This stage, in combination with the 
description of the prioritised root causes, is proceeded with the process where the selected 
technologies are linked to the prioritised root causes. During this process, a formal, structured 
validation process is used to determine whether the final linkages are feasible according to 
various experts in PV. This validation process also allows for any necessary changes to be made 
to the linkages between the technologies and the root causes.  
1.10. Chapter 1 conclusion 
Chapter 1 provides an overview of the thesis, discussing the research background and rationale, 
problem statement, research aim and objectives, limitations of the research, validation strategy, 
key terminologies, and the research methodology. Succeeding this chapter is a study of the PV 
challenge landscape. 
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Figure 2: Research methodology roadmap. 
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Chapter 2: The pharmacovigilance landscape 
___________________________________________________________________________ 
This chapter1 is primarily concerned with the PV landscape. The chapter is divided into two 
sections - the PV system and the PV challenge landscape. To gain a comprehensive 
understanding of the challenges faced by PV, it is valuable to first understand the composition 
of a PV system. This will better enable the relationships between the PV system and its 
challenge landscape to be discerned. Subsequently, the PV system is described, based on the 
system perspective presented by Strengthening Pharmaceutical Systems (2009) in Figure 3. 
Figure 3: Stages of a PV system (Reproduced from Strengthening Pharmaceutical Systems 
(2009)). 
2.1. Data collection and ADR reporting and data collation 
ADR reporting is the cornerstone of PV (Irujo et al., 2007). Serving as the starting point to a 
PV system, ADR reports are essential to its functionality. ADR reporting has been the subject 
of a number of research studies, including Hill (2014), De Abajo (2005), Irujo et al. (2007), and 
Rodrigues & Khan (2011). Hill (2014) describes five types of ADR reporting methods that are 
used in modern PV systems, namely: targeted reporting; cohort event monitoring; spontaneous 
reporting; electronic health record mining; and intensified ADR reporting.  Detail on each of 
these reporting methods is provided in Table 1. 
Hill (2014) states that the choice of most appropriate reporting method is based on three aspects: 
the medicine under investigation, the population of participants, and the type of reports required 
by the represented authorities. In support of Hill (2014), De Abajo (2005) and Irujo et al. (2007) 
dub spontaneous reporting as the first generation reporting method of PV. Spontaneous 
reporting is still used today, especially in developing countries, because of its relative simplicity 
and inexpensive nature (De Abajo, 2005). 
                                                 
1 A large portion of the contents of this chapter has been published in an article that was included in the proceedings of the 
Southern African Institute for Industrial Engineering’s 28th annual conference (SAIIE28 2018). A copy of this article is included 
in Section A.1 in Appendix A. 
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Table 1: Types of PV reporting systems. (Data source: Hill, 2014.) 
PV method Objective 
Targeted reporting 
To learn more about the ADR profile of a specific medicine(s) in your 
population or to estimate the incidence of a known ADR to a specific medicine. 
Cohort event monitoring 
(CEM) 
To gather more information on the safety profile of a new chemical entity in 
early post-marketing phase. 
Spontaneous reporting A functional ADR reporting system to monitor the safety of all medicines. 
Electronic health record 
(EHR) mining 
Utilise electronic health records to identify emerging drug safety issues. 
Intensified ADR reporting To enhance ADR reporting of specific medicines in early post-marketing phase. 
 
Proceeding ADR reporting is data collation, where most ADR reports are gathered by 
municipal–, provincial– or national PV centres. Depending on the severity and repetition of an 
ADR, countries often resolve the issue internally, without consulting the UMC (Stahl et al. 
2003). The UMC is, however, still made aware of the reported ADRs. 
2.2. Causality analysis and risk assessment 
Causality analysis is the process where the source of an ADR is determined with the aid of the 
appropriate participants and resources (Edwards, 2017). This stage is critical to the PV process, 
as it determines whether further investigations will be conducted. Edwards (2017) describes 
this stage as being dependent on detailed data, openness and the involvement of all stakeholders.  
Although causality analysis methods differ in many respects, Agbabiaka et al. (2008) are of the 
opinion that they share a common goal: to arrive at a conclusion on the source of the suspect 
drug. Causality analysis is routine not only at the UMC, but also at PV centres around the world, 
allowing a wider range of stakeholders to be involved during such a process (Agbabiaka et al., 
2008).  
Risk assessments, aimed at identifying and attending to the risk factors associated with ADRs, 
are used to complement causality analyses (Edwards, 2017). Risk assessments must identify 
the risk factors to the use of a certain drug, as well as the risks of further complications to 
patients after an ADR has been reported. Holden et al. (2003) also describe risk assessments as 
a collaborative effort, requiring the input of various stakeholders such as pharmaceutical 
companies, healthcare workers, patients, consumers and PV organisations.  
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2.3. Decision making and governance, appropriate action, and evaluation 
of outcomes 
Following ADR reporting, data collation, causality analysis, and risk assessment, a decision is 
made on the appropriate action to be taken. Waller & Evans (2003) describe a decision-making 
method regularly used, known as the robust decision-making approach. The robust decision-
making approach includes the following steps: analysis of evidence, which is similar to that of 
a causality analysis and a risk assessment described by Edwards (2017), identification of 
options, and final decision-making. Waller & Evans (2003) state that there is greatest scope for 
innovation in respect to the latter. Modern regulatory models used for decision-making consider 
many factors prior to taking appropriate action including the strength of the evidence, balance 
of risks and benefits, public health consequences, and likely effectiveness of potential 
preventative strategies (Waller & Evans, 2003).  
Finally, Agbabiaka et al. (2008) emphasise the need for post-action evaluation. Following the 
implementation of any system, evaluation of outcomes are important to determine whether the 
intended results are accomplished (Strengthening Pharmaceutical Systems, 2009). Waller & 
Evans (2003) refer to two measures often used for measuring outcomes: the extent to which a 
process of PV is effective in the protection of public health; and possibilities of further 
improvements to be made. Waller & Evans (2003) are also of the opinion, however, that true 
measures of outcomes would also provide estimates of the impact of interventions on morbidity 
and mortality. 
2.4. Introducing the pharmacovigilance challenge landscape 
Each stage of a PV system is associated with a specific set of challenges and Pan (2014) states 
that the challenge landscape as well as the PV landscape is vast. It is therefore advantageous to 
this research that these challenges be identified, thereby enabling associations to be made 
between the challenges and the various stages of a PV system.  
2.5. Research approach to the pharmacovigilance challenge landscape 
Due to the large landscape of PV challenges, a systematic review was conducted to ensure that 
a significant portion of the existing research conducted in the challenge landscape, is considered 
in this research. Three academic databases were used, namely: Scopus, Google Scholar, and 
PubMed. The Scopus database was used for the primary systematic search protocol, while the 
PubMed and Google Scholar databases were used for snowballing and other informal search 
methods.  
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In total, 2 301 relevant documents are available based on specific search terms (these search 
terms are detailed in Section A.2 in Appendix A). These search terms were based on a cursory 
review of an initial batch of articles, uncovered on the databases via serendipitous discovery. 
In addition, opinions found in grey literature were used to determine the search terms used in 
the databases.  
To reduce the number of articles to a more manageable quantity and to only look at the 
challenges that are identified as most relevant according to several sources, only the articles 
published during the year 2000 and onwards were included in the search. The abstracts were 
then consulted to determine the applicability of the article to the research. An important 
inclusion criterion was that the abstract had to contain words associated with PV, such as 
“pharmacovigilance”, “drug safety monitoring” or “drug safety surveillance”. The documents 
were filtered to 64 documents of which the majority are referenced in the proceeding section.  
2.6. Succinct overview of the pharmacovigilance challenge landscape 
The most prevalent PV challenges were organised into a network (Figure 4), illustrating the 
inter-related nature of the challenges found in the PV landscape. This was done by interpreting 
the suggestions made in literature, and by considering both the severity and prevalence of the 
challenge in literature. The dark grey blocks indicate the classification of the challenges, 
whereas the blue blocks indicate the specific challenges in PV. As seen in Figure 4, the 
overarching challenge is culture. All other challenges identified in the PV landscape fall into 
one of two sub-categories of culture, namely PV infrastructure and data management.  
The proceeding section is limited to a succinct overview of the PV challenge landscape. This is 
done to demarcate the scope of the research in an effort to focus on specific challenges that are 
most prevalent in modern PV. Subsequently, the network of challenges is briefly discussed, 
providing an overview of the challenges found in PV. 
2.7. Culture 
PV is based on the culture of safety, where PV professionals provide the foundation upon which 
the principles of this culture are built (Olsen & Whalen, 2009). Literature argues that there is a 
need to improve the culture in modern PV systems (Edwards et al., 2015). It is believed that 
the improvement of PV culture will lead to the improvement of the other challenges in PV, such 
as ADR under-reporting discussed in Section 2.9.2. It is often discussed that the improvement 
of PV culture requires participation across all disciplines to become a reality. 
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Figure 4: PV challenge landscape network. 
2.8. Pharmacovigilance infrastructure 
The challenges that are grouped under PV infrastructure in this research are: transparency; 
insufficient resources; PV centres; country-specific factors; technical capacity; partnerships; 
and public participation. These challenges are subsequently discussed. 
2.8.1. Transparency 
In close association with the culture found in PV (discussed in Section 2.7), the lack of 
transparency amongst the stakeholders in PV may lead to failed PV initiatives (Rubel et al., 
2017). It is essential that key stakeholders, especially those with the relevant experience in PV, 
share relevant information with their peers. This will enable participants in PV to learn of new 
ways in solving the problems they might be experiencing. Increasing the visibility of 
information in PV is critical (Rubel et al., 2017), as it will support an improved drug safety 
culture. 
It is also essential that the existence of PV systems in countries be publicly unveiled. It is 
described in literature that HCWs in many countries do not contribute to PV, simply because 
they are not aware of the existing PV infrastructure in their location. 
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2.8.2. Insufficient resources 
It is well-known that PV operates within a resource-constrained environment (Isah et al., 2012). 
Moreover, in developing countries where other challenges such as drought and war are of high 
priority, PV organisations struggle to implement new PV systems (Isah et al., 2012). In these 
developing countries, the available resources are rather invested elsewhere, leaving little for the 
requirements of PV. 
The resources required by PV systems are unique in specific countries e.g. a country might have 
the necessary expertise and manpower to assist a PV system, but lack the governmental funding. 
In contrast, another country might have the necessary budget but lack the required manpower 
(Pan, 2014). Countries experiencing this phenomena include sub-Saharan African countries 
(Isah et al., 2012), India (Rama et al., 2011), and certain South-East Asian countries 
(Suwankesawong et al., 2016).  
Common resources required by PV systems include monetary assistance, hardware and 
software infrastructure, expertise and training curricula amongst healthcare professionals, and 
common PV knowledge amongst both healthcare professionals and consumers (Isah et al., 
2012; Pan, 2014). PV systems are dependent on the combination of these resources and are not 
able to function properly without them (Isah et al., 2012). Heinrich (2015) refers to effective 
resource management, a crucial element to the successful operation of a PV system. 
2.8.2.1. Lack of pharmacovigilance centres 
Serving as the base of operation for PV monitoring efforts, PV centres are important elements 
of the PV industry. According to Zhang et al. (2014), there is a certain structure or hierarchy 
associated with PV in general. The UMC is the international database, taking ownership of 
millions of ADR reports received from numerous countries each year (Rama et al., 2011). 
Serving as a filter to these ADR reports are national PV centres, supported by provincial centres, 
usually located in provincial hospitals and other medical institutions. Municipal centres serve 
as the first line of defence, i.e. initially receiving and processing ADR reports, before sending 
these to PV centres further up the PV centre network hierarchy. Zhang et al. (2014) provide a 
description of the Chinese PV centre network, consisting of one national PV centre, 34 
provincial centres and 400 municipal centres, all ultimately reporting to the UMC.  
The challenge faced, especially in developing countries, is the gaps found within this PV centre 
network. The case of sub-Saharan Africa, where there are many countries with no or few 
municipal– and provincial centres is discussed by Isah et al. (2012). Olsson et al. (2010) and 
Isah et al. (2012) are of the opinion that this deficit is due to the lack of resources such as 
Stellenbosch University  https://scholar.sun.ac.za
18 | P a g e  
 
tangible infrastructure, human resources, training and capacity building, governance, 
sustainable methodologies, and innovations within a number of areas in the sub-Saharan 
African context. With no intermediate body to receive and filter initial ADR reports, it is 
difficult for healthcare professionals and consumers, in countries with no municipal– or 
provincial PV centre, to report ADRs to the appropriate authorities (Zhang et al., 2014). 
2.8.2.2. Country-specific factors 
Country-specific factors refer to challenges faced by PV organisations outside the traditional 
resource architecture, these are described by Edwards (2017) and Härmark & Van Grootheest 
(2008). Closely related to the effect of the public on PV, the social factors of an area must be 
considered—which includes the culture, religion, age groups, and sex groups of a specific 
region. It is often a burden to clearly identify these factors since it requires manpower and 
funding that are not always readily available. 
Situational factors including border regulations, policies for implementation, governmental 
budget constraints, conflict in countries, and environmental issues such as severe drought, must 
also be considered. Often governments refuse to authorise and support the implementation of 
new PV systems as its priorities are elsewhere (World Health Organization, 2002), thus 
delaying the implementation of PV systems. Similar to the case for social factors, the required 
resources needed to identify these situational factors are not always available, contributing to 
the failed deployment of PV initiatives. 
2.8.2.3. Technical capacity 
Technical capacity refers to the ability of individuals and teams working in PV to conduct their 
work efficiently and effectively. Very closely associated with the country-specific factors 
discussed under Section 2.8.2, Mehta (2017) is of the opinion that it deserves to be 
independently categorised. The challenge faced here, especially in developing countries where 
there are limited resource-capacities, is that the individuals or teams working within the PV 
systems often lack the necessary skills and experience to conduct their work effectively and 
efficiently.  
Over the years, PV has grown to be a large and complex system. The nature of PV has changed 
from a single oriented discipline, to a cross-functional discipline. Individuals and teams from 
different a background than that of healthcare (e.g. statisticians, programmers, and engineers) 
are more often being consulted and involved in PV, since they offer additional perspectives that 
may be of benefit to PV (Mehta, 2017). 
Stellenbosch University  https://scholar.sun.ac.za
19 | P a g e  
 
2.8.3. Partnerships 
PV is a collaborative endeavour (Pan, 2014). Sustained collaboration and commitment are vital 
to attend to future challenges of PV (World Health Organization, 2002); World Health 
Organization, 2004), and ineffective partnerships pose a threat to PV (World Health 
Organization, 2004). Operating in a resource-constrained environment, partners in PV must 
sometimes provide expertise, training, political support, scientific infrastructure, and a capacity 
to accomplish comprehensive monitoring and investigations of the safety of medicines (Pan, 
2014). Failure in providing such resources, could amount to ineffective partnerships that can 
lead to failed PV initiatives. In order to maintain a certain inventory of these resources, it is 
vital that PV organisations form lasting relationships with their partners. Management for 
Science (2012) emphasises the importance of relationships between partners and how failed 
relationships often lead to PV failures. 
2.8.3.1. Public participation 
The scope of PV is large (Rodrigues & Khan, 2011), as it is concerned with monitoring a wide 
range of new and existing drugs in several countries, therefore requiring the participation of 
numerous stakeholders. Consumers and patients are described as key stakeholders (BEUC, 
2008), having the ability to contribute through an integrated and efficient reporting system. 
These direct reporting systems enable PV professionals to detect ADRs much earlier, as well 
as to remove the healthcare professional as filter to reporting ADRs.  
However, patients and consumers have been losing faith in the pharmaceutical industry. A 
survey of the US public, conducted in 2006, illustrated this loss in trust with approximately 
42% of public participants indicating that they are sceptical of the pharmaceutical industry 
(Olsen & Whalen, 2009). Similarly, a study conducted in 2007 indicated that there was a decline 
in public trust towards the healthcare system in some resource-constrained countries (Gilson 
2006). The findings of surveys such as these serve as proof that the PV industry must shift its 
focus in maintaining collaboration with the consumer and patient. 
2.9. Data management 
In this research, there are several challenges that are grouped under data management. These 
challenges are: quality of ADR reports; under-reporting of ADRs; text-mining; passive versus 
active systems; lack of data; lack of feedback; clinical trials; causality analyses; signal 
detection; and legislation. These challenges are subsequently discussed. 
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2.9.1. Quality of ADR reports 
The quality of medical data, in a PV context, is of utmost importance (François et al., 2013). 
Without ADR reports, PV systems cannot function and literature regularly emphasises the need 
for advancements to be made regarding the quality of such reports (Sarker et al. 2015).  
Spontaneous reporting is a widely used method in PV (Hill, 2014), dependent on both 
healthcare professionals and the consumer. However, Bandekar et al. (2009) describe a looming 
threat to spontaneous reporting: the poor quality of the reports. These quality issues, regularly 
found in reports by non-healthcare professionals, include issues with credibility, uniqueness, 
frequency, and salience of the data contained in the report (Sarker et al., 2015). Such issues can 
be attributed to the lack of necessary PV knowledge amongst consumers.  
Poor quality reports are, however, not restricted to those generated by consumers—quality 
issues also exist in reports generated by healthcare professionals. Such poor quality is evident 
in a study by Bandekar et al. (2009), where ADR reports from ten different countries were 
collected, with the objective of determining the quality of the reports. It was found that several 
reports lacked critical information (e.g. pregnancy status, age, sex, and allergic status), even 
though many of these reports were generated by healthcare professionals. Sub-Saharan African 
countries were rated particularly poorly, achieving below 50% with regards to the quality 
standard baseline. 
The poor quality of ADR reports can be traced back to the culture of PV (Bandekar et al., 2009). 
The establishment of a culture where more emphasis is put on the quality of ADR reports, as 
described by Edwards et al. (2015), may therefore contribute to the improvement of ADR 
reports. 
2.9.2. Under-reporting of ADRs 
Under-reporting of ADRs occur when healthcare workers (HCWs) (i.e. general practitioners, 
nurses, surgeons, pharmacists, etc.) fail to efficiently report new and existing ADRs (Herdeiro 
et al., 2006). In the interest of consumers and patients who experience ADRs, it is crucial that 
all ADRs be reported to the relevant authorities to enable signal detection, leading to 
investigations into the specific ADR. Without ADR reports that generate signals of a 
problematic ADR, investigations that aim to address these problems cannot take place. 
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2.9.3. Text-mining 
Text mining is defined as the computational process of extracting meaningful information from 
large amounts of unstructured text (Harpaz et al. 2014). In a PV context, meaningful 
information is regarded as information that can support ADR detection and assessment (Yang 
et al., 2015). Contrary to popular belief, a major challenge faced in text mining, as described 
by. Harpaz et al. (2014), is not necessarily the extraction of useful information from severely 
unstructured text, but rather realising the value text mining holds for the PV industry. Extraction 
is a challenge (Yang et al. 2015), but advancements in software have simplified information 
extraction efforts (Harpaz et al. 2014). 
The use of text-mining on social media is regularly discussed in literature (Harpaz et al., 2014; 
Yang et al., 2015; Nikfarjam et al., 2015). The challenge of some PV organisations not realising 
the value of text mining , is evident in the late adoption rate of social media (Harpaz et al., 
2014). Nikfarjam et al. (2015) are of the opinion that this unwillingness to use social media for 
ADR reporting is due to the informal nature of social media. For example, consumers make use 
of informal words and phrases to report a suspected ADR, therefore PV organisations are 
sceptical of the quality of information that can be gathered from social media. Harpaz et al. 
(2014) and Yang et al. (2015) argue that technological developments are only contributing to 
an increased adoption rate of text-mining to a limited extent. 
2.9.4. Passive vs active systems 
Regulatory enforcement and increased accountability drive demand for the protection and 
welfare of patients, and forces the PV industry to be more active (also referred to as proactive) 
in its efforts (Lu, 2009). These regulations govern active PV systems that must include 
comprehensive risk management plans and signal detection and analysis throughout a clinical 
product’s lifecycle (Lu, 2009). Active PV is not only able to respond to ADRs prior to the 
marketing stage of drugs, but also decreases the probability of a known ADR being experienced 
during such a large scale deployment (Rodrigues & Khan, 2011).  
Certain modern PV systems are outdated (Giezen et al., 2009). Spontaneous reporting, as 
described by Hill (2014), is the first ADR reporting system implemented in PV. Such reports 
are of a passive (also referred to as reactive) nature, depending on healthcare professionals and 
consumers to report ADRs after a drug has been marketed and the ADR experienced. 
Spontaneous reports are still widely used, increasing the pressure on PV systems in which these 
are prevalent to make a transition towards active operation (Rodrigues & Khan, 2011). 
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2.9.5. Lack of data 
PV relies on good information, meaning information of sufficient quality (Pan, 2014). It is 
argued that a lack of data, as well as the insufficient quality of such data, burdens PV systems 
(Rachlis et al., 2016), thereby limiting the possibility of investigations. This argument is 
supported by case studies conducted by Rachlis et al. (2016) and Weber-Schoendorfer & 
Schaefer (2016) that made the phenomenon of insufficient data apparent. This phenomenon is 
closely related to under-reporting of ADRs and the quality of ADR reports. 
2.9.6. Lack of reporter feedback 
A challenge faced by the PV industry, regularly overlooked by researchers, is the lack of 
feedback given to ADR reporters (Aljadhey et al., 2015; Al Dweik et al., 2016; Ríos et al., 
2016; de Vries et al., 2016; Kabore et al., 2013)). For example, a study of Saudi Arabia’s PV 
system indicated that participants of the existing ADR reporting network see no point in 
reporting ADRs if they cannot get feedback and support from the country’s PV authorities 
(Aljadhey et al., 2015). As another example, a similar study completed in the UK, Netherlands, 
and Australia found that ADR reporters, especially patients, want personal feedback to put them 
at ease that their voices and opinions are heard by the relevant PV authorities (Al Dweik et al., 
2016).  
This need for personal feedback as a sociological component of PV, is described by Ríos et al. 
(2016) as a routinely overlooked component of the PV system. The lack of adequate feedback 
is also evident further up the PV authority hierarchy, where gaps in the PV centre network (as 
described under Section 2.8.2) are regularly found. 
2.9.7. Clinical trials 
Clinical trials are conducted premarket and are used to determine the effect that a drug will 
have on consumers, as well as to identify certain ADRs that cannot be predicted in laboratory 
conditions (Cheaib, 2016). Similarly, Dubey & Handu (2013) state that clinical trials are 
important to determine the drug’s effect on humans, as it cannot be directly extrapolated from 
preclinical animal studies.  
Although the results obtained from clinical trials are beneficial to the PV industry, clinical trials 
are burdened by some limitations (Cheaib, 2016; Raschi et al., 2016; Dubey & Handu, 2013; 
Härmark & Van Grootheest, 2008). Though clinical trials undoubtedly play a vital role in drug 
safety, they can sometimes deliver limited results (Härmark & Van Grootheest, 2008). For 
example, due to the limited number of patients participating, it is generally not possible to 
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identify ADRs that occur only rarely (Cheaib, 2016). Consequently, ADRs will only be 
identified and investigated after a drug has been marketed to the public. Another example of 
the limitations of clinical trials, is a possible lack of correspondence in characteristics (e.g. age 
and sex), between the populations in which a drug is tested and those where it will be deployed 
(Dubey & Handu, 2013). This limits the potential to extrapolate results obtained from clinical 
trials to the population at large (Härmark & Van Grootheest 2008). 
Another challenge posed by clinical trials is what is known as special control programmes 
developed with a specific purpose, e.g. treating malaria or HIV. In many sub-Saharan countries, 
the challenge is that these programmes are coordinated separately from the national PV system, 
and do not report ADRs to the national system. There is a need to bring together such 
programmes under one umbrella so that relevant experiences can be shared (Jusot, 2017).  
2.9.8. Causality analyses 
Establishing causality in PV is a difficult and time consuming process, requiring resources such 
as manpower, expertise, and funding that is often scarce and hard to come by (Edwards, 2017). 
Avorn & Schneeweiss (2009) refer to this issue, stating that it is a common challenge 
experienced in various locations. Even though a large body of ADR data exists (Avorn & 
Schneeweiss, 2009), the volume is often too much for causality initiatives. Like the case 
described earlier, undertaking the analysis of such a volume of data requires resources that are 
not always available. This lack of resources and the difficulty in identifying linkages between 
ADRs and their root cause, are hindering causality analyses from being conducted in a timely 
fashion. 
2.9.9. Signal detection 
Signal detection and its assessment is one of the most important aspects of PV (Kumar & Khan 
2015). A signal is regarded as “reported information on a possible causal relationship between 
an adverse event and a particular drug, of which the relationship is unknown or incompletely 
documented previously” (World Health Organization, 2002). A limited number of reports, such 
as spontaneous ADR reports, can serve as a signal. Signal detection is thus the early detection 
of such signals. The early detection of signals is increasingly important to contribute to 
improved health amongst patients and consumers. However, modern PV signal detection 
systems are burdened by some challenges, including (Pontes et al., 2014): 
 The variance in ADR reports, especially spontaneous reports, such as quality, accuracy, 
and completeness; 
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 An ADR report is only an indication of the suspicion, opinion, or observation of an 
individual reporter, and does therefore not necessarily constitute an actual association 
to a specific drug; 
 Under-reporting of ADRs; 
 The unavailability of population exposure data; 
 Patients are frequently not identifiable, or the case history is not clearly reported for 
each patient; and 
 Non-compliance, medication errors, or other factors may often be related to ADRs. 
The challenges described by Pontes et al. (2014), are closely related to the other challenges 
discussed in the PV challenge landscape, including ADR under-reporting, poor quality of ADR 
reports, lack of data, and insufficient resources. It is therefore believed that addressing those 
challenges might contribute to the improvement of signal detection in PV. 
2.9.10. Legislation 
Literature suggests that legislation in PV is multi-faceted as it is either enforced too strictly or 
not strictly enough. The latter is particularly the case in developing countries, also referred to 
as low– and middle income countries by Olsson et al. (2010). A questionnaire-based analysis 
performed by Olsson et al. (2010) showed that many of the participating countries indicated 
that there is a need for better legislation regarding PV. Although PV is covered in many 
developing countries’ national legislation, which is proven by the fact that the countries 
reported that a budget exists for PV, the poor condition of PV systems in these countries suggest 
that these lack strength and focus (Olsson et al., 2010). 
On the other hand, PV legislation is sometimes too strictly enforced. This phenomenon is 
especially experienced in developed countries where PV systems have already exited the infant 
stage of development. According to Callréus (2011), legislation in such countries burden drug 
development, especially during the post-approval stage. This delay in the life cycle of drug 
development means that drugs, with the potential of helping a wide range of individuals, often 
enter the market later than could feasibly be achieved. 
2.10. Pharmacovigilance challenge landscape and the pharmacovigilance 
system 
As discussed in Section 2.4 on p.14, it is useful to establish in which stages of the PV system 
the various challenges play a role. The associations between the various stages of the PV system 
and the challenges that have been identified in this chapter are indicated in Table 2, which has 
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been validated by a SME who is a PV consultant at an university. Establishing how widely a 
specific challenge affects the PV system is a step towards prioritising the PV challenge 
landscape, a necessary step in the completion of this research, as described in Chapter 1. The 
rationale behind the construction of Table 2 is provided in Table 3. When read in combination 
with the PV system illustration in Figure 1 on p.2, Table 2 enables the identification of 
appropriate stakeholders to be consulted in attending to the challenges and contributing to the 
overall improvement of PV. 
2.11. Chapter 2 conclusion 
In this chapter, an overview of the PV system is provided. The PV system is described from a 
systems perspective, clearly illustrating the stages of a PV system. Furthermore, an overview 
of the PV challenge landscape is provided. Finally, an association is made between the PV 
system and the challenge landscape.  
The PV industry is riddled with challenges and it is therefore challenging to address all these 
challenges. To focus the scope of this research, the next chapter prioritises the PV challenge 
landscape based on the suggestions made from different sources.  
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Table 2: The PV system and the PV challenge landscape matrix. 
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Data 
collation 
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analysis 
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outcomes 
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Table 3: Rationale behind Table 3. 
Challenges 
associated with PV 
system 
Description 
ADR reporting 
Culture and 
transparency 
The overall culture of ADR reporting is a challenge faced in modern PV systems. ADR reporters must conform to an efficient culture and be willing to share information 
with their peers in order to contribute to the success of PV. 
Insufficient resources ADR reporting require certain resources to be operational. Such resources are sometimes not readily available, resulting in inefficient reporting systems. 
Country-specific 
factors 
These factors are unique to the country of implementation e.g. in many African countries, remote villages are far from hospitals and clinics. It is therefore difficult to report 
ADRs that might surface in these villages since the inhabitants rarely come to the hospital or clinic. 
Technical capacity Often, HCWs lack the technical skills to complete an ADR form. This might be because they were not aware of ADR reporting or were not adequately trained to do so. 
Partnerships Ineffective partnerships between ADR reporters (consumers, patients, and healthcare professionals) and the PV industry results in struggling PV systems. 
Public participation Public participation is critical as it not only increase the reach of ADR reporting, but also ensures that the rarest of ADRs are reported. 
Under-reporting Under-reporting is a major challenge of ADR reporting since not all ADRs are reported to the appropriate authorities. 
Passive vs active 
ADR reporting should be of active nature i.e. prior to life threatening illnesses, side-effects of a certain drug must be reported to attend to the patients or consumer in an early 
stage. 
Legislation In many countries, few ADRs are reported, because legislation allows only healthcare workers, not patients or consumers, to report ADRs.  
Data collation 
Culture and 
transparency 
It is of great importance that each ADR report be collated, especially the outliers that might contain the details of rare ADRs. A culture amongst healthcare workers to 
contribute to improve PV by doing non-mandatory work is crucial. 
Insufficient resources A collective combination of manpower, expertise and experience is required to collate all ADR reports and conduct screening and filtering of these reports. 
Lack of PV centres PV centres are needed to serve as collection points for ADR reports, also accommodating screening efforts of ADR reports. 
Country-specific 
factors 
Countries where war or drought are of more importance than PV, it is difficult for collection efforts of all ADR reports. Also, since the governments in these countries focus 
its efforts elsewhere, screening efforts of ADR reports are limited since the needed infrastructure and manpower are not of abundance.  
Technical capacity Persons who have the necessary experience regarding data collation are not always in abundance. 
Partnerships PV organisations need to form alliances with existing medical infrastructures to serve as consolidation centres for ADR reports. 
Quality of ADR 
reports 
During the collation and initial screening process of ADR reports, it is essential that the physical ADR reporting forms be of such quality that it can be easily categorised and 
triaged, especially those containing the details of rare ADRs. 
Text-mining Since ADR reports contain great detail, text-mining makes the extraction process of this data much simpler and quicker. 
Lack of data Lack of essential data such as the name of the drug believed to have caused the ADR is a challenge since more investigations are necessary to identify the drug. 
Continued on next page… 
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…continued from previous page. 
Challenges 
associated with PV 
system 
Description 
Clinical trials The data collected during clinical trials is often limited in its validity because of the controlled environments in which these clinical trials are carried out. 
Signal detection Prior to the investigation of certain ADRs carried out during causality analyses, a signal of an ADR must be detected through data collation. 
Causality analysis and risk assessment 
Culture and 
transparency 
The danger posed by certain rare ADRs serve as proof that thorough analyses be completed in finding solutions. It is essential that participants in these analyses share 
information and experience with their peers to aid one another in attending to the ADR on hand. 
Insufficient resources Similar to the above case, the lack of resources such as manpower, infrastructure, funding, and experience burdens both causality analyses and risk assessments. 
Country-specific 
factors 
Countries vary in respect to the characteristics of its inhabitants e.g. race, age and sex ratios etc. These characteristics are limiting factors to clinical trials since the effect on 
other participants, with different characteristics than that of the country where the trial was done, are unknown. 
Technical capacity Special skills and experience is needed to conduct causality and risk assessments. Often, there are few individuals, with these characteristics, who are available to PV. 
Partnerships It is essential that partners with the necessary expertise provide aid and take lead during these stages of the PV system. 
Quality of ADR 
reports 
The lack of proper quality in ADR reports is a limiting factor to causality analyses and risks assessments since the information on the ADR report is either missing or vague 
Text-mining Text-mining is an effective tool to use during causality analyses, as it reduces the time spent on data collection from ADR reports. 
Lack of data The lack of data is a burden to causality and risk assessments, as it limits the extent to which investigations can be done. 
Clinical trials The causality analyses and risk assessments conducted during clinical trials are limited by the fact that the trials were carried out in controlled environments. 
Causality analysis Causality analyses are regularly burdened by the lack of manpower and expertise that are not always available.  
Decision making 
Culture and 
transparency 
Transparency is needed during decision making. Peers need to share their experiences of similar ADRs in order to aid others in determining the best course of action. 
Insufficient resources The determination process during which the best course of action is decided upon, require various resources such as manpower and funding that are not always in abundance. 
Lack of PV centres The opinions of local representatives working in local PV centres, who have knowledge of the region where implementation is to be done, are needed. 
Country-specific 
factors 
Social factors, such as cultural – and religious beliefs, of the specific region must be considered during the decision making process to ensure that the community will accept 
and support the improvement initiative. 
Technical capacity 
During the decision making stage, it is beneficial that persons who have the necessary experience and skills be consulted and involved in the process. Such persons are not 
always in abundance. 
Partnerships Partnerships are essential to provide the necessary expertise and experience during decision making, to determine the appropriate action to be taken. 
Continued on next page… 
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…continued from previous page. 
Challenges 
associated with PV 
system 
Description 
Lack of reporter 
feedback 
 
It is essential that ADR reporters be notified that their reports have been received. Also, they need to be made aware of the decision that is taken following their report. 
Appropriate action 
Culture and 
transparency 
Similar to the previous stage of the PV system, transparency amongst peers who have experienced similar conditions of implementation are essential to increase the chances 
of successful implementation. 
Insufficient resources Depending on the scale of the action, resources are required to make the implementation process a reality. 
Lack of PV centres Serving as the base of operations, local PV centres are essential during the implementation process. 
Country-specific 
factors 
Similar to the decision making stage, it is critical that social factors such as cultural – and religious beliefs be considered during the implementation process. 
Technical capacity 
Implementation of new initiatives are not simple, therefore PV rely on individuals and teams who have experience in this regard to aid during this stage. However, these 
individuals or teams are not always available to PV. 
Partnerships During the implementation – or deployment process of the improvement initiative, partners are essential to provide aid in certain areas of these processes. 
Public participation Public members such as local leaders must be consulted during the implementation of the appropriate action to increase the chances of successful implementation. 
Passive vs active 
systems 
Due to the dangers posed by several ADRs, it is critical that active actions be taken to attend to possible ADRs before it surfaces. 
Legislation The multi-faceted nature of legislation (either too strict or too lenient) limits the range of actions that can be taken to improve PV systems. 
Evaluation of outcomes 
Culture and 
transparency 
The right mind-set towards PV evaluation is important and participants must be motivated to do the necessary evaluation. Similarly, transparency is also important to enable 
peers to share information on the experiences they had with similar evaluation processes. 
Insufficient resources 
Evaluation of outcomes cannot be done without the necessary resources such as funding and manpower. It is therefore of great importance that these resources be made 
available. 
Lack of PV centres Local PV centres are essential to accommodate the infrastructure required during evaluation efforts. 
Country-specific 
factors 
The hierarchy of leadership and networks within certain communities must be consulted, as well as involved in the evaluation process. This enables for ownership of 
evaluation efforts, increasing the reliability of the feedback provided by the relevant stakeholders. 
Technical capacity In many countries, there is a lack of people working in PV who have experience and skills regarding evaluation and continuous monitoring of PV systems. 
Partnerships Collaboration with partners with the ability to monitor and evaluate PV systems are essential. 
Public participation The public is an effective evaluator of PV initiatives since they experience the effects of these initiatives first hand. 
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Chapter 3: Prioritisation of the pharmacovigilance challenge 
landscape 
___________________________________________________________________________ 
In this chapter2 the challenges that make up the PV challenge landscape are prioritised, based 
on suggestions gleaned from various sources. At the onset of this chapter, the importance of 
prioritisation, specifically within the context of PV, is highlighted. Subsequently, the method 
employed to prioritise the challenges identified as part of the PV challenge landscape developed 
in Chapter 2 is discussed. The sources that are used to prioritise the challenges in the PV 
challenge landscape are identified and described thereafter, and succeeded by the prioritisation 
of the PV challenge landscape exercise. This is then followed by a detailed description of the 
prioritised challenges, to provide a holistic overview of such challenges.  
3.1. The importance of prioritisation 
The demand for healthcare has increased substantially over the last decade, and this has 
increased the pressure on the healthcare industry to manage its already constrained resources to 
meet its clinical responsibilities (Barnieh et al., 2014). This has given rise to the realisation of 
the importance of prioritisation, a process which governs the allocation of resources to 
demarcate the scope of clinical activities (Barnieh et al., 2014). Prioritisation of clinical 
activities is not a new concept, and in fact has been a popular topic of debate since the late 
1990s (Barnieh et al., 2014).  
Healthcare systems across the globe regard prioritisation as inescapable (Newton, 2010). This 
includes countries such as Norway, Sweden, the United States of America, and the United 
Kingdom (Sabik & Lie, 2008). Several events such as the denial of life-saving treatments, ever-
expanding waiting lists, and inefficient allocation of health insurance packages were catalysts 
to these countries to invest more time and resources towards prioritisation (Sabik & Lie, 2008). 
All these healthcare systems rely heavily on different sources of funding, which are classified 
as either public or private. The contributions of these groups fluctuates significantly due to 
factors such as exchange rates, healthcare needs, and resource availability (Sabik & Lie, 2008). 
As a result, the resources these funding bodies and investment groups provide are often 
unpredictable, which further emphasises the importance of prioritisation.  
                                                 
2 A significant portion of the contents of this chapter has been included in an article (shown in Section B.1 in Appendix B) that 
is in the process of being submitted to an appropriate journal. 
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However, prioritisation is challenging, and is often described as an inevitably disorganised 
process (Klein, 1998). Klein (1993) states that given that prioritisation is inherently the 
rationing of resources, healthcare systems struggle to find a balance between managing their 
already constrained resources and continuing to meet the demand for healthcare services. 
Moreover, the absence of a universally accepted framework that can be used to simplify the 
process of prioritisation makes this even more of a challenging process (Sabik & Lie, 2008). 
Therefore, organisations rely on different approaches for prioritisation, such as ad-hoc 
committees and advisory boards, which make use of different techniques to prioritise challenges 
and activities (Sabik & Lie, 2008). 
When considering PV specifically, as evidenced by the systematic review conducted in Chapter 
2, the PV systems, in both developed and developing countries, are experiencing an assortment 
of challenges. It is becoming increasingly difficult to address each of the challenges identified 
in this study because of the increasing requirement for resources to address these challenges 
effectively and efficiently. Therefore, it is essential that the challenges that are deemed most 
prevalent, or have the most significant impact on the PV system, be addressed as a matter of 
priority. By adopting this systematic approach to addressing the most prominent and impactful 
challenges first, it enables a process by which to systematically progress through the challenges 
in the PV challenge landscape. 
3.2. Prioritisation process 
To identify which of the challenges in the PV challenge landscape are of priority, different 
sources are used. The sources that are used, include: the PV system and PV challenge landscape 
matrix (Table 2); and SMEs. At the onset, the PV system and the PV challenge landscape matrix 
(Table 2) illustrate which challenges appear across the entire PV system spectrum, thus also 
facilitating the process of prioritising the challenges in this research. Second, suggestions by 
SMEs are used since they are front line participants in PV who have the necessary knowledge 
of the prevalent and severe challenges in PV. The SMEs consulted in this regard are shown in 
Table 4. Two of the SMEs are affiliated with a multi-national pharmaceutical company, 
whereas the other is an experienced PV researcher affiliated with a university. 
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Table 4: SMEs consulted to prioritise the PV challenge landscape. 
Occupation Affiliation 
1 
Medical Lead Access, Regional Medical Director. 
Leading the preparation for the launch of a new 
product within severely resource constrained 
environments. 
Multi-national pharmaceutical 
company 
2 
This SME has practical experience and knowledge in a 
PV enhancement project linked to Malaria vaccines. 
Multi-national pharmaceutical 
company 
3 
This SME is an independent PV consultant with more 
than 20 years of experience within PV, including 
policy development and implementation. 
Locally renowned university 
(Public Health department) 
 
3.3. Prioritised pharmacovigilance challenge landscape 
An important parameter in a prioritisation exercise such as this is the degree of impact 
(Ebrahim, 2013), i.e. what is the expected impact of the challenge? Defining impact, it is an 
iterative process, and is described as an evidence-based process of assessing the implementation 
and effectiveness of several actions in a specific context (Ebrahim, 2013). As seen in the 
definition, impact evaluation is an “evidence-based” process, requiring real-world data 
(Ebrahim, 2013). Acquiring such data is a tedious process, and due to time constraints is not 
included in the scope of this research. Instead, impact evaluation is incorporated during the 
consultations with the SMEs. I.e. if an SME indicates a specific PV challenge has a significant 
impact on the PV system, it is regarded as priority. Furthermore, and in support of the opinions 
of the SMEs, the PV systems and PV challenge landscape matrix in Table 2 is used to indicate 
the PV challenges that should be prioritised. When a challenge is experienced during each of 
the stages of a PV system, the specific challenge is regarded as a priority. This matrix in Table 
2 was also validated by the previously mentioned SMEs. The results from these two sources 
(the SME feedback and the PV systems and PV challenge landscape matrix in Table 2) are 
combined in order to develop a list of challenges in PV that should be prioritised. 
Consequently, the challenges that are regarded as priority (indicated as an “X” symbol), 
according to the PV system and PV challenge landscape matrix and the SMEs, are shown in 
Table 5. The challenges deemed challenges that should be prioritised are culture, transparency, 
insufficient resources, country-specific factors, technical capacity, partnerships, and under-
reporting of ADRs Subsequently, these challenges are discussed in more detail than presented 
in Chapter 2, allowing for a comprehensive understanding of such challenges. 
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Table 5: The prioritised challenges of the PV challenge landscape. 
PV challenge landscape 
PV system and PV challenge 
landscape matrix 
Opinions of SMEs 
Culture X X 
X 
Transparency X X 
X 
Insufficient resources X X 
X 
X 
Lack of PV centres - - 
Country-specific factors X X 
X 
Technical capacity - X 
Partnerships X X 
Public participation - - 
Under-reporting of ADRs - X 
X 
Quality of ADR reports - - 
Text-mining - - 
Passive vs. active systems - - 
Lack of data - - 
Lack of reporter feedback - - 
Clinical trials - - 
Causality analysis - - 
Signal detection - - 
Legislation - - 
 
3.4. Culture in pharmacovigilance 
Culture (also referred to as organisational culture) has been defined differently in many 
disciplines, remaining a controversial concept. Conflicting definitions of organisational culture 
exist, and there is constant debate over the most appropriate methods for defining and assessing 
culture (Bellot, 2011).  
3.4.1. Defining organisational culture in pharmacovigilance 
Following the introduction of culture in in Section 2.7, defining organisational culture is 
challenging, because of the different conceptions of culture (Bellot, 2011). In an attempt to 
define organisational culture from a general perspective, Naidoo & Martins (2014) define it as 
“an integrated pattern of human behaviour which is unique to a particular organisation and 
which originated as a result of the organisation’s survival process and interaction with its 
environment”. Culture is said to direct an organisation to goal attainment, and newly appointed 
employees must be taught what is regarded as the correct way of behaving (Naidoo & Martins, 
2014). Another perspective of organisational culture is that it is a social construct, the product 
of groups and not individuals. It is based on the experiences of groups and it is unique to each 
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organisation. It is also said to be malleable, adapting to the continual changes found in 
organisations, and it develops over time (Fortado & Fadil, 2012). 
The definition of organisational culture given by Naidoo & Martins (2014) clearly places the 
focus on the behaviour of the human participants of an organisation as the manifestation of an 
organisation’s culture. The PV system can be viewed as an organisation, consisting of different 
processes managed by people. Like any other organisation, groups with different multi-
disciplinary backgrounds and experiences take part in PV. Considering Naidoo & Martins' 
(2014) definition of organisational culture, the behaviour of the individuals in these groups 
creates the culture in the PV system.  
3.4.2. Factors that influence organisational culture 
Returning to the definition of organisational culture provided in the preceding section, Naidoo 
& Martins (2014) emphasise that the human behaviour that manifests an organisation’s culture 
is a response to an “organisation’s survival process and interaction with its environment”. 
There is agreement in literature that many factors influence organisational culture. Though 
these factors are sometimes unique to a specific industry or organisation, a succinct overview 
of some of the most salient factors are presented here to provide a general perspective on factors 
that may influence the organisational culture in a PV context. 
First, the business environment in which an organisation operates determines its culture. Within 
the market, the speed of change; the level of competitiveness; the value placed on technology; 
and the demands of the customer; influences the values; and norms and behaviours associated 
with the organisational culture (Alan, 2001). Second, leadership influences organisational 
culture (Al‐Alawi et al., 2007), especially in newly created organisations (Alan 2001). Leaders 
help establish organisational culture through their own ambitions and actions e.g. setting 
standards for behaviour by being an example to the people in the organisation. Third, 
management practices influence organisational culture. Alan (2001) believes the way an 
organisation is managed3 is likely to influence the beliefs, attitudes, and behaviours of the 
employees.  
Last, formal and informal socialisation processes play an important role in propagating the 
organisational culture (Alan, 2001; Al‐Alawi et al., 2007). Formal socialisation activities 
include induction training, hosted by the managers and leaders of an organisation. On the other 
                                                 
3 For the purpose of this discussion, leadership is distinguished from management based on its providing vision and long-term 
direction to an organisation (Alan, 2001).  
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hand, informal socialisation refers to individual activities within a group context. Al‐Alawi et 
al. (2007) discern a distinctive relationship between these socialisation processes and the people 
in an organisation, stating that it is essential to focus on people and their behaviours when 
attempting to assess or change organisational culture. Moreover, Al‐Alawi et al. (2007) include 
organisational structure, trust, information systems, and reward systems as critical success 
factors to organisational culture, with specific reference to the relationship between 
organisational culture and knowledge management.  
All of these factors influence PV in some way, making it increasingly challenging to maintain 
a culture of universal drug safety. Furthermore, and in addition to the known factors that 
influence organisational culture (discussed in Section 3.4.2), additional factors are expected to 
affect a safety culture in PV, due to the large scope of the PV system. Examples of such factors 
include hierarchical networks, location specific factors such as religion and culture and resource 
management practices. 
3.4.3. Singular versus plural organisational culture in pharmacovigilance 
Since the PV system has such a large scope, the question: “Is the culture found in PV of singular 
or plural origin?” should be asked. Sprouting from the discussion of Bellot (2011) who makes 
reference to singular– and plural organisational culture, it should be considered whether PV has 
a unique yet homogenous culture, or whether there is a presence of subcultures, also referred to 
as nested cultures or cultural pluralism.  
Cultural pluralism exists in many organisations, and it relates to different jobs, different levels 
of organisational status, and class (Alan, 2001). A PV system consists of several stages and 
different groups of role players are regarded as stakeholders within the various stages. The 
stakeholders that participate in PV, range from healthcare specialists to consumers and patients 
to administrative workers and these stakeholders display both individual and group behavioural 
phenomena. These behavioural aspects, reflecting the identity and purpose of the group, results 
in the formation of a variety of subcultures within the PV system. Subcultures also exist in PV 
systems that operate in different countries, where the country specific conditions influence the 
behaviours of the PV system’s participants in a particular geographic location.  
Considering that subcultures exist in PV, the question posed at the beginning of this sub-section 
is answered: PV culture is of plural origin since many subcultures exist in different stages of 
PV systems and in different locations where the PV system operates. Comprehensively 
understanding these subcultures is difficult due to the large scope of PV. However, since PV is 
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based on a safety culture, these subcultures do incorporate certain shared behavioural 
phenomena related to a safety culture.  
3.5. Partners in pharmacovigilance 
Many partners exist in PV, operating from both within and outside the PV system. For instance, 
partners that operate within PV include the UMC, national PV centres, and healthcare workers. 
Partners that operate outside PV include local governments or regulators and private investors. 
Both these partners provide different forms of expertise, training, political support, scientific 
infrastructure, and a capacity to accomplish comprehensive monitoring and investigations of 
the safety of medicines (Pan, 2014). It is essential that sustained collaboration exists between 
partners, because they supply resources to a resource-constrained system. As stated in Section 
2.8.3, this type of collaboration is not always achieved. Moreover, providing services and 
resources to the PV system may not necessarily result in a high-profit margin, hindering the 
establishment and maintenance of partnerships even further. 
3.5.1. Different partners in pharmacovigilance 
Partners in PV form an entire network of collaboration, with each partner (both operating 
internally and externally to PV) retaining unique expertise, resource capacities, responsibilities, 
and power to influence PV systems. In Table 6 the partners in PV are identified and briefly 
described. 
As described in literature, effective and efficient PV systems that are able to operate without 
disruptions can only exist with assistance and support from partners. An extensive network of 
partners exists, making it increasingly difficult to establish and manage partnerships with all 
the required role players to effectively deliver PV on a global scale. Moreover, the different 
interests and expectations of partners further burden PV systems. In a society with increasing 
demand for healthcare provision, it is becoming increasingly challenging for PV systems (as 
well as for many other healthcare systems) to meet the demands of its partners, and for the 
partners to meet the needs of the PV system. 
3.5.2. Comparing partners to stakeholders in pharmacovigilance 
Considering the term “stakeholders”, Mathur et al. (2007) describe them as “influencers” to 
certain situations. Alluding to partners in PV while still considering this description of 
stakeholders, one could say that “partners” and “stakeholders” are interchangeable terms, since 
partners also influence PV. The perspective of Mathur et al. (2007) on stakeholders is therefore 
applied to the partners in PV. 
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Partners have different levels of power and interest (Brugha & Varvasovszky, 2000). It is 
critical to the success of PV that these are defined. The levels of power and influence of various 
partners will differ from one country to another, however, a general estimation of both the level 
of power and the level of interest in PV can be determined, representing a so-called industry 
average. To portray the different levels of power and interest of partners in PV, a stakeholder 
analysis technique explained by Mathur et al. (2007) is used. Considering that partners and 
stakeholders share similar characteristics, the analysis is used to investigate partners in PV. The 
diagram in Figure 5 illustrates the different levels of power and interest of partners in PV. The 
numbers in the diagram represent the partners in PV, according to the numbering system used 
in Table 6 
Figure 5: Level of power versus level of interest of partners in PV (based on 
the previously mentioned technique described by Mathur et al. (2007)). 
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Table 6: The partners that operate in PV. 
Number Partners Brief description 
1 Healthcare workers Healthcare workers (general practitioners, nurses, pharmacists) are responsible for reporting ADRs and promoting PV.  
2 Governments Collaboration with governmental bodies are essential since they hold the power to authorise a PV system. 
3 Manufacturers of 
hardware and software 
Modern PV systems rely on software (e.g. used for text-mining and administrative purposes) and hardware (e.g. mobile phones used for 
patient engagement) to operate to its fullest potential. 
4 Non-governmental 
organisations (NGOs) 
NGOs in the private sector often provide essential support to PV systems, especially in the form of funding. Other NGOs also include the 
WHO and the UMC who provide frameworks and policies for use in PV systems. 
5 Non-profit organisations 
(NPOs) 
NPOs who already operate in a specific country can provide essential knowledge and expertise on a country that might help the planning 
process of a PV system. 
6 Community leaders Leaders in communities can be used to motivate the public to promote PV systems. 
7 
Pharmaceutical companies 
Pharmaceutical companies play a major role in PV because it is their product being monitored. They also play a major role during drug risk 
assessments. 
8 Media The media can be utilised to promote PV in a community. 
9 Public health systems 
(South Africa Infection 
Prevention and Control, 
Poison Control Centres, 
etc.) 
Public health systems that already operate in a certain area can provide important information to PV organisations on different 
considerations that are unique to a country e.g. people’s knowledge of healthcare systems. A collaboration with these health systems can be 
beneficial to PV, possibly offering some form of expertise and knowledge. 
10 Drug administration 
programmes (e.g. drug 
administration 
programmes during an 
epidemic) 
Like public health systems, drug administration programmes (e.g. malaria or HIV/AIDS vaccination programmes) can offer expertise and 
knowledge that might be beneficial to PV systems.  
Continued on next page… 
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…continued from previous page 
11 PV centres (e.g. WHO 
Programme for 
International Drug 
Monitoring, UMC) 
PV centres, especially those who form part of the high-level network described in Section 2.8.2, provide much needed frameworks, 
policies, models, assessment tools, and expertise used in PV systems. 
12 Academic institutions Academic institutions aid PV by conducting much needed research, aiming to improve the impact of PV. 
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As mentioned, the diagram in Figure 5 represents a generalised depiction of the levels of power 
and interest of partners in PV. A brief discussion of Figure 5, with the help of the key in Table 
7, follows. 
Table 7: Key used to explain the analysis of the partners in PV (Reproduced from Mathur et 
al. (2007)). 
 Involve Collaborate Monitor 
High support Optimal Missed opportunity Missed opportunity 
Could support 
(oppose) 
Risk Optimal Missed opportunity 
High threat 
(resistance) 
Risk Risk Risk 
Low support Resource waste Resource waste Optimal 
 
In Table 7 three actions are displayed: involve, collaborate, and monitor, representing the 
suggested actions for collaboration between partners, as described by Mathur et al. (2007). 
Depending on the level of interest, different scenarios (optimal, risk, missed opportunity, and 
resource waste) are possible. In an ideal world, the optimal state would give rise to effective 
and efficient collaborations between PV and its partners. In reality, however, the best PV 
organisations can do is to strive towards the optimal state.  
3.5.3. Synthesising partnerships in pharmacovigilance 
Focussing on the outliers shown in Figure 5, the authority of governmental bodies poses a risk 
to PV systems. Governments have control over all public-based systems and may therefore 
have the power to inhibit PV systems from being implemented in a country. Very closely related 
to the country-specific factors challenging PV systems (discussed in Section 2.8.2), 
governmental focus may be invested elsewhere. This risk of non-support must be considered 
by PV organisations, who must put effort into building a close collaboration with governmental 
bodies.  
Pharmaceutical companies and PV centres are also important partners in PV. First, 
pharmaceutical companies are close collaborators in PV, since it is mostly their product 
monitored by PV systems. Active engagement is needed to ensure that these companies are 
consulted during causality– and risk assessments, because they can provide the necessary 
scientific infrastructure and resources. Second, PV centres such as the WHO Programme for 
International Drug Monitoring and the UMC are obvious partners and have major influence in 
PV, providing essential support in the form of policies, frameworks and models used by PV 
systems.  
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In the Monitor quadrant of the diagram shown in Figure 5, an outlier to consider is the media. 
Pivoting between a risk or a missed opportunity, the media is an effective tool to use during 
public participation (discussed in Section 2.8.3.1). Having the ability to convey important 
information, such as news on ADR reporting (discussed in Section 2.9.2) or providing feedback 
to ADR reporters (discussed in Section 2.9.6), the media can deliver messages to a wide range 
of consumers and patients. On the other side of the spectrum, the media also poses a risk to PV, 
for example, the PV system could suffer reputational damage if the media were to only report 
its failures. It is essential that PV systems collaborate with the media to enable balanced 
reporting, thereby increasing the public’s awareness of PV and their willingness to participate 
in the system as active partners.  
3.6. Transparency in pharmacovigilance 
As mentioned previously, efficient and effective operation of the PV system relies on the 
collaboration of several partners. Collaboration on this scale is challenging to achieve and is 
often hindered by poor communication (Jusot 2017). Communication is one of the most 
important aspects of collaboration in any industry, and serves as the foundation to basic 
business. Transparency is a key element of communication (Jusot 2017). 
Transparency is defined as “the level of availability and accessibility of market information to 
its participants” (Granados et al., 2010). Transparency means that all relevant information is 
made available to the relevant stakeholders. In PV, and in healthcare in general, transparency 
is crucial because the information being shared either directly or indirectly relates to patient– 
and public health. There are many forms of failed transparency between stakeholders in PV, 
some of which are discussed in Table 8. The different forms of failed transparency in PV shown 
in Table 8 does not constitute an exhaustive list, but the examples provided do emphasise the 
need for transparency amongst the stakeholders in PV. 
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Table 8: Different forms of transparency between stakeholders in PV. 
Transparency between stakeholders Description 
HCWs and HCWs 
HCWs may fail to effectively communicate about PV-
related tasks, such as capturing ADR reports on a computer, 
which might lead to lost ADR reports. 
PV centres and HCWs 
In some cases, HCWs fail to provide the right information 
regarding PV-related tasks (e.g. ADR reports) to PV centres 
who are requesting specific information, leading to wasted 
time for both entities since the entire process must be 
revisited. 
PV centres and governments 
As mentioned in Section 3.5.3, governments are major role-
players in PV. The lack of transparency between PV centres 
and governments may lead to the ineffective and inefficient 
operation of a country’s PV system.  
PV centres and pharmaceutical companies 
The lack of transparency between PV centres who are public 
entities and pharmaceutical companies who are private 
entities may lead to failed follow-ups of ADR reports. For 
example, if the former does not make ADR information 
available to the latter, the latter may not be able to conduct 
proper assessments in order to address possible ADRs 
associated with its product. 
 
3.7. Insufficient resources in pharmacovigilance 
In order to understand the challenge posed by insufficient resources in PV, one should first 
consider the differentiation between the types of resources referred to when making reference 
to insufficient resources in PV.  
Different resources exist, ranging from tangible– to intangible resources. Tangible resources 
comprise of physical assets such as machinery, buildings, and equipment; whereas intangible 
resources comprise everything else that has no physical presence, including trademarks, 
software programs, and business processes (Jurevicius, 2013a). Resource management systems 
(RMSs) are widely used to help organisations manage these two types of resources more 
effectively and efficiently. Furthermore, Li et al. (2017) describe that the modern era of 
business operates under high resource-consumption rates, as well as high market-uncertainty. 
According to Li et al. (2017), RMSs perform two core functions namely resource acquisition 
and resource accumulation. The latter refers to the development of resources from internal 
sources (e.g. expertise and experience), allowing for the expansion of an organisation’s internal 
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resources. Resource accumulation is necessary since the external market cannot provide all the 
required resources to an organisation (Li et al. 2017). Resource acquisition is concerned with 
procuring resources from the external market. 
Imperative for active management of resource portfolios and the adoption of strategic flexibility 
(Li et al., 2017), an effective and efficient RMS, that identifies resource acquisition and 
accumulation is essential (Li et al., 2017). 
3.7.1. Resource accumulation and resource acquisition in pharmacovigilance 
Taking into consideration the market conditions described by Li et al. (2017), PV operates in 
an environment of high resource-consumption and high market-uncertainty due to an increasing 
demand for healthcare. To meet the increasing demand for healthcare and be strategically 
flexible, the PV system requires active management of its resource portfolios, including both 
resource accumulation and resource acquisition activities.  
Resource acquisition plays a vital role in PV. PV systems rely on external partners to provide 
resources such as computer hardware and software, and funding. To ensure a timely supply of 
such resources, PV organisations and their partners must collaborate and communicate (also 
associated with the need for improved transparency as indicated in Section 3.6) and ensure that 
both parties’ needs are met. 
The PV system is also dependent on effectively harnessing internal resources, such as the 
expertise that specialists from different backgrounds can offer in formulating business models, 
policies, frameworks, and internal processes, through the process of resource accumulation. 
Resource accumulation is especially valuable as it allows for differentiated resources that have 
been developed specifically to accommodate the unique features of the PV system. 
3.8. Country-specific factors in pharmacovigilance 
In 2013, a study was conducted by numerous healthcare researchers (Tomoaia-Cotisel et al., 
2013) aimed at advancing both internal– and external validity of healthcare research by 
delivering their opinions on the importance of reporting contextual factors in healthcare 
research. It was stated that contextual factors are rarely reported in healthcare research, leading 
to failed attempts in replicating such research. The study also indicated that efforts to translate 
research into practice fail because contextual factors that are important for understanding and 
knowledgably synthesising findings across studies are not known.  
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Several factors, defined differently in various disciplines, affect PV. Experts from disciplines 
such as sociology and social anthropology are increasingly being included in the development 
and planning of not only PV systems, but many other healthcare initiatives such as vaccination 
administration programmes.  
3.8.1. Distinguishing between factors that might affect pharmacovigilance 
Sociocultural factors and contextual or systemic factors are closely linked to the geographical 
location and are considered in this section. Covering a wide range of factors that might impact 
PV systems, sociocultural factors distinguish between social factors such as attitudes, ethnic 
identities, linguistic differentiations, and power structures, as well as cultural factors such as 
cross-cultural differences, cultural identity, and religious beliefs (Buse et al. 2005).  
Contextual factors, also referred to as systemic factors refer to political, economic and social 
factors, both national and international levels. Contextual factors are categorised, according to 
Buse et al. (2005), as follows:  
 Situational factors: Transient or impermanent conditions such as drought and war. 
 Structural factors: The relatively unchanging elements of society such as the political 
system, health expenditure, gross domestic product (GDP) per capita, and the degree to 
which the public can participate in decision-making etc. 
 Cultural factors: Like sociocultural factors, cultural factors refer to aspects such as 
power hierarchies, linguistic differences, and religious beliefs. 
 International or exogenous factors: Closely related to partnerships, collaborations are 
often needed to aid in the implementation and operation of systems.  
There is an overlap between sociocultural factors and some of the categories of contextual 
factors i.e. contextual and sociocultural studies identify and assess similar influential factors. 
Identifying and assessing sociocultural and contextual, or systemic factors, is a complex 
process, requiring multi-disciplinary groups including sociologists, anthropologists, and 
governmental agencies (Buse et al. 2005). 
3.8.2. Example of the effect of country-specific factors on pharmacovigilance 
As stated earlier, country-specific factors significantly affect the operation of PV systems. A 
significant effect one of the country-specific factors identified in the previous section, cultural 
factors, is reported in PV (Varallo et al. 2014). Varallo et al. (2014) reports that there are many 
causes of ADR under-reporting, including causes linked to cultural factors. It is often reported 
that people who experience ADRs do not report it to the necessary authorities since they believe 
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it can either be addressed by a doctor, or they feel that they do not have the authority to reach 
out to local healthcare facilities. It is clear that this country specific factor is a stumbling block 
in PV, since it reduces the number of ADR reports that are of utmost importance to PV.  
Although this is only one example of the potential effects country-specific factors could have 
on PV systems, it is regarded as one of the most significant challenges in PV (Varallo et al. 
2014). This highlights the need to address the effect country-specific factors have on PV 
systems. 
3.9. Technical capacity 
Technical capacity refers to the ability of an organisation or person conducting a specific action 
that is meant to achieve some outcome. This is closely related to the KAP model which is 
described in further detail in Section 3.10.2. Often categorised as an insufficient resource, 
Mehta (2017) is of the opinion that it deserves to be independently categorised, because it is 
such an influential aspect that is lacking in many countries, especially developing countries. 
Many factors contribute to the ability of an organisation or individual to exercise a specific 
action, which includes past experience, personal and personnel skills, ability to utilise 
resources, and education or training.  
The only way in which experience, personal skills, and the ability to utilise resources can be 
achieved is by both theoretical– and practical training. Theoretical training closely relates to 
academic education and plays an essential role in developing foundations and thinking patterns 
in individuals who enter practice (Mehta 2017). Practical training is often significantly more 
difficult to obtain since training often conflicts with working schedules. However, Mehta 
(2017) is of the opinion that it is of importance that practical training is provided to those who 
fail to achieve the desired objectives. Practical training is in many cases considered more critical 
than theoretical training (Mehta 2017). Reasons for this may include that a portion of the 
workforce may not attended an academic institution. 
The lack of technical training negatively affect PV in several ways, which include (Mehta 
2017): 
 PV personnel who lack the necessary technical capacity may take longer to complete 
PV-related tasks (e.g. capturing ADR reports on a computer). 
 There is also poor human resource-efficiency because the responsibility of PV-related 
tasks is given to many employees who might not have the necessary skills and 
knowledge.  
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Improving technical capacity is not as simple as one might think (Mehta 2017). Not even 
considering the cost implications of theoretical training provided by academic education, 
practical training is often also very difficult to provide. Training sessions in the form of 
workshops and brainstorming sessions require resources that are often not available. One of 
these scarce resources are access to individuals who have the desired technical capacities and 
are able to convey their skills and experiences. 
Regardless of the challenges facing technical capacity, there are several studies that conclude 
that the lack of technical capacity is a major obstacle in PV, and must be addressed on a large 
scale (Schramm et al., 2017; Abubakar, Chedi, et al., 2015; Abubakar & Haque 2016; 
Abubakar, Ismail, et al., 2015; Abubakar, Simbak, et al., 2015; Mehta 2017). 
3.10. ADR under-reporting in pharmacovigilance 
Two prominent models that explain the causes of under-reporting of ADRs are widely cited in 
literature, namely Inman’s model of the seven deadly sins of under-reporting (Varallo et al., 
2014) and the KAP (knowledge, attitude and practice) model of under-reporting (Herdeiro et 
al., 2006). Taken together, these two models provide a comprehensive overview of the lead 
causes of under-reporting of ADRs (Herdeiro et al., 2006). 
3.10.1. Inman’s seven deadly sins of under-reporting 
In the 1990s, Dr William Inman conducted research on PV with specific reference to the causes 
of under-reporting of ADRs (Varallo et al., 2014). The findings of this study, known as Inman’s 
seven deadly sins of under-reporting, are widely cited in literature (Varallo et al., 2014; Hazell 
& Shakir, 2006; Irujo et al., 2007; Rodrigues & Khan, 2011). More recent studies have 
confirmed the findings, specifically highlighting the ignorance, insecurity and indifference 
aspects of the model. (Varallo et al., 2014; Rodrigues & Khan, 2011) 
The so-called sins of Inman’s model are (Varallo et al., 2014): 
 Fear: Of litigation; 
 Indifference: About contributing to the general advancement of knowledge; 
 Ambition: To collect and publish a personal case series; 
 Guilt: At having caused an adverse effect; 
 Complacency: The mistaken belief that only safe drugs are licensed; 
 Ignorance: Of the need for reporting; and 
 Diffidence: About reporting a mere suspicion. 
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A number of subsequent studies have validated Inman’s model. In 2014, a study was conducted 
amongst hospitals and physicians in Spain (Varallo et al., 2014). The objective of the study was 
to identify the main causes of under-reporting ADRs by health professionals in Spain. It was 
found that the main causes of under-reporting was ignorance, insecurity, and indifference, all 
associated with Inman’s model (Varallo et al., 2014). Also, Rodrigues & Khan (2011) 
conducted research with the intention of identifying the cause of under-reporting amongst 
surgeons and surgical wards in an unknown context. The findings of the research also correlated 
with Inman’s model. Rodrigues & Khan (2011), Varallo et al. (2014) and Hazell & Shakir 
(2006) are all of opinion that Inman’s model is and will be applicable to future PV initiatives. 
Many of these so-called sins such as indifference, ambition, complacency, and diffidence 
strongly relate to the culture in PV (discussed in Section 3.4) and research in eliminating these 
sins is believed to improve the overall culture within PV. 
3.10.2. KAP model 
The first aspect of the KAP model is knowledge, closely related to education (Herdeiro et al., 
2006). The shortcomings of PV in the undergraduate and postgraduate syllabus of medical 
students is regularly referred to in literature (Schramm et al., 2017; Abubakar, Chedi, et al., 
2015; Abubakar & Haque 2016; Abubakar, Ismail, et al., 2015; Abubakar, Simbak, et al., 
2015). These shortcomings are also not unique to specific countries. Studies in Nigeria 
(Abubakar, Chedi, et al., 2015), Malaysia (Abubakar, Ismail, et al., 2015), Portugal (Herdeiro 
et al., 2006), Turkey (Toklu & Uysal, 2008), India (KC et al., 2013), and China (Su et al., 2010) 
all discuss the need for medical students’ curriculum to either include or improve PV education. 
The aforementioned countries’ specific studies also highlight the lack of sufficient knowledge 
on the correct PV practices in practicing healthcare professionals. Toklu & Uysal (2008) discuss 
the need for improved PV knowledge amongst community pharmacists in Turkey, Passier et 
al. (2009) the need for improved PV knowledge amongst general practitioners in the 
Netherlands, and Herdeiro et al. (2006) the need for improved PV knowledge amongst 
pharmacists in Portugal. Thorough knowledge of PV is a challenge, hurdling several PV 
initiatives to be completely successful in many countries. 
Secondly, the KAP model refers to the general attitude of healthcare professionals towards PV. 
This element of the KAP model is closely related to the indifference and ignorance aspects of 
Inman’s model and relates strongly to the culture aspects of the PV challenge landscape. Some 
examples of the role of attitude in under-reporting are given in a recent study by Shamim et al. 
(2016) who seek to build an understanding of the general attitude of physicians, pharmacists, 
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and nurses towards PV in Pakistan. It was found that a large portion of these healthcare 
professionals are indifferent towards PV, with only 14.3% being aware that there was an ADR 
reporting organisation in Pakistan. Similarly, a study within a Spanish context also discusses 
the poor attitude of healthcare professionals towards PV (Varallo et al., 2014). The indifference 
found in the Spanish context is associated with the lack of interest of healthcare professionals 
to register for ADR reporting and a lack of time for the many activities in the clinical routine.  
Lastly, the lack of sufficient practice (relating to first-hand experience within PV, as well as 
skills and knowledge needed within PV) in PV is also a challenge faced in the PV industry. 
Closely associated with training, Varallo et al. (2014) is of the opinion that the lack of sufficient 
practice has recently surfaced and is nowadays referred to as the eighth sin of Inman’s model. 
The lack of practice in PV is regularly referred to in literature, including Aronson (2012) 
discussing the need for increased, real-world PV practice amongst British healthcare 
professionals and Beckmann et al. (2014) who similarly emphasises this need in a general 
context. 
3.10.3. Synthesising Inman’s model and the KAP model in pharmacovigilance 
Under-reporting of ADRs is a burden to PV systems in many countries, limiting the extent to 
which action can be taken to improve medicines’ safety. There is a need for the culture 
surrounding ADR reporting (relating back to the lack of safety culture in PV as discussed in 
Sections 2.7 and 3.4) to improve to a state where healthcare professionals, patients, and the 
public feel unthreatened and assured to report ADRs (Jusot, 2017). It is important to consider 
that PV systems in different countries are unique, and might therefore require a comprehensive 
investigation to understand the attributes that affect ADR reporting (e.g. understanding how 
country-specific factors, described in Section 3.8, might affect ADR reporting). 
3.11. Chapter 3 conclusion 
The challenges described in this section are culture, transparency, insufficient resources, 
country-specific factors, partnerships, technical capacity and under-reporting of ADRs. These 
are the challenges that are identified as challenges that should be prioritised. Such challenges 
differ in nature and bring forth numerous additional challenges to PV. Yet, some of these 
challenges are inter-related (e.g. under-reporting of ADRs are in certain aspects related to the 
culture of PV), meaning that addressing one may also affect another. Subsequently, the 
challenges are further contextualised to facilitate the process of understanding and evaluating 
how these challenges could potentially be addressed through the use of technology. 
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Chapter 4: Translating the pharmacovigilance challenge 
landscape 
___________________________________________________________________________ 
This chapter4 discusses the translation process of the prioritised PV challenge landscape from 
a strategic level to an operational level, i.e. identifying the root causes. An investigation into 
different translation methodologies is done to identify methods which would be appropriate to 
use in this research. One of these methods is then implemented in the PV challenge landscape, 
translating the prioritised PV challenge landscape. 
4.1. Business levels in an organisation 
In an organisation, different levels exist within the structures of the organisation, referred to as 
strategic–, tactical–, and operational levels (Boundless Management 2016). These levels are the 
foundation on which most organisations are developed, conduct planning, communicate and 
make decisions. 
4.1.1. Strategic level 
The strategic level is where an organisation develops and plans its strategy for the long-term 
i.e. examining where the organisation is now, deciding where it should go and planning how it 
will get there. The strategic level considers both the tactical– and operational level, taking into 
consideration the requirements of these levels to support the organisation-wide strategy. 
Strategic decisions are usually made by upper-management and directors, but managers on the 
tactical– and operational levels are consulted to give meaningful input on how they believe the 
organisation can achieve its strategy. 
4.1.2. Tactical level 
Oscillating between the strategic– and operational levels, the tactical level focusses on the 
actual steps that are needed to achieve the strategy of the organisation. Tending to be more 
short-term focussed (usually one year or less), planning on a tactical level considers the current 
business activities across the entire organisation, and determines the requirements that are 
needed to achieve the organisations’ strategy. 
                                                 
4 A significant portion of the contents of this chapter has been published in an article that was included in the 
proceedings of the International Association for the Management of Technology’s 2018 annual conference 
(IAMOT2018). A copy of this article is included in Section C.1 in Appendix C. 
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4.1.3. Operational level 
At the operational level, day-to-day activities are the focal point. These refer to the actual output 
of the organisation such as number of products manufactured daily, quality standards of these 
products, and worker schedule adherence. Planning on an operational level links strategic goals 
and objectives to that of the tactical level. The idea behind operational control is to streamline 
a process to minimise costs and increase efficiency. 
4.2. Translating strategy into operations 
Executives and managers who have not moved through the ranks of operational management 
and as a consequence are not familiar with operations, frequently fail to consider the influence 
of operations on an organisation’s overall strategy (Hammer, 2004). According to both Hammer 
(2004) and Croxton et al. (2001), being aware of both the opportunities posed and the 
limitations associated with various operational strategies will allow these previously mentioned 
executives and managers to add to their strategic arsenal to become influential market players. 
Companies such as Dell and Toyota have shown that operational innovation offers many 
benefits, and Hammer (2004) is of the opinion that many other companies can learn a great deal 
from these companies who have been investing more towards operational management. 
Provided that more effort needs to be shifted towards processes and activities related to 
operational management (Croxton et al., 2001), there is a need to define and investigate 
strategic level processes and activities at an operational level. Thus, strategies need to be 
translated to an operational level to understand how these influence the different functions 
within an organisation (Naghibi & Baban, 2011). Considering this within the PV context, to 
propose actionable solutions to the strategic level challenges that have been identified in the PV 
landscape, these must be translated to an operational level. Formalising the operational level 
challenges in this manner will enable knowledge sharing and debate about these in literature 
and will enable researchers and practitioners to differentiate between the effects that these 
challenges have on the various functions in PV. 
Hewitt-Taylor (2012) argue that, for challenges to be described on an operational level, the root 
causes must be identified. It is argued that it is often more feasible to address these root causes, 
rather than to address the challenges on a strategic level, because the root causes will represent 
tangible problems that can be more easily addressed. 
Therefore, the rationale behind the proposition that the PV challenge landscape must be 
translated to a lower level of abstraction is: (i) such a translation will make it clear how strategic 
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challenges influence the different functions in an organisation, or in the case of PV, the stages 
of which PV systems are composed; and (ii) identifying the root causes of strategic challenges 
will make it increasingly easier to address such challenges at an operational level. 
Such a translation, however, is not always simple, and according to Chmutova (2015), 
businesses often struggle with this process, given that they fail to leverage existing 
methodologies in guiding the entire translation process. Some of the methodologies that have 
been developed for this translation process are considered in the subsequent section. 
4.3. Translation methodology assessment 
To identify the different methodologies that can be used to translate the PV challenge landscape, 
a literature review was conducted in two databases, namely Google Scholar and Scopus, as well 
as grey literature. Using the search terms “root cause analysis”, “translation methodologies 
and approaches”, and “problem solving”, the literature review uncovered some of the more 
widely used methodologies, namely root-cause analyses (RCAs), the 5Why method and 
fishbone diagrams, and problem tree analyses. Additionally, the 5W2H method, key 
performance indicators (KPIs), and value chain analyses, methods that are commonly used for 
analysing and defining systems in the Industrial Engineering discipline, are added to the list of 
methodologies that are considered for application.  
4.3.1. Root cause analysis 
According to Jones & Despotou (2016), RCA is by far the most widely used analysis tool for 
investigating problems, especially in the healthcare environment. RCAs focus on the root cause 
of problems, while avoiding emphasis on any mistakes made by specific individuals. Ideally, a 
team-based approach, where teams are composed of individuals from different backgrounds 
and contexts, is the best approach to conducting a RCA, as this will ensure that a range of root 
causes to the same problem are identified.  
There are different techniques that can be used to conduct a RCA, the most popular being the 
5Why method and fishbone diagrams. 
4.3.1.1. 5Why method and fishbone diagrams 
The 5Why method was developed by Sakichi Toyoda, one of the fathers of the establishment 
of the car company Toyota in the late 1940s (Warner, 2015). Adopted by the global market in 
the 1970s, the 5Why method became one of the most renowned methodologies able to identify 
the root causes of specific problems. 
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In essence, this form of RCA is completed by asking the why question, on average, five times 
(Warner, 2015), which will lead to the identification of the root cause of a given problem. 
Additionally, in order to capture the thinking processes during this exercise, a fishbone diagram 
can be developed, which will provide a visual representation of the possible root causes to a 
given problem (Pojasek, 2000; Jones & Despotou, 2016).  
The 5Why method, in combination with fishbone diagrams, offers several benefits to its users, 
including (Pojasek, 2000): 
 It is a very quick and simple method to use, provided that the user has some background 
and understanding of the appropriate strategy to implement the method. 
 The nature of the why question is highly relatable, since why is so often asked in real-
life. 
 Fishbone diagrams serve as visual representations to the 5Why method, providing a 
holistic view of the effects that stem from a certain root cause. 
 The process initiates a thinking process in the individuals that make up the team, 
allowing them to come up with an answer more quickly. 
 The one right answer syndrome is eliminated since the method is a team-based approach 
i.e. a broad range of answers from different perspectives or departments within the 
organisation are given. 
Regardless of the benefits offered by the 5Why method and fishbone diagrams, there are also 
some challenges associated with it, namely (Pojasek, 2000): 
 Facilitation is needed to guide the process followed during the execution of this method 
in order to ensure that the participants understand how the method works. 
 It is not always straightforward to answer the simple question of why, since many 
internal and external factors may affect the answer. 
 When used incorrectly, these methods can lead to finger pointing i.e. one individual or 
group can be blamed for a mistake. 
A number of studies have endorsed the efficacy of the 5Why method in combination with 
fishbone diagrams as a mechanism for translating problems that have been defined on a strategic 
level to a more tactical or operational level where some of the root causes may exist (Pojasek, 
2000; Bulsuk, 2009; Sonkiya, 2014; Brundage et al., 2017; Mpanza, 2016). 
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4.3.2. Problem tree analysis 
Problem tree analyses (PTAs) visually represent problems, their causes and the effects in the 
form of a tree, where the problem is shown as the tree trunk, the causes as the roots, and the 
effect as the branches (Hewitt-Taylor, 2012). These types of analyses are comprehensive and 
make clear differentiation between the causes and the effects of a problem.  
PTAs offer several benefits, which include (Hewitt-Taylor, 2012): 
 Clearly distinguishing between the causes and the effects of problems. 
 Providing a holistic overview of the different effects of a specific problem. 
There are also some limitations to using PTAs, which include (Hewitt-Taylor, 2012): 
 PTAs can become difficult to manage if there are too many links between causes and 
effects. 
 The PTA development process can become tedious, given that both causes and effects 
must be identified. 
Regardless of these limitations, PTAs offer businesses the opportunity to distinguish between 
the causes and the effects of a problem, leading to the identification of different links between 
effects and likely root causes.  
4.3.3. 5W2H method 
The 5W2H method is a highly efficient and simple management tool (Veyrat, 2016). It is 
constructed of well-defined stages, serving as structures to action planning. The name of this 
method originates from the questions that are asked. These questions are: “What will be done?”, 
“Why will this be done?”, “Where will it be done?”, “When will it be done?”, “Who will do it?”, 
“How will this be done?” and “How much will it cost?” Given that strategies constantly change 
within the competitive market, strategies must continuously be adjusted. As a result new 
strategic challenges come to light. According to Veyrat (2016), going through the process of 
the 5W2H method will allow organisations to define their strategies, and determine how these 
strategic challenges can be addressed. 
The 5W2H method has a variety of applications, including quality planning, purchases 
planning, human resource planning, and risk planning (Bau et al., 2012). The simplicity of this 
method allows it to be used in many industries and applications such as those mentioned earlier. 
The 5W2H method offers many benefits, including (Bau et al., 2012; Veyrat, 2016): 
 It is a simple method to implement since straightforward questions are asked. 
Stellenbosch University  https://scholar.sun.ac.za
54 | P a g e  
 
 It enables businesses to comprehensively define the problem at hand, which in turn 
make it simpler to identify areas where improvements are necessary. 
 The simple questions enable individuals from different backgrounds and experiences to 
provide their input. 
 The simplicity of the method allows it to be used in many different industries. 
As with any methodology, there are also some limitations that might prevent businesses from 
fully utilising the 5W2H method, which includes: 
 The method is most effective with the help of experienced facilitation.  
 It is not always easy to answer the questions asked by the method, and there may be 
conflicting views on the correct answer. 
There are arguments for and against this method, which must be weighed against one another. 
Veyrat (2016) is of the opinion that, when used correctly, the 5W2H method can effectively 
help businesses translate their strategic goals. 
4.3.4. Key performance indicators (KPIs) 
Most businesses make use of KPIs to translate their strategy into quantifiable and measurable 
objectives (Baroudi, 2014). For example, a manufacturing business’ strategy may be to increase 
overall productivity. Measuring a business’ overall productivity is most likely difficult or 
infeasible, therefore, operational level KPIs such as the total hours of machine downtime per 
day, or the total number of defective raw materials per month are used instead. These 
operational KPIs can be measured in a direct and standardised manner and enable businesses 
to determine whether productivity has increased or decreased.  
Different types of KPIs exist such as absolute numbers, indexes, percentages, rankings, ratings, 
and ratios (Baroudi, 2014), these are regularly classified as either output KPIs or driver KPIs. 
Output KPIs measure the output of past activity e.g. the total sales in the last three months. In 
contrast, driver KPIs measure the activities that are influential to the outcome e.g. customer and 
employee satisfaction. Driver KPIs are often said to be more powerful than output KPIs, 
because these allow managers and individuals to adjust their behaviours to achieve the desired 
outcome (Eckerson, 2009).  
Different levels of authority in a business use KPIs for different purposes, for example: 
executives use KPIs to define and communicate strategic goals to their managers and other 
employees; managers use KPIs to measure both individual and team performance, as well as 
guide these individuals and teams to success; and employees use KPIs to focus on what is 
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required from them to achieve a specific outcome (Eckerson, 2009). In all applications, 
however, KPIs serve to guide businesses to achieve their overall strategic goals. 
Using KPIs offer certain benefits, including (Baroudi, 2014): 
 Increasing individual and team focus. 
 Encouraging departments to meet their goals. 
 Serving as a link between individual and departmental goals. 
 Allowing executives, managers, and employees to identify possible areas for 
improvement. 
 Defining and communicating both the expected and achieved performance levels. 
Some potential drawbacks associated with the use of KPIs include (Baroudi, 2014): 
 Unclear definitions of KPIs can negatively affect other KPIs that are crucial to the 
measurement of the success of a business. 
 Employees will sometimes focus more on what is expected of them, rather than focus 
on how these expectations will be met, leading to possible health and safety risks. 
Developing KPIs is often a tedious and difficult process. To minimise the risk, it is essential 
that businesses consult the relevant stakeholders as they may have valuable inputs that have not 
been considered before (Baroudi, 2014).  
4.3.5. Value chain analysis 
A value chain analysis is defined as “a process where a firm identifies its primary and support 
activities that add value to its final product [or service] and then analyse these activities to 
reduce costs or increase differentiation” (Jurevicius, 2013b). It enables businesses to identify 
underperforming business processes and activities, allowing them to make necessary 
adjustments. It also highlights influential factors (environmental factors, participating actors 
etc.) that affect a value chain, delivering a comprehensive image of how a value chain and its 
components interact. In Figure 6, an example of a value chain analysis framework is shown. 
Value chain analyses offer several benefits, which include (Simister, 2011): 
 It is a flexible strategic tool and can be adapted towards many different industries. 
 It focusses on the activities needed to deliver the value proposition, highlighting the 
processes and activities that contribute to satisfying customer demand.  
 It is a well-known strategic tool and has delivered insight into many industries as to how 
and where they need to improve. 
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It is also important to be aware of the limitations to using value chain analyses, which include 
(Simister, 2011): 
 Although the value chain analysis is flexible, it is not a plug and play instrument, 
therefore necessary changes must be made to adapt the analysis to a specific industry.  
 The fact that the method was originally designed for use in the manufacturing industry 
may deter other industries from using it. 
 The scale and scope of a value chain analysis can be intimidating since it considers a 
value chain in its entirety. 
 Though many people are familiar with the concept of a value chain analysis, few are 
experts, and facilitation is therefore often needed to guide the development of such an 
analysis. 
A value chain analysis is a comprehensive strategic tool that offers many benefits, and when 
implemented with consideration and management of the limitations of the approach, it can assist 
businesses in making necessary improvements across their value chains to deliver a better value 
proposition. 
4.4. Translation methodology selection 
To select the most appropriate translation methodology for application to the PV system, the 
methodologies are compared to one another by evaluating their capability of meeting certain 
qualification criteria. A set of indicators that was developed by the World Health Organisation, 
Figure 6: Example of a value chain analysis (Source: Franz et al., (2015)). 
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and used to evaluate the inputs, outputs, processes, and impacts of PV systems (World Health 
Organization, 2014) was used as starting point when defining these qualifying criteria: 
 Stakeholder identification: Does the methodology allow the user to identify the 
stakeholders that participate in the PV system? 
 Distinguishing: Does the methodology distinguish between the different stages in the 
PV system? 
 Flexibility: Does the methodology adapt well to different input data and structures? 
 Relationship identification: Does the methodology indicate the effect that different 
elements may have on another? 
 Reproducible: Can the methodology be reproduced by anyone, regardless of their 
background? 
 Measurable outcome: Does the methodology deliver measurable outcomes? 
The sought-after translation process consists of two stages, which, when used in combination, 
will contribute to the translation of the PV challenge landscape to a lower level of abstraction, 
where tangible problems can be defined and addressed. These stages are: 
1) Defining the influence of the PV challenge landscape between the different functions, 
or stages, of a PV system; and 
2) Identifying the root causes of the disseminated PV challenges within a PV system. 
The comparison of the methodologies according to the set of qualifying criteria is shown in 
Table 9. Based on this analysis, the following two methodologies are selected to address the 
two stages of the desired translation process: 1) value chain analysis, and 2) the 5Why method 
and fishbone diagrams. A defining feature of both methodologies is the fact that they are 
flexible, making them suitable candidate methodologies for this application. The value chain 
analysis offers a distinct advantage in the fact that it can distinguish between the functions of a 
value stream, making it a suitable methodology for the first stage of the translation process. A 
specific benefit of the 5Why method, in combination with fishbone diagrams, is that it can assist 
in identifying possible relationships between different problems, and can also be relatively 
easily reproduced by anyone. Moreover, it was originally designed for the specific purpose of 
identifying root causes of problems. To provide even further justification, some examples of 
the success achieved via the implementation of these methodologies are provided in the 
following two subsections. 
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Table 9: Comparing the different translation methodologies. 
Translation 
methodology 
Stakeholder 
identification 
Distingui
shing 
Flexibility 
Relationship 
identification 
Reproducible 
Measurable 
outcomes 
5Why and 
Fishbone 
diagrams 
X - X X X - 
Problem Tree 
Analysis 
X - X X - - 
5W2H X - X - X - 
KPI - - - - - X 
Value chain 
analysis 
X X X X - - 
 
4.4.1. The value chain analysis 
A recent report by Franz et al. (2015) discusses a value chain analysis conducted in the energy 
market system in sub-Saharan African countries. The framework (like that of Figure 6) that was 
used consisted of a value chain analysis, of which the energy market chain served as the 
foundation. The influence of additional inputs, services, finances and enabling environmental 
factors such as socio-cultural and political factors, were differentiated for the various functions 
of the energy market system. This allowed the developers to comprehensively understand the 
operation of the current energy market system in sub-Saharan African countries, which in turn 
allowed them to identify improvement initiatives (Franz et al., 2015). Similarly, the United 
Nations also implemented a value chain analysis, which focussed on the living conditions of 
disabled persons. Several influential factors such as disabled rights, policies, and financial 
structures were identified, indicating problem areas where improvements or changes were 
necessary (United Nations, 2012).  
The prospects of leveraging the value chain analysis for translating challenges in the PV system 
that have been defined at a strategic level to an operational level in a specific context is evident 
in these two cases. Moreover, with reference to the qualifying criteria in Table 9, value chain 
analyses enables the following: the user to differentiate between the stakeholders in PV 
(“stakeholder identification”); allows the user to distinguish between the different functions of 
a value chain or in this case a PV system (“distinguishing”); can be adapted towards the PV 
context (“flexibility”); and enables the user to identify any possible relationships that might be 
shared between the different influences in a value chain (“relationship identification”). The 
methodology therefore satisfies four of the six qualifying criteria defined in Section 4.4. This 
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justifies the use of a value chain analysis for the first stage of the translation process i.e. defining 
the influence of the PV challenge landscape on the functions in a PV system. 
4.4.2. The 5Why method and fishbone diagrams 
There are many reported cases where the 5Why method and fishbone diagrams have enabled 
businesses to follow a systematic approach in identifying the root causes of challenges they are 
experiencing. Myszewski (2013) describes a case where an unknown company regularly 
produced a certain electric cable that did not conform to certain quality standards. To identify 
the root cause of this phenomenon, the 5Why method was used, which helped the company 
identify four possible root causes. Additionally, a fishbone diagram was also used to graphically 
present the thinking process of the 5Why method, which enabled the company to revisit 
previously discussed possible root causes. Another case of the successful application of the 
5Why method and fishbone diagrams is described by Jones & Despotou (2016). Several 
hospitals based in the United Kingdom reported numerous unintended consequences from the 
use of electronic health records. Although these consequences are not named in the article, 
Jones & Despotou (2016) described that through a combination of the 5Why method and 
fishbone diagrams, investigators were able to identify the root causes of these consequences 
and were subsequently able to address the problems. 
These two cases represent only a small portion of the many reported cases of the success 
achieved by the 5Why method and fishbone diagrams, yet they substantiate the rationale that 
these methodologies are suitable to support the translation of the PV challenge landscape to an 
operational level. Providing even further justification, and with reference to the qualifying 
criteria depicted in Table 9, the 5Why method, in combination with fishbone diagrams: allow 
the user to differentiate between the key role players in a PV system (“stakeholder 
identification”); can be adapted towards a PV context (“flexibility”); and can be easily 
reproduced by someone who might be lacking a certain degree of technical capacity 
(“reproducible”). The methodology therefore satisfies three of the six qualifying criteria 
defined in Section 4.4 and this justifies the use of the 5Why method and fishbone diagrams for 
the second stage of the translation process i.e. identifying the root causes of the PV challenge 
landscape. 
Subsequently, an instance of the application of the two stages of the translation of the PV 
challenge landscape is provided through a worked example. 
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4.5. Stage 1: Implementation of a value chain analysis 
Given that a value chain analysis cannot be reproduced by someone who does not have some 
form of past experience in this regard (Simister, 2011) and to map out the systematic thinking 
process needed to produce such an analysis, a roadmap to mediating a PV value chain analysis 
is proposed, clearly illustrating the steps that should be taken to complete such an exercise. 
4.5.1. Roadmap to developing a pharmacovigilance value chain analysis 
The roadmap, which was used to develop the PV value chain analysis in Section 4.5.2, is shown 
in Figure 7 and discussed in more detail in Table 10. Each stage in the roadmap is executed 
differently, processing different inputs to deliver specific outputs, and can be completed with 
the help of specific methods. The end product delivered by the roadmap is a PV value chain 
analysis, which is based on the framework design used by Franz et al. (2015), coupled with 
some amendments that are subsequently discussed. 
Firstly, serving as the foundation of the analysis and replacing the energy market value chain, 
are the stages found in the generic PV system, namely data collection and ADR reporting, data 
collation, data analysis (causality and risk assessments), decision-making and governance, 
appropriate action and evaluation of outcomes, all of which are discussed in detail by 
Strengthening Pharmaceutical Systems (Strengthening Pharmaceutical Systems, 2009). 
Secondly, replacing the inputs, finances, and services level of Franz et al.'s (2015) framework 
is the PV challenge landscape. All these challenges are investigated separately, given that they 
are defined differently within each stage of the PV system. Lastly, substituting the 
environmental, political, regulatory, social and cultural factors level, are the stakeholders that 
participate during each stage, all of which are discussed in more detail in Table 6.  
Each of the influences identified in the analysis relates to different stakeholders e.g. the lack of 
awareness of the importance of reporting ADRs relates specifically to healthcare workers, the 
public, and patients. Thus, these stakeholders embody the target population of investigations 
on how these challenges can be addressed. Thus, identifying the stakeholders will assist 
researchers to be clear on who to consult and engage with when developing a new initiative and 
when attempting to roll-out a new project. 
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Define the PV 
value chain
Identify the 
PV challenge 
landscape
Validate the 
PV challenge 
landscape with 
an SME
Is there access to 
SMEs?
Prioritise the 
PV challenge 
landscape
Is the scope of the PV 
challenge landscape too 
vast?
Identify the 
applicable 
stakeholders
Have any additional 
challenges surfaced?
Insert the data 
into the PV 
value chain 
template
Define the 
specific 
challenges in 
the PV value 
chain
Identify any 
possible 
relationships 
between the 
challenges 
specified in 
Step 7
Is there access to SMEs?
Validate the 
PV value chain 
with an SME
Are there any changes 
necessary according to the 
SME?
Where possible, identify the 
root causes of the challenges 
identified in the value chain 
analysis
YES
NO
YES
NO
NO
NO
YES
YES
YES
NO
1
2
3
4
5
6
7
8
9
10
 Figure 7: Roadmap to developing a PV value chain analysis. 
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Table 10: Description of the PV value chain analysis roadmap. 
Stage Description Inputs Outputs Possible methods 
1 
Identify the stages that constitutes the PV 
system. 
Literature PV value chain Literature review 
2 
On a high level of abstraction, identify the 
challenges that are experienced throughout 
the PV system. 
Literature and 
SMEs 
PV challenge 
landscape 
Systematic 
review. 
3 
If possible, validate the PV challenge 
landscape with an SME. 
SME 
Validated PV 
challenge 
landscape 
Personal or virtual 
interview, email 
correspondence, 
workshops. 
4 
In order to reduce the scope of the PV 
challenge landscape, prioritise the 
challenges that are deemed of priority. 
Literature and 
SMEs 
Prioritised PV 
challenge 
landscape 
Degree of 
prevalence 
(similar to the 
matrix developed 
by Lamprecht, 
Bam, and de Kock 
(Lamprecht et al. 
2017), Impact 
analysis. 
5 
Identify the stakeholders that participate 
across the PV system. 
Literature and 
SMEs 
Relevant 
stakeholders 
- 
6 
Make use of the PV value chain analysis 
outline in Figure 8 and insert the 
applicable data from the previous stages. 
PV value 
chain analysis 
template 
Preliminary PV 
value chain 
analysis 
- 
7 
With specific reference to each block in 
the analysis, identify the specific 
challenges that are experienced in that 
specific stage of the PV system, within the 
confines of the specific challenge. 
Literature and 
SMEs 
Preliminary PV 
value chain 
analysis 
- 
8 
Identify which of these challenges share 
relationships with one another i.e. 
addressing the one might affect another. 
Literature and 
SMEs 
Preliminary PV 
value chain 
analysis 
- 
9 
If possible, validate the PV value chain 
analysis with an SME. 
SMEs 
Validated PV 
value chain 
analysis 
Personal or virtual 
interview, email 
correspondence, 
workshops. 
10 
In order to further translate the challenges 
in the PV value chain analysis, identify the 
root causes of these challenges. 
Literature, 
SMEs 
Root causes of 
the challenges 
Root cause 
analysis or 5Why 
analysis. 
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4.5.2. The pharmacovigilance value chain analysis 
Using the roadmap described in Section 4.5.1, each stage was completed to develop a PV value 
chain analysis (shown in Figure 9). The sections of this thesis document in which these stages 
have been completed are shown in Table 11. Many of the challenges identified in the analysis 
share relationships with others. Illustrated by double-headed arrows as in Figure 9, these 
relationships indicate that when the one challenge is addressed, there will either be a direct or 
indirect effect on the other(s). 
Table 11: Sections in which the stages of the roadmap have been completed. 
Stage 1 2 3 4 5 6 7 8 9 10 
Section 2.1-2.3 
2.6-
2.10 
3.1 
3.3-
3.10 
3.5 
Figure 
8 
4.5 4.5 4.5.2 4.6 
Page 
number 
12-14 15-24 30 32-46 36 63 60 60 63 67 
4.5.3. Key points highlighted by the pharmacovigilance value chain analysis 
By integrating the PV challenge landscape in the PV value chain, several key points that would 
have been difficult to identify by simply considering the PV challenge landscape in isolation 
were highlighted. The analysis also sheds some light on the relationships within the  
Figure 8: PV value chain analysis template. 
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Value chain analysis of the PV system – Illustration of the challenges faced within the confines of each stage in the PV system 
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Evaluation of outcomesData collection and ADR Reporting Data collation Data analysis (Causality and Risk assessment) Decision making and Governance Appropriate action
Data collection 
and ADR 
reporting
Data collation
Data analysis 
(Causality and 
risk assessment)
Decision-
making and 
governance
Appropriate 
action
Evaluation of 
outcomes
 HCWs (GPs, specialists, 
pharmacists etc.)
 Public & patients
 Hardware and software 
manufacturers (H&S)
 Media
 Academics
 Government
 PV centres
 Government
 H&S
 Acamedics
 PV centres
 Non-profits (NPOs) (e.g. 
UMC, WHO)
 Specialists in C&R
 H&S
 Pharma companies
 Academics
 Government
 PV centres
 Government
 NPOs
 Non-governmental 
(NGOs)
 Public & patients
 HCWs
 PV centres
 Government
 Media
 NPOs
 H&S
 NGOs
 PV centres
 H&S
 Government
 HCWs
 Public & patients
Inadequate access  
to reporting tools 
Lack of central coordinat ion 
of data collection
Inadequate access  to ADR 
reporting forms 
(spontaneous  report ing)
Lack of access to electronic 
hardware and software to 
accommodate report ing 
systems
Lack of 
awareness of the 
importance of 
ADR reporting 
among healthcare 
workers and 
patients
Public unclear on 
existing ADR 
reporting facil ities 
and methods.
Lack of 
collaboration 
between 
healthcare and 
allied 
healthcare 
profession 
councils
Inman s seven 
deadly sins
Overly 
complicated 
reporting sys tems 
e.g. too much 
detai ls are 
required
HCWs don t 
know how to 
report ADRs – 
sometimes 
leading to poor 
quality
Public and patients don t 
know how to report – 
sometimes leading to poor 
quality
Lack of access to 
sufficiently trained 
personnel who can 
synthesise data
Lack of personnel 
who can do data 
collation
Lack of access to 
local ly developed 
or locally adapted 
data management 
systems
Disagreement on 
what  data is 
essential  during 
collation
Failure to 
understand 
importance of 
data collation
Limited data 
collated due to 
under-reporting
PV personnel 
don t know how 
to collate data
Existing resources 
used for data 
collation not 
util ised
Lack of  access to 
expertise who can 
conduct data 
analysis
Lack of expert ise 
who can conduct 
data analysis
Peers in data 
analysis fail to 
share relevant  
information 
with other in 
different  
locat ions
Pharma 
companies fai l 
to provide all  
information 
regarding data 
analysis
Lack of funding 
given by industry 
to PV systems to 
conduct 
independent data 
analyses
Data analys is not 
done due to 
under-reporting
Existing PV 
personnel don t 
always have 
sufficient 
knowledge to 
conduct data 
analysis
Failure to util ise 
existing resources  
available to C&R
Proposed solution 
not feasible to due 
a lack of access to 
expertise
Stakeholders 
unclear of the 
rationale and 
meaning of the 
problem on hand
Lack of overarching 
PV policy and 
platforms for 
information sharing 
between stakeholders
Lack of access to a 
broad spectrum of 
expertise required to 
oversee and conduct 
PV act ivities
Difficult ies in 
implementing the 
solut ion due to 
situational and 
environmental 
factors
Local users resist  
to using and 
exercising new 
policies regarding 
PV
Lack of access 
resources to 
implement 
init iat ive
Lack of funding, H&S, 
and personnel  to 
implement ini tiative
Resistance to 
change (e.g. have 
to use new 
technology all  of 
a sudden)
Lack of expert ise 
and experience to 
implement the 
init iat ive in a 
region
Failure to util ise 
existing resources  
during 
implementation
Difficult ies to 
evaluate PV 
init iat ives  e.g. in 
remote vil lages
Lack of access to 
personnel who are 
able to conduct 
evaluation
Lack of training 
in evaluation
Unclear 
instructions and 
lack of awareness 
of what is  
important during 
evaluation
Indifference of 
industry to 
support 
evaluation of PV 
systems
Lack of access to 
expertise and 
individuals  who 
have experience 
regarding 
evaluation
Failure to util ise 
existing resources  
during evaluation
Competing priorit ies of 
healthcare staff
Inadequate feedback 
(newsletters, emails 
etc.) given to ADR 
reporters and other 
stakeholders
The KAP 
(knowledge, 
attitude, and 
practice) model 
leading to under-
reporting
Lack of access to data 
management systems  that 
can synthesise and analyse 
existing electronic records
Non-adherence of 
industry 
(pharmaceutical 
companies) to 
reporting 
guidelines of 
regulatory agency
Lack of access to 
tools  such as 
signal analys is 
tools
Industry tends  to 
bias data analyses 
to ensure that the 
marketing of their 
product is not 
negatively 
influenced
Failure to develop 
local ly relevant  
indicators  to 
determine the 
success of a PV 
system
Unclear definition 
of the roles and 
ownership of 
stakeholders 
Lack of advocacy 
from industry 
towards the 
importance and 
awareness of 
ADR reporting
Cultural barriers preventing 
ADR reporting e.g. wrong 
advice given by community 
healers to address ADRs
Inabil ity or 
unwillingness of 
industry and PV 
systems to share 
information
Unwillingness to 
share information 
to relevant parties 
who are able to do 
necessary 
analyses (e.g. 
academic 
inst itutions)
Lack of 
regulatory 
capacity to 
enforce relevant 
PV guidelines by 
industry
Lack of a governance 
structure to guide and 
coordinate data analyses 
process to ensure best 
outcome and prevent biased 
outcomes
Lack of a governance 
structure to guide and 
coordinate data analyses 
process to ensure best 
outcome and prevent biased 
outcomes
Public not made aware of 
improvements – No feedback 
given
Lack of sustainable funding 
for expanding and 
improving effect iveness of 
survei llance systems
Lack of standardised training 
programme for ADR reporting at 
univers ities and healthcare 
facilites
Inadequate technical 
oversight of collation data 
management processes  as a 
whole
Lack of an overarching 
national PV policy that 
provides  a cohesive basis 
for interaction between 
stakeholders 
Failure of stakeholders to 
recognise the public health 
impact of PV
Lack of robust  
local  data limits 
the extent to 
which decision 
making can be 
done
Inadequate 
enforcement 
power by 
regulatory 
authori ties and 
con-compliance 
by manufacturers
Failure to develop 
local ly relevant  and 
easily measurable 
indicators  of 
performance of PV 
systems
Lack of funding for 
data collect ion via 
other surveillance 
systems
Figure 9: The PV value chain analysis. 
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PV challenge landscape, as well as the actual meaning of the influence of challenges in PV. 
These key points are briefly described in the subsequent subsections. 
4.5.3.1.  Prominent role players 
Governmental bodies, also referred to as regulatory authorities, are key role players in PV. This 
is because, in most countries, regulatory authorities govern PV systems, developing the 
necessary policies and investing the required resources for PV systems to operate. Although 
some countries (e.g. South Africa) are trying to privatise a portion of the power held by 
regulatory authorities, these authorities will remain key role players in PV.  
4.5.3.2.  Snowballing effect caused by adverse drug reaction under-reporting 
Within the ADR under-reporting lane, it is shown that many of the challenges in the 
downstream PV value chain share relationships with this phenomenon. This emphasises the 
limitations caused by the phenomenon of ADR under-reporting that is so often cited in 
literature.  
4.5.3.3.  Many challenges faced at the start of the pharmacovigilance value stream 
Many challenges are found at the start of the PV value chain i.e. within the data collection and 
ADR under-reporting, and data collation stages, which highlights the limitations posed by a 
lack of robust qualitative and quantitative data. Data plays a major part in PV and it is therefore 
important that the efforts towards acquiring such data are as efficient and effective as possible.  
4.5.3.4.  Exchanges between country-specific factors and insufficient resources 
There are frequent exchanges between the challenges associated with country-specific factors 
and insufficient resources Therefore, it is worthwhile exploring whether there is a causal 
relationship between these two strategically defined challenges. In other words, when it is found 
that there are insufficient resources within a certain country, it is possible that it is a unique case 
to that specific country, i.e. another country may not experience the same problem. 
4.5.3.5.  Role played by country-specific factors 
Many challenges have been identified within the country-specific factors lane. This supports 
the rationale that an exercise such as globalisation and standardisation of PV systems on an 
international scale may be significantly challenging, given that PV systems in different 
countries are unique and are influenced by different factors. 
4.5.3.6. Failure to understand the effects of pharmacovigilance 
It is often the case that those within the PV system, as well as those outside–such as the partners 
who operate within and outside the scope of PV (described in Section 3.5)–fail to realise the 
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importance of PV and the influence that PV has, not only on an individual patient level, but on 
the entire healthcare system. 
4.5.3.7. Lack of access 
The lack of access to resources is regularly reported in the analysis. It is not necessarily the case 
that the expertise, experience, funding, training, technology and other resources do not exist, 
but rather that PV systems are not given access to such resources. One of the main reasons for 
this can be attributed to the fact that PV may not be regarded as priority within a certain country. 
Therefore, it does not receive the necessary funding to access the required resources. 
4.5.3.8. Adoption by the widespread healthcare industry 
Dissecting the PV challenge landscape, shows that PV is a large and complex system with many 
opportunities for problems to arise. Consequently, PV needs to be adopted by the wider 
healthcare industry, and must be regarded as a priority, not only to those actively involved in 
PV, but also to those outside the boundaries of the PV system.  
4.5.3.9. Lack of technical capacity 
The lack of training, knowledge or practice, all of which contribute to technical capacity (as 
identified and described in Section 3.9), are often limiting factors in PV systems. This can be 
traced back to the phase before healthcare workers enter into the working environment i.e. 
university, college or any other form of tertiary education or training. It is essential that training 
starts on a tertiary level, where the basics of PV are taught. 
4.5.4. Concluding stage one of the translation process 
These key points all contribute to the initial translation process i.e. understanding that the PV 
challenge landscape affects the different stages in the PV value chain in different ways. It is 
critical to a system such as PV, where drug and patient safety are of primary concern, that 
researchers understand how the challenges affect a PV system, which will allow them to make 
the necessary improvements to the system.  
To validate the PV value chain analysis, an SME has been consulted. The SME is an 
independent PV consultant at a local university. The feedback of the SME is already 
incorporated into the value chain analysis provided in this chapter. 
To identify the root causes of challenges in the PV landscape, the second stage of the translation 
process proposed in Section 4.5.1 is essential. An example of this second translation step is 
given in the following section. 
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4.6.  Stage 2: The 5Why method and fishbone diagrams 
Up to this point, the translation of the strategically defined PV challenge landscape has reached 
an intermediate stage. To complete the translation, the root causes of these challenges must be 
identified, which will translate these challenges into tangible problems that can be addressed at 
an operational level. To do this, the 5Why method, in combination with fishbone diagrams, can 
be used. In illustration of the implementation of these methodologies, Figure 10 shows one of 
the fishbone diagrams used to identify root causes. As seen in Figure 10, the “lack of robust 
local data limits the extent to which decision-making can be done” is used as the base challenge. 
From there, the 5Why method is implemented (as discussed in Section 4.3.1.1). This allows for 
several possible root causes to be identified for the initial challenge.  
The 5Why method, in combination with fishbone diagrams, are implemented on the following 
challenges: (1) the inadequate access to ADR reporting forms (spontaneous); (2) the failure to 
develop locally relevant and easily measurable indicators of performance of PV systems; (3) 
the lack of robust local data that limits the extent to which decision-making can be done; (4) 
the inadequate feedback given to ADR reporters and other stakeholders; (5) the inadequate 
access to data management systems that can synthesise and analyse existing electronic health 
records; (6) failure to utilise existing resources to conduct data collection, collation, and 
analysis; (7) lack of overarching platforms for information sharing between stakeholders; and 
Figure 10: Example of a fishbone diagram used to identify root causes. 
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(8) the lack of sufficient knowledge of existing PV personnel to conduct the necessary data 
analysis. Section C.2 in Appendix C contains the fishbone diagrams that have been developed 
to identify the root causes of these challenges. 
The eight challenges listed in the previous paragraph were chosen because of their potential to 
highlight areas in PV where technology can be implemented to address the many challenges it 
faces, thereby linking to the primary topic of this research. The root causes that have been 
identified are shown in Table 12. These root causes highlight several key findings that are 
subsequently discussed. 
4.6.1. Key points highlighted by the implementation of the 5Why method, in combination 
with fishbone diagrams 
Certain key points can be concluded from the identification of the root causes, highlighting 
distinct features of the PV system that may not have been known before. 
4.6.1.1. Wide spectrum of possible root causes 
When conducting these types of analyses, it is possible to either identify numerous possible 
root causes of a specific problem, or only a few. This is evident from the wide spectrum of root 
causes identified in the examples provided. This phenomenon is a result of the nature of 
answering a simple “Why?” question, which may have more than one possible answer.  
4.6.1.2. Unclear association between the possible root causes and the overall problem 
Some of the root causes identified may be deemed as implausible i.e. it may seem that the root 
cause and the overall problem may not have anything in common, and this may make 
stakeholders resistant to using the 5Why methodology. For example, a root cause for the 
inadequate access to ADR reporting forms is the lack of funding to access software 
technologies. As Warner (2015) described, however, analyses such as the 5Why methodology 
have delivered many positive results, and therefore one should at the very least devote some 
effort towards investigating the possible interactions these seemingly non-associated root 
causes and challenges may share.  
4.6.1.3. Shared root causes 
As indicated by the analysis of the failure to develop locally relevant and easily measurable 
performance indicators of PV systems, and the lack of robust local data that limits the extent of 
decision-making which is supported, certain possible root causes may affect different problems. 
This is proof that the challenges in the PV challenge landscape share relationships, as illustrated 
in the PV value chain analysis in Figure 9. 
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4.6.1.4. Inconsistent levels of complexity 
Referring to the diagrams in Section C.2 in Appendix C, the number of successive layers of 
root causes are inconsistent, with some challenges being traced back to several successive layers 
of root causes, whereas others are linked to only one or two layers of root causes. It is important 
to remember that the set of root causes identified in the analyses are not necessarily exhaustive, 
meaning that there may also be other root causes to the challenges that are not considered in 
this study. The process of the second translation stage merely proves that such an analysis can 
contribute to the identification of several root causes that can be addressed on the operational 
level, but, especially when one considers the vast scope of the PV system and the role of 
country-specific factors, it is clear that it is not feasible to generate an exhaustive set of root 
causes. 
4.6.1.5. Root causes 
The challenges identified in the PV value chain analysis can sometimes already represent the 
root cause of a challenge. Such a phenomenon can be seen in the last diagram in Section C.2 in 
Appendix C, where it is shown that there are no further root causes related to the lack of 
sufficient knowledge of existing PV personnel to conduct the necessary data analysis. It is 
already made apparent that the only possible solution to this is to provide sufficient training to 
these groups to equip them with the required skills and knowledge to conduct crucial data 
analyses.  
4.6.2. Concluding stage two of the translation process 
In combination with the first stage of the translation process where the influence of the PV 
challenge landscape on the PV value chain is investigated, the root cause analysis identifies 
tangible problems that may have been unknown. To organise the identified root causes, the 
following categories are used: funding, management, training, advocacy and technology. 
Organising the root causes into these categories, allows for the identification of the types of 
root causes that are most regularly experienced. This categorisation is shown in Table 13. 
 
Stellenbosch University  https://scholar.sun.ac.za
70 | P a g e  
 
Table 12: Root causes of the challenges identified in the PV value chain analysis. 
Challenge identified in the PV 
value chain analysis 
Root causes 
Inadequate access to ADR 
reporting forms (spontaneous) 
There is a lack of funding to access software technologies that can assist the coordination of the deliveries of spontaneous ADR reporting 
forms. 
There is no existing software technology that can assist the coordination of the deliveries of spontaneous ADR reporting forms. 
The individuals responsible for coordinating the deliveries of spontaneous ADR reporting forms are not sufficiently trained to execute the 
necessary tasks. 
There is no designated transportation service to distribute the ADR reporting forms. 
The person in charge of re-ordering the ADR reporting forms is not sufficiently trained in stock control. 
The person in charge of re-ordering the ADR reporting forms is situated in a remote location, and as a consequence, users of the forms 
struggle to make contact with this person. 
The users of the forms have competing priorities, and simply do not have time to notify the person in charge of re-ordering the ADR 
reporting forms. 
Failure to develop locally relevant 
and easily measurable indicators of 
performance of PV systems 
Key stakeholders are not aware of the health impact of PV. 
There are only globally defined performance indicators that may not include features of a unique, local PV system. 
The lack of robust local data that 
limits the extent to which decision-
making can be done 
PV is not sufficiently advocated to the necessary stakeholders. 
PV is not included in the undergraduate syllabus of healthcare tertiary education. 
The ADR reporting forms are overly complicated and are time-consuming. 
Key stakeholders are not aware of the health impact of PV. 
Inadequate feedback (newsletters, 
emails etc.) given to ADR reporters 
and other stakeholders 
There is no translation services that can prepare these reports for the specific context. 
Feedback is not deemed as a priority. 
The importance of feedback is not advocated sufficiently. 
Continued on next page… 
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…continued from previous page. 
Challenge identified in the PV 
value chain analysis 
Root causes 
Inadequate access to data 
management systems that can 
synthesise and analyse existing 
electronic health records 
There is a lack of ownership of managing this process. 
Lack of access to technology to simplify this process. 
Lack of training provided those who report ADRs. 
Difficulties in providing such training to all individuals in remote locations in a timely fashion. 
Failure to utilise existing resources 
to conduct data collection, 
collation, and analysis 
There is no resource management system in place to manage the resource inventories. 
There is a lack of ownership taken to manage these resources. 
No training is provided to educate PV personnel on how to use these resources. 
Lack of overarching platforms for 
information sharing between 
stakeholders 
Lack of funding to access modern information sharing platforms. 
PV personnel are insufficiently trained in using existing platforms. 
There are no set regulations that governs the standardisation of data. 
It is unclear what data should be shared with which stakeholder. 
ADR reporters are not sufficiently trained in providing the sought after data. 
Lack of sufficient knowledge of 
existing PV personnel to conduct 
necessary data analysis 
Lack of sufficient knowledge of existing PV personnel to conduct necessary data analysis. 
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Table 13: Categorisation of the root causes. 
Category Root cause 
Funding 
There is a lack of funding to access software technologies that can assist the coordination of the deliveries of spontaneous ADR reporting forms. 
Lack of funding to access modern information sharing platforms. 
Management 
There is no designated transportation service to distribute the ADR reporting forms. 
The person in charge of re-ordering the ADR reporting forms is situated in a remote location, and as a consequence, users of the forms struggle to make contact with 
this person. 
The users of the forms have competing priorities, and simply do not have time to notify the person in charge of re-ordering the ADR reporting forms. 
There are only globally defined performance indicators that may not include features of a unique, local PV system. 
PV is not included in the undergraduate syllabus of healthcare tertiary education. 
There is a lack of ownership of managing this process. 
There is a lack of ownership taken to manage these resources. 
There are no set regulations that governs the standardisation of data. 
It is unclear what data should be shared with which stakeholder. 
Training 
The individuals responsible for coordinating the deliveries of spontaneous ADR reporting forms are not sufficiently trained to execute the necessary tasks. 
The person in charge of re-ordering the ADR reporting forms is not sufficiently trained in stock control. 
The ADR reporting forms are overly complicated and are time-consuming. 
Lack of training provided those who report ADRs. 
Difficulties in providing such training to all individuals in remote locations in a timely fashion. 
No training is provided to educate PV personnel on how to use these resources. 
PV personnel are insufficiently trained in using existing platforms. 
ADR reporters are not sufficiently trained in providing the sought after data. 
Lack of sufficient knowledge of existing PV personnel to conduct necessary data analysis. 
 
Continued on next page… 
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…continued from previous page. 
Category Root cause 
Advocacy 
Key stakeholders are not aware of the health impact of PV. 
PV is not sufficiently advocated to the necessary stakeholders. 
Key stakeholders are not aware of the health impact of PV. 
Feedback is not deemed as a priority. 
The importance of feedback is not advocated sufficiently. 
Technology 
There is no existing software technology that can assist the coordination of the deliveries of spontaneous ADR reporting forms 
There is no translation services that can prepare these reports for the specific context. 
Lack of access to technology to simplify this process. 
There is no resource management system in place to manage the resource inventories. 
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4.6.3. Validating the root causes 
Two SMEs that are employed in the pharmaceutical sector were consulted to validate the root 
causes identified in this section. The inputs of each of the SMEs are summarised in Table 14. 
In summary, the SMEs agreed that the root causes identified in this research represent some of 
the real-world root causes. Additionally, they added some root causes, which have already been 
incorporated into this research. Most importantly, they highlighted the root causes that should 
be regarded as priority to this research. Thus, these selected sets of root causes are investigated 
in the subsequent part of this research (specifically, Chapter 6). 
4.7. Chapter 4 conclusion 
The focus of this chapter is the translation of the PV challenge landscape from a strategic– to 
an operational level thus lowering the level of abstraction of the PV challenge landscape. 
Firstly, the concept of strategic–, tactic–, and operational levels in businesses was discussed, 
followed by the argument that the PV challenge landscape has thus far been described at a 
strategic level. This was followed by a discussion that provided the rationale for the importance 
of translating the strategically defined PV challenges landscape to an operational level and 
where it was concluded that such a process should be done in two stages. Several methodologies 
that could be employed during this translation process were investigated, concluding that the 
PV value chain analysis and the 5Why analysis, in combination with fishbone diagrams, are the 
most appropriate methodologies to use during the proposed two-stage translation process. 
Following the implementation of these methodologies executing two stages of the translation 
process, it became clear that the methodologies that have been implemented highlighted several 
key points that may have been difficult, or even impossible, to conclude if the PV challenge 
landscape was only defined at a strategic level. As a result, several tangible problems were 
identified. 
The set of root causes identified during the analysis is not necessarily exhaustive, therefore it is 
possible that other root causes exist that are not considered in this study. It is particularly 
difficult to consider each possible root cause to a challenge, given that the scope of root causes 
differs severely based on the context in which the PV system operates. However, the analyses 
conducted in the two-stage translation process have identified root causes that can be assumed 
to lead to challenges in the PV system in a general sense. The worked example also serves as 
proof that these analyses can be used to identify tangible problems in PV systems that may not 
have been known before. 
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Table 14: Input from SMEs regarding root causes. 
Occupation Affiliation Input 
1 
Medical Lead Access, 
Regional Medical Director. 
Leading the preparation for 
the launch of a new product 
within severely resource 
constrained environments. 
Multi-national 
pharmaceutical 
company 
The focus of this research should be towards the 
first two challenges taken from the PV value 
chain analysis i.e. inadequate access to ADR 
reporting forms (spontaneous); and failure to 
develop locally relevant and easily measurable 
indicators of performance of PV systems. 
2 
Medical Affairs Executive 
and Named Safety Contact 
for an African country. 
Multi-national 
pharmaceutical 
company 
The root causes identified in the study represent 
most of the possible root causes that exist in 
practice. One key issue, regarding ADR 
reporting, is the lack of ownership taken by 
healthcare workers and PV experts to report 
ADRs via the applicable channels. Furthermore, 
the root causes that were identified represent 
another key issue within PV; key stakeholders 
not understanding the importance of PV within 
the context of healthcare. 
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Chapter 5: The technology landscape 
___________________________________________________________________________ 
Following the translation of the PV challenge landscape to a lower level of abstraction (i.e. 
from a strategic to an operational level) in the previous chapter, several root causes have been 
identified. As stated in Chapter 1, the aim of this research is to investigate the potential of 
technology to address these root causes. Technology selection frameworks can be a useful tool 
towards achieving this aim. These frameworks facilitate the technology selection process, 
guiding the user by referring to key characteristics that should be considered during the 
selection process.  
In the first section of this chapter, the technology selection framework landscape is investigated, 
and the selection of an appropriate framework for this research is motivated. In the second 
section of this chapter, the technology landscape is investigated to identify candidate 
technologies that can be implemented to address the root causes identified in the previous 
chapter. 
5.1. Technology selection 
In an ever-changing business environment, new technologies are frequently developed to 
perform specific functions. This increase in new technologies entering the market is making it 
increasingly difficult for businesses to determine which technologies are best suited for their 
needs (Shen et al., 2010). It is important that the right technologies are selected because 
technology plays an instrumental part in any business and has the potential to either contribute 
to the success and growth of a business or contribute to severe monetary losses.  
Consequently, businesses should follow a comprehensive process, known as the technology 
selection process, during which they investigate the technology landscape in an effort to find 
the most appropriate technologies to meet their requirements (Ruder, Pretorius & B. T. Maharaj, 
2008). Considering many factors such as business processes, environmental conditions, social 
and cultural factors and political influences, the technology selection process compares 
alternative technologies in order to refine the list of technologies to those best suited for the 
business (Shehabuddeen et al., 2006).  
To provide guidance to the technology selection process, technology frameworks are used. 
These frameworks, developed from both a theoretical– and empirical background 
(Shehabuddeen et al., 2006), provide essential insight into the stages that should be followed 
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during the technology selection process and serve to highlight the influential factors that should 
be considered during the process (Shen et al., 2010).  
5.2. Technology selection frameworks 
A large number of technology selection frameworks exist in literature. Although many of these 
technology selection frameworks incorporate generic elements, they tend to be developed with 
specific contexts or application areas in mind, and therefore generally also contain elements 
that are specifically tailored to the intended context or application area. Consequently, the 
literature review described in Section 5.3 did not uncover a universally acceptable technology 
selection framework that can be implemented within any setting. 
Due to the lack of a universally accepted framework, it is recommended that the best course of 
action to find an appropriate technology selection framework for application in this research 
would be to investigate several of the frameworks that are published in literature. The choice 
of a technology selection framework for use in this research will be based on the following 
factors (the terms given in brackets are those used in Table 15): (1) Does the framework 
incorporate some elements of healthcare (focus)? (2) Does the framework consider resource 
constraints (resource constraints)? (3) Is there a focus on the patient or end-user (patient 
orientation)? (4) Can the framework be used within more than one context (flexibility)? (5) Can 
the framework be used more than once (re-evaluation)? Subsequently, the technology 
frameworks are assessed. 
5.3. Technology selection framework assessment 
A search in the Google Scholar, Scopus, and PubMed research databases using the search terms 
“technology selection frameworks”, “technology selection”, and “technology evaluation” 
revealed 15 technology selection frameworks. These frameworks are identified and briefly 
described in Table 16. The authors of these frameworks are also provided, as well as the context 
in which the frameworks were initially developed. With reference to the context in which these 
frameworks were developed (indicated in Table 16), many have been developed within a 
general context, using either quantitative– or qualitative data to make the necessary decisions. 
The other contexts in which the frameworks were developed include telecommunications, 
information technologies, aerospace and training technologies. Given that many of the 
frameworks were developed within a general context, the process of selecting an appropriate 
framework is simpler, since these frameworks do not incorporate elements that are unique to a 
specific industry. 
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After careful consideration of these frameworks, it is concluded that the framework by Chan & 
Kaufman (2010), titled: “A technology selection framework for supporting delivery of patient-
oriented health interventions in developing countries” is appropriate for the purpose of this 
research effort.  
5.4. Technology selection framework selection 
As shown in Table 15, the framework by Chan & Kaufman (2010) was chosen because it 
embodies several of the characteristics that were deemed desirable in a framework for 
application to this research, as defined in Section 5.2. The framework was originally developed 
to support the delivery of patient-oriented health interventions in developing countries, with a 
specific focus on healthcare information technologies. The framework is structured around 
three levels (with Level 2 being sub-divided into two components), serving as filters and 
constraints, narrowing the decision space for selecting technologies. These levels are described 
in Table 17. 
Table 15: Characteristics of Chan & Kaufman (2010)’s technology selection framework. 
Characteristic Explanation 
Focus 
The framework was initially developed to be used within developing countries, which 
aligns with the focus of this research. 
Resource 
constraints 
The framework has been developed for resource constrained environments, making it 
especially applicable to PV, since resource deficiencies are regarded as a priority 
challenge in PV. 
Patient 
orientation 
The framework is focussed around patient orientation, which is a major element of PV. 
Flexibility 
The authors propose that the conditions and settings in which the framework can be 
applied are dynamic i.e. in addition to the delivery of patient-oriented health 
interventions, the framework can be applied to other health interventions as well. The 
framework is designed to explore how and whether technologies can support the 
delivery of health interventions towards different target populations, meaning it can be 
used within PV where multiple stakeholders need to be considered. 
Re-evaluation 
The framework is not a “once-off” instrument that can only be used upon initial 
technology acquisition. It is clearly stated that the framework can be used for re-
evaluation of technologies, enabling it to adapt to the rapidly changing technology 
environment. 
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Table 16: Technology selection frameworks. 
Framework Source Description 
Context in which 
framework is 
developed 
Delphi technique Shen et al. (2010) 
A systematic collection of opinions and judgments from SMEs through a specially 
designed set of questionnaires. 
General 
Fuzzy Delphi 
technique 
Shen et al. (2010) 
The fuzzy Delphi technique is similar to the Delphi technique, however, uses fewer 
rounds of questionnaires to speed-up the process of collecting opinions. 
General 
Analytical hierarchy 
process (AHP) 
Shen et al. (2010) 
The AHP is a multi-criteria approach, making use of weights, defined at the start of 
the process, to determine the best alternative. 
General 
Delphi hierarchy 
process (DHP) 
Khorramshahgol 
& Moustakis 
(1988) 
A combination of the AHP and the Delphi method, the DHP consists of a six stage 
process in which both questionnaires and the mathematical approach to comparing the 
opinions and judgements of SMEs are used. 
General 
A Quantitative Model 
for the Evaluation of 
Technological 
Alternatives 
Sharif & 
Sundararajan 
(1983) 
A model that combines both quantitative and qualitative factors and then uses a 
mathematical model to unify the results from these factors. 
General 
A filter system for 
technology evaluation 
and selection 
Yap & Souder 
(1993) 
This model makes use of two filters stages, the first of which eliminates technologies 
based on predefined capabilities and environments of a business. This is followed by a 
second filter stage where in depth evaluations are done. 
General 
From theory to 
practice: challenges in 
operationalising a 
technology selection 
framework 
Shehabuddeen et 
al. (2006) 
The framework relies heavily on filters in order to reduce the number of candidate 
technologies under evaluation. These filters are based on certain characteristics that 
are used to make the decision as to which technologies will be eliminated from the 
process. 
General 
Continued on next page… 
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…continued from previous page. 
Framework Source Description 
Context in which 
framework is 
developed 
A Technology 
Selection Framework 
for the 
Telecommunications 
Industry in Developing 
Countries 
Ruder, Pretorius 
& B.T. Maharaj 
(2008) 
This framework is based on systematic, seven phase process, relying on certain inputs 
in order to deliver certain outputs, ultimately unveiling a refined list of candidate 
technologies. 
Telecommunications 
A technology selection 
framework for 
supporting delivery of 
patient-oriented health 
interventions in 
developing countries 
Chan & Kaufman 
(2010) 
Originally developed with regards to patient-oriented technologies, this framework 
consists of three levels of factors (situational factors, the relationship of the 
technology with regards to health interventions, and empirical evidence) that serve as 
filters, refining the candidate technologies. 
Patient-oriented health 
interventions 
A framework for 
evaluating and 
selecting learning 
technologies 
Zaied (2007) 
This framework is based on learning technologies, and contains several criteria that 
have been developed based on the opinions of certain groups in universities. These 
criteria can ultimately be used to compare different candidate technologies that can be 
used as learning technologies. 
Education and training 
A hybrid selection 
model for emerging 
technology 
Shen et al. (2010) 
This model uses the fuzzy Delphi, AHP and patent co-citation approaches and 
integrates certain aspects of each to compare technologies. 
General 
Continued on next page… 
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…continued from previous page. 
Framework Source Description 
Context in which 
framework is 
developed 
A decision model for 
information technology 
selection using AHP 
integrated TOPSIS-
Grey: The case of 
content management 
systems 
Oztaysi (2014) 
This model makes use of a combination of the AHP method (described earlier), and 
the Grey-TOPSIS method (Technique for Order Preference by Similarity to Ideal 
Solution). The AHP method is used to determine the weight of the criteria used in the 
framework, which is then followed by the evaluation of the alternatives by the Grey-
TOPSIS method. 
Information 
technology 
A systems approach 
for technology 
assessment and 
selection 
Demirkıran & 
Altunok (2012) 
This is a systematic model that uses quantitative data to determine which technologies 
are candidate technologies. The model also defines critical technology elements of a 
system that should be considered. 
General 
Framework for 
selecting the 
technology in public 
sector 
Hong (2013) 
This framework’s focus is on technology selection in the public sector, where social 
and economic impact of technology plays a key role. IT uses a technique called the 
fuzzy analytical network process, which is a technique that can deal with ambiguity 
involved during the evaluation of candidate technologies. 
General (with focus on 
the public sector) 
A method for 
technology selection 
based on benefit, 
available schedule and 
budget resources (TIES 
method) 
Kirby & Mavris 
(2000) 
The framework is based on an eight stage process, ranging from technology 
identification to selection. Using customer acceptance and satisfaction as starting 
criteria, as well as budgetary constraints, the framework is able to identify candidate 
technologies. 
Aerospace systems 
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Table 17: Description of the three levels and the associated focus areas in the technology 
selection framework developed by Chan & Kaufman (2010). 
Level Category in framework Description 
L
ev
el
 1
 
S
it
u
a
ti
o
n
a
l 
fa
ct
o
rs
 
Clinical domain 
It must be clear in what clinical domain (e.g. HIV, malaria, 
vaccines, educational programmes etc.) the framework is to 
be implemented. 
Setting 
This stage focusses on the influence of factors such as 
environmental conditions, security infrastructures for 
technology, and infrastructure such as internet connectivity 
and electricity access that will support the technology. 
L
ev
el
 2
 
T
ec
h
n
o
lo
g
y
 a
n
d
 h
ea
lt
h
 
in
te
rv
en
ti
o
n
 Workforce 
It must be determined whether the workforce that will be 
using the technology is adequately skilled. There should also 
be supporting staff (e.g. staff support, IT staff, and 
technology experts etc.) who are able to ensure the effective 
and efficient use of technologies. 
Delivery mechanisms 
The delivery of the technologies must not burden existing 
health intervention deliveries, and must rather meet the 
needs and communications of the health interventions. 
T
ec
h
n
o
lo
g
y
 a
n
d
 t
a
rg
et
 p
o
p
u
la
ti
o
n
 
Meaningful access 
The target population should have meaningful access to the 
technology. This relates to aspects such as affordability, 
connectivity, and ongoing technology support. 
Use patterns 
If, for instance the health intervention entails handling of 
sensitive information of patients, more secure and personal 
technology is needed. Other use habits such as the frequency 
in which a user checks their emails should be considered. 
Interface 
The interface of the technology should be simple and 
appropriate for interaction. Different languages must also be 
available. 
L
ev
el
 3
 
E
m
p
ir
ic
a
l 
e
v
id
en
ce
 
Potential for 
application 
The implementers of the framework should not only focus 
on the framework. They should be willing to learn from real-
world implementations of similar frameworks in similar 
target populations. 
Research needs 
Any missing links that have been found during the real-
world implementation should be re-assessed to determine 
ways in which to improve it. For example, research into the 
evaluation metrics can highlight specific requirements for 
different technologies. 
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In Chapter 6, the framework developed by Chan & Kaufman (2010) will be used to link the 
root causes identified in Chapter 4 to the technologies that are subsequently identified in the 
remainder of this chapter. The framework will facilitate the selection process and ensure that 
essential factors (embodied within the framework) are considered. 
5.5. Investigating the technology landscape 
As discussed in Section 1.7, technology has a broad definition in this research. This broad view 
of technology is leveraged towards the benefit of this research i.e. the technologies investigated 
are not limited to only hardware and software. The technologies that are identified and assessed 
can each be used to improve the daily activities in a PV system, making it more effective and 
efficient. 
5.5.1. Technology landscape assessment 
To identify technologies that can be used to address the root causes of the prioritised PV 
challenge landscape, two sources were used, namely: grey literature, and a focus group. The 
search terms used to identify technologies in grey literature were: “Technologies used to 
address …” and “Emerging technologies used to address …” The prioritised challenges in PV, 
namely: culture, transparency, partnerships, insufficient resources, country-specific factors, 
ADR-under reporting and technical capacity were used in the place of the ellipses in each search 
term. 
To ensure additional credibility, a focus group was held to populate the technology landscape 
investigated in this research. The participants of the focus group (one professional Industrial 
Engineer and researcher; and eight postgraduate students in Industrial Engineering) originate 
from an Industrial Engineering background, and therefore have a fairly good understanding of 
the role that technologies play in the modern world. Prior to the start of the focus group, each 
participant was sent a summarised version of this section of the research, providing some 
background and stating the purpose of the focus group. All the relevant information regarding 
the focus group is shown in Section D.1 in Appendix D, which includes the identification of 
the participants, the document containing the summarised version of the research discussed, 
and the agenda for the focus group. 
Subsequently, the technologies identified with the use of the previously mentioned sources 
(grey literature and the focus group) are described, along with some benefits and drawbacks. It 
should be made clear that the technologies are all described at a high-level i.e. specific instances 
of these technologies are not identified. The goal of this discussion is merely to identify the 
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technology landscape, after which the technology selection framework will be used to 
determine which of these technologies have the potential to be used in addressing some of the 
root causes identified in the previous chapter. 
5.5.1.1. Resource management systems 
Resource management systems are used for the planning and control of resources (Spacey, 
2015). These systems manage several different types of resources, including human resources, 
natural resources, financial resources, tangible and intangible infrastructures and information 
technologies. According to Smith (2014) it is vital to have a balance between these different 
resources, because any system relies on a combination of many interacting resources. Resource 
management systems are able to provide a global view on the available resources (Smith, 2014), 
and facilitate the management of these resources to ensure both efficiency and effectiveness. 
An example of a widely used resource management system, is the SAP (Systems Applications 
and Products) models, developed by the SAP Company. These management systems provide 
organisations with the ability to improve their resource management efforts and allow them to 
predict their resource requirements in future business. 
Regardless of the many benefits mentioned earlier, there are some drawbacks to resource 
management systems as well. These include high initial acquisition and installation costs of the 
system (software) itself, resistance of employees to integrate such a system into their everyday 
routine, and the need to train employees to use these systems. 
5.5.1.2. Big data analytics  
Big data analytics is defined as “a data analysis methodology enabled by recent advances in 
technologies that support high-velocity data capture, storage and analysis” (Zakir et al., 2015).  
Essentially, big data analytics allow organisations to expand their scope of data analysis to 
include data from unstructured databases, such as emails, mobile device outputs and sensor-
generated data. Big data analytics have grown to assist organisations in analysing exceedingly 
large amounts of data and are able to provide large samples of statistical data that can be used 
to enhance analytical tool results (Russom, 2011).  
There are numerous technologies that are based on big data analytics, ranging from tools such 
as structured query language (SQL) servers, Hadoop and SAP, to simple tools such as Microsoft 
Excel (Zakir et al., 2015). Many of these are open source software (i.e. are freely available to 
the public). These tools do, however, require users to possess specific skills to effectively utilise 
the tools (Zakir et al., 2015).  
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5.5.1.3. Cloud technology 
Cloud technology refers to the online space that can be used to store and share data (Harris, 
2017). Examples of cloud technologies include Dropbox, Google Drive, Amazon Drive and 
Apple iCloud. These platforms can be used for two purposes; data storage, and data sharing 
(Harris, 2017). This eliminates the need to store and share data on external data storage devices 
such as external hard-drives or flash drives that can easily be corrupted, stolen, damaged or lost.  
Many cloud technology platforms are open source software (i.e. are freely available to the 
public). These platforms are simple to use, and can be accessed by anyone from any location, 
provided that they have access to the internet, both simplifying and speeding up the sharing of 
information with relevant parties (Baiju, 2017). There are shortcomings to cloud technology. 
The first is that one can only access a limited storage capacity. When this predefined capacity 
is exceeded, a fee must be paid to access further storage capacity. Another shortcoming is that 
cloud technology can only be accessed with an internet connection (Baiju, 2017). 
5.5.1.4. Online teaching services 
Online teaching services are popular platforms used to replace the need to physically attend a 
lecture (Palloff & Pratt, 2001). These platforms are delivered through the internet i.e. lectures 
can be accessed online. There are many forms of online teaching services, such as online classes 
(courses that are delivered on the Internet), or hybrid courses (a combination of traditional, 
face-to-face classes and online courses) (Tallent-Runnels et al., 2006). In some cases, online 
teaching services are regarded as a form of cloud technology, however, in this research, these 
services are classified outside the jurisdiction of cloud technology. 
Online teaching services offer several benefits. The first is the fact that individuals in remote 
locations can access the necessary materials at their own discretion. The cost associated with 
online teaching is also less than that of traditional, face-to-face lectures. There is no need for a 
classroom, lecturer, or transportation to and from a venue (Armstrong, 2013). Online teaching 
also enables users to learn at their own pace, without a constant pressure to learn a large portion 
of work in a short time period (Norman, 2016).  
There are disadvantages to online teaching services. These platforms cannot accommodate 
human interaction, which is often a critical element of teaching. Also, these platforms can only 
be accessed with internet connectivity (Armstrong, 2013).  
5.5.1.5. Remote internet accessibility  
Remote internet accessibility is defined as “the ability to access a network from a remote 
distance” (Rouse, 2005). The context of this definition only refers to one part of the intended 
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meaning of remote internet accessibility. The intended meaning refers mostly to accessing the 
internet in remote locations where there is often insufficient electricity and network 
infrastructures. Since many PV systems’ scope include activities in these locations, it is 
necessary for the inhabitants of these locations to have access to some sort of network to share 
and access relevant information.  
There are numerous remote internet accessibility technologies on the market. One that has 
recently been receiving much attention is a robust, self-powered router that provides internet 
service to its users, developed by a company in Kenya. This device, one of many designed by 
the company, has proven to work in remote locations in Kenya, and is already used by the 
education departments of several sub-Saharan countries (Lamprecht, 2017). 
Remote internet accessibility technologies offer several benefits, which include providing 
access to important information, increasing economic growth of local businesses and 
entrepreneurs, and reducing the incidence of diseases through improved information sharing 
between patients and healthcare practitioners (Booth, 2003;  Deloitte, 2014). There are 
shortcomings in these technologies, which include high initial acquisition costs, maintenance 
costs and skill required to operate certain devices.  
5.5.1.6. Internet of Things 
The internet of things (IoT) has been a popular topic of debate in many circles and is a growing 
technology that is receiving increasing attention and investment. It is often regarded as a subset 
of big data analytics. For this research, however, IoT is investigated as a separate entity. The 
premise of IoT is that many objects used on a daily basis are connected on a network, allowing 
for numerous forms of communication (Gubbi et al., 2013). For example, in an ideal world, a 
fridge will be able to communicate with a mobile phone to notify that some products are almost 
empty or expired, and that these products must be replaced. Other examples of potential areas 
include traffic control, transportation, electricity usage (Gubbi et al., 2013), and healthcare 
(Islam et al., 2015).  
IoT offers a variety of benefits. With the implementation of IoT, access to information will be 
improved. A broader range of information that has not been captured before will be available. 
Cost saving is another benefit since devices are used more efficiently and effectively, reducing 
costs such as water and electricity usage. Transparency is also improved with IoT, because 
information is shared across several platforms that can be accessed by numerous parties (Gaille, 
2016; Varun, 2016). 
Stellenbosch University  https://scholar.sun.ac.za
87 | P a g e  
 
There are shortcomings to IoT that should be considered. Firstly, there is a cost component 
related to the physical infrastructure that must be installed. Secondly, IoT could reduce 
employment since daily activities are automated. Lastly, because IoT is still in its infancy and 
because it is a complex network, the chances of failure are still high (Gaille, 2016; Varun, 2016).  
5.5.1.7. Mobile technology 
Mobile technology refers to technologies that are used for cellular communication and other 
related aspects (Macwan, 2017). Gaining increasing popularity and injection into new markets 
(Kendrick, 2013), mobile technologies have been one of the most successful technological 
developments (Macwan, 2017). There are many different technologies that are categorised 
under mobile technology, such as cellular phones, smartphones, portable computers, tablets, 
PDAs (personal digital assistant) and GPS devices. Many of these technologies are used in 
combination and interact to connect people in different locations and allow them to share many 
different types of information.  
There are several benefits offered by mobile technologies. These technologies are mobile and 
can be used in nearly any location. In the healthcare industry, sharing of information enabled 
by mobile technology has allowed for distant healthcare monitoring. These technologies are 
able to transmit information much quicker, and enable individuals in remote locations to stay 
in contact with other communities (Kendrick, 2013).  
One should consider the shortcoming of mobile technologies. There are both acquisition and 
maintenance costs that should be considered. Integration of mobile technologies into an existing 
infrastructure might also pose a problem since compatibility of devices may be a challenge. 
Another shortcoming is that the tangible devices might get stolen, damaged or lost and must 
therefore be closely monitored (Kendrick, 2013). 
5.5.1.8. User videos 
User videos are predominantly used for training and education. Videos are created by 
individuals or teams who are knowledgeable about a certain topic and shared with others to 
train or educate them in a specific field or guide them through a certain process. These videos 
are often used in education departments to train and educate both teachers and students in 
remote locations where it is difficult to gain physical access (Lamprecht, 2017). 
There are limitations to these types of videos. The videos cannot be accessed without the 
necessary hardware, such as computers or tablet devices. The planning and creation of these 
videos must also be done meticulously, because missing or wrong information may cause 
complications (Lamprecht, 2017).  
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5.5.1.9. Block chain 
Block chain is defined as “a decentralised ledger of all transactions across a peer-to-peer 
network…participants can confirm transactions without the need for a central certifying 
authority” (Morrison & Sinha, 2016). In simple terms, block chain allows for transactions such 
as payments and record sharing to occur between peers, without the need for an intermediary 
who manages the exchange. This technology has been receiving increased attention over the 
last decade, and is already used by some of the world’s top professional services organisations 
(Hackett, 2016). The potential application areas of block chains are many, including financial 
services, political voting, transportation and healthcare. To provide an example of the latter, 
block chains can be used to share private patient related data with several parties without the 
risk of privacy breaches (Morrison & Sinha, 2016). 
Block chain offers several benefits, such as reduced transaction costs, improved protection of 
private data, permanent record keeping of transactions, and increased transparency between 
peers (Morrison & Sinha, 2016). However, there are shortcomings to consider. The technology 
is still in its infancy stage, meaning that the technology and systems used are complex. There 
may also be a clash in priorities between regulatory agencies and organisations seeking to rely 
increasingly on block chain technologies since the need for external, regulatory involvement is 
reduced. Lastly, the implementation of block chain technologies in the contemporary setting 
may also create challenges with regard to integration and compatibility with existing systems 
(Morrison & Sinha, 2016). 
5.5.1.10. Non-traditional transportation 
Non-traditional transportation refers, in this case, to those modes of transportation that are not 
commonly used. In other words, it does not refer to transportation modes such as trucks, trains, 
or aeroplanes, but rather modes on a smaller scale, such as bicycles and pushcarts. Over the last 
decade, the Coca Cola Company has led the way in the exploitation of non-traditional 
transportation in several African countries (Berry, 2010). The areas in which the company’s 
product is consumed are often inaccessible, because of the poor conditions of the roads leading 
to these areas. To address this obstacle, the Coca Cola Company employed local entrepreneurs 
to distribute their product to these areas, with the use of bicycles or pushcarts. As a 
consequence, the inhabitants of vastly remote locations have increased access to the products 
of the Coca Cola Company (Berry, 2010). 
Non-traditional transportation services offer several benefits, which include increased local 
entrepreneurship and the simplification of delivery modes since no trucks are needed. There are 
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limitations to consider, such as an increased probability of damage to the product (bicycles are 
unsteady and might lead to product damage) and the limitation with regards to how much 
product can be shifted on one delivery (there is limited space on a bicycle or pushcart). 
5.5.1.11. Mobile applications 
Mobile applications, better known as mobile apps, are software programmes designed for 
mobile devices to enable a wide array of functionalities. Mobile apps are used for a number of 
purposes, which include navigation, entertainment, sport, fitness, and productivity 
(Viswanathan, 2017). These apps can be accessed on many different platforms, such as Google 
Play or Apple App Store. The use of mobile apps have grown exponentially over the last decade, 
with an estimated 197 billion apps forecasted to be downloaded in 2017 (Viswanathan, 2017).  
Mobile apps are relatively easily maintained (depending on the degree of complexity of the 
functionalities enabled by the app), easily modifiable for different requirements and platforms 
and relatively simple to develop for nearly any function. There are limitations to consider. These 
include a limited scope of functions that can be executed, and the need for a smartphone or 
tablet device to access these apps (Singh, 2017). 
5.5.1.12. Educational television and radio programmes 
Educational television programmes refer to programmes that incorporate different elements of 
education. These programmes are aired across a television network, with a wide target market. 
Many shows are aimed at children within a low age range (1-5 years), whereas other 
programmes are aimed at adults (Western Governers University, 2017). The latter may 
incorporate different social elements and provide essential educational aspects, such as safe sex 
practices and anti-drug initiatives. 
There are several benefits associated with these educational television programmes. These 
programmes allow for a large audience to be reached, even in remote locations. It also 
eliminates the need for the physical presence of educators or trainers. One potential 
disadvantage is that the intended message of these types of programmes can be misinterpreted, 
which might lead to unintended behaviours. According to Ostrov et al. (2013), another potential 
disadvantage is that some of these programmes can lead to aggravated behaviours and attitudes, 
especially amongst the younger population. 
Radio programmes, like educational television programmes, are educational programmes 
intended to convey a certain message of a subject to a certain target audience. However, instead 
of using the television, educational radio programmes are delivered across radio broadcasts. 
The benefits and limitations of these types of educational programmes are like educational 
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television programmes. However, there is one additional limitation to consider, namely that 
radio programmes allow only for audible communication, which limits the amount of 
information that can be shared.  
5.5.1.13. Wireless Application Protocol based messaging 
Wireless Application Protocol (WAP) is a “specification for a set of communication protocols 
to standardise the way that wireless devices, such as cellular telephones…can be used for 
Internet access, including e-mail, the World Wide Web, newsgroups, and instant messaging” 
(Rouse 2010). WAP based messaging refers to messaging platforms that are based on WAP 
technology, such as Mxit, and Blackberry messenger. For this research, the well-known 
application, WhatsApp, is not included in these messenger platforms, since it can only be 
accessed with more advanced smartphones, compared to the other platforms. 
WAP based messaging does not require advanced smartphones, but rather less expensive 
mobile technologies. It also allows for information to be shared in real-time. On the other hand, 
WAP based messaging can only be used within an area where there is access to a mobile 
network, which may be an obstacle to use in some areas. 
5.5.1.14. Routine assessments 
Routine assessments can be done in many ways, such as examinations, interviews, projects, or 
surveys. These assessments are used to assess the knowledge and experience of employees, and 
determines whether a specified threshold is met (Lamprecht, 2017). These assessments are used 
in many disciplines, such as healthcare and education. Often, it is seen as a type of incentive 
scheme, since some form of incentive (e.g. funding or promotions) is given to those who excel 
in these assessments.  
Routine assessments allow for a routine check-up on the level of expertise, which enables those 
in management positions to intervene where necessary. These types of assessments also 
eliminate the need for the physical presence of an SME since the assessments are mostly done 
on computers. There are shortcomings to these assessments. It is possible for those being 
assessed to cheat i.e. get information from colleagues. Also, in some areas where there are no 
access to computers and internet networks, these assessments cannot be used (Lamprecht, 
2017). 
5.5.1.15. Game-based learning 
Game-based learning is a method of incorporating educational content or learning principles 
into video games (Coffey, 2007). Game-based learning is the use of educational games to teach 
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the user certain aspects of the real world. Many of these games are developed as mobile apps 
(described in an earlier section) and are widely available.  
Game-based learning engages and motivates students with a custom learning experience and 
promotes long-term memory. It also contributes to the development of certain computer skills, 
which is a necessity in modern society. An important criticism is that this type of learning may 
be more distracting than more traditional teaching methods. Additionally, game-based learning 
can be resource intensive, since it requires a computer, tablet, or smartphone to be accessed. 
5.5.2. Concluding the technology landscape assessment 
There are numerous technologies that can possibly be implemented in PV to address some of 
the root causes identified in Chapter 4. Each of these technologies offer several benefits that 
could potentially be leveraged towards the improvement of PV. However, there are also some 
shortcomings or limitations to each of these technologies that must be considered. The potential 
of each technology to address some of the root causes of prominent challenges in the PV 
landscape will be explored in the next chapter. 
5.6. Chapter 5 conclusion 
This chapter is made up of two sections, namely a brief overview of technology selection 
frameworks, and an overview of the technology landscape that is applicable to PV. In the first 
section, it is argued that, for this research, it would be beneficial to select an appropriate 
technology selection framework for application. Several technology selection frameworks are 
investigated, followed by a concluding argument that justifies the selection of a specific 
framework that will be used in the subsequent chapter. The focus of the second part of this 
chapter is the technology landscape. The purpose is to identify several technologies that can 
possibly be leveraged towards the benefit of PV. 
In the next chapter, the two sections of this chapter will be merged i.e. the technology selection 
framework will be used as linkage between the technologies and the root causes identified in 
the previous chapter. In other words, the technology selection framework will be used to create 
a context that provides further explanation of the root causes, which will be used to refine the 
list of technologies to several candidate technologies for application to each root cause.  
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Chapter 6: Investigating technology and root causes 
___________________________________________________________________________ 
In this chapter5 the root causes identified in Chapter 4 are linked to the technologies identified 
in Chapter 5, using the technology selection framework developed by Chan & Kaufman (2010) 
as guidance. The landscape of potential technologies is condensed to a list of candidate 
technologies that could feasibly be used to address the challenges in PV. This is followed by 
establishing a link between the selected technologies and the prioritised root causes, where it is 
discussed which technologies can be used to address which root cause. 
In the previous chapter, the primary focus was on the implementation of certain tools and 
techniques in order to achieve a specific outcome. In large part, this is an essential component 
of Industrial Engineering i.e. finding the appropriate methodologies that can be used to address 
a specific problem. However, this chapter moves away from this, and in fact, is a guiding 
discussion of qualitative data.  
It should be made clear that the discussions that follow are non-exhaustive, and that the 
researcher is aware of this. In order to provide a maximum amount of suggestions and to provide 
a comprehensive overview, validation is used. This ensures that the discussions and overviews 
not only contain the opinion of the researcher, but also those of SMEs who have more 
experience in the field of PV. The validation process is described and shown in Section 6.9. 
6.1. Technology selection framework implementation outline 
It is important to define how each of the categories in the technology selection framework, 
developed by Chan & Kaufman (2010), are used to assess the technology landscape in order to 
make it clear exactly how the framework categories are defined for the purpose of this research. 
Table 18 indicates which categories of the framework are used to describe the root causes, and 
which to describe the technologies. The root causes are described within the clinical domain 
(first category in Level 1), to formulate a problem statement, where the particulars of the 
problem are described. The remaining category in Level 1 (setting), as well as the categories in 
Level 2, are used to filter the landscape of potential technologies to a set of candidate 
technologies that could feasibly be implemented within PV. The factors that are considered 
during this filtering process are: (i) the characteristics of the setting within which the technology 
would need to operate; (ii) the skills development required for the workforce to effectively 
                                                 
5 A large portion of the contents of this chapter has been published in an article that has been submitted to the 
IAMOT2019 conference. A copy of this article is included in Section E.1 in Appendix E. 
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implement, utilise, and manage the technology; (iii) the feasibility of integrating the technology 
into the existing communication modalities; (iv) the degree of affordability and connectivity to 
determine the potential for meaningful access; and (v) the interaction with the technologies 
regarding interface. Once the candidate technologies have been identified, Level 3 of the 
framework is utilised to describe how each of the candidate technologies can be implemented 
within PV, by describing real-world examples of possible applications. 
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Table 18: Outline of how each category in the technology selection framework is used. 
Level Category in framework Description of the assessment of each technology during each category 
L
ev
el
 1
 
S
it
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a
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o
n
a
l 
fa
ct
o
rs
 
Clinical domain 
Define and describe each root cause within the context of the clinical domain, providing an explanation in the form of a 
problem statement. 
Setting 
Define how each technology will be influenced by the environmental settings (e.g. weather conditions) and by infrastructure 
support (e.g. access to electricity and security measures). 
L
ev
el
 2
 T
ec
h
n
o
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g
y
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n
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h
ea
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h
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n
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o
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Workforce 
Describe the requirements regarding existing and additional training of users, leadership commitment, and technical 
expertise for each technology. 
Delivery mechanism 
Describe the integration of each technology into the existing infrastructure about communication modalities, and highlight 
any obstacles that might surface during this stage. 
T
ec
h
n
o
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g
y
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n
d
 
ta
rg
et
 p
o
p
u
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o
n
 
Meaningful access Describe the feasibility of each technology in terms of affordability and connectivity. 
Interface 
Where applicable, identify essential requirements about the interface of the technology, and highlight possible obstacles that 
should be overcome concerning the physical interaction with the information display (e.g. screen) or input of the technology. 
L
ev
el
 3
 
E
m
p
ir
ic
a
l 
ev
id
en
ce
 
Potential application 
and research needs 
After the technology landscape has been refined to a set of candidate technologies, possible, real-world implementations of 
the technologies are provided, giving a tangible indication of how these technologies can be leveraged towards addressing 
some of the challenges in PV. Additionally, existing research and future research of technology in healthcare and 
pharmacovigilance is discussed. 
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6.2. Clinical domain-based root cause description 
In order to determine which root causes should be addressed in this analysis, the suggestions 
made by SMEs, as described in Section 4.6.3, are used. As part of the exercise during which 
the root causes were validated, distinctions were made between the root causes that deserved 
greater attention compared to others. In essence, similar to the approach taken with the 
prioritisation of the PV challenge landscape in Chapter 3, the SMEs indicated which root causes 
should be prioritised in this research, based on their experience within the PV context. 
Therefore, these root causes were deemed to be of priority and form the focus of subsequent 
discussions. The intention is, however, not to suggest that the other root causes should be 
ignored, merely that it does not form part of the set of root causes prioritised for investigation 
in this research project. Other than the opinions of the SMEs consulted during the validation of 
all the identified root causes, there are two additional reasons why the selected set of root causes 
are singled out for further investigation:  
 Some of the root causes cannot necessarily be addressed with technology alone. Instead, 
other interventions such as additional funding or adjusted management practices are 
more plausible for addressing these root causes; and 
 Focussing on only a selected set of root causes reduces the scope of this research effort, 
allowing for a more in-depth analysis on the most important root causes, rather than a 
more superficial focus on a larger set of root causes. 
In line with the implementation plan for the technology selection framework described in 
Section 6.1, the root causes summarised in Table 196 are described in term of the clinical 
domain category in Level 1 of the technology selection framework. This is shown in Table 20. 
 
 
                                                 
6 The process of identifying root causes was described in Chapter 4. The set of root causes summarised in Table 21 were 
identified using fishbone diagrams documented in Section C.2 in Appendix C, with the set of root causes summarised in Table 
12. 
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Table 19: Prioritised root causes according to the SMEs (as discussed in Section 4.6.3). 
Originally 
identified 
challenge 
(strategic level) 
Challenge identified during Stage 1 of the 
translation process 
Root causes identified during Stage 2 of the translation process 
Insufficient 
resources 
Inadequate access to ADR reporting forms 
(spontaneous). 
1. There is no designated transportation service to distribute the ADR reporting forms to the different 
facilities. 
2. The users of the forms have competing priorities, and do not have time to notify the person in charge 
of re-ordering the ADR reporting forms when stock is depleted. 
3. The individuals responsible for coordinating the deliveries of spontaneous ADR reporting forms are 
not sufficiently trained to execute these tasks. 
Country-specific 
factors 
Failure to develop locally relevant and easily 
measurable indicators of performance of PV 
systems. 
1. Key stakeholders are not aware of the health impact of PV on the healthcare system. 
ADR under-
reporting 
The lack of robust local data limits the extent 
to which decision-making can be done. 
1. Key stakeholders are not aware of the health impact of PV on the healthcare system. 
2. PV is not included in the undergraduate syllabus of tertiary healthcare education. 
3. The ADR reporting forms are overly complicated and take too long to complete. 
Transparency 
Inadequate feedback (newsletters, emails etc.) 
given to ADR reporters and other 
stakeholders. 
1. The importance of feedback is not sufficiently advocated. 
Continued on next page… 
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…continued from previous page. 
Originally 
identified 
challenge 
(strategic level) 
Challenge identified during Stage 1 of the 
translation process 
Root causes identified during Stage 2 of the translation process 
Insufficient 
resources 
Inadequate access to data management 
systems that can synthesise and analyse 
existing electronic health records. 
1. There is a lack of ownership of managing the process of data management. 
2. There is a lack of training provided to those who report ADRs. 
3. There are difficulties in providing the necessary training to individuals in remote locations in a timely 
manner. 
Insufficient 
resources 
Failure to utilise existing resources to conduct 
data collection, collation, and analysis. 
1. There is a lack of ownership to manage existing PV-related resources. 
2. There is a lack of training to educate PV personnel on how the available resources should be used. 
3. There is no resource management system in place to manage existing resource inventories. 
Transparency 
Lack of overarching platforms for information 
sharing between stakeholders. 
1. PV personnel are not sufficiently trained in using existing platforms. 
2. It is unclear what data should be shared with which stakeholders. 
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Table 20: Root causes described in terms of the clinical domain. 
Root cause Clinical domain 
1 
There is no designated 
transportation service to 
distribute the ADR reporting 
forms to the different facilities. 
In some settings, the transportation of the physical ADR reporting forms is challenging. There is not a designated transportation service in 
place that is able to collect ADR reporting forms from the location where these are created, and to transport the forms to different 
locations for use. Since many ADRs are still reported on a spontaneous reporting form, it is critical that these forms be readily available 
on demand. 
2 
The users of the forms have 
competing priorities, and do not 
have time to notify the person 
in charge of re-ordering the 
ADR reporting forms when 
stock is depleted. 
Due to severe workloads, especially in sub-Saharan African countries where the healthcare system is under-resourced, healthcare 
practitioners forget or for other reasons fail to request that the stock of ADR reporting forms be replenished. As a result, stock-outs of 
ADR reporting forms within healthcare facilities are frequently experienced. This leads to frustration on the part of the healthcare workers 
that are responsible for reporting ADRs and ultimately results in ADRs not being reported. It is possible that, in some cases, the person in 
charge of managing the ADR reporting form stock is not situated in the same healthcare facility in which healthcare practitioners reside, 
meaning calls must be placed to request that depleted form stocks be replenished. 
3 
The individuals responsible for 
coordinating the deliveries of 
spontaneous ADR reporting 
forms are not sufficiently 
trained to execute these tasks. 
It has been validated that in some cases, the lack of technical expertise with regards to ADR reporting form delivery management is an 
issue. As a result, healthcare facilities that need the reporting forms are not receiving sufficient stock. Consequently, a snowballing effect 
takes place where ADR reporting form stock is not replenished in time, which leads to ADR under-reporting, putting further pressure on 
the overall healthcare system since patients experiencing ADRs re-enter the healthcare system. Therefore, there is a need to address the 
lack of technical expertise with regards to the management of the delivery of ADR reporting forms. 
 
4 
Key stakeholders are not aware 
of the health impact of PV on 
the healthcare system. 
Key stakeholders might not be aware of the impact of PV not only on PV itself, but also the impact it has on the entire healthcare system. 
When a PV system is not functioning properly, the healthcare system will experience increasing pressure. The key stakeholders among 
which PV awareness should be increased are patients, healthcare practitioners, nurses, and pharmacists. These stakeholders represent a 
group that are most exposed to ADR reporting. The obstacle that surfaces during the creation of awareness amongst these stakeholders is 
that existing awareness programmes struggle to reach a wide audience, especially audiences in remote locations.   
 
Continued on next page… 
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…continued from previous page. 
Root cause Clinical domain 
5 
PV is not included in the 
undergraduate syllabus of 
tertiary healthcare education. 
In some undergraduate healthcare syllabuses, PV is not deemed a priority, and therefore does not receive the necessary attention. 
According to Mehta (2017), it is not a simple process to change existing syllabuses to focus more attention towards PV. As a result of the 
lack of PV education, increasing pressure is faced in the PV system where PV-related activities, especially ADR reporting, are not 
executed properly. Healthcare practitioners frequently do not know how or where to report ADRs.  When they do, the quality of the data 
they provide is poor. As many of the graduates of these programmes are currently employed in the healthcare system, the definition of this 
root cause within the clinical domain should be expanded to also include a lack of PV education amongst current healthcare system 
workers. A lack of training on ADR reporting is defined as a separate root cause in this table, the scope of training referred to here, 
however, extends beyond the scope of ADR reporting only to encompass an understanding of the PV system as a whole and ties in with 
the previous root cause to also include an understanding of the role of PV within the broader healthcare system. Like the previous root 
cause, the obstacle that one would expect to surface when attempting to provide PV education to the current healthcare workforce include 
reaching a wide audience, including audiences in strategic locations throughout a country. 
6 
The ADR reporting forms are 
overly complicated and are 
time-consuming. 
As reported in a study by Khan (2013), in many countries patients and healthcare workers are deterred from reporting ADRs due to overly 
complicated ADR reporting forms, as well as the great effort required to complete each of the fields in these forms. This is a phenomenon 
that is especially experienced in areas where spontaneous ADR reporting forms are used. Healthcare workers do not want to fill in these 
long documents, and would rather divert their attention and time to attending to patients, especially when they are remunerated on a 
patient-basis7. This issue is closely related to the lack of technical capacity discussed in the third and fifth root cause discussed in this 
table. Each of these three root causes ties back to the lack of technical capacity.  
Continued on next page… 
                                                 
7 This phenomenon is usually experienced in healthcare facilities where the healthcare worker to patient ratio is low i.e. there are only a small number of healthcare workers compared to the large number 
of patients. In these facilities, remuneration for healthcare workers is usually based on a patient-basis, meaning the healthcare workers (mostly doctors and specialists) are payed according to the number 
of patients they attend to. This is very closely related to the second root cause discussed in this table, which also relates to the competing priorities of healthcare workers. 
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…continued from previous page. 
Root cause Clinical domain 
7 
The importance of feedback is 
not sufficiently advocated. 
The feedback referred to here is the feedback given to ADR reporters. These reporters include both patients and healthcare workers. In 
some countries, feedback is not regarded as a priority, which is a mind-set that should be changed. Some of the PV systems have some 
form of feedback system in place, however, these systems are severely limited in capabilities. The only form of feedback is in the form of 
a once-off, automated response once an ADR report is submitted. Thereafter, no form of feedback is provided. It is argued in this research 
that feedback should be regarded as a priority. As shown in a study by Al Dweik et al. (2016), the lack of feedback is a barrier to ADR 
reporting in several countries. 
8 
There is a lack of ownership of 
managing the process of data 
management. 
 
The data management systems referred to here are the systems within local healthcare facilities. Since many of the staff in these facilities 
already have an overloaded schedule (similar to the second and sixth root causes discussed in this table), there may be a lack of ownership 
of managing the PV system, or in this case, the PV data management system (e.g. ensuring ADRs are reported, all the reports are 
collected, and the forms are captured on a computer). As a result, the PV systems in these facilities are of poor quality. It is therefore 
necessary to improve these PV systems, or rather PV data management systems. 
9 
There is a lack of training 
provided to those who report 
ADRs. 
ADR under-reporting, as described numerous times in this research, is one of the major challenges in PV. Since ADR reporting is the 
front-end of PV, it is critical that all possible ADRs are reported. It is often reported in there is a lack of training provided to the public, 
patients, and healthcare workers on ADR reporting. 
10 
There are difficulties in 
providing the necessary training 
to individuals in remote 
locations in a timely manner. 
This issue is closely related to the previously discussed root cause. Existing training initiatives struggle to provide the necessary ADR 
reporting (and broader PV-related activities) training to the public, patients, and healthcare workers in remote locations. It is severely 
important that individuals in these remote locations be aware of ADR reporting, since they might be the ones who, unknowingly, are 
experiencing ADRs. 
Continued on next page… 
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…continued from previous page. 
Root cause Clinical domain 
11 
There is a lack of ownership to 
manage existing PV-related 
resources. 
The resources referred to here are those intended for PV activities in local healthcare facilities, such as ADR reporting forms, computers, 
smartphones, tablets, and human resources. Resources form the cornerstone of any system, and should be efficiently managed. Since in 
many cases existing healthcare staff already have an overloaded schedule, there may be no one who is willing to take ownership of 
managing PV resources, and in turn, manage the PV system. It is therefore essential to intervene in these cases, by ensuring PV does not 
interfere with the schedules of the staff, but that PV is regarded as a priority and receives the necessary attention. This issue is closely 
related to the second and sixth root cause discussed in this table, which also relates to the overloaded schedules of healthcare workers. 
12 
Lack of training to educate PV 
personnel on how the available 
resources should be used. 
Closely associated with the lack of ADR reporting training previously discussed, the lack of training provided to healthcare staff in local 
facilities on how PV resources should be used is proving to burden the PV system in those facilities. It is essential that staff are trained on 
how to manage PV resources, such as ensuring the availability of ADR reporting forms, filling in ADR reporting forms, and capturing the 
data on a computer. This training should not only be provided to healthcare facilities in major cities or towns, but also to facilities in 
remote locations. 
13 
There is no resource 
management system in place to 
manage existing resource 
inventories. 
This is closely related to the two previously discussed issues that refer to the management of PV resources. It is incredibly challenging to 
manage these resources without some sort of system that is able to track and monitor inventories. It is not surprising that, in healthcare 
facilities where PV is not regarded as a priority, there are no initiatives taken to implement such a resource management system.  
14 
PV personnel are not 
sufficiently trained in using 
existing platforms. 
The platforms referred to here are those used between healthcare workers to share information with their peers, which can be in the form 
of emails, online chatrooms, blogs, or cloud technologies (e.g. Google Drive). These technologies are available, however, are still 
unfamiliar to some of the staff. There is a need for some sort of training to be provided to these individuals in order to ensure that each 
member of a healthcare facility know how information can be shared with the relevant parties.  
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Following the discussions in Table 19 and Table 20, it is now clear which root causes are 
regarded as priority in this research. The primary focus of the subsequent research is on these 
prioritised root causes. Shifting focus away from the root causes and towards the technology 
landscape, the subsequent section investigates the feasibility of implementing the technologies 
identified in Section 5.5 in PV in order to address the prioritised root causes. 
6.3. Determining the feasibility of the technologies 
The next step, according to the implementation plan for the technology selection framework 
described in Section 6.1., is to analyse each of the technologies identified in Section 5.5 
according to the setting, workforce, delivery mechanism, meaningful access, and interface 
categories (described in Table 18) of the technology selection framework. These categories 
define several key considerations that are used to determine the feasibility of implementing 
each technology in the PV challenge landscape. 
For the sake of clarity, the 15 potential technologies that were identified for application to the 
PV landscape in Section 5.5 are summarised in Table 21. In the remainder of this section, each 
of these technologies will be analysed according to the aforementioned five categories, defined 
in the technology selection framework. 
Prior to the investigation of the analysis of the technology landscape, some terminologies that 
are used by the researcher throughout the analysis are clarified. These terminologies are 
explained in Table 22. 
Table 21: The 15 potential technologies identified for application in the PV landscape. 
Technology landscape 
Resource Management Systems (RMSs) 
Remote internet 
accessibility 
Educational television and 
radio programmes 
Big data analytics 
Internet of Things 
(IoT) 
Block chain WAP based messaging 
Cloud technology Mobile technology 
Non-traditional 
transportation 
Routine assessments 
Online teaching 
services 
User videos Mobile applications Game-based learning 
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Table 22: Terminologies used throughout the analysis of the technology landscape. 
Terminology Description 
Feasibility 
The term feasibility is used to describe whether or not it will be possible to implement a 
technology within a specific setting or context. 
Potential 
The term potential is used to describe, in this case, whether or not there is an acceptable 
likelihood that a technology can implemented within a specific setting or context. 
Tangible The term tangible is used to describe something that is perceptible to touch. 
Intangible 
The term intangible is used to describe something that cannot be touched or does not 
have a physical presence. 
Setting 
Not referring to the “setting” category used to assess the technologies, the term setting is 
used to describe resource limited setting, primarily in sub-Saharan Africa. 
Internet 
connection 
When referring to internet connections, intranet connections are included in the 
discussion. 
Technical support 
Technical support is used to make reference to the general need for assistance with 
procuring, installing, and operating hardware (computers, smartphones, tablets, etc.) and 
software. 
6.3.1. Resource management systems (RMSs) 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of resource management systems. 
6.3.1.1. Setting 
Resource management systems are not tangible, but rather intangible systems that are operated 
with the use of tangible technologies such as computers, tablets, and smartphones. Therefore, 
environmental factors are not applicable for assessing the feasibility of these systems. 
Infrastructure support, however, is an important element. Resource management systems rely 
heavily on electricity supplies to be operated. In many areas in several developing countries, 
electricity infrastructures are not dependable, and in some cases, non-existent. As a result these 
systems cannot be used in such countries where there is not a dependable electricity 
infrastructure. Another element of infrastructure support on which resource management 
systems rely is internet connectivity. Many of these systems rely on information being shared 
across several platforms in different locations. In countries where internet connectivity is not 
reliable, these systems may struggle to operate effectively. This is an area where remote internet 
accessibility, another technology assessed in this research, can be used to provide internet 
connectivity to areas where it is needed.  
Lastly, since resource management systems are accessed via hardware such as computers or 
tablets, security measures must be implemented to secure these devices from theft or vandalism.  
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6.3.1.2. Workforce 
Resource management systems are complex, because they incorporate several elements of an 
already complex system i.e. PV. Due to this complexity, resource management systems tend to 
become increasingly complex, and challenging to effectively implement and manage. 
Therefore, a large portion of the strategy to implement a resource management system would 
entail the training of the existing workforce to operate such a system. These training sessions 
must encompass a substantial portion of understanding of these systems, and as a result often 
become time-consuming and expensive. Another consideration is the influence of leadership or 
individuals in influential regulatory positions. Adopting a resource management system is a 
significant undertaking, and will therefore require a champion in an influential position to 
advocate the entire process. 
6.3.1.3. Delivery mechanism 
Resource management systems make use of communication modalities through an internet 
connection. In other words, the information generated by these systems can be accessed where 
there is access to an internet connection. This can be an obstacle, since internet networks in 
several settings are not reliable (as mentioned in Section 6.3.1.1). Therefore, it may be 
challenging to utilise resource management systems properly. 
6.3.1.4. Meaningful access 
Comprehensive and complex resource management systems are expensive, regarding both 
acquisition and integration into an existing system. This is a major shortcoming since many 
countries do not have sufficient monetary resources to access these systems. There are, 
however, less expensive resource management systems on the market that are likely more 
feasible for implementation in several resource-limited settings. Additionally, resource 
management can be adapted, where the principles of resource management systems are 
implemented in more generic application software. For example, existing software such as 
Microsoft Excel can be used to develop a simple resource management system which measure 
several characteristics such as resource utilisation and availability. To further exploit resource 
management systems, internet connectivity should be addressed, as already pointed out in the 
earlier sections. In other words, these systems should be universally accessible. This can be 
done by supplying internet connectivity to areas where the existing infrastructures are not 
sustainable. A technology such as remote internet accessibility can be used to provide such an 
internet connectivity infrastructure. 
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6.3.1.5. Interface 
Since resource management systems are accessed via a computer, tablet, or smartphone, 
interface plays a prominent role. Arguing that many employees in a workforce have limited 
knowledge about resource management and technology interaction, simplicity should be 
designed into these systems, making it easy for employees to both navigate through the system 
and access the necessary information. 
6.3.2. Big data analytics 
Only four of the five categories from the technology selection framework are used to assess the 
feasibility of big data analytics. Interface is not a relevant subject, since big data analytics 
mostly refers to behind-the-scenes software that are not visible to a user. 
6.3.2.1. Setting 
Similar to resource management systems, big data analytics are intangible, but rely on tangible 
products such as computers. Therefore, environmental factors are not applicable for assessing 
the feasibility of these systems. Focus should shift towards infrastructure support. Big data 
analytics are best utilised where there is a reliable internet connectivity. These systems gather 
data from several sources in different locations, making internet connectivity a requirement. 
However, in several developing countries, internet connectivity is not reliable and sometimes 
not available, therefore, implementing big data analytics will not be feasible.  
6.3.2.2. Workforce 
Big data analytics, similar to resource management systems, entail complex systems, 
algorithms, skills, and processes that are challenging for individuals, who are not familiar with 
the realm of big data, to understand. Therefore, a significant part of the implementation of big 
data analytics would be to train the existing workforce in PV to make use of the available 
systems and processes to capture and analyse large amounts of data. Such training will require 
several monetary resources to provide the necessary expertise, hardware, software, and 
materials. A network of technical support will also be needed, at least during the initial stages 
of system implementation, to provide constant assistance regarding system use and 
maintenance. Lastly, leadership is a critical element for the adoption of big data analytics, 
especially on a large scale. Leadership should provide both advocacy and guidance to the 
implementation of big data analytics in PV. 
6.3.2.3. Delivery mechanism 
The communication modalities used by big data analytics software depend on internet 
connections (and by implication any and all infrastructure related to internet connections) or 
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intranet connections. It is essential that these networks are maintained (as mentioned in Section 
6.3.2.1), since big data analytics collect and synthesise information from several sources in 
different locations. This can only be achieved when all these sources are connected to an online 
network, where it is possible for a single big data analytics system to gather the necessary data. 
The benefit of how assessed data is communicated on big data analytics software is that it offers 
visual representations that can be analysed by anyone with the necessary knowledge and skills. 
6.3.2.4. Meaningful access 
Since the operation of big data analytics software require a certain degree of knowledge and 
skills that may be lacking in developing countries and within the context of PV, adopting and 
integrating these systems into the existing infrastructure can prove to be too costly, especially 
within the short to medium term. However, a gradual approach may be more feasible, where 
smaller parts of a big data analytics system are implemented over a period of time, ultimately 
building the overall system. Big data analytics also significantly rely on internet or intranet 
connectivity (as mentioned before), meaning the existing internet network must be assessed to 
determine whether or not it can accommodate big data analytics systems. This can be an 
obstacle in several countries where the internet network is not reliable and sustainable. 
6.3.3. Cloud technology 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of cloud technology. 
6.3.3.1. Setting 
Cloud technology, similar to the previous technologies, is intangible, and relies on tangible 
items such as computers to be accessed. Therefore, environmental factors are not applicable for 
assessing the feasibility of these technologies. Cloud technology relies on internet connectivity, 
and in fact, cannot be used without it. Therefore, in locations where internet connectivity is not 
reliable, cloud technologies cannot be used for information sharing. Technologies such as 
remote internet connectivity is a candidate that can be used to supply such internet connectivity 
networks. 
6.3.3.2. Workforce 
Since cloud technology is a relatively simple platform to use, the burden of training of a 
workforce is not as large as that of resource management systems and big data analytics. These 
platforms are user-friendly, allowing for easily understandable processes by which one can 
store and share information. However, a critical element of cloud technology, technical support, 
must be considered. Since cloud technology rely on internet (and intranet) networks, a well-
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established technical support system should be in place to provide the necessary assistance 
where it might be needed. 
6.3.3.3. Delivery mechanism 
Regardless of the fact that cloud technology relies heavily on internet networks (as mentioned 
before), the communication modalities are vast. In fact, it depends entirely on the data types 
loaded onto these platforms. These platforms allow for several types of data to be shared, such 
as visual displays and audio files. This is especially beneficial towards PV, where data of 
different types are generated in many locations. 
6.3.3.4. Meaningful access 
The cost component of cloud technology is negligible, since most of the platforms are freely 
accessible. The only noticeable cost component comes with the purchase of additional storage 
space, since many of these platforms offer a limited capacity of storage at no charge. Any 
additional storage space must be bought. However, this cost is not significant (when compared 
with the cost of running PV systems), since it is structured around a small, monthly fee. Similar 
to big data analytics, cloud technology can also only be accessed with an internet (or intranet) 
connection. If the internet connection is insufficient, the cost component of cloud technology 
will become significant, since the internet connectivity network must be installed or improved. 
6.3.3.5. Interface 
Since the interfaces of cloud technology platforms such as Google Drive8 and Dropbox9 cannot 
be altered, interface interaction is not a major cause for concern. A noteworthy consideration is 
the training that should be made available to teach a workforce on how to interact with these 
platforms. 
6.3.4. Online teaching services 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of online teaching services. 
6.3.4.1. Setting 
Online teaching services, similar to the previous technologies, are intangible, and relies on 
tangible items, such as computers, to be accessed. Therefore, environmental factors are not 
applicable for assessing the feasibility of these technologies. Online teaching platforms are 
                                                 
8 URL: https://www.google.com/drive 
9 URL: https://www.dropbox.com 
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accessed via an internet connection and require reliable internet connectivity. It cannot be used 
in areas where internet connectivity is not sufficient. Another form of these teaching services, 
user videos, can be accessed without the use of the internet. 
6.3.4.2. Workforce 
Training of workforce with regards to online teaching services is a negligible factor, since the 
workforce is not responsible for the creation of these services. The materials that are used in 
online teaching services are developed by experts in the particular field, and will most likely 
have sufficient knowledge of the creation of these materials. The two forms of training one can 
associate with online teaching services are teaching PV workforce on accessing these services 
and improving computer literacy where it may be lacking. Technical support is, to a certain 
degree, negligible, since the developers of the online teaching services will most probably have 
access to technical support. Therefore, the end-users of the materials will not require technical 
support. Lastly, leadership support is another factor that does not have a large footprint in the 
adoption of online teaching services. The only form of leadership support is in the form 
managers motivating their workforce to spend the time in gaining the necessary knowledge 
from online teaching services. 
6.3.4.3. Delivery mechanism 
As per definition, online teaching services can only be accessed via an internet connection (as 
mentioned in Section 6.3.4.1), which will be a limitation in areas where internet networks are 
sub-optimal for such online services. However, online teaching services offer several 
communication modalities i.e. data of different types can be accessed. Both visual and audio 
data are offered by these services. Real-time interaction, where one can interact with some 
expert via a chatroom or video call, is also made possible with these services. 
6.3.4.4. Meaningful access 
The only significant cost components of online teaching services is access to an internet 
connection and the subscription to the online teaching services providers. It is possible that the 
latter be negligible, since several online teaching services are freely available to the public. As 
per definition of online teaching services, a reliable internet connection is necessary to access 
these services (as mentioned before). Therefore, in settings with poor or non-existing internet 
networks, online teaching services is not a feasible option. However, user videos that do not 
require internet connections, can be used as an alternative. The cost associated with technical 
support is not as significant as the previously mentioned cost components. It should be 
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considered as some form of technical support should be available to the users of online teaching 
services.  
6.3.4.5. Interface 
It is important to consider the level of knowledge of the audience for which online teaching 
services are created. This is applicable to both the workforce on a lower level of authority and 
responsibility and workforce on a higher level of authority, such as managers and supervisors. 
Learning new materials will most probably be challenging to anyone who are not familiar with 
the subject, and should therefore be designed to accommodate the level of knowledge of the 
target audience, as well as materials that challenge them to learn new skills and obtain 
knowledge. 
6.3.5. Remote internet accessibility 
Only four of the five categories from the technology selection framework are used to assess the 
feasibility of remote internet accessibility. Delivery mechanism is not a relevant subject, since 
the purpose of these technologies are to create and provide access to communication modalities 
such as emails. 
6.3.5.1. Setting 
Remote internet accessibility refers specifically to tangible items, such as router devices used 
for Wi-Fi connectivity. Therefore, environmental factors should be considered. For example, 
in areas with high humidity and heat or with a high frequency rainfall, devices should have a 
robust design to withstand such weather conditions. Another consideration is the location in 
which the devices will be installed, as well as usage patterns. In areas where infrastructure 
support is not adequate, such as poor security, provision should be made to implement certain 
security measures to ensure that the devices are not stolen or damaged. The aspect of power 
should be considered. Since some devices rely on batteries to draw power, the rate at which 
these batteries need replacement should be considered. Since several locations’ electricity 
supply is unreliable, batteries should be designed to be minimally reliant on electricity supplies, 
but rather to rely on renewable sources, such as solar energy. 
6.3.5.2. Workforce 
Given that remote internet accessibility, within this context, refers to tangible products such as 
router devices, workforce training is a requirement. Although companies developing these 
devices put a great deal of effort into simplicity, there will always be a certain degree of training 
needed. Personnel will have to be taught how these devices should be operated to supply an 
internet connection, including recharging of these devices. Another aspect that should be 
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considered is technical support. As with any form of internet connectivity network, technical 
support for remote internet accessibility technologies is essential. Some companies provide 
some form of technical assistance, via email correspondence or phone calls. However, 
maintaining these technical support systems in many different settings may be an obstacle. 
6.3.5.3. Meaningful access 
According to the researcher of this thesis, there are three significant cost components associated 
with remote internet accessibility, namely: acquisition, training, and maintenance. The first 
component is non-negotiable, since several tangible products such as router devices must be 
purchased in order to create a network of connectivity. Secondly, the cost associated with 
training a workforce on how to use the remote internet accessibility technologies should be 
considered. Lastly, the cost of maintaining both the hardware and software associated with 
remote internet accessibility technologies such as upgrades and updates respectively, should be 
considered. However, these maintenance costs are negligible in the short to medium term, since 
these technologies are designed to require few updates and upgrades. If these cost components 
become too significant, remote internet accessibility technologies may not be a feasible option. 
6.3.5.4. Interface 
The interface component of remote internet accessibility refers to the integration of the 
hardware (e.g. router device) into the existing infrastructure. In other words, the workforce must 
be trained on how hardware devices such as smartphones or computers can be connected to the 
network provided by the remote internet accessibility technologies. The interface pathway 
should be designed as simple as possible, to reduce the demand for technical support. 
6.3.6. Internet of Things 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of IoT. 
6.3.6.1. Setting 
IoT refers to intangible software, and relies on tangible items such as computers, smartphones, 
or tablets to function. Therefore, environmental factors are not applicable for assessing the 
feasibility of these technologies. Probably the most important factor associated with IoT is 
internet connectivity. Since IoT functions as a network where information is shared across 
several platforms, internet connectivity is a requirement. It is the only way through which these 
networks can function. Therefore, in areas where there is a lack of internet connectivity, IoT is 
not feasible. Remote internet accessibility can possibly be used in support of IoT to provide the 
necessary internet connections. 
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6.3.6.2. Workforce 
IoT adoption brings with it a requirement for a substantial amount of training, since the entire 
technology is based around both hardware and software interaction. Training to operate certain 
hardware devices such as computers and software platforms will be essential. The adoption of 
IoT on a large scale depends on significant monetary investments, and constant technical 
support systems. The lack of available funds to invest in such operations can hinder a large 
scale implementation. Therefore, small scale implementation of IoT technologies, followed by 
a gradual adoption of the broader system may be a more feasible course of action since it 
requires smaller monetary investments over a longer period of time. Another key requirement 
for the adoption of IoT is constant support from leadership, especially those holding influential 
positions, in order to encourage the workforce to utilise such systems. 
6.3.6.3. Delivery mechanism 
One of the several benefits offered by IoT is that it allows for different kinds of communication 
modalities. Once an IoT system is online, large amounts of information can be shared across 
several platforms, in both visual and audio configurations. Even though IoT is largely 
dependent on an internet network, which can be a major obstacle, the benefit of information of 
several types being shared across many platforms, accessible to nearly anyone, serve as a 
motivating factor for investments to be made towards the leveraging of IoT. 
6.3.6.4. Meaningful access 
If there is a lack of the necessary hardware and software, the cost component of IoT may be 
significant since it relies largely on hardware and software. IoT relies on the integration of 
several hardware and software products, by making use of complex algorithms that may be 
difficult to understand by those who are not familiar with IoT technology. Embedded in its 
name, IoT is also extremely reliant on internet connections. Therefore, in settings where internet 
networks are poor or non-existing, IoT may not be a feasible option (as mentioned in Section 
6.3.6.1).  
6.3.6.5. Interface 
The interface component of IoT is similar to that of remote internet accessibility technologies 
i.e. the integration of IoT into the existing infrastructure. Personnel should be trained in 
navigating the software interfaces of IoT. These interfaces must also incorporate simplistic 
designs to reduce the demand for technical support. 
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6.3.7. Mobile technology 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of mobile technology. 
6.3.7.1. Setting 
Mobile technology refers to tangible technologies that can be used by almost any individual for 
the main purpose of communication and information sharing. Environmental factors play a 
significant role in the realm of mobile technologies. Regions where severe weather conditions 
such as constant rain, or severe heat are often recorded, require robust mobile technologies able 
to withstand these conditions. Also, the manner in which these technologies will be used should 
be considered. Robust mobile technologies is once again a suggested requirement since many 
of these technologies will sustain wear and tear in some way. Another consideration is the 
existing mobile phone network. Mobile technologies rely on these networks to function. 
Therefore, in areas where mobile phone networks are not sufficient, mobile technologies are 
not feasible. Lastly, security measures are needed to protect mobile devices from theft or 
vandalism. 
6.3.7.2. Workforce 
Given that mobile technology has reached a rather mature state in several countries and its 
increased penetration in developing countries’ markets, the implementation of mobile 
technologies does not carry a large burden concerning training. In particular, mobile phones, 
smartphones, PDA devices, and tablets are user-friendly, reducing the need for constant training 
in operating these devices. However, in settings where mobile technology is not yet a 
mainstream technology, training is a requirement. As with many other training requirements, 
this training will demand monetary resources, since experts in these technologies must be 
consulted to assist those providing the necessary training. Technical support is another aspect 
to consider. Regardless of the many benefits offered by mobile technology, it is limited 
regarding technical issues. Reliable technical support networks will be a requirement to provide 
technical assistance where needed. 
6.3.7.3. Delivery mechanism 
Mobile technology offers two distinct communication modalities, namely: audible (phone calls) 
and textual communication (text messaging) (Chan & Kaufman, 2010). These modalities are 
already used in several contexts within PV, such as education, reminders and alerts as well as 
monitoring. Moreover, new generation mobile technologies add more to the existing modalities, 
such as Bluetooth, cameras and applications. However, these types of technologies that own all 
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these modalities tend to be more expensive than other technologies that without these 
modalities, which is a cost consideration.  
6.3.7.4. Meaningful access 
Mobile technology is an extremely popular technology used throughout the world, and is 
experiencing an increasing penetration in many developing markets (Chan & Kaufman, 2010). 
Therefore, the cost component of mobile technologies is becoming less of an obstacle towards 
adopting these technologies. However, some mobile technologies, such as smartphones, are still 
challenging to obtain due to significant costs to supply on a large scale. Other mobile 
technologies such as PDA devices that have been used more often in developing countries are 
more feasible options (at least in the short-term) than the more advanced mobile technologies. 
In the long-term, efforts should be diverted towards the large-scale adoption of advanced mobile 
technologies, such as smartphones. 
6.3.7.5. Interface 
Interface interaction is an important element of mobile technologies. There are several 
components of interface that should be considered. Arguing that there are individuals working 
in PV who have limited mobile technology literacy, especially smartphone technology, overly-
complicated icons, navigation pathways and menu structures may not be the sought after 
solution. Instead, these should be designed to be simple enough for any individual, with a 
certain level of training, to use on a daily basis with ease, without requiring constant support. 
6.3.8. User videos 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of user videos. 
6.3.8.1. Setting 
User videos refer to intangible products that rely on tangible products such as computers or 
tablets to function. Therefore, environmental conditions are not applicable. However, certain 
situational factors must be considered. Since one route of accessing user videos is often via the 
internet, connectivity infrastructures should be sufficient and able to accommodate access to 
such videos. The other route to access user videos is off-line, and does not rely on internet 
connectivity. The hardware used to access these videos should be considered. In areas where 
there is no existing infrastructure to support computers, additional hardware such as tablets or 
smartphones should be made available. However, these devices cause additional challenges. 
Security measures should be implemented to protect these devices from theft or damage. 
Additional security measures for software should also be implemented to ensure data privacy 
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is not breached. Tablets and smartphones are limited due to the requirement of batteries to be 
charges frequently. 
6.3.8.2. Workforce 
User videos are developed by experts in a particular field and accessed by others. There is no a 
significant burden associated with workforce training. A notable requirement is training the 
workforce in accessing these videos, and ensuring that they have the skills necessary to execute 
the work taught in the videos. As previously mentioned, these types of training carry a certain 
financial burden that should be considered. Depending on the level of knowledge of the target 
audience, technical support may not be a significant factor associated with user videos, since 
these materials are more than likely maintained by role players with access to the necessary 
resources. An important factor that may contribute to the successful adoption of user videos is 
leadership advocacy. Since user videos require the workforce to sacrifice their time, 
encouragement from management may be needed to motivate the workforce to put in the hours 
to access and learn from user videos. 
6.3.8.3. Delivery mechanism 
User videos offer the same communication modalities as online teaching services, except that 
interactive, real-time interaction is not possible. User videos only offer communication in the 
form of audio and visual material i.e. videos, that offer users the opportunity to access 
interactive materials (e.g. the process of navigating a particular software) that will equip them 
with the necessary skills and knowledge. Even though user videos might be offering less when 
compared to online teaching services, it can be argued that it is a more feasible option since it 
does not rely on an internet connection.  
6.3.8.4. Meaningful access 
A significant cost component associated with user videos is an indirect component, and is not 
directly related to the videos. In order to access and view these videos, one must have access to 
some type of hardware (e.g. smartphone, computer, tablet, or laptop). In several settings, these 
hardware products are not always available. Therefore, when determining the possible impact 
of user videos in PV, one should consider whether there is access to the necessary hardware to 
access these videos. Another cost component that should be considered is the cost of purchasing 
these videos, or purchasing access to these videos, which might be substantial. 
6.3.8.5. Interface 
The interface component of user videos is identical to that of online teaching services. The 
materials used in these videos should consider the audience. It should accommodate the level 
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of knowledge and skills of the target audience and challenge their intellect which is needed to 
provide them with new skills and knowledge about a specific subject such as ADR reporting 
via a mobile application. 
6.3.9. Block chain 
Only four of the five categories from the technology selection framework are used to assess the 
feasibility of block chain. Interface is not a relevant subject, since block chain technology, like 
big data analytics, refers to behind-the-scenes software that are not visible to the user. 
6.3.9.1. Setting 
Block chain is an intangible product functioning beyond the immediate view of the user. 
Environmental factors are therefore not applicable. The impact of certain situational factors 
should, however, be considered. Block chain relies on internet connectivity, which suggests 
that the lack of infrastructure implies that block chain may not feasible. Remote internet 
accessibility technologies can possibly be implemented to provide internet connections which 
will allow for the adoption of block chain. Since block chain is still in its infancy (Iansiti & 
Lakhani, 2017), information technology maintenance may be needed on a frequent basis. 
Therefore, maintenance support systems should be put in place to ensure that the installed block 
chain technologies operate efficiently and effectively.  
6.3.9.2. Workforce 
The adoption of a large scale block chain infrastructure may require a substantial amount of 
training if the users of the software do not have the required knowledge and skills. Since block 
chain technology is largely software based, the workforce should be provided with the 
necessary knowledge to operate these programmes. It should be considered that such training 
will be largely resource dependent, especially monetary resources. Ongoing technical support 
should also be provided. In settings where there is no technical support infrastructure, it may 
be challenging to implement and integrate block chain technologies into the existing system. 
Lastly, leadership support should be advocated. The adoption of complex systems such as block 
chain technologies, and in fact any new technology, may experience a certain degree of 
resistance from the workforce. Therefore, advocacy from those in leadership positions will be 
required to champion the entire process. 
6.3.9.3. Delivery mechanism 
Block chain technologies, being a revolutionary innovation, offer many communication 
modalities, which include textual and audible communication, Bluetooth, camera, applications 
and internet capabilities. In combination, these modalities can possibly be leveraged to the 
Stellenbosch University  https://scholar.sun.ac.za
116 | P a g e  
 
advantage of nearly any system. These modalities are already enabling an array of 
functionalities in the healthcare industry, such as low bandwidth data exchange, tracking and 
monitoring and device synchronisation (Chan & Kaufman, 2010). 
6.3.9.4. Meaningful access 
Block chain technology is still in its infancy stage, even in developed countries (Iansiti & 
Lakhani, 2017). Multinational companies such as PwC and Deloitte have only recently started 
pilot projects to test the feasibility of block chain technologies (Iansiti & Lakhani, 2017). This 
results in a substantial monetary investment, especially in developing countries. Therefore, the 
integration of block chain technologies in a PV system may not receive much attention in the 
short to medium-term due to the monetary constraints. However, in the long term, when block 
chain technologies have matured, it may be a feasible option in a PV system.  
6.3.10. Non-traditional transportation 
Only three of the five categories from the technology selection framework are used to assess 
the feasibility of non-traditional transportation. Delivery mechanism is not relevant, since this 
transportation is not a new addition, but rather the exploitation of an existing transportation 
network. Interface is not relevant, since there is no visual interaction with an electronic screen. 
6.3.10.1. Setting 
Environmental factors should be considered when assessing the feasibility of non-traditional 
transportation. Is areas where the raining seasons are long, provision should be made for the 
protection of the contents being transported via bicycles or pushcarts. Due to the frequent rain 
and possible storms, there may be delays in the delivery of the contents being transported, as 
well as possible damage to the contents being transported. 
6.3.10.2. Workforce 
Non-traditional transportation is not severely labour intensive, since existing transportation 
networks are exploited, ultimately creating job opportunities. A noteworthy training 
requirement that should be provided is to educate these transporters regarding administration 
behind the transportation of specific goods, such as preferred routes, locations of facilities, and 
the paperwork needed for confirmation of delivery. Another consideration is in the form of 
ownership, where an individual or team should take responsibility of the entire network of non-
traditional transportation services. 
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6.3.10.3. Meaningful access 
The need for financial support with regards to non-traditional transportation services depends 
largely on the existing state of an area. In other words, in areas where locals already have access 
to bicycles and pushcarts, the noteworthy cost component is associated with the employment 
of these individuals. On the other hand, if there is a lack of access to bicycles or pushcarts, the 
cost component becomes significant since there is a lack of access to the required transportation 
hardware. In such a situation, provision should be made for acquiring these modes of 
transportation, as well as the employment of individuals. 
6.3.11. Mobile applications 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of mobile applications. 
6.3.11.1. Setting 
There are certain situational factors that should be considered when assessing the feasibility of 
mobile applications. First, access to the mobile technology (smartphones or tablets) needed to 
access mobile applications should be assessed. It may not feasible to develop a state of the art 
application if there is no access to the hardware needed to use that application. Secondly, access 
to an electricity infrastructure should be assessed, since the devices needed to run mobile 
applications must be charged on a frequent basis, which can only be done when there is reliable 
electricity or some form of charging station. The lack of electricity affects the feasibility of 
mobile applications.  
6.3.11.2. Workforce 
In many cases, intensive training for the use of mobile applications may not be necessary, since 
they are designed to be simple and easy to use. The one form of training that should receive 
attention is at the start of the roll-out of a new mobile application, where users are shown how 
to use the application. Another form of training would be to educate certain individuals who 
can act as technical experts to serve as technical support and provide technical assistance to 
those who might be struggling to use or understand a particular function within the application. 
6.3.11.3. Delivery mechanism 
The communication modalities offered by mobile applications depend on the development of 
the application. Some applications offer both audible and visual communication, whereas some 
offer only one of the two. It can be argued that an application offering both modalities can be 
more beneficial. However, it depends entirely on the context in which the application is 
developed, because in some cases it may not be necessary for both modalities. 
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6.3.11.4. Meaningful access 
Since many mobile applications are freely accessible, the cost component to acquire these 
applications is negligible. However, there is an indirect cost to consider. Since these 
applications can only be accessed with hardware such as smartphones or tablets, the cost of 
acquiring these hardware components should be considered. In other words, in areas where 
there is no access to these types of technologies, the cost component of mobile applications 
becomes considerably more compared to areas where there is access to the necessary hardware 
(e.g. smartphones or tablets). 
6.3.11.5. Interface 
The interface component of mobile applications should receive considerable attention. Since 
applications are relatively easy to develop and maintain, adjustments can be made to its 
interface. Many applications make use of a hierarchical menu design, which is simple and easy 
to understand. The graphics of these application allow for easy navigation and understanding 
the instructions that should be followed.  
6.3.12. Educational television and radio programmes 
Only four of the five categories from the technology selection framework are used to assess the 
feasibility of educational television and radio programmes. Workforce is a negligible category 
since educational television and radio programmes do not require any form of training. These 
programmes are simply sent to local television and radio stations to be aired to local 
communities. 
6.3.12.1. Setting 
One critical situational factor should be considered when determining the feasibility of 
educational television and radio programmes, which is the local access to televisions and radios. 
In other words, in areas where access is limited, it may not be feasible to implement education 
television and radio programmes, since it will not reach a large audience.  
6.3.12.2. Delivery mechanism 
When referring to the communication modalities offered by educational programmes, a 
distinction must be made between television and radio. Educational television programmes 
offer two communication modalities in the form of audio and visual material. Having access to 
both modalities is advantageous since different kinds of information can be transferred. With 
reference to educational radio programmes, only audible communication is possible, since there 
is no visual representation of the information being discussed.  
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6.3.12.3. Meaningful access 
Since the television and radio industry has grown considerably in the last decade, especially in 
sub-Saharan African countries, the cost component of the education programmes delivered 
across these platforms is not significant, since there is no need for the provision of televisions 
and radios on a large scale. However, cost component to be considered is the development of 
these educational programmes. There may be costs involved with purchasing these programmes 
for use in a specific area, or purchasing access to these programmes. 
6.3.12.4. Interface 
The interface component of educational programmes relates largely to those programmes aired 
across a television network. Many of these types of programmes are designed to be as simple 
as possible, easily understandable, yet manages to convey an important message. Depending 
on the message delivered and the mode used (television or radio), the materials on these 
programmes should be clear and understandable to anyone outside the realm of the context in 
which the programme was developed.  
6.3.13. Wireless application protocol based messaging 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of wireless application protocol based messaging. 
6.3.13.1. Setting 
The influence of both environmental and situational factors should be considered with regards 
to WAP based messaging. Firstly, WAP based messaging is done via hardware, such as mobile 
phones or computers. In areas with high humidity and extended raining seasons, provision 
should be made for robust hardware, able to withstand these extreme weather conditions. 
Security measures are also needed to secure the hardware from theft or vandalism. Secondly, 
with reference to situational factors, access to electricity and mobile networks should be 
determined, since WAP based messaging hardware is ultimately dependent on these networks. 
The lack of networks indicates that WAP based messaging may not be feasible.  
6.3.13.2. Workforce 
WAP based messaging, similar to mobile applications, need some form of training. When such 
a messaging system is made available, there should be an initial training session provided to 
educate users on how these systems work, and how it should be used. Provisions should also 
be made for technical support, which will provide technical assistance on a regular basis. 
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6.3.13.3. Delivery mechanism 
WAP based messaging, depending on the platform used, offer either audible or visual 
communication, or both. These communication modalities allow users to talk to one another in 
real-time, and also enable them to share relevant pictures and documents. For example, MxIt 
can be used to easily share pictures and communication between individuals who might not be 
in the same location in real time. 
6.3.13.4. Meaningful access 
Access to WAP based messaging may not be a significant cost component, since many of these 
messaging platforms are freely available. There is, however, an indirect cost consideration. The 
use of these messaging platforms depends largely on access to hardware such as smartphones 
or computers. Thus, if there is poor access to these types of hardware, the cost component 
becomes considerably larger, since provision must be made for these hardware devices.  
6.3.13.5. Interface 
The interface of WAP based messaging platforms is fairly easy to understand, since it makes 
use of simple menu structures and navigation pathways. There may be some degree of training 
required for users to understand these interfaces. This training is mostly a once-off training 
session, and not regularly required. 
6.3.14. Routine assessments 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of routine assessments. 
6.3.14.1. Setting 
A key consideration with regards to routine assessments is the degree of access to the mode 
through which these assessments are carried out. In other words, when these assessments are 
done via computers, the access to computers should be assessed. In areas where there is no 
widespread access to computers, it may challenging to fully utilise these types of assessments. 
Additionally, a paper-based system can be used if there is a lack of access to computers. 
6.3.14.2. Workforce 
A noteworthy training component of routine assessments depends on the mode used to deliver 
these assessments. For example, if these assessments are done on a computer, users should be 
provided with training to educate them on navigation (i.e. computer literacy) and completion 
of the assessments. On the other hand, if a paper-based system is used, the training component 
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is not as significant as that of a computer-based system, since there is minimal interaction with 
technologies such as computers. 
6.3.14.3. Delivery mechanism 
Depending on the type of routine assessment, the communication modalities differ. In some 
cases, for example assessments done on a computer, both audible and visual communication is 
enabled which, in some cases, allow for a wider range of information to be shared. When 
considering a paper-based routine assessment system, only visual communication is possible, 
since there is no provision for audible communication such as videos, which can be an obstacle. 
6.3.14.4. Meaningful access 
The cost component of routine assessments depends largely on the mode through which these 
assessments are delivered. For example, if the system is a computer-based assessment, there 
may be a cost component related to the creation of an online and computer-based platform to 
be used to conduct these assessments. On the other hand, if it is a paper-based system, the cost 
component will be structured differently. The need for several provisions such as the printing 
of hardcopy assessments, as well as the distribution, collection and analysis of these 
assessments should be considered.  
6.3.14.5. Interface 
Regardless of the type of routine assessment (computer– or paper-based), the interface 
component should be assessed carefully. Computer based assessments should have easy-to-
understand menu structures and navigation pathways. The icons and graphics used to represent 
certain types of information (e.g. an envelope icon representing a messaging forum) should also 
be relevant to ensure that no-one is unclear on how to navigate these assessments. On the other 
hand, paper-based assessments should also be thoroughly investigated to ensure that there is no 
ambiguity and uncertainty, which may lead to wrong interpretations of the questions. 
6.3.15. Game-based learning 
Each of the five categories from the technology selection framework are used to assess the 
feasibility of game-based learning. 
6.3.15.1. Setting 
There are both environmental and situational factors to consider when assessing the setting 
aspect with regards to game-based learning. Firstly, the environmental impact on the hardware 
used to access these game-based learning platforms should be considered. Provisions should be 
made to supply robust hardware to areas with severe weather conditions such as high humidity 
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and heavy rainfall. Security measures is also needed to secure these devices from theft and 
vandalism. A situational factor to consider is the access to electricity infrastructures needed to 
maintain the hardware. Therefore, in areas with a lack of access to a reliable electricity network, 
game-based learning may not be feasible. 
6.3.15.2. Workforce 
In many instances, game-based learning may need routine training sessions to educate users on 
the use these platforms. Since many of these game-based learning platforms regularly update 
or change, some form of training should be provided to educate users of the purpose of these 
games, and show them how the principles taught in these games reflect in real-world 
applications. A certain degree of technical support may also be needed, since access to games-
based learning platforms requires a certain level of computer literacy, which may be a challenge 
in settings where some individuals may not be computer literate.  
6.3.15.3. Delivery mechanism 
The communication modalities offered by game-based learning depends on the type of game. 
In some cases, the game can be designed to contain both visual and audible information, which 
is in its own way advantageous, since some individuals may learn much quicker with audible 
and visual communication. Other game-based learning platforms may only offer visual or 
audible communication, which can be a limiting factor regarding the amount and quality of 
information shared. 
6.3.15.4. Meaningful access 
There are two noteworthy cost components associated with game-based learning, namely: the 
development of the game itself and access to these games. These costs largely depend on the 
context in which the game-based learning platforms are implemented.  
For example, in areas where access to the hardware needed for the learning platforms is not 
sufficient, provision must be made to supply the hardware, implying that the cost component 
may become considerably larger. 
It is therefore important to consider the context in which these game-based learning platforms 
are developed, since these context-specific factors govern the cost associated with these 
platforms. 
6.3.15.5. Interface 
Game-based learning platforms, which is essentially games on computers or smartphones, 
should not be too complex. The navigation pathways should be clear and simple to navigate to 
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ensure that the principles contained in these games are correctly interpreted. Another 
consideration is that the visual contents in the game should be relevant to the subject at hand. 
In summary, 15 technologies have been assessed according to setting, workforce, delivery 
mechanism, meaningful access, and interface, the categories found in Level 1 and Level 2 of 
the technology selection framework developed by Chan & Kaufman (2010) (the technology 
selection framework deemed most applicable for the purpose of this research). 
6.4. Refining the technology landscape 
Making use of the discussions in the previous section, the 15 technologies identified in Section 
5.5.1 and assessed in Section 6.3, are refined to a selected set of technologies that are feasible 
for implementation in PV. Three distinct exclusion criteria are used to determine which of the 
technologies are to be excluded from this research, namely: (i) cost; (ii) development-time; and 
(iii) workforce. These three criteria are based on the opinions of the SMEs consulted during the 
validation process discussed in Section 6.9. These criteria are discussed in Table 23. 
The technologies that are excluded (big data analytics, IoT and block chain) from the selected 
set of technologies are summarised in Table 24 where their exclusion is briefly motivated. 
These technologies are primarily excluded due to the need for a significant resources (regarding 
cost, development-time and workforce-intensity) in the short to medium-term. 
Table 23: Exclusion criteria for technology landscape. 
Criteria Description 
Cost 
If a technology is deemed too resource-intensive to implement on a large scale due to 
the required monetary investments within the short to medium-term, it is excluded 
from further research. 
Development-
time 
If it may not be possible for a technology to be developed and adapted towards a 
specific PV system in a specific setting within the short to medium-term, it is 
excluded from further research. 
Workforce-
intensity 
If the implementation and operation of a technology would be exceptionally 
workforce-intensive (requiring a considerable investment towards large scale 
workforce training, or requiring specific individuals with specific skills) it is excluded 
from further research. 
 
The selected technologies are RMS, cloud technologies, online teaching services, remote 
internet accessibility, mobile technologies, user videos, non-traditional transportation, mobile 
applications, educational television and radio programmes, WAP-based messaging, routine 
assessments, and game-based learning. Regarding the three exclusion criteria (cost, 
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development-time and workforce-intensity), no significant limitations in the short to medium-
term, as well as in the long-term, were identified for any of these technologies in the discussion 
in Section 6.3. Though some of these technologies, such as RMSs, mobile technologies, and 
online teaching services do require significant resources, it is argued that the implementation 
and adoption of these technologies are nonetheless more feasible than is the case for the 
excluded technologies (big data analytics, IoT, and block chain). 
In the subsequent section, the link between the selected technologies and the prioritised root 
causes (as identified in Section 6.2) is created by describing how the technologies can be used 
to address the root causes. 
Table 24: The technologies excluded from the selected set of technologies. 
Technology Reason for exclusion 
Big data 
analytics 
The fact that big data analytics are still only a relatively recent addition in healthcare 
(Raghupathi & Raghupathi, 2014), raises some cost concerns for implementation in PV, 
especially in resource-limited settings. Firstly, as stated under the setting category, big data 
analytics is largely dependent on reliable internet networks. In several settings, these types 
of internet networks may not be available, resulting in a requirement for an increased 
monetary investment to improve these networks. Secondly, as stated under the workforce 
category, big data analytics are labour intensive, requiring a workforce with advanced skills 
and knowledge to fully utilise these systems. In several settings, such a workforce is not 
available, and may require a substantial amount of training which may be a limiting factor 
due to substantial costs. Given that cost (one of the exclusion criteria) is a major limiting 
factor, big data analytics are excluded from subsequent research. 
Internet of 
things (IoT) 
Similar to big data analytics, and as per definition, IoT relies largely on reliable internet 
networks (argued under the setting category), which in several settings, are not available. 
Adopting IoT brings with it a significant amount of training requirements (as argued under 
the workforce category). A workforce that may have limited knowledge of the subject are 
supposed to learn complex interactions between hardware and software. Providing this type 
of training can be extremely resource intensive, which might deter local governments and 
investors from supporting such an initiative. Given that cost and workforce-intensity (two of 
the exclusion criteria) appear to be considerable limitations, IoT is excluded from 
subsequent research. 
Block chain 
The main reason why block chain technology is excluded is because it is still in its early 
stages of adoption in developed countries (as stated under the meaningful access category). 
As reported by Iansiti & Lakhani (2017), companies such as PWC and Deloitte have only 
recently started to pilot block chain projects. It is reasonable to expect that it will take a 
considerable amount of time for block chain technology to be adopted by developing 
countries. Given that the development time (one of the exclusion criteria) of block chain 
technologies may be too long, block chain technology is excluded from subsequent research. 
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6.5. Linking the technologies to the root causes 
In order to complete the implementation of Chan & Kaufman (2010)’s technology selection 
framework, the potential for application category in Level 3 is used to describe real-world 
examples of how the selected technologies can be used to address the root causes in Table 20.  
In Table 25, it is indicated which technologies can be used to address which root causes. This 
analysis is derived from the perception of the researcher, which is based on the rationale drawn 
from the discussions of the prioritised root causes in Table 20, and the assessment of the 
selected technologies in Section 6.3. The root causes are shown by numbers, following the same 
sequential order as in Table 20. There are two key findings that can be concluded from Table 
25, these are subsequently identified and discussed. 
6.5.1. Shared technologies 
As seen in Table 25, the root causes can be addressed with more than one type of technology. 
Some of these technologies can address the root causes on their own, but most rely on other 
technologies to support them. For example, mobile applications can be used to address several 
root causes, however, these cannot function without mobile technology such as smartphones.  
6.5.2. Technologies that can address several root causes 
Another conclusion that can be drawn from Table 25 is that some technologies can be used to 
address several root causes. For example, online teaching services, user videos, mobile 
technology, and mobile applications are all technologies that can address several root causes. 
Consequently, it can be concluded that it would be beneficial to invest more in these 
technologies, since doing so is likely to be a cost-effective way to address several root causes.  
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Table 25: Illustration of which technologies can be used to address which root causes. 
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6.6. Possible implementations of technologies 
As stated in Section 6.1, the implementation of Chan & Kaufman's (2010) technology selection 
framework is concluded with the implementation of Level 3, where real world examples of how 
the selected technologies can be used to address the root causes are described. Subsequently, 
each root cause is investigated separately to describe how the technologies can be used to 
address the specific root cause, as described in Table 20.  
It should be made clear, as in previous sections, that the discussions that follow are illustrative, 
and do not represent an exhaustive list of possible solutions to root causes provided. 
Root cause #1: There is no designated transportation service to distribute the ADR 
reporting forms to different facilities 
Envisaged technologies: Non-traditional transportation, mobile technologies and mobile 
applications. 
Firstly, in areas where there is a lack of designated transportation services such as delivery 
trucks or fleet vehicles, ADR reporting forms (those supplied by regulatory authorities) can be 
distributed with the use of bicycles or pushcarts. The system will work as follows: The ADR 
reporting forms will be collected from a central point by the individuals on bicycles or 
pushcarts. Each collection will be signed off to ensure that there is a paper trail to monitor the 
distribution of the forms. Then, the ADR reporting forms will be transported to the necessary 
healthcare facilities, where delivery will be confirmed by the recipient. This type of 
transportation network is already used by one of the world’s largest beverage companies, Coca 
Cola (Berry, 2010), whom have proven its success.  
The second solution is the adoption of an electronic ADR reporting form. This can be done with 
the use of mobile applications, in combination with mobile technologies. Electronic ADR 
reporting removes the need for a distribution network such as the one described earlier, since 
there are no tangible reporting forms in circulation. A simple solution would be to provide one 
or two smartphones to healthcare facilities, since it is not necessary to supply smartphones to 
each healthcare worker.  
By making use of a mobile application, if designed correctly, the process of filling in the ADR 
reporting form will be simplified and much quicker, causing minimal disruption of the 
overloaded schedules of healthcare workers. 
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The mobile application also removes the need for data capturing, since the data is already 
electronically submitted. This will reduce the time spent on the process of converting a paper-
based ADR reporting form to an electronic version, which will allow for signal detection to 
occur much more quickly. 
Root cause #2: The users of the form have competing priorities, and simply do not have 
time to notify the person in charge of re-ordering the ADR reporting forms when stock 
is depleted 
Envisaged technologies: RMS, remote internet accessibility, mobile technologies, mobile 
applications and WAP-based messaging. 
Firstly, RMSs can be implemented to maintain a record of the movement of ADR reporting 
forms. If maintained, these systems can keep track of the number of ADR reporting forms used, 
as well as the left-over stock. Such a system will allow anyone to be aware of the ADR reporting 
form stock levels, enabling them to reorder new forms in time. In areas where there is not a 
reliable internet network, remote internet accessibility technologies can be used to provide 
access to internet, which will allow individuals in different locations to access the same RMS.  
The second option is using mobile applications, in combination with mobile technologies. 
Mobile applications can be used in the same way as RMS, except for the use of mobile 
technologies. RMSs, as described in the earlier section, are accessed via a computer or tablet, 
whereas mobile applications can be accessed via smartphones. This allows the user to have 
constant and immediate access to the ADR reporting form stock levels. Mobile applications can 
also be accessed by anyone, which is beneficial in the case where the individual in charge of 
managing the ADR reporting form stock may be situated in a remote location where healthcare 
facilities may have difficulties to communicate. 
Lastly, WAP-based messaging can be used to partially address this issue. Notwithstanding that 
WAP-based messaging cannot be used as a RMS, it can be used to address the issue of 
communication. By making use of these communication platforms, healthcare facilities can 
constantly communicate with their ADR reporting form supplier. 
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Root cause #3: The individuals responsible for coordinating the deliveries of 
spontaneous ADR reporting forms are not sufficiently trained to execute these tasks 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, 
game-based learning and routine assessments. 
Firstly, online teaching services can be used to provide essential training to these individuals. 
These teaching services replace the need for a physical presence of an expert in a remote 
location who provides face-to-face training. Rather, training videos can be accessed via the 
internet, at any time and in any location. This is beneficial since the individuals who need the 
training can access these videos in their own time, and complete any necessary assessments in 
the comfort of their own workplace. Remote internet accessibility technologies can be used in 
support of online teaching services to provide access to internet in areas where it might be 
lacking.  
The second option is similar to online teaching services, except that it does not require access 
to an internet connection. Physical copies of user videos can be distributed to different locations 
and accessed by those who might need the training.  
The final option is with the use of game-based learning, where individuals are provided with 
the training in a gaming format. These types of learning platforms allow the user to learn several 
real-world processes in a virtual world, and allow them to understand the implications their 
actions might have on an overall system. In the end, individuals will be equipped with key skills 
that they can leverage in their daily tasks of ADR reporting form management.  
In support of all three of these possibilities are routine assessments, which allow for periodic 
evaluation to be done in order to determine whether the individuals who are coordinating the 
delivery of spontaneous reporting forms have gained the necessary experience in managing 
ADR reporting forms. These assessments can be done in several ways, such as paper-based or 
using a computer, and can therefore accommodate the specific resource availabilities. 
Root cause #4: Key stakeholders are not aware of the health impact of PV on the 
healthcare system 
Envisaged technologies: Online teaching services, remote internet accessibility, routine 
assessments, user videos and educational television and radio programmes. 
Firstly, online teaching services can be used to provide healthcare workers with the necessary 
knowledge and awareness of the health impact of PV. If this method is used, it should be made 
mandatory for healthcare workers to access and review these online learning materials, in order 
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to ensure that they actually read through the necessary materials. Additionally, in areas where 
there is a lack of access to internet networks, remote internet accessibility technologies can be 
used to provide access to such networks. Routine assessments or assignments can be used to 
ensure that all healthcare workers allocate the time and effort to access online teaching services. 
In order to further motivate these workers, an incentive programme can be implemented 
whereby healthcare workers receive a certain number of points which will contribute to the 
yearly mandatory points they must gather in order to remain registered as professional 
healthcare workers. The continual professional development (CPD) programme, used by 
professional councils in sectors such as medicine, engineering, and accounting, is an example 
of such an incentive scheme. 
The second option is similar to online teaching services, however, it does not require access to 
an internet network. Physical copies of user videos could be distributed to different locations, 
and viewed by relevant parties. Similar to online teaching services, these training videos do not 
only remove the need for the physical presence of a person knowledgeable within a specific 
field, but create awareness amongst healthcare workers of the impact of ADRs, which motivate 
them to support PV. 
The third option is largely aimed at public awareness. Since many people in several locations 
have access to either televisions or radios, educational television and radio programmes can be 
used to promote PV and create awareness amongst the public. This will not only motivate the 
public to support and contribute to PV, but will provide them with the necessary knowledge on 
key aspects such as the source of ADRs, where ADRs should be reported and when to know 
that an ADR is experienced. An example of an educational television programme that has been 
broadcasted for a number of years is Takalani Sesame, a children’s television programme aimed 
to improve general early childhood education, with a view to school readiness. 
Root cause #5: PV is not included in the undergraduate syllabus of tertiary healthcare 
education 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, 
routine assessments and game-based learning. 
As indicated by Mehta (2017), it is a difficult to change a healthcare syllabus, because there are 
numerous important aspects of healthcare that deserve attention. Ideally, the solution would be 
to include PV training in the syllabus of healthcare professionals’ training. However, this can 
be a difficult and time-consuming project. In order to provide the necessary PV education to 
healthcare workers who have been minimally exposed to PV in their undergraduate training, 
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this training can be provided in their workplace. In this instance, online teaching services can 
be used. These services, as described in earlier sections, remove the need for healthcare workers 
to take time away from their full work schedules to physically attend training sessions. Online 
teaching services allow them access to the necessary materials at any time they prefer while 
providing them with the necessary PV knowledge. In areas with poor internet networks, remote 
internet accessibility technologies can be implemented to create access to such networks.  
Similar to online teaching services, the second option provide healthcare workers with the 
necessary PV knowledge in their workplace without requiring access to internet. User videos 
can be accessed on a computer or smartphone at any time and in any location. This reduces the 
pressure on healthcare workers, since they can consult these materials at their own discretion. 
In order to ensure that healthcare workers put in the time and effort to access either online 
teaching services or user videos, routine assessments can be used to assess whether the workers 
have gained the necessary PV knowledge such as ADR reporting. A similar point system as 
discussed under the previous root cause, where healthcare workers are obligated to obtain a 
certain number of points to maintain registration as professional healthcare workers, can be 
implemented. 
Lastly, PV knowledge can be conveyed via game-based learning platforms. These platforms 
will provide its users with the necessary knowledge, such as ADR reporting, in a virtual world, 
which can then be implemented within the real world.  
Root cause #6: The ADR reporting forms are overly complicated and are time-
consuming 
Envisaged technologies: Mobile applications and mobile technologies. 
Two possible solutions to this issue are envisaged. As indicated in the study by Khan (2013), 
the time required of healthcare workers to complete overly complicated ADR reporting forms 
is a major barrier to ADR reporting. It is therefore important that, in order to motivate healthcare 
workers to continuously support PV and contribute towards the improvement of ADR reporting, 
any initiatives should ideally be minimally invasive and non-disruptive concerning their daily 
routines. In this instance, mobile applications, in combination with mobile technology, can be 
used. ADR reporting forms can be changed into electronic reporting forms, which can be 
accessed via mobile applications. Such mobile application based ADR reporting forms are 
already used. For example a recent development named WEB-RADR has been released in 
Burkina Faso in 2017 (Uppsala Monitoring Centre, 2017).  
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These forms should also be made up of as few as possible data entries, and should only serve 
as an initial ADR report. In order to reduce complexity during ADR analyses that takes place 
during a later stage in the PV system, these initial ADR reports should be somewhat 
standardised in order to ensure that the same information is being shared from reports 
originating from different countries. Once a signal has been detected (a number of ADRs have 
been reported in the same location), a second stage of ADR reporting can commence, where 
supporting information, related to the already supplied information, is submitted, resulting in a 
growing ADR report which contains only the relevant information.  
Root cause #7: The importance of feedback is not sufficiently advocated 
Envisaged technologies: Educational television and radio programmes, mobile applications, 
mobile technologies and WAP-based messaging. 
Three possible solutions to this issue are envisaged. In order to provide feedback to the public 
regarding ADR reporting, educational television and radio programmes can be used. Instead of 
printing and distributing tangible reports, these programmes are able to reach a large audience 
in many different locations. This types of feedback can be done on a monthly or quarterly basis. 
It is important that periodic feedback is provided in order to reassure the public that any ADRs 
they might have reported are investigated.  
An electronic ADR reporting system can be explored, with the use of a mobile application, in 
combination with mobile technologies. Not only may such a system reduce the time and effort 
required for ADR reporting, but it will also enable feedback to be provided through the 
application, which can be viewed by the reporter at any time. 
Another form of feedback, aimed at both the public and healthcare workers, is in the form of 
WAP based messaging. These messaging platforms can be used to provide feedback to ADR 
reporters during strategic stages in the PV system, such as a notification when the ADR report 
is received, and when it is being investigated, and finally when certain steps are being taken to 
address the particular ADR. WAP based messaging is specifically aimed at resource-limited 
healthcare facilities who might not have access to online reports. A simple SMS might reassure 
healthcare workers that their voices are heard (their ADR reports are investigated), which may 
motivate them to regularly report ADRs. 
 
Root cause #8: There is a lack of ownership of managing the process of data 
management 
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Envisaged technologies: Online teaching services, remote internet accessibility, user videos, 
RMS, mobile applications and mobile technologies. 
Firstly, two major causes of concern can be concluded from the seeming lack of ownership. It 
can either be the case that there is a lack of personnel with the necessary skills and appropriate 
training to maintain the data management system, or it can be that there are significant time 
constraints, thus individuals with the necessary and appropriate skills are not able to add PV 
data management to their schedule. Either way, both of these possible causes must be accounted 
for. Considering the first case, two possible technologies are envisaged (as illustrated in Table 
25) to be implemented to address the issue of a lack of training. Firstly, online teaching services 
can be used to provide an individual or team with the necessary knowledge and skills to 
maintain PV data management, which in turn will motivate them to take complete ownership 
of that system. In areas where there is no access to internet (in order to access online teaching 
services), remote internet accessibility technologies can be used to provide such networks.  
Secondly, similar to online teaching services, user videos can be used to provide training with 
regards to data management. User videos may be more practical than online teaching services 
in certain settings, since they do not require access to internet. However, they a drawback 
associated with using videos is the inability for the viewer to interact with the host in real-time.  
In order to address the second cause of the lack of ownership, the issue of limited capacity for 
clinical activities and responsibilities, two technologies (as illustrated in Table 25) are 
envisaged to be implemented. Firstly, RMSs can be implemented. These systems maintain not 
only records of resources, but also allow for data management to be done. With a system that 
automatically does data management, requiring minimal interaction, individuals are expected 
to be less deterred from PV data management, and may feel more obliged and comfortable to 
take ownership of data management. 
Another candidate technology is mobile applications, in combination with mobile technologies. 
Providing stakeholders with access to PV data management systems anywhere and at any time 
will facilitate the execution of their PV responsibilities and activities since they are not limited 
concerning the location from where they are able to perform this work. They will also most 
likely be able to notice any possible warnings or mistakes more rapidly. 
Root cause #9: There is a lack of training provided to those who report ADRs 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, 
and game-based learning, and educational television and radio programmes. 
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Three possible solutions to this issue are envisaged. With specific aim at healthcare workers, 
online teaching services can be used to provide them with the necessary knowledge and skills 
of ADR reporting, such as how to know when a patient is experiencing an ADR, which essential 
data to submit on ADR reports and where to report ADRs. These services are more user-friendly 
when it comes to interference with the schedules of healthcare workers since they can view 
these materials at their own discretion and according to their own schedule. In areas where there 
is no access to internet networks, remote internet accessibility technologies can be used to 
provide access to such networks.  
The second option, similar to online teaching services, is the use of user videos. These videos 
are minimally invasive on the schedules of healthcare workers, since it can be viewed at any 
time. User videos do not require access to internet networks, which in some settings is 
advantageous.  
Lastly, game-based learning initiatives can be used to provide healthcare workers with the 
necessary skills to report ADRs. These virtual platforms can teach them key aspects of ADR 
reporting which they can implement in the real world.  
Focussing on the public and the patients who can also report ADRs, educational television and 
radio programmes can be used to educate the public on PV-related activities, such as when to 
know an ADR is experienced and where ADRs can be reported. Since many people have access 
to either a television or radio, these educational programmes will be able to reach a large 
audience in remote locations.  
Root cause #10: There are difficulties in providing the necessary training to individuals 
in remote locations in a timely manner 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, 
mobile applications, and mobile technologies. 
Four possible solutions to this issue are envisaged. This root cause is similar to the one 
described in the previous section. However, it focusses on the barrier of providing training to 
the public and healthcare workers in remote locations. In this case, online teaching services, in 
combination with remote internet accessibility technologies, user videos, and game-based 
learning can be applied in the same manner as the case previously discussed. The fourth 
technology added to this list is mobile applications, in combination with mobile technologies. 
Given the widespread adoption of mobile technologies (not smartphone technology) in sub-
Saharan African countries (Data Team, 2017), mobile applications can be used to provide 
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training to those residing in remote locations. By making use of a technology they are familiar 
and comfortable with, mobile application based training can be used to supply both the public 
and healthcare workers with the necessary knowledge regarding ADR reporting. 
Root cause #11: There is a lack of ownership to manage existing PV-related resources 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, 
mobile applications, mobile technologies, game-based learning and RMS. 
Similar to the eighth root cause, the lack of ownership can be contributed to two possible causes. 
It can either be that there is a lack of personnel who have the necessary knowledge and skills 
to manage PV resources, or it is possible that there is simply no one who can add PV resource 
management to their existing portfolios. As described under the discussion of the eighth root 
cause in this section, the first cause can be addressed with the implementation of either online 
teaching services (in combination with remote internet accessibility technologies), user videos, 
mobile applications (in combination with mobile technologies) or game-based learning. Each 
of these technologies offer different ways of teaching which can be used to provide essential 
resource management training.  
Another technology that has great potential regarding adding PV resource management to the 
schedule of an individual or team, is a RMS. These systems maintain electronic records of all 
the resources available to PV activities, and also track their movements, and therefore require 
a minimal degree of intervention. Therefore, if RMSs are well maintained and updated, resource 
management would be much simpler and less invasive to the overloaded schedules of healthcare 
workers. 
Root cause #12: Lack of training to educate PV personnel on how available resources 
should be used 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, 
mobile applications, mobile technologies, game-based learning and routine assessments. 
There are several different forms of training that can be provided to individuals in order to 
provide them with the necessary knowledge on how to fully utilise PV resources such as ADR 
reporting forms, computers and smartphones. Online teaching services (in combination with 
remote internet accessibility technologies), user videos, mobile applications (in combination 
with mobile technologies) or game-based learning are all technologies that remove the need for 
face-to-face interaction by providing training which can be accessed through computers, 
smartphones, or tablets. All these technologies are marginally invasive i.e. slightly interferes 
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with the daily routine of healthcare workers. Additionally, and in support of these training 
platforms, routine assessments, which can either be paper– or computer based, can be used to 
assess whether or not healthcare workers have dedicated the time and effort to learn using the 
aforementioned learning technologies. 
Root cause #13: There is no resource management system in place to manage existing 
resource inventories 
Envisaged technologies: RMS and remote internet accessibility. 
One possible solution to this issue is envisaged, namely RMSs. These systems, if well 
maintained, simplify the process of PV resource management by monitoring the available 
resources and keeping track of the movement of resources. These types of systems can also be 
accessed by anyone in any location, provided that there is access to an internet network, which 
can be provided by remote internet accessibility technologies. This can be beneficial in several 
ways. For example, the distribution centre for ADR reporting forms can simply log on to the 
RMS of a healthcare facility, check their available ADR reporting form stock, and start 
distributing more forms to the facility if necessary. Another instance is where the system keeps 
track of the available PV resources. For example, the system keeps record of who might be 
using a smartphone intended for ADR reporting. If something were to happen, such as 
vandalism or the item is lost, the individual who last used the smartphone can be tracked down. 
Root cause #14: PV personnel are not sufficiently trained in using existing platforms 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, 
mobile applications, mobile technologies, game-based learning and cloud technologies. 
The platforms referred to in this case are information sharing platforms such as emails, 
chatrooms, or blogs. Each of these platforms allow for different parties to communicate with 
one another and share relevant information. In order to provide training to healthcare workers, 
especially in areas where they are not familiar with these platforms, three different technologies 
can be used, namely: online teaching services (in combination with remote internet accessibility 
technologies), user videos or game-based learning. Each of these technologies, as mentioned in 
earlier sections, removes the need for face-to-face interaction. It also reduces the degree of 
interference in the daily routine of healthcare workers, since they can access these training 
materials at their own discretion. The one technology that can also, to a certain extent, be used 
to simplify the process of information sharing is cloud technology. These technologies are 
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freely available to the public and can be used to share large amounts of data, such as ADR 
reports.  
6.7. Concluding remarks of the link between the root causes and the 
technologies 
In conclusion, a link between the prioritised root causes (shown in Table 20) and the selected 
technologies (identified in Section 6.4) have been created. It is clearly stated which of the 
selected technologies can possibly be used to address the prioritised root causes in this research. 
In most cases, there are several technologies (and combinations of technologies) that can be 
used to address the root causes, showing the potential of a wide range of technologies that can 
be investigated for implementation. 
Subsequently, and in conclusion of the implementation of Chan & Kaufman's (2010) 
technology selection framework, the second category in Level 3, research needs, is addressed 
by providing some examples of existing studies conducted in the use of technology in PV. 
6.8. Existing research in the technology landscape and pharmacovigilance 
In order to provide further empirical evidence of the implementation of technology in PV, the 
research needs category in Level 3 of Chan & Kaufman's (2010) technology selection 
framework is used. Level 3 of Chan & Kaufman's (2010) technology selection framework 
entails an investigation into both existing research and implementations (case studies) of the 
technologies in the healthcare and PV industry, as well as an investigation into specific research 
needs that should be pursued to further support the existing research according to the user of 
the framework. 
6.8.1. Research needs 
There are several research needs (opportunities) that will contribute to the successful adoption 
of technology in PV. These research opportunities are subsequently discussed. 
6.8.1.1. Further research to assess the existing conditions 
There is a need for further research regarding the assessment of the current landscape of PV 
systems. These research initiatives should be done within the context of the categories found in 
Chan & Kaufman's (2010) technology selection framework, namely: setting, workforce, 
delivery mechanisms, meaningful access and interface. These categories, all used to assess the 
feasibility of the technologies identified in this research, should be used to determine the 
condition of the existing infrastructure within countries. In other words, research should be 
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conducted to, considering for example the setting, determine the existing state of electricity and 
internet infrastructures. If it is found that these infrastructures are reliable, then it can be 
concluded that the technologies can possibly be implemented within these settings.  
6.8.1.2. Study of existing technologies in pharmacovigilance 
There are several existing studies investigating the role of technology in PV, some of which are 
investigating the effects of some of the technologies identified in this research. Some studies 
are exploring the use patterns of several technologies in developing countries, focussing on the 
effect it might have on the overall population health (Donner, 2008; Mishra & Singh, 2008). 
There is emerging research on the effect of mobile technology in PV, with a recent report by 
the UMC indicating the effect of mobile application-based ADR reporting (Uppsala Monitoring 
Centre, 2017). Closely related to this report is a study that investigated the level of 
understanding of simple hierarchy structures found on mobile applications amongst a specific 
group of South Africans (Chan & Kaufman, 2010).  
Other well-known technologies that are currently used in PV are VigiBase (a drug safety data 
repository owned by the WHO), VigiRank (a “data-driven predictive model for emerging safety 
signals”), and VigiGrade (“a tool to identify well-documented individual case reports”) (Caster 
et al., 2017; Bergvall et al., 2014). 
6.8.1.3. Research needs relating to the excluded technologies in this research 
Additionally, there is a research need, or rather opportunity, for the development and 
preparation of the three technologies excluded in this research, namely: big data analytics, IoT, 
and block chain technologies. These represent a generation of technologies that are changing 
the way technologies can be leveraged in the modern world. As mentioned in earlier sections, 
these technologies are used by several industries and businesses, and have already delivered 
several benefits, such as increased data privacy (block chain), technology synchronisation 
(IoT), and data mining (big data analytics). As a result, there is a need for further research that 
investigates how these technologies can be leveraged towards PV systems. The functionalities 
offered by these technologies hold great promise for PV, and can be leveraged towards PV, 
including areas such as ADR reporting (IoT), signal detection (big data analytics) and patient 
information protection (block chain). 
6.8.1.4. Research needs related to socio-technical aspects 
A key aspect of all the technologies discussed in this research that should be prioritised in future 
research relates to the socio-technical side of the implementation of these technologies in PV. 
The socio-technical aspect marries the social and technical sides of technologies. In other 
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words, socio-technical studies determine how technologies should be designed in order for it to 
be accepted by a certain group of stakeholders. For example: if a technology is extremely 
complex to operate, a community in a remote area might not use this technology, since they are 
not familiar with it, and lack the technical capacity to do so. It is critical that the work building 
on this research incorporates the socio-technical aspect of the implementation of the suggested 
technologies in PV. 
6.8.2. Conclusion: Research needs 
In conclusion, it is clear that there are several opportunities for investigating the effect 
technology can have on PV. It is believed that research into the opportunity areas identified will 
contribute towards the improvement of PV systems, especially in resource-limited countries. 
Subsequently, in order to validate the link drawn between the prioritised root causes and the 
selected technologies, formal, structured validation strategy is implemented. 
6.9. Validating the link between the technologies and root causes 
As stated in Section 1.9.5, a formal, structured validation strategy is used to validate the link 
drawn between the technology landscape and the prioritised root causes. Nine SMEs were 
contacted for the purpose of validation, However, only five (details of the SMEs are provided 
in Table 26) managed to respond and provide feedback. The document that was sent to each 
SME containing the request for validation as well as the required information is shown in 
Section E.2 in Appendix E. Subsequently, their feedback is summarised, showing the concerns 
that were raised by the SMEs, and how these concerns were addressed in the research. 
6.9.1. Replacing paper-based systems with electronic ADR reporting 
A concern was raised that applies to the suggestion made in the first root cause, where it is 
suggested that a ADR reporting form delivery system, similar to that used by Coca-Cola, is 
used to provide ADR reporting forms to healthcare facilities. The concern is two-fold. Firstly, 
it is said that this suggestion is not feasible, since PV systems do not have the access to resources 
that are comparable to that of a company such as Coca-Cola. However, the suggestion made in 
this research is aimed at resource-limited settings. Contracting local inhabitants with bicycles 
or push-carts is not resource-intensive and will only require minimal resources in the form of 
training and payment due to the delivery persons.  
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Table 26: Occupation and affiliation of SMEs consulted during the validation process. 
Occupation Affiliation 
1 Regional Medical Director (Kenya) Multi-national pharmaceutical company 
2 
Member of PV enhancement project for Malaria 
(Democratic Republic of Congo) 
Multi-national pharmaceutical company 
3 
Medical Affairs Executive and Named Safety 
Contact (Kenya) 
Multi-national pharmaceutical company 
4 
PV Pharmacist, Deputy National Safety Officer 
(South Africa and export countries) 
Multi-national pharmaceutical company 
5 PV Manager (South and Southern Africa) Multi-national pharmaceutical company 
 
The second part of the concern relates to the nature of the proposed delivery system just 
mentioned, which is aimed at providing paper-based ADR reporting forms to healthcare 
facilities. The SMEs argued that it is not feasible to suggest that more paper-based ADR 
reporting forms be pushed into PV. This is understandable, given that they are resource-
intensive. The suggestion made in this research is a short to medium-term solution, and is meant 
to be adopted by PV systems operating in severely resource-constrained settings. Electronic 
ADR reporting is the sought after method for reporting in PV and is suggested in this research 
in the form of mobile applications. However, it is not feasible at this stage to suggest that 
electronic ADR reporting be adopted in resource-limited settings, given that this will require a 
considerable amount of resources, many of them related to infrastructure, that are not 
necessarily currently available. In the long-term, when more resources are provided to these 
settings, electronic ADR reporting can be pursued. 
6.9.2. Security concerns regarding mobile phones 
One SME pointed out that vandalism and theft is a problem that has been reported in several 
healthcare systems where mobile phones were introduced, and it can possibly curb the adoption 
of mobile phones in PV. This issue has been pointed out in this research (Section 6.3.7), where 
it is mentioned that the introduction of mobile technologies in resource-limited settings do carry 
the risk of theft and vandalism. This is an inevitable risk which can only be managed. The 
introduction of mobile technologies in healthcare systems has proven to be a success. With this 
introduction, however, it is necessary to consider the risk of theft and vandalism, by introducing 
security measures to protect the hardware.  
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6.9.3. Failing to sensitise healthcare workers to advocate and support pharmacovigilance 
Another concern that was raised is the fact that HCWs who are at the front line of reporting 
ADRs are not sensitised to pursue and advocate PV. Consequently, the introduction of 
electronic ADR reporting may not always be a feasible solution, given that these reporting 
systems will not be properly used, resulting in under-utilisation and resource-wastage.  
This concern is raised in this research. Specifically, in order to sensitise HCWs through PV 
training and awareness campaigns, the technologies assessed in Sections 6.3.4, 6.3.8, 6.3.12, 
6.3.14, and 6.3.15 (online teaching services, user videos, educational television and radio 
programmes, routine assessments and game-based learning) are all technologies specifically 
aimed at achieving this particular outcome. Not only are these technologies aimed at HCWs, 
but they are also aimed at raising PV awareness amongst the public.  
6.9.4. Healthcare professionals are desensitised with regards to pharmacovigilance 
One SME pointed out that in many sub-Saharan African countries, healthcare professionals are 
not sensitised with regards to PV. This is not necessarily due to overloaded work schedules, 
which is a phenomenon that is routinely used as excuse. In fact, healthcare professionals simply 
fail to support PV. This phenomenon is closely related to Inman’s model of ADR under-
reporting (discussed in Section 3.10.1), which identifies factors such as complacency, guilt and 
ignorance as causes for desensitised healthcare professionals.  
This particular concern is addressed by one technology that is assessed in Section 6.3.14, 
namely routine assessments. These assessments can be used as a mechanism to sensitise 
healthcare professionals who fail to support PV due to reasons previously mentioned. 
6.9.5. Dedicated pharmacovigilance personnel 
Another concern raised by an SME is that the introduction of some technologies in PV will 
require dedicated PV personnel that take responsibility for PV-related activities in a healthcare 
facility. This concern is addressed in this research, specifically in Section 4.6.2. It is mentioned 
that not all of the challenges in PV can be addressed with technology, but rather finances, 
business process improvement, managerial changes, or a change in national PV guidelines and 
policies. Although this research focusses on technology, this concern has been pointed out. 
Additionally, this is discussed in the opportunities for future research section (Section 7.5), 
mentioning that a similar research approach (to that used in this research) can be used to 
investigate how the other challenges in PV can be addressed with management (which includes 
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the appointment of dedicated PV personnel), financial investment and business process 
improvement. 
6.9.6. Target audience for routine assessments 
One SME raised a question, rather than a concern, regarding the target audience of the proposed 
use of routine assessments. It is worthwhile to briefly explain the use of routine assessments. 
Routine assessments are proposed in this research for the specific goal of sensitising HCWs and 
professionals to support and advocate PV. Specifically, routine assessments can be used to 
evaluate whether or not these individuals are actively supporting and pursuing PV activities 
such as ADR reporting. 
6.9.7. Harmonisation of ADR reporting 
A recommendation was made by an SME that harmonisation and standardisation of PV 
reporting is essential. This can definitely be achieved with the adoption of certain technologies 
in PV. Firstly, mobile technologies and applications can be used to standardise ADR reporting 
and ensure harmonisation between ADR reports from different settings and contexts. 
Additionally, the introduction of IoT and big data analytics will contribute to the harmonisation 
and standardisation of reporting in PV. Although it will still take some time for these two 
technologies to be adopted by PV, the capabilities they hold can be leveraged to the benefit of 
PV. 
6.9.8. Training requirements of resource management systems 
A concern regarding the training requirements for using RMSs has been raised by an SME. The 
training requirements associated with RMSs have been raised as a factor to consider when 
implementing these types of systems (specifically in the discussion of the first root cause). 
Initially, there is no need for complex RMSs and these will consequently not require many 
resources pertaining to training, making it feasible solutions in resource-limited settings. Once 
more resources have been devoted towards PV systems that currently operate within resource-
constrained settings, more complex RMSs that have additional capabilities can be adopted. 
Only then will the training requirements become significant. However, as proven by the 
adoption of RMSs in many other industries, RMSs can be of significant benefit towards PV. 
6.9.9. Providing feedback to ADR reporters 
The lack of feedback given to ADR reporters is one of the prioritised challenges discussed in 
this research. There are several technologies that can be used to improve these feedback 
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processes, all of which are identified and discussed in the seventh root cause. Included in the 
feedback from the SMEs was the statement that emails can also be used to provide feedback to 
ADR reporters. Although not specifically mentioned in this research, feedback in the form of 
emails inherently forms part of the recommendation made that electronic ADR reporting (via 
mobile applications or social media platforms) is needed. When comparing paper-based ADR 
reporting, feedback in the form of emails is possible, however, this will be time-intensive. Once 
an electronic ADR reporting system is implemented, automatic email replies and personal 
communication with ADR reporters will be possible. This will enable timely personal feedback 
to be provided to ADR reporters, providing them with a sense of contribution which is likely to 
encourage them to continue reporting and advocating ADR reporting. 
6.9.10. Capacity support for pharmacovigilance data management 
A suggestions was made that National Regulatory Authorities should be encouraged to invest 
in Integrated Information Management Systems that link to both paper-based and electronic 
ADR reporting to enable real-time data analysis and simplify ADR reporter feedback. 
Recollecting the contents of Section 6.4, three technologies (big data analytics, IoT, and block 
chain) were excluded from this research, primarily because these technologies are deemed too 
complex and expensive to feasibly be implemented in PV at present. However, in the future, 
once more research, investment and has been made in the development of these technologies, 
it can be adopted by PV. In combination, these technologies (especially IoT and big data 
analytics) can be used to create the sought after “Integrated Information Management Systems 
that link to both paper-based and electronic ADR reporting to enable real-time data analysis 
and simplify ADR reporter feedback”.  
6.9.11. Conclusion: SME validation 
Regardless of the fact that only some of the SMEs managed to provide feedback, each of these 
SMEs operate in PV on a daily basis, and have relevant experience when it comes to the 
improvement of PV. Consequently, their feedback serves as validation of the final 
recommendations of this research.  
6.10. Chapter 6 conclusion 
The foundation of this chapter is the implementation of Chan & Kaufman's (2010) technology 
selection framework. Firstly, 14 prioritised root causes are used to describe the clinical domain 
within the PV landscape. This provides some clarity on what exactly is implied by each root 
cause, and also highlights some key issues that should be addressed. This is followed by an 
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investigation into the technology landscape, where five of the categories found in Level 1 and 
Level 2 of Chan & Kaufman's (2010) technology selection framework (setting, workforce, 
meaningful access, delivery mechanisms and interface) are used to assess these technologies. 
This allows for several benefits and shortcomings to be highlighted, which are used to 
determine which technologies are feasible for implementation in PV. Following the 
implementation of this stage, the technology landscape is refined to a list of candidate 
technologies that can be implemented in PV. In order to complete the implementation of Chan 
& Kaufman's (2010) technology selection framework, Level 3 is implemented. In particular, 
the potential for application category is used to describe real-world implementations of how 
the technologies can be leveraged towards the addressment of these root causes. Additionally, 
the research needs category, found in Level 3, is used to briefly provide some examples of 
existing studies conducted in the implementation of technology in PV and to highlight some 
areas where further research would be beneficial. 
The chapter is concluded with a validation process, where SMEs provided input and feedback 
on the technologies that are suggested as offering potential solutions to the prioritised root 
causes identified in this research. The SME feedback is summarised, to provide an overview of 
the most salient concerns and suggestions. Included in these summaries are discussions of how 
each of these concerns and suggestions are addresses in this research. 
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Chapter 7: Recommendations and future research 
___________________________________________________________________________ 
In Chapter 6, the link between the PV challenge landscape and the technology landscape is 
made, as discussed in Chapter 1. In particular, real-world implementations are provided to 
indicate how a combination of certain technologies can be leveraged towards the root causes of 
several of the challenges found in the PV challenge landscape. This shows that there are areas 
for opportunity in the PV challenge landscape for the intervention of technology to address the 
challenges faced on a daily basis. Subsequently, this chapter serves as the conclusion to this 
research. A project summary, contributions to the PV industry, key contributions offered to 
academic literature, achievement of the research objectives, and opportunities for future 
research are provided and discussed. 
7.1. Project summary 
In Chapter 1, a background and introduction to PV, the research rationale, problem statement, 
research aim and objectives, limitations and assumptions, validation strategy, and research 
methodology are provided and discussed. Chapter 2 deals with the initial key literature 
investigation into PV. Contextual information regarding PV and PV as a system is provided. 
Additionally, the PV challenge landscape is identified, conceptualised and elaborated on. In 
Chapter 3, the challenges that constitutes the PV challenge landscape is prioritised, refining the 
PV challenge landscape to a selected set of prioritised challenges that form the focus of the 
subsequent research. Each of the prioritised challenges are investigated in sufficient detail to 
provide a clear understanding of each challenge. The investigation of translation strategies that 
can be used to translate the prioritised PV challenge landscape to root causes comprises the first 
part of Chapter 4. This is followed by the implementation of a two stage translation process, 
where a PV value chain analysis, and the 5Why method, in combination with fishbone 
diagrams, are used to identify several root causes to which the prioritised PV challenges can be 
attributed to. In order to further focus the scope, the root causes that are deemed ones that could 
be addressed by technology were identified. After which, this set of root causes was subjected 
to a second prioritisation exercise during which a number of specific root causes were 
prioritised by SMEs. Chapter 5 consists of two parts, the first of which is an investigation into 
the technology selection framework landscape, where a specific framework is selected as an 
appropriate framework to be used in this research. The second part of Chapter 5 is geared 
towards an investigation of the technological landscape, where numerous technologies are 
identified and defined. Combining the results from Chapter 4 and Chapter 5, resulting in the 
foundation of Chapter 6, i.e. the implementation of the selected technology selection 
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framework. Several categories are used to assess the prioritised root causes and the 
technological landscape. Consequently, specific technologies, that are deemed feasible for 
implementation in PV, are selected. In conclusion, the technological landscape and the 
prioritised root causes are linked in Chapter 6. Furthermore, each of the root causes are 
investigated separately, and real-world implementations of the selected technologies are 
provided to indicate how such technologies can be used to address the PV challenge landscape. 
7.2. Research contributions to the pharmacovigilance industry 
In this research it was found that a challenge faced within PV is the ability to fully comprehend 
the challenges PV systems face on a daily basis, and to determine how these challenges can be 
addressed with technology. The PV challenge landscape is ever-expanding, and the effects of 
the challenges are intensifying, burdening PV systems from achieving universal drug safety. As 
a possible solution, the feasibility of the intervention of technology to address the PV challenge 
landscape is investigated in this research. The solution developed in this research, is comprised 
of several stages, all of which contribute to addressing the barrier of understanding the true 
effects of the PV challenge landscape and determining how these effects can be alleviated by 
means of employing technology.  
In this research, seven challenges (culture, transparency, partnerships, insufficient resources, 
technical capacity, country-specific factors and ADR under-reporting) were highlighted as 
priority in PV. It can be argued that these challenges are a true representation of the PV 
challenges that should be of priority in the real world, since these challenges were validated by 
SMEs.  
Translating PV challenges to a lower level of abstraction is a useful step in uncovering the 
operational-level root causes that can potentially be addressed by technological solutions. A 
translation strategy, consisting of two stages, that allows one to achieve this is recommended 
in this research. In the first stage, the prioritised PV challenge landscape is evaluated according 
the stages of the PV system with the use of a PV value chain analysis, in order to understand 
the meaning and effect of the challenges in each stage of the PV system. During the execution 
of this stage, it was found that the challenges have different meanings and impacts in the 
different stages of the PV system, and are either based on managerial practices, business process 
restructuring, financial investment or technological intervention. With specific focus on the 
challenges that are based on technological intervention, the second stage of the translation 
strategy was implemented in order to identify the root causes of these challenges. It was found 
that there are several root causes to many of these challenges, all of which will affect the PV 
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challenge landscape differently. Additionally, it can be concluded that the root causes identified 
in this research represent the root causes found in the real world, since it was validated by 
several SMEs. The SMEs also indicated that 14 of these root causes should be of priority in this 
research. 
Provided with the prioritised root causes of the prioritised PV challenge landscape, PV systems 
can continue by determining how technologies can be leveraged towards addressing these root 
causes, which can be achieved with the implementation of Chan & Kaufman's (2010) 
technology selection framework. Several frameworks were investigated in this research, 
however, it was found that this specific framework is appropriate for implementation within a 
PV context. Prior to the implementation of this framework, candidate technologies should be 
identified. Fifteen technologies were identified in this research with the use of literature and a 
focus group. Each of these technologies can somehow be leveraged towards PV. In order to 
determine which of the technologies are feasible for implementation in PV, Chan & Kaufman's 
(2010) technology selection framework is used. Making use of the categories found in the 
framework (setting, workforce, meaningful access, delivery mechanism and interface), each of 
these 15 technologies were assessed, highlighting several elements that should be considered. 
These assessments were then used to refine these technologies to a list of 13, all of which are 
deemed feasible for implementation in PV. Additionally, the clinical domain category, also 
found in Chan & Kaufman's (2010) technology selection framework, was used to assess the 
prioritised root causes, clearly defining the meaning of each. Ultimately, this allowed for the 
link to be established between the root causes and the technologies, where it was shown which 
technologies can be used to address the respective root causes. 
In conclusion, this research contributes to the PV industry in several ways. Not only can the 
final results of the research i.e. the link between the technology landscape and the PV challenge 
landscape root causes, be extrapolated into the existing PV system, many of the tools and 
techniques used in the research can be adopted by the industry. The prioritisation exercise, 
translation strategy, technology selection framework, and proposed technologies holds value 
for PV systems, and can facilitate a comprehensive understanding of the meaning and effect of 
the challenges faced in PV. In addition, the outlined approach can be implemented to determine 
which technologies can be leveraged towards the addressing the challenged faced by PV 
systems. 
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7.3. Key contributions offered to academic literature 
There are several key contributions of this research that contribute to the existing academic 
literature, which include: 
 The results of the systematic literature review constitutes a holistic overview of the 
challenges found in the PV challenge landscape. 
 The prioritisation of the PV challenge landscape provides guidance on challenges 
towards which research efforts should be addressed. Since two sources are used to 
prioritise the PV challenge landscape (SMEs and the PV system and PV challenge 
landscape matrix), it can be concluded with fair certainty that these selected challenges 
should be of priority in PV.  
 Proceeding the prioritisation of the PV challenge landscape, this research also proposes 
a translation strategy that can be used to translate the PV challenge landscape to a lower 
level of abstraction in order to identify root causes to these challenges. This translation 
strategy is also implemented in this research, with the likely root causes of a number of 
the prominent challenges in the PV landscape being identified. 
 Lastly, potential technological solutions to some of the prominent root causes of 
challenges in the PV challenge landscape is investigated using a technology selection 
framework. It is believed that this is a novel contribution to PV literature, offering a 
new perspective on addressing the PV challenge landscape. 
7.4. Achieving research objectives 
The research aim and objectives, as set out in Chapter 1, have successfully been achieved in 
this research. In Table 27, the chapters, sections and page numbers where each of the objectives 
have been achieved are shown. 
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Table 27: Research aim and objectives achieved. 
Research aim and objectives 
Chapter and 
Section 
Page number 
i. Conduct a comprehensive literature review to: 
a. Comprehensively understand the various sub-systems of which PV systems are comprised of. 
b. Identify and understand the challenges faced in the PV industry. 
Chapter 2 
2.1-2.3 
2.4-2.10 
12-25 
12-14 
14-24 
ii. Prioritise the PV challenge landscape to allow for more in-depth research: 
a. Clearly define and understand the prioritised PV challenge landscape. 
Chapter 3 
3.3-3.10.3 
27-48 
32-48 
iii. Develop a translation strategy that can be used to translate the prioritised PV challenge landscape, by doing the following: 
a. Investigate the methodologies that can be used to translate challenges from a high level of abstraction to a lower level. 
b. Select appropriate methodologies that can be used for this translation process and describe how each will be used. 
c. Implement the translation strategy in order to identify root causes to the prioritised PV challenges landscape. 
d. Validate and prioritise the root causes with SMEs in order to determine which root causes should be the main focus point of this 
research. 
Chapter 4 
4.3-4.3.5 
4.4-4.4.2 
4.5-4.6.2 
4.6.3 
49-74 
51-55 
56-59 
60-69 
74 
iv. Investigate the technology landscape in order to: 
a. Identify a technology selection framework that is applicable for implementation within the PV context. 
b. Identify a number of technologies that can possibly be implemented within PV. 
Chapter 5 
5.2-5.4 
5.5-5.5.2 
76-91 
77-78 
83-91 
v. Implement the selected technology selection framework in order to assess the prioritised root causes and the technology landscape; 
a. Establish the link between the technology landscape and the prioritised root causes by describing how the technologies can be used 
to address these issues. 
Chapter 6 
 
6.6 
92-143 
 
127-137 
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7.5. Opportunities for future research 
It is recommended that the following opportunities for future research can be explored, since 
each will build on this research: 
i. Taking a context-specific perspective, use the technology selection framework to 
determine which technologies can be leveraged in addressing context-specific PV 
challenges. This will include an investigation into the existing technology infrastructure 
to determine the scale of technological implementation, i.e. to determine which 
technological infrastructures should be implemented in addition to the adoption of the 
technologies identified in this research. 
ii. Determine how the technologies identified in this research can be leveraged with 
regards to large scale adoption and financial investment by, amongst others, developing 
a cost model to determine the cost implications of these technologies. 
iii. Investigate the technological landscape in greater detail to determine more specifically 
the model types of the identified technologies that could be implemented to address the 
challenges in the PV challenge landscape. Given the above recommendation regarding 
including a context-specific perspective, this can be also be investigated within a 
specific context. 
iv. Establish how the impact of the technologies can be monitored and evaluated to 
determine whether the sought after results are obtained. 
v. Expand the research focus from ADRs to adverse events following immunisation 
(AEFIs), especially within a sub-Saharan African context. AEFIs and ADRs differ in 
many ways, and as a result will entail different root causes, requiring that different 
groups of technologies are needed to address the challenges associated with AEFIs.  
vi. It has been highlighted in this research that not all challenges can be addressed with 
technology. Using a similar research approach, address the PV challenge landscape by 
redirecting focus away from technology, focusing instead on aspects such as finance, 
business processes, and management. 
7.6. Research conclusion 
Technology has developed considerably over the last couple of decades, and has become an 
integral part society and of many organisations. Given that technology plays such a significant 
role in the modern society, it is of utmost importance for the value of technology in PV to be 
realised, especially in resource-limited countries. To address the challenges burdening PV 
systems, it is evident from the recommendations made in this research that existing technologies 
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can be used. Not only are the majority of the technologies identified in this literature already in 
existence, they are also already well developed, with a higher degree of access compared to a 
decade ago. Moreover, the three technologies (big data analytics, IoT, and block chain) 
excluded from this research hold substantial potential for PV, and can most definitely benefit 
PV systems once further developed.  
When healthcare systems, especially those within resource-limited countries, adopt technology 
on a large scale, PV systems might benefit significantly. Since PV is a component of the 
healthcare system that few patients or members of the general public are likely to have 
interacted with, it can easily be overlooked when investment in the healthcare sector is made. 
By leveraging technology in healthcare, and proving its benefit and value, investors may be 
more likely to invest in the adoption of technology in PV.  
The value of technology in PV is already starting to gain publicity in several countries; however, 
many of these countries operate within resource-rich environments. Although this is a positive 
outcome, one can argue the case that PV systems in resource-limited countries are significantly 
more important, because of large scale disease burdens such as HIV, tuberculosis and malaria. 
It is important for the gap between PV systems in developing– and developed countries to be 
narrowed. This will allow for more research to be conducted in the adoption of technology in 
PV systems in these countries, which will ultimately contribute to the realisation of universal 
drug safety. 
7.7. Chapter 7 conclusion 
This chapter serves as conclusion to this research. It provides the project summary, research 
contributions to the PV industry, key attributes offered to academic literature, sections and page 
numbers where the research objectives were achieved, opportunities for future research, and 
the research conclusion. 
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Appendix A: Chapter 2 supporting content 
This appendix provides the supporting content of Chapter 2. In this appendix, two sections are 
provided, namely: 
 Section A.1: SAIIE28 annual conference article – This section contains the article that 
was published in the SAIIE28 annual conference proceedings, produced from a large 
portion of the content in Chapter 2 of this thesis.  
 Section A.2: Structured literature search protocol – This section contains the structured 
literature search protocol, referenced in Section 2.5, used during the literature search in 
order to identify the PV challenge landscape. 
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Section A.1: SAIIE28 annual conference article 
An investigation into the prospects of existing technologies to address the challenges faced by 
pharmacovigilance systems 
 
Izak V.B. Lamprecht1, Louzanne Bam1, Imke H. de Kock1 
 
1Health Systems Engineering and Innovation Hub, 
Department of Industrial Engineering, 
Stellenbosch University, South Africa 
17574846@sun.ac.za & louzanne@sun.ac.za & imkedk@sun.ac.za 
 
ABSTRACT 
 
Pharmacovigilance (PV) is defined as the science and activities relating to drug safety surveillance, i.e. the 
detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Even 
though substantial progress has been made over the past several decades to improve the effectiveness and 
efficiency of PV systems, literature suggests that the vast majority of PV systems are still burdened by similar 
challenges. Typical challenges often relate to aspects considered to have the ability to facilitate improved PV, 
i.e. engaging the public, building collaborations and partnerships, incorporating informatics into PV systems, 
adopting a global (standardised) approach, and assessing the impact of efforts. Furthermore, researchers argue 
that these challenges are not new and have been, and still is, pivotal research objectives within PV studies.  
 
Advances in science and technology over the past couple of decades have seen technologies being developed, 
and subsequently successfully employed, to address similar challenges in other industries. The impact of these 
technologies are described in literature, proving their success. This paper argues the case for such technologies 
within PV systems, proposing a research agenda for identifying technologies that hold the potential to address 
the challenges faced by PV systems. 
 
OPSOMMING 
 
Pharmacovigilance (PV) word gedefinieer as die wetenskap en aktiwiteite wat verband hou met farmaseutiese 
dwelm veiligheid toesig, dit wil sê, die opsporing, assessering, verstaan en voorkoming van ongunstige gevolge 
of enige ander dwelm-verwante probleem. Ten spyte van die aansienlike vordering oor die afgelope paar jaar 
om die effektiwiteit en doeltreffendheid van PV sisteme te verbeter, stel literatuur steeds voor dat ‘n groot deel 
van PV sisteme steeds belas word met soortgelyke uitdagings. Tipiese uitdagings hou dikwels verband met aspekte 
met die vermoë om verbeterde PV te fasiliteer, dit wil sê, die innemendheid van die publiek, die verbetering 
van samewerking en vennootskappe, die inkorporëring van informatika in PV sisteme, die aanneming van ‘n 
globale (gestandaardiseerde) benadering, en die assessering van die impak van pogings. Verder argumenteer 
navorsers dat hierdie uitdagings nie nuut is nie en was, en is steeds, deurslaggewende navorsingsdoelwitte in PV 
studies. 
 
Vorderings in wetenskap en tegnologie oor die afgelope paar jaar het leiding gegee tot ontwikkelings in tegnologie 
wat gevolglik suksesvol onderneem is, wat soortgelyke uitdagings in ander nywerhede aanspreek. Die impak van 
hierdie tegnologieë word beskryf in literatuur en dien as bewys van die sukses behaal deur hierdie tegnologieë. 
Hierdie navorsingsverslag beweer die toepassing van hierdie tegnologieë en stel ‘n navorsingsagenda voor vir die 
identifikasie van sulke tegnologie wat die potensiaal het om die uitdagings in PV aan te spreek. 
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1. INTRODUCTION: Background 
 
The Thalidomide disaster of the 1960s ((Toklu & Uysal 2008); (Isah et al. 2012)) has been described as the largest 
man-made medical disaster in history (Vargesson 2015), that led to nearly 10 000 babies worldwide being born 
with extremity defects (Wang et al. 2009). Speculation followed on the true nature of these defects and whom 
is to be held responsible (De Abajo 2005). To this day survivors of the tragedy are compensated by both 
government and the original manufacturers of the drug, however, they still live with the consequences (Vargesson 
2015). Various researchers (including Wang et al. (Wang et al. 2009); De Abajo (Stolk 2012); and Klausen & Parle 
(Klausen & Parle 2015)) concur that this disaster made the need for drug safety monitoring and surveillance to 
prevent a tragedy of similar stature occurring in the future apparent. 
 
Subsequently, pharmacovigilance (PV) was introduced to the healthcare environment in the late 1960’s (De Abajo 
2005). At this time, the World Health Organisation (WHO) unveiled the WHO Programme for International Drug 
Monitoring, an organisation consisting of multiple international partners aimed at international monitoring and 
surveillance of new and existing drugs (World Health Organization 2002). PV enjoys much attention in this 
programme, now co-ordinated by the Uppsala Monitoring Centre (UMC) (World Health Organization 2002). 
 
THE PHARMACOVIGILANCE SYSTEM 
 
The WHO defines PV as the “science and activities relating to the detection, assessment, understanding and 
prevention of adverse effects or any other possible drug-related problems” (World Health Organization 2002). 
Regularly associated with PV are adverse drug reactions (ADRs) or adverse drug events (ADEs) which describe the 
unintentional and unpredicted reactions to, or side-effects of new or existing drugs (World Health Organization 
2014). When such unpredicted reactions or side effects occur, the ideal is that it is reported to the appropriate 
authorities. Depending on the degree of severity of the reaction, the report is either terminated at the national 
level or sent on to the UMC (Strengthening Pharmaceutical Systems (SPS) 2009). 
 
Referring to the nature of PV, the WHO describe it as being based on surveillance (World Health Organization 
2004). It is therefore reasonable to expect that, at least at an abstract systems level, the PV challenge landscape 
will share some characteristics with other surveillance based industries. More specifically, it is reasonable to 
expect that at least some of the challenges faced in the PV landscape will be similar to those faced in other 
surveillance based industries. 
 
The common ground that exists between the PV challenge landscape and other industries is clear in the resource 
management (in particular human resource management) use case described by Rabiul et al. (Rubel et al. 2017). 
A study is conducted in a software based model known as high-involvement human resource management (Rubel 
et al. 2017), which is implemented in a variety of organisations, delivering good results in terms of increased 
organisational process efficiency and reduced human resource expenses.  
 
The use case illustrates the relationship that exists between PV and other industries, both requiring resource 
management in general and human resource management in particular. It is clear that there are existing 
technological developments that can have a beneficial impact on PV. Prior to the investigation of such 
developments, the PV system and the PV challenge landscape are described, providing an understanding of the 
current condition of PV. This allows for the research to pinpoint exactly where in the PV landscape improvements 
are necessary.  
 
2. The PV system 
 
PV is described from a systems perspective by the organisation Strengthening Pharmaceutical Systems 
(Strengthening Pharmaceutical Systems (SPS) 2009), who categorise the PV system into people, functions, 
structures, and expected outcome and impact. This systems view of PV is briefly described in this section. 
 
Within the PV system, people are categorised as either reporters or evaluators (Strengthening Pharmaceutical 
Systems (SPS) 2009). Reporters are those who report ADRs (or suspected ADRs) to the relevant authorities, known 
as the evaluators. Evaluators largely consist of various healthcare professionals whom have the ability to do the 
necessary analysis to identify and categorise ADRs from the data that is reported. Forming part of the processes 
are the functions associated with PV, from ADR reporting to analysis and implementation of solutions. Critical to 
the effective and efficient operation of these processes are the structures and bodies involved including PV 
organisations, medical infrastructures and networks, regulatory bodies, product manufacturers, and the media 
(Strengthening Pharmaceutical Systems (SPS) 2009). These structures, as well as the people involved, are 
essential in providing the necessary resources and managing the overall PV system. 
 
A PV system consists of several sequential stages. Figure 1 provides an overview of the six stages (Strengthening 
Pharmaceutical Systems (SPS) 2009). 
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Figure 1: Stages of a PV system 
 
As one would expect, the increasing scope of PV systems has increased the complexity and number of challenges 
faced within the PV landscape ((Edwards 2017) and (Pan 2014)), giving rise to challenges such as the under-
reporting of ADRs, ineffective culture, lack of transparency, and the lack of sufficient resources. Pan (Pan 2014) 
also states that increased pressure is put on new technological developments that are intended to counter the 
challenges in the PV landscape. The WHO describes how the inter-relatedness of the various stages in a PV system 
cause challenges that exist within the PV landscape to have a system-wide impact (World Health Organization 
2002). The under-reporting of ADRs is an example of a prominent PV challenge that has a system-wide impact. 
PV systems are initiated by ADR reports, serving as the line of communication between PV authorities and the 
people experiencing certain ADRs (Varallo et al. 2014). Due to the integrated global nature of PV monitoring (as 
managed by the UMC), the impact of a challenge such as under-reporting of ADRs can also stretch beyond a 
specific PV system to the global PV monitoring level. 
 
3. Overview of the PV challenge landscape 
 
Each stage of a PV system is associated with a specific set of challenges and Pan (Pan 2014) states that the PV 
challenge landscape is vast. It is therefore advantageous to this research that these challenges be identified, 
enabling associations to be made between the challenges and the various stages of a PV system where they are 
likely to have an impact.  
 
Due to the large landscape of PV challenges, a systematic review was conducted in order to ensure that a 
significant portion of existing research conducted in the challenge landscape is considered in this research. Three 
academic databases were used, namely: Scopus, Google Scholar and PubMed. The Scopus database was used for 
the primary systematic search protocol while the PubMed and Google Scholar databases were used for snowballing 
and other informal search methods. In total, 2301 relevant documents are available based on specific search 
terms (these search terms are detailed in Appendix 1). These search terms were based on the suggestions made 
by the articles found on the databases. Also, suggestions made by grey literature were used as search terms. To 
reduce the number of articles to a more manageable quantity, only the articles published during the year 2000 
and onwards were included in the search. Then, the abstracts were consulted to determine the applicability of 
the article to the research. An important inclusion criteria was that the abstract had to contain words associated 
with PV, such as “pharmacovigilance”, “drug safety monitoring”, or “drug safety surveillance”. The documents 
were filtered to 64 documents of which the majority are referenced in the proceeding section.  
 
Shown in Figure 2, the most prevalent PV challenges were organised into a network, illustrating the inter-related 
nature of the PV challenge landscape. This was done by interpreting the suggestions made by literature, taking 
into account both the severity and prevalence of the challenge. The PV challenge landscape has been organised 
into two categories, namely partnerships and ADR reporting, both overarched by culture: 
 
 Culture can be regarded as an overarching element of the PV challenge landscape, underpinning the 
other challenges in PV. The suggestion that the improvement of PV culture will contribute to the 
improvement of the entire PV system is regularly made by literature ((Olsen & Whalen 2009); and 
(Rodrigues & Khan 2011)). 
 Partners are regarded as essential to a system such as PV, responsible for providing essential resources. 
The public is a key partner in PV, as they can be utilised across the PV spectrum, especially during ADR 
reporting ((World Health Organization 2002); and (World Health Organization 2004)).  
Evaluation of outcomes
Process of monitoring the success of the action taken to address the ADR
Decision making and Appropriate action
Determining the best action to be taken in attending to and eliminating the reported ADR
Risk assessment
Identifying the pre-merket risks of drugs, as well as the risks to patients after an ADR has been 
experienced
Causality analysis
Determining the cause of the reported ADRs
Data collation
Collection of all ADR reports and preparation efforts for investigation
ADR reporting
Process during which ADRs are reported to the relevant authorities
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 ADR reporting is widely regarded as one of the most important stages of a PV system (Hill 2014), as it 
serves as the starting point for the PV system providing the data on which the system relies to identify 
ADRs.  
 
Each of the challenges presented in Figure 2 are briefly described in the following section, providing a succinct 
overview of the PV challenge landscape. 
 
Figure 2: The PV challenge landscape network 
 
3.1. Culture 
 
PV is based on the culture of safety, where PV professionals provide the foundation upon which the principles of 
this culture is built (Olsen & Whalen 2009). Literature, however, argues that there is a need to improve the 
culture in modern PV systems (Rodrigues & Khan 2011). It is believed that the improvement of PV culture will 
give lead to the improvement of the other challenges in PV, as illustrated in Figure 2. It is often discussed that 
the improvement of PV culture requires participation across all disciplines in order to become a reality.  
 
The culture of PV is closely related to both Inman’s – and the KAP models of under-reporting (Rodrigues & Khan 
2011), discussed in Section 3.3.2. To achieve this culture, the challenges presented by these models should be 
investigated. This is also the opinion of Rodrigues & Khan (Rodrigues & Khan 2011), who refer to the need to 
develop a safety culture, associated with the reporting of ADRs, amongst surgeons and surgical wards. The 
establishment of a culture of safety amongst healthcare professionals across the globe is time-sensitive (Edwards 
et al. 2015), emphasising the need for the timely establishment of such a culture. 
 
3.2. Partnerships 
 
PV is a collaborative endeavour (Pan 2014). Sustained collaboration and commitment are vital to attend to future 
challenges of PV ((World Health Organization 2002); and (World Health Organization 2004)). However, ineffective 
partnership is a threat to PV (World Health Organization 2004). Operating in a resource constrained environment, 
partners in PV must sometimes provide expertise, training, political support, scientific infrastructure, and a 
capacity to accomplish comprehensive monitoring and investigations of the safety of medicines (Pan 2014). 
Failure in providing such resources, ineffective partnerships can lead to failed PV initiatives. In order to maintain 
a certain inventory of these resources, it is vital that PV organisations form lasting relationships with its partners. 
Management for Science (Management for Science 2012) emphasises the importance of relationships between 
partners and how failed relationships often lead to failures. 
 
3.2.1. Public participation 
 
The scope of PV is large (Rodrigues & Khan 2011), as it monitors a wide range of new and existing drugs in several 
countries, therefore requiring the participation of numerous stakeholders. Consumers and patients are described 
as key stakeholders (BEUC 2008), having the ability to contribute through an integrated and efficient reporting 
system. These direct reporting systems enables PV professionals to detect ADRs much earlier, as well as remove 
the healthcare professional as filter to reporting ADRs.  
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However, patients and consumers have been losing faith in the pharmaceutical industry. A survey of the US 
public, conducted in 2006, illustrated this loss in trust with approximately 42% of public participants indicating 
that they are sceptical of the pharmaceutical industry (Olsen & Whalen 2009). Similarly, a study conducted in 
2007 on similar participants also indicated that the public had indeed lost confidence in the pharmaceutical 
industry (Olsen & Whalen 2009). Surveys such as these serve as proof that the PV industry must shift its focus in 
maintaining collaboration with the consumer and patient. 
 
3.2.2. Transparency 
 
In close association with the culture found in PV, the lack of transparency amongst the stakeholders in PV may 
lead to failed PV initiatives (Edwards et al. 2015). It is essential that key stakeholders, especially those with the 
relevant experience in PV, share information with their peers. This will enable participants in PV to learn of new 
ways in solving the problems they might be experiencing. Increasing the visibility of information in PV is critical 
(Edwards et al. 2015), as it will support an improved drug safety culture. 
 
3.2.3. Insufficient resources 
 
It is well-known that PV operate within a resource constrained environment (Isah et al. 2012). Especially in 
developing countries where other challenges such as drought and war are of high priority, PV organisations 
struggle to implement new PV systems (Isah et al. 2012). In these countries the available resources are rather 
invested elsewhere, leaving little for the requirements of PV. 
 
The resources required by PV systems are unique in specific countries e.g. a country might have the necessary 
expertise and manpower to assist a PV system but lack the governmental funding, whereas another country might 
have the necessary budget but lack the required manpower (Pan 2014). Countries experiencing this phenomena 
include Sub-Saharan African countries (Isah et al. 2012), India (Rama et al. 2011), and certain South-East Asian 
countries (Suwankesawong et al. 2016). Common resources required by PV systems include monetary assistance, 
hardware and software infrastructure, expertise and training curricula amongst healthcare professionals, and 
common PV knowledge amongst both healthcare professionals and consumers ((Isah et al. 2012); and (Pan 2014)). 
PV systems are dependent on the combination of these resources and are not able to function properly without 
it (Isah et al. 2012). Heinrich (Heinrich 2015) make reference to effective resource management, a crucial 
element to the successful operation of a PV system. 
 
Lack of PV centres  
 
Serving as the base of operation for PV monitoring efforts, PV centres are important elements of the PV industry. 
Zhang et al. (Zhang et al. 2014) describes the PV centre network: the UMC is the international database, taking 
ownership of millions of ADR reports received from numerous countries each year (Rama et al. 2011). Serving as 
filter to such ADR reports are national PV centres, supported by provincial centres, usually located in provincial 
hospitals and other medical institutions. Lastly, municipal centres serve as the first line of defence i.e. initially 
receiving and processing ADR reports before sending it to PV centres further up the PV centre network hierarchy. 
Zhang et al. (Zhang et al. 2014) provides a description of the Chinese PV centre network, consisting of one 
national PV centre, 34 provincial centres and 400 municipal centres, all reporting to the UMC.  
 
The challenge faced, especially in developing countries, are the gaps found within this PV centre network. The 
Sub-Saharan Africa case where there are many countries with no or few municipal – and provincial centres is 
discussed by Isah et al. (Isah et al. 2012). Olsson et al. (Olsson et al. 2010) and Isah et al. (Isah et al. 2012) are 
of the opinion that this deficit is due to the lack of resources such as tangible infrastructure, human resources, 
training and capacity building, governance, sustainable methodologies, and innovations within a number of areas 
in the Sub-Saharan Africa context. With no intermediate body to receive and filter initial ADR reports, it is 
difficult for healthcare professionals and consumers, in countries with no municipal – or provincial PV centre, to 
report ADRs to the appropriate authorities (Zhang et al. 2014). 
 
Clinical trials 
 
Clinical trials are conducted premarket and are used to determine the effect that a drug will have on consumers, 
as well as to identify certain ADRs that cannot be predicted in laboratory conditions (Cheaib 2016). Similarly, 
Dubey & Handu (Dubey & Handu 2013) state that clinical trials are important to know the drug’s effect on humans 
as it cannot be directly extrapolated from preclinical animal studies. Although the results detained from clinical 
trials are beneficial to the PV industry, clinical trials are burdened by some limitations ((Cheaib 2016); (Raschi 
et al. 2016); (Dubey & Handu 2013); and (Härmark & Van Grootheest 2008)). 
 
Though clinical trials undoubtedly play a vital role in drug safety, they can sometimes deliver limited results 
(Härmark & Van Grootheest 2008). For example, due to the limited number of patients participating, it is 
generally not possible to identify ADRs that occur  rarely (Cheaib 2016) and such ADRs will therefore only be 
identified and investigated after a drug has been marketed to the public. Another example of the limitation to 
clinical trials, is a possible lack of correspondence in characteristics (e.g. age and sex) between the populations 
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in which a drug is tested and those where it will be developed post-market (Dubey & Handu 2013). This limits 
the extrapolation of results obtained from clinical trials to the population at large (Härmark & Van Grootheest 
2008). 
 
Country-specific factors 
 
Country-specific factors refer to challenges faced by PV organisations outside the traditional resource 
architecture and are described by Edwards (Edwards 2017) and Härmark & Van Grootheest (Härmark & Van 
Grootheest 2008). Closely related to the effect of the public on PV, the social factors of an area must be 
considered which includes the culture, religion, age groups, and sex groups of a specific region. It is often a 
burden to clearly identify these factors, since it requires manpower and funding that are not always available. 
 
Situational factors which refer to border regulations, policies for implementation, governmental budget 
constraints, conflict in countries, and environmental issues such as severe drought must also be considered. 
Often governments refuse to authorise and support the implementation of new PV systems since its priorities are 
elsewhere (World Health Organization 2002), delaying the implementation of PV systems. Similar to the social 
factors, the required resources needed to identify these factors are not always available, proving to contribute 
to the failed deployment of PV initiatives. 
 
3.3. ADR reporting 
 
ADR reporting is widely regarded as the starting point of a PV system. An ADR report is present across the entire 
PV system, serving as source of information to the relevant authorities conducting the investigations into the 
ADR query. Furthermore, many ADR reporting techniques exist in practice including spontaneous reporting, 
targeted reporting, cohort event monitoring, and electronic health record mining (Hill 2014).  
 
3.3.1. Quality of ADR reports 
 
The quality of medical data, in a PV context, is of utmost importance (François et al. 2013). Without ADR reports, 
PV systems cannot function and literature regularly emphasises the need for advancements to be made with 
regards to the quality of such reports (Sarker et al. 2015).  
 
Spontaneous reporting is a widely used method in PV (Hill 2014), dependent on both healthcare professionals and 
the consumer. However, Bandekar et al. (Bandekar et al. 2009) describes a looming threat to spontaneous 
reporting: the poor quality of the reports. These quality issues, regularly found in reports by non-healthcare 
professionals, include issues with credibility, uniqueness, frequency, and salience of the data contained in the 
report (Sarker et al. 2015). Such issues can be motivated by the lack of necessary PV knowledge amongst 
consumers.  
 
However, poor quality reports are not restricted to those generated by consumers, but is also generated by 
healthcare professionals. Such poor quality is evident in a study by Bandekar et al. (Bandekar et al. 2009), where 
ADR reports from ten different countries were collected, with the objective of determining the quality of the 
reports. It was found that several reports lacked critical information (e.g. pregnancy status, age, sex, and allergic 
status), regardless of the fact that many of these reports were generated by healthcare professionals. Sub-
Saharan African countries were rated particularly poorly, achieving below 50% with regards to the quality 
standard baseline. 
 
The poor quality of ADR reports can be traced back to the culture of PV (Bandekar et al. 2009). The establishment 
of a culture where more emphasis is put on the quality of ADR reports, as described by Edwards et al. (Edwards 
et al. 2015), may therefore contribute to the improvement of ADR reports. 
 
3.3.2. ADR under-reporting 
 
Under-reporting of ADRs occur when healthcare workers (HCWs) (general practitioners, nurses, surgeons, 
pharmacists etc.) fail to efficiently report new and existing ADRs. Two prominent models that explain the causes 
of under-reporting are widely cited in literature namely Inman’s model of the seven deadly sins of under-
reporting and the KAP (knowledge, attitude, and practice) model of under-reporting. Taken together, these two 
models provide a comprehensive overview of the causes of under-reporting of ADRs. The KAP model is said to be 
the leading cause, in association with Inman’s model, of under-reporting of ADRs (Herdeiro et al. 2006). 
 
Inman’s seven deadly sins of under-reporting 
 
In the 1990s Dr William Inman conducted research on PV with specific reference to the causes of under-reporting 
(Varallo et al. 2014). This study, known as Inman’s seven deadly sins of under-reporting, is widely cited in 
literature ((Varallo et al. 2014); (Hazell & Shakir 2006); (Irujo et al. 2007); and (Rodrigues & Khan 2011)). More 
recent studies ((Varallo et al. 2014); and (Rodrigues & Khan 2011)) have confirmed the findings, specifically 
highlighting the ignorance, insecurity and indifference aspects of the model. 
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The so-called sins of Inman’s model are: 
 Fear: Of litigation, 
 Indifference: About contributing to the general advancement of knowledge, 
 Ambition: To collect and publish a personal case series, 
 Guilt: At having caused and adverse effect, 
 Complacency: The mistaken belief that only safe drugs are licensed, 
 Ignorance: Of the need for reporting, and 
 Diffidence: About reporting a mere suspicion. 
 
Many of these so-called sins such as indifference, ambition, complacency, and diffidence strongly relate to the 
culture in PV and research in eliminating these sins is believed to improve the overall culture within PV. 
 
KAP model 
 
The first aspect of the KAP model is knowledge, closely related to education according to Herdeiro et al. 
(Herdeiro et al. 2006). The shortcomings of PV in the undergraduate and postgraduate syllabus of medical 
students is regularly referred to in literature ((Schramm et al. 2017); (Abubakar, Chedi, et al. 2015); (Abubakar 
& Haque 2016); (Abubakar, Ismail, et al. 2015); and (Abubakar, Simbak, et al. 2015)). These shortcomings are 
also not unique to specific countries. Studies in Nigeria (Abubakar, Chedi, et al. 2015), Malaysia (Abubakar, 
Ismail, et al. 2015), Portugal (Herdeiro et al. 2006), Turkey (Toklu & Uysal 2008), India (KC et al. 2013), and 
China (Su et al. 2010) all discuss the need for medical students’ curriculum to either include or improve PV 
education. 
 
The aforementioned country specific studies also highlight the lack of sufficient knowledge on the correct PV 
practices in practicing healthcare professionals. Toklu & Uysal (Toklu & Uysal 2008) discuss the need for improved 
PV knowledge amongst community pharmacists in Turkey, Passier et al. (Passier et al. 2009) the need for 
improved PV knowledge amongst general practitioners in Netherlands, and Herdeiro et al. (Herdeiro et al. 2006) 
the need for improved PV knowledge amongst pharmacists in Portugal. It is clear that thorough knowledge of PV 
is a challenge, hurdling several PV initiatives to be completely successful in many countries. 
 
Secondly, the KAP model refers to the general attitude of healthcare professionals towards PV. This element of 
the KAP model is closely related to the indifference and ignorance aspects of Inman’s model and also strongly 
relates to the culture aspects of the PV challenge landscape. Some examples of the role of attitude in under-
reporting are given in a recent study by Shamim et al. (Shamim et al. 2016) who seek to build an understanding 
of the general attitude of physicians, pharmacists, and nurses towards PV in Pakistan. It was found that a large 
portion of these healthcare professionals are indifferent towards PV, with only 14.3% being aware that there was 
an ADR reporting organisation in Pakistan. Similarly, a study within a Spanish context also discuss the poor 
attitude of healthcare professionals towards PV (Varallo et al. 2014). The indifference found in the Spanish 
context is associated with the lack of interest of healthcare professionals to register for ADR reporting and a lack 
of time for the many activities in the clinical routine.  
 
Lastly, the lack of sufficient practice in PV is also a challenge faced in the PV industry. Closely associated with 
training, Varallo et al. (Varallo et al. 2014) is of the opinion that the lack of sufficient practice has recently 
surfaced and is nowadays referred to as the eight sin of Inman’s model. The lack of practice in PV is regularly 
referred to in literature, including Aronson (Aronson 2012) discussing the need for increased, real-world PV 
practice amongst British healthcare professionals, and Beckmann et al. (Beckmann et al. 2014) who similarly 
emphasises this need in a general context. 
 
3.3.3. Text-mining 
 
Text mining is defined as the computational process of extracting meaningful information from large amounts of 
unstructured text (Harpaz et al. 2014). In a PV context, meaningful information is regarded as information that 
can support ADR detection and assessment (Yang et al. 2015). Contrary to popular belief, a major challenge 
faced in text mining, as described by Harpaz et al. (Harpaz et al. 2014), is not necessarily the extraction of 
useful information from severely unstructured text, but rather realising the value text mining holds for the PV 
industry (Harpaz et al. 2014). Extraction is a challenge (Yang et al. 2015), but advancements in software have 
simplified information extraction efforts (Harpaz et al. 2014). 
 
The use of text-mining on social media is regularly discussed in literature ((Harpaz et al. 2014); (Yang et al. 
2015); and (Nikfarjam et al. 2015)). The challenge of some PV organisations not realising the value of text mining, 
as described by Harpaz et al. (Harpaz et al. 2014), is evident in the late adoption rate of social media. Nikfarjam 
et al. (Nikfarjam et al. 2015) is of opinion that this unwillingness to use social media for ADR reporting is due to 
the informal nature of social media i.e. consumers make use of informal words and phrases to report a suspected 
ADR, therefore PV organisations are sceptical of the quality of information that can be gathered from social 
media. Harpaz et al. (Harpaz et al. 2014) and Yang et al. (Yang et al. 2015) argue that technological 
developments are only contributing to an increased adoption rate of text-mining to a limited extent. 
 
3.3.4. Proactive versus reactive systems 
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Regulatory enforcement and increased accountability demands for the protection and welfare of patients, forces 
the PV industry to be more proactive in its efforts (Lu 2009). These regulations govern proactive PV systems that 
must include comprehensive risk management plans and signal detection and analysis throughout a clinical 
product’s lifecycle (Lu 2009). Proactive PV is not only able to respond to ADRs prior to the marketing stage of 
drugs, but also decreases the probability of a known ADR to be experienced during such a large scale deployment 
(Rodrigues & Khan 2011).  
 
Certain modern PV systems are outdated (Giezen et al. 2009). Spontaneous reporting, as described by Hill (Hill 
2014), is the first ADR reporting system implemented in PV. Such reports are of reactive nature, depending on 
healthcare professionals and consumers to report ADRs after a drug has been marketed and the ADR experienced. 
Spontaneous reports are still widely used, increasing the pressure on PV systems in which these operate to make 
a transition towards proactive operation (Rodrigues & Khan 2011). 
 
Existing PV systems struggle with the reactive to proactive conversion process ((Lu 2009); and (Giezen et al. 
2009)). It is simpler to design a proactive PV system from scratch than to convert an existing PV system to a 
proactive mode of operation. Resistance to change is a major cause of this struggling transformation since it is 
well known that people often prefer an existing system rather than having to learn the functions of a new system 
(Hill 2014). 
 
3.3.5. Lack of data 
 
PV relies on good information i.e. information of proper quality (Pan 2014). It is argued that the lack of the 
physical data as well as the quality of such data burdens PV systems (Rachlis et al. 2016), limiting the possibility 
of investigations. Pan (Pan 2014) also discusses the limitation to current PV data. This argument is supported by 
case studies conducted by Rachlis et al. (Rachlis et al. 2016) and Weber-Schoendorfer & Schaefer (Weber-
Schoendorfer & Schaefer 2016) that made the phenomenon of insufficient data apparent. This phenomenon is 
closely related to under-reporting and the quality of ADR reports.  
 
3.3.6. Lack of reporter feedback 
 
A challenge faced by the PV industry, regularly overlooked by researches, is the lack of feedback given to ADR 
reporters ((Aljadhey et al. 2015); (Al Dweik et al. 2016); (Ríos et al. 2016); (De Vries et al. 2016); and (Kabore 
et al. 2013)). A study of Saudi Arabia’s PV system indicated that participants of the existing ADR reporting 
network see no point in reporting ADRs if they cannot get feedback and support from the country’s PV authorities 
(Aljadhey et al. 2015). 
 
A similar study completed in the UK, Netherlands, and Australia found that ADR reporters, especially patients, 
want personal feedback to put them to ease that their voices and opinions are heard by the relevant PV 
authorities (Al Dweik et al. 2016).  
 
This need for personal feedback as a sociological component of PV is described by Rios et al. (Ríos et al. 2016) 
as a routinely overlooked component of the PV system. The lack of adequate feedback is also evident further up 
the PV authority hierarchy, where gaps in the PV centre network are regularly found. 
 
3.3.7. Causality analysis 
 
Establishing causality in PV is a difficult and time consuming process, requiring resources such as manpower, 
expertise, and funding that is often scarce and hard to come by (Edwards 2017). Avorn & Schneeweiss (Avorn & 
Schneeweiss 2009) make reference to this issue, stating that it is a common challenge experienced in various 
locations. Even though a large body of ADR data exists (Avorn & Schneeweiss 2009), the volume is often too much 
for causality initiatives. Similar to the case described earlier, undertaking such a volume of data require resources 
that are not always available. This lack of resources and the difficulty in identifying linkages between ADRs and 
its source are hindering causality analyses from being conducted in a timely fashion. 
 
4. Relationship between the PV system and the challenge landscape 
 
As discussed in Section 2, literature suggests that relationships exist between the stages of a PV system and the 
challenge landscape. Table 1 depicts the proposed relationships between the challenges (as organised in Figure 
2) and the stages of a PV system (as shown in Figure 1).  
 
Table 1illustrates where exactly in the PV system the challenge landscape has an impact. From the table it is 
evident that challenges such as partnerships, culture, and transparency are prominent and the dominant 
positioning of these three challenges in the typology of the challenge landscape presented in Figure 2 is thus 
supported. Cognisant of the vast number of challenges that exist in the PV landscape, Table 1 can be useful in 
assisting to direct future research efforts by enabling researchers to prioritise those challenges that have the 
most far-reaching impact on the PV system. Thus encouraging more in-depth research in specific challenges that 
are likely to have a system-wide positive impact. 
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Table 1: Relationship between a PV system and the challenge landscape. 
 
Stages of a PV 
system 
ADR 
reporting 
Data 
collation 
Causality 
analysis 
Risk 
assessment 
Decision-
making 
Appropriate 
action 
Evaluation 
of 
outcomes Challenge 
landscape 
Culture X X X X X X X 
Partnerships X X X X X X X 
Public 
participation 
X     X X 
Transparency X X X X X X X 
Insufficient 
resources 
X X X X X X X 
Lack of PV 
centres 
 X   X X X 
Clinical trials  X X X    
Country-
specific 
factors 
X X X X X X X 
Quality of 
ADR reports 
 X X X    
ADR under-
reporting 
X       
Text-mining  X X X    
Proactive vs 
reactive 
systems 
X     X  
Lack of data  X X X    
Lack of 
reporter 
feedback 
    X   
Causality 
analysis 
  X X    
 
5. Prospects of technological developments from other industries 
 
As discussed in the introductory chapter, it is believed that PV shares common characteristics with other 
surveillance based industries. The ever increasing environment of technological developments (such as tangible 
hardware, software, business processes, frameworks, and models) in various industries that have a similarity to 
PV, is believed to hold the potential to address aspects of the PV challenge landscape.  
 
Limited research has been conducted with regards to the prospects of existing technological developments to 
address the challenges faced by PV systems, therefore, this section is limited to a brief overview of the existing 
technological developments. Subsequently, a succinct overview of three technological developments, believed 
to have a possible impact on the PV challenge landscape, is provided. 
 
5.1. Improving PV transparency with Workmate 
 
As discussed in Section 3.2.2., transparency, especially between key stakeholders, is a challenge faced in PV. 
Literature often claims that transparency in PV is essential as it allows for healthcare workers to share 
experiences with certain ADRs and support one another in attending to such ADRs.  
 
A software program, Workmate, a human resource management system developed by HRCloud, an organisation 
developing software models for human resource management purposes (HRCloud 2017), can be used for the 
general improvement of transparency in PV. It enables users, in this case PV stakeholders, to share experiences 
and recognise peers’ work and achievements. This software has the capacity to improve transparency in PV, as 
well as contribute to the improvement of PV culture. 
 
5.2. Understanding the attitudes, perceptions and behaviours of stakeholders in PV with the Health Belief 
Model 
 
The health belief model is a popular theory used in health education and health promotion, first developed in 
the 1950s as a way to explain why medical screening programs offered by the US Public Health Service were not 
successful (Stretcher & Rosenstock 1997). The model consists of various elements, with the ultimate goal of 
identifying the attitudes, perceptions and behaviours of participants towards certain health services. It has been 
applied in various contexts, especially in nutritional studies (Deshpande et al. 2009).  
 
This model can also be applied in the PV industry, enabling researchers to understand the phenomenon of the 
ADR under-reporting. Directly associated with Inman’s model and the KAP model discussed in Section 3.3.2., the 
attitudes of both healthcare workers and the public can be determined. This allows for research to determine 
the appropriate actions to be taken to address the findings of the health belief model. 
 
5.4. Partnership Success Model 
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Literature makes reference to various business partnership models that have the capacity to aid the 
establishment of partner relationships. One of these models, the partnership success model, can be used to 
contribute to improved partnership management in PV. This model states that in order to achieve success in 
partnerships, certain attributes must be established. These attributes are the key characteristics of partnerships 
such as commitment and trust, communication behaviours such as information sharing and participation from all 
parties, and finally effective conflict resolution techniques (Hill 2014). 
 
5.5. Conclusion: Potential of technology to contribute to PV 
 
It is evident that there are existing technological developments that can be used to address the PV challenge 
landscape. Further investigation of other technological developments such as algorithms developed for big data 
analysis, existing resource management systems, sociological studies to understand the country-specific factors, 
and transition models for changing reactive reporting systems into proactive systems, is therefore motivated as 
there is reason to believe that these may have the capacity to address aspects of the PV challenge landscape. 
 
6. Conclusion and further research 
 
The association made between a PV system and the PV challenge landscape is discussed in this paper. A succinct 
overview of the PV challenge landscape is provided, where it is made clear that PV culture is in need of 
improvement. This can be done by addressing the challenges arising from PV culture. The associations made 
between the PV system and the PV challenge landscape illustrates the challenges that are most prevalent, making 
it clear that research in these challenges is necessary.  
 
A succinct overview of the prospects of existing technological developments in addressing the PV challenge 
landscape is provided. This shows that there are technological developments, used outside the PV context, which 
can be applied to the PV challenge landscape. 
 
For further research, subject matter experts and literature will be essential in prioritising the PV challenge 
landscape, allowing for more in-depth research to be conducted in the most prevalent challenges in PV, which 
will allow for a comprehensive understanding of these challenges. Subsequently, research into the prospects of 
technological developments in industries that experience similar challenges than that of PV can continue. 
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Appendix 1: structured literature search protocol 
 
As described in Section 3, a structure search protocol was followed to identify literature for inclusion in the 
review of the PV challenge landscape. In total, 33 searches were conducted, the protocol used for each search 
is detailed in Table 2. The “W/” operator indicated in the table is used in Scopus to denote that terms must 
appear within the specified number of words from one another. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Structured literature review search protocol. 
 
Search 
ID 
Search terms 
1 pharmacovigilance  AND  challenge*  
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2 adverse  AND drug  AND reaction  AND  area*  W/3  improvement* 
3 adverse  AND drug  AND reaction  AND  area*  W/1  improvement* 
4 adverse  W/0  drug  W/0  event  OR  reaction*  AND  area*  W/1  improvement* 
5 limitation*  AND  clinical  AND trials  AND  pharmacovigilance  
6 limitation*  W/1  clinical  AND trials  AND  pharmacovigilance  
7 pharmacovigilance  AND  culture 
8 pharmacovigilance  AND  culture  AND  challenge 
9 pharmacovigilance  AND  feedback  
10 pharmacovigilance  AND  feedback  AND  challenge*  
11 pharmacovigilance  AND  feedback  AND  limitation* 
12 adverse  AND drug  AND reaction  AND report*  AND  feedback  
13 pharmacovigilance  AND  minimal  W/0  data 
14 adverse  AND drug  AND reaction  AND report*  AND  minimal  W/0  data  
15 adverse  AND drug  AND reaction  AND report*  AND  lack  W/0  of  W/0  data  
16 pharmacovigilance  AND  education 
17 pharmacovigilance  AND  education  AND  limitation 
18 pharmacovigilance  AND  expertise 
19 adverse  AND drug  AND reaction  AND  expertise 
20 adverse  AND drug  AND reaction  AND  expertise  AND  challenge  
21 adverse  AND drug  AND reaction  AND  training  AND  challenge  
22 adverse  AND drug  AND reaction  AND  training  AND  limit* 
23 adverse  AND drug  AND reaction  AND  partner* 
24 adverse  AND drug  AND reaction  AND  partner*  AND  challenge 
25 pharmacovigilance  AND  proactive 
26 pharmacovigilance  AND  proactive  W/0  system  
27 pharmacovigilance  AND  public  AND  participation* 
28 adverse  AND drug  AND reaction  AND  public  AND  participation* 
29 adverse  AND drug  AND reaction  AND  consumer*  AND  challenge 
30 adverse  AND drug  AND reaction  AND report*  AND  poor  W/0  quality  
31 adverse  AND drug  AND reaction  AND report*  AND  text-mining 
32 adverse  AND drug  AND reaction  AND report*  AND  under-reporting 
33 pharmacovigilance  AND  under-reporting  AND  challenge 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
XIX | P a g e  
 
Section A.2: Structured literature search protocol 
Search 
ID 
Search terms 
1 pharmacovigilance  AND  challenge*  
2 adverse  AND drug  AND reaction  AND  area*  W/3  improvement* 
3 adverse  AND drug  AND reaction  AND  area*  W/1  improvement* 
4 adverse  W/0  drug  W/0  event  OR  reaction*  AND  area*  W/1  improvement* 
5 limitation*  AND  clinical  AND trials  AND  pharmacovigilance  
6 limitation*  W/1  clinical  AND trials  AND  pharmacovigilance  
7 pharmacovigilance  AND  culture 
8 pharmacovigilance  AND  culture  AND  challenge 
9 pharmacovigilance  AND  feedback  
10 pharmacovigilance  AND  feedback  AND  challenge*  
11 pharmacovigilance  AND  feedback  AND  limitation* 
12 adverse  AND drug  AND reaction  AND report*  AND  feedback  
13 pharmacovigilance  AND  minimal  W/0  data 
14 adverse  AND drug  AND reaction  AND report*  AND  minimal  W/0  data  
15 adverse  AND drug  AND reaction  AND report*  AND  lack  W/0  of  W/0  data  
16 pharmacovigilance  AND  education 
17 pharmacovigilance  AND  education  AND  limitation 
18 pharmacovigilance  AND  expertise 
19 adverse  AND drug  AND reaction  AND  expertise 
20 adverse  AND drug  AND reaction  AND  expertise  AND  challenge  
21 adverse  AND drug  AND reaction  AND  training  AND  challenge  
22 adverse  AND drug  AND reaction  AND  training  AND  limit* 
23 adverse  AND drug  AND reaction  AND  partner* 
24 adverse  AND drug  AND reaction  AND  partner*  AND  challenge 
25 pharmacovigilance  AND  proactive 
26 pharmacovigilance  AND  proactive  W/0  system  
27 pharmacovigilance  AND  public  AND  participation* 
28 adverse  AND drug  AND reaction  AND  public  AND  participation* 
29 adverse  AND drug  AND reaction  AND  consumer*  AND  challenge 
30 adverse  AND drug  AND reaction  AND report*  AND  poor  W/0  quality  
31 adverse  AND drug  AND reaction  AND report*  AND  text-mining 
32 adverse  AND drug  AND reaction  AND report*  AND  under-reporting 
33 pharmacovigilance  AND  under-reporting  AND  challenge 
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Appendix B: Chapter 3 supporting content 
This appendix provides the supporting content of Chapter 3. In this appendix, one section is 
provided, namely: 
 Section B.1: Journal article – This section provides the article that has been produced 
from a large portion of the content on Chapter 3. During the time of this thesis hand-in, 
an applicable journal is still being decided upon. 
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Section B.1: Journal article 
Prioritising the challenges found in pharmacovigilance 
Izak van Biljon Lamprecht; Louzanne Bam; Imke de Kock 
Abstract 
Background: The scope of pharmacovigilance is constantly expanding. As a consequence, an increasing number 
of challenges burden pharmacovigilance systems. From literature it is clear that there are numerous challenges of 
varying severity and impact that influence the many functions in pharmacovigilance. In order to address these 
challenges, researchers and practitioners are investigating, developing and implementing an array of solutions, 
but are however, struggling to address the challenges in the pharmacovigilance challenge landscape. As a result, 
some of the challenges that have a severe impact on pharmacovigilance systems are not addressed. In order to 
counteract the exclusion of challenges with the most significant impact on pharmacovigilance systems, 
prioritisation of the pharmacovigilance challenge landscape is essential, as this will enable researchers and 
practitioners to shift their focus to the challenges that warrant the greatest attention.  
Methods: Several techniques that can be used to guide the research process were investigated. A set of techniques 
were subsequently selected and used to prioritise the pharmacovigilance challenge landscape. With the use of 
literature, the prioritised challenges are discussed in detail in order to provide a clearer understanding of each. 
Results: Due to the lack of a universally accepted technique, a technique or combination of techniques, deemed 
suitable and applicable for the specific context, can be implemented. Following the implementation of two 
prioritisation techniques, it was found that there are seven challenges within the pharmacovigilance challenge 
landscape that should be prioritised, namely: (i) culture; (ii) transparency; (iii) partnerships; (iv) insufficient 
resources; (v) country-specific factors; (vi) adverse drug reaction under-reporting; and (vii) technical capacity.  
Conclusions: As the pharmacovigilance challenge landscape is becoming an increasing burden for 
pharmacovigilance systems in numerous countries, it is becoming progressively difficult to address each of these 
challenges. Consequently, prioritisation has become essential, especially in countries where the available 
resources to pharmacovigilance are severely constrained. This paper thus proposes that emphasis be placed on the 
seven challenges that are identified to be of priority, as it is argued that the identified challenges to be prioritised 
represent a set of challenges that have the most significant impact on pharmacovigilance. 
Keywords: pharmacovigilance; challenge landscape; prioritisation. 
Background 
Following the Thalidomide tragedy in the 1960s, pharmacovigilance (PV) was introduced to healthcare [1]. 
Defined as the “science and activities relating to the detection, assessment, understanding and prevention of 
adverse effects or any other possible drug-related problems” by the World Health Organisation (WHO) [2], the 
functions, resources, and stakeholders in PV collaborate to optimise drug benefits and minimise the risks of 
existing and newly marketed drugs. In the last decade, PV has been the recipient of much research and 
investments, which has led to an expansion of activities, ranging from drug efficacy, drug misuse, and drug 
interactions [2].  
As a consequence of this increasing scope of PV the capacity for challenges has also grown, and has led to 
numerous PV systems in many countries being burdened with an array of problems. Especially in developing 
countries where resources are scarce, these challenges are limiting the extent to which PV systems can execute 
the necessary activities both effectively and efficiently [3]. Much research and investments, from both private – 
and regulatory bodies, have been devoted to these struggling PV systems in an effort to address some of the 
challenges experienced. However, when consulting literature, it is clear that many PV systems still experience 
problems, many of which are unique to a specific context.  
Following a literature review, Lamprecht et al. [4] identified a large portion of the challenges faced by modern 
PV systems, including challenges related to culture, transparency, resources, PV centres, country-specific factors, 
technical capacity, partnerships, public participation, adverse drug reaction (ADR) under-reporting, quality of 
ADR reports, text-mining, lack of data, clinical trials, causality assessments, signal detection, and legislation. It 
is evident that the PV challenge landscape is vast, containing many different challenges of dissimilar impact and 
severity. Addressing each of these challenges simultaneously is difficult, therefore, prioritisation is needed. 
Arguing the importance of prioritisation 
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The demand for healthcare has increased substantially over the last decade, and as a result has increased the 
pressures on the healthcare industry to manage its already constrained resources to meet its clinical responsibilities 
[5]. This has given rise to the realisation of the importance of prioritisation, a process which governs the allocation 
of resources in an effort to demarcate the scope of clinical activities. Prioritisation of clinical activities is not a 
new concept, and in fact has been a popular topic of debate in the late 1990s.  
Healthcare systems across the globe regard prioritisation as inescapable [6], including countries such as Norway, 
Sweden, United States of America, and the United Kingdom [7]. Several events such as the denial of life-saving 
treatments, ever-expanding waiting lists, and inefficient allocation of health insurance packages were catalysts to 
these countries to invest more time and resources towards prioritisation [7]. All of these healthcare systems rely 
heavily on different sources of funding, which are classified as either public or private. The provisions these 
groups offer fluctuates severely, be it because of factors such as exchange rates, healthcare needs, or resource 
availabilities [7]. As a result, the invaluable resources these groups provide are often unreliable, which only further 
emphasises the importance of prioritisation.  
However, prioritisation is extremely difficult, and is often described as an inevitably messy process [8]. Provided 
with the argument of Klein [9] who states that prioritisation is inherently the rationing of resources, healthcare 
systems struggle to find a balance between managing its already constrained resources and continuously meeting 
the demand for healthcare services. Moreover, the absence of a universally accepted framework that can be used 
to simplify the process of prioritisation makes this even more of a difficult process [7]. Therefore, countries rely 
on different approaches to prioritisation, such as ad hoc committees and advisory boards, all of which make use 
of different techniques to prioritise challenges and activities. 
Redirecting attention towards PV, as evidenced by the literature review completed by Lamprecht et al. [4], the 
PV systems in both developed and developing countries are experiencing an assortment of challenges. It is 
becoming increasingly difficult to address each of the challenges because of an unbalanced resource supply and 
demand system [4], therefore, it is essential that the challenges that are most prevalent, or have the largest impact 
on the PV system, be addressed first. By addressing these challenges first, will one be able to systematically 
progress through the PV challenge landscape and address the challenges along the way.  
Methods 
As discussed, prioritisation has become a major topic of debate in healthcare, which has led to the development 
of numerous techniques that can guide such a process. Given that there is no universally accepted prioritisation 
technique [7], the context in which these techniques can be used differs severely. Regardless, these techniques 
can be leveraged to simplify and guide the process of prioritisation, or in this case, the prioritisation of the PV 
challenge landscape.  
A literature review was conducted in order to identify prioritisation techniques that are still being used today. Both 
literature and grey literature were consulted, using the following search protocols: “prioritisation methods”, 
“prioritisation techniques”, and “how to prioritise challenges”.  
Following an investigation into the various prioritisation techniques that were identified in the literature review, 
it was decided that two of the techniques will be used to prioritise the PV challenge landscape, namely the Action 
Priority matrix and the system and challenge landscape matrix. A brief description of each technique is 
subsequently provided. 
The Action Priority matrix 
The Action Priority matrix measures issues on a two axis graph in terms of two parameters, namely: impact and 
effort [11], or importance and satisfaction [12]. Also relying on a group of theoretically and practically 
knowledgeable individuals to rate the issues, the Action Priority matrix is divided into four quadrants, named: low 
effort and high impact, high effort and high impact, low effort and low impact, and high effort and low impact 
issues [11]. Researchers can then decide which quadrant’s issues they want to focus on. Usually, the two quadrants 
that receive the most attention are low effort and high impact, and high effort and high impact [12]. Both these 
quadrants embody certain benefits and risks which researchers must consider when deciding which issues will be 
addressed first. 
The system and challenge landscape matrix 
The system and challenge landscape matrix is a prioritisation technique that has been developed by Lamprecht at 
al. [4]. This matrix to compare the PV system to the PV challenge landscape. The matrix serves as a visual 
representation, indicating which challenges are experienced during which stages of the PV system. Challenges 
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that were experienced during each stage of the PV system were deemed as priority. Such a matrix is highly 
flexible, and can be adapted towards nearly any industry [4]. 
The development process of both prioritisation techniques 
The PV challenge landscape identified by Lamprecht et al. [4] was used as foundation to the prioritisation exercise. 
As previously mentioned, two prioritisation techniques (the Action Priority matrix and the system and challenge 
landscape matrix) were used to prioritise the PV challenge landscape. Following the implementation of the 
techniques, the obtained results were combined in order to establish which PV challenges should be prioritised. 
In order to complete the Action priority matrix, three subject matter experts from different backgrounds were 
consulted. The role of each subject matter expert is subsequently described: 
i. The first subject matter experts in the Regional Medical Director in Kenya, who is leading the preparation 
for the launch of a new product within severely resource-constrained environments. 
ii. The second subject matter expert is an expert in the field of PV with several years of practical experience, 
and is actively involved in PV enhancement projects linked to Malaria vaccines in the Democratic Republic of 
Congo.  
iii. The third subject matter expert is a Medical Affairs Executive and named safety contact for Kenya. 
In order to develop a system and challenge landscape matrix, the same subject matter experts as those consulted 
during the development of the Action Priority matrix were consulted, as well as an additional subject matter 
expert, whose role is subsequently described. 
i. The fourth subject matter expert, a PhD recipient, is a PV consultant for the South African National 
Department of Health with more than 20 years of experience in PV, and has been actively involved in many PV- 
related projects in several countries. 
Following the prioritisation of the PV challenge landscape, literature was consulted in order to investigate each 
of the prioritised challenges. This was done to develop a better understanding of the impact of each challenge on 
PV. 
Results 
Combining the results from both prioritisation techniques, it was found that there are seven challenges within the 
PV challenge landscape that should be prioritised, namely: culture, transparency, partnerships, insufficient 
resources, country-specific factors, ADR under-reporting, and technical capacity. These challenges relate in large 
part to a sub-Saharan African context since each of the subject matter experts work within these settings. 
Subsequently, these challenges are described in more detail. 
Culture 
PV is based on the culture of safety, where PV professionals provide the foundation upon which the principles of 
this culture is built [13]. Literature, however, argues that there is a need to improve the culture in modern PV 
systems [14]. The culture of drug safety is not always sufficiently advocated, leading to several additional 
challenges within PV, such as ADR under-reporting. Consequently, it is argued that the improvement of PV 
culture will give lead to the improvement of some of the other challenges in PV.  
There are three aspect of culture that is critical to consider, namely: definition, influential factors, and assessment. 
By taking these aspects into consideration, it would be much easier to identify opportunities for improving the 
culture of PV. 
Defining culture 
Diverting focus  from PV, and focussing on culture  is an abundance of literature that one can draw from. As an 
initial step towards improving culture, it is essential to understand how culture is defined. Naidoo & Martins [16] 
defines culture as “an integrated pattern of human behaviour which is unique to a particular organisation and 
which originated as a result of the organisation’s survival process and interaction with its environment”. Another 
perspective of culture is that it is a social construct, the product of groups and not individuals. It is based on the 
experiences of groups and it is unique to each organisation. It is also said to be malleable, adapting to the continual 
changes found in organisations, and develops over time [17]. 
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The definition of culture, as described by Naidoo & Martins [16], clearly situates the limelight on the human 
participants of culture. In particular, groups operating across the spectrum of processes in an organisation are 
pinnacle to establish an effective and efficient culture in an organisation [17] 
PV is an organisation, consisting of different processes managed by people. Similar to any other organisation, 
groups with different multi-disciplinary backgrounds and experiences take part in PV. Considering Naidoo & 
Martins’ [16] definition of culture, these groups are responsible for the establishment of a culture in PV which is 
focussed on patient and consumer safety. In an effort to improve this safety culture, research should focus more 
on the individual behaviour phenomena of the groups working in PV. For instance, under-reporting of ADRs is 
routinely found in PV, proving to burden the PV system. Since people (e.g. healthcare workers, consumers, and 
patients) are responsible for reporting ADRs, focus should be more towards understanding the behaviours of these 
groups regarding ADR reporting. 
Factors that influence culture 
There is agreement in literature that many factors influence culture. Many researchers identify specific factors 
affecting culture, however, these factors are sometimes unique to a specific industry or organisation. Preferably, 
the underlying factors that influence culture gives a general perspective on culture since these factors are not 
necessarily unique to a specific industry, simplifying its application in a PV context. 
Firstly, the business environment in which an organisation operates determines its culture. Within the market, the 
speed of change, the level of competitiveness, the value placed on people with regards to technology, and the 
demands of the customer influence the values, norms and behaviours one would associate with culture [18]. 
Secondly, leadership is regarded as an influence to culture [19], especially newly created organisations [18]. 
Leaders help establish culture through their own ambitions and actions i.e. setting the standards by being an 
example to the people in the organisation.  
Thirdly there are management practices. Alan [18] is of the opinion that the manner in which an organisation is 
managed is likely to influence the beliefs, attitudes, and behaviours of the employees. There should be a fine 
balance between management and leadership, where the latter is regarded as the vision and long-term direction of 
an organisation through visions and strategy [18].  
Lastly there is the formal and informal socialisation processes ([18]; and [19]). Formal socialisation activities 
include training and induction training, hosted by the managers and leaders of an organisation. On the other hand, 
informal socialisation refers to individual behaviours within a group context. Al-Alawi et al. [19] draws a 
distinctive relationship between these socialisation processes and the people in an organisation, stating that it is 
essential to focus on people and their behaviours when attempting to assess or change culture. Moreover, Al Alawi 
et al. [19] include organisational structure, trust, information systems, and reward systems as critical success 
factors to culture, with specific reference to the relationship between culture and knowledge management.  
Each of the above mentioned factors have an impact on the way culture is established and maintained, as it helps 
to develop a basis on which an effective and efficient culture is built. 
Assessing culture 
It can be concluded from literature that many conceptualisations of culture are of deep, intangible phenomena not 
easily objectified [15]. Organisations often struggle to determine objectives that can be used to assess its culture 
[20]. There is much debate over the most effective culture assessment techniques, and if it should be of qualitative 
and quantitative nature. Supporters of a qualitative approach blame quantitative approaches to be unable to capture 
the subjective and unique aspects of culture, whereas opponents of qualitative approaches asserted that a 
comparison between cultures is not possible using this approach [15]. There is, however, the possibility of 
combining qualitative and quantitative approaches, able to help develop a more detailed understanding of all the 
layers of culture within an organisation [21]. 
A range of assessment tools with differing characteristics exist, all of which have limitations in terms of their 
scope, ease of use, and measurement capabilities. Examples of such tools include the Competing Values 
Framework, the Quality Improvement Implementation Survey, the Culture Inventory, and Harrison’s 
Organisational Ideology Questionnaire [21]. The choice of assessment tool depends on how an organisation 
conceptualise culture, the purpose of the assessment, intended use of the results, and the availability of resources. 
Scott el al. [21] identifies several culture assessment tools that can be used within the healthcare setting (e.g. the 
Corporate Culture Questionnaire, Hofstede’s Culture Questionnaire, and the Core Employee Opinion 
Questionnaire), but states that researchers searching for the ideal assessment tool will be frustrated, since no such 
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tool exist. Bellot [15] is also of the opinion that no ideal culture assessment tool exist, since no organisation share 
identical cultures.  
In order to address the shortcomings of culture in PV, the three aspects (definition, influential factors, and 
assessment) of culture should be combined in order to firstly understand the current culture in PV, and secondly 
to determine where areas for improvement exist. 
Transparency 
In close association with the culture found in PV, the lack of transparency amongst the stakeholders in PV may 
lead to failed PV initiatives [22]. It is essential that key stakeholders, especially those with the relevant experience 
in PV, share relevant information with their peers. This will enable participants in PV to learn of new ways in 
solving the problems they might be experiencing. Increasing the visibility of information in PV is critical [22], as 
it will support an improved drug safety culture. 
It is also essential that the existence of PV systems in countries be publically unveiled. It is described in literature 
that healthcare workers in many countries do not contribute to PV, simply because they are not aware of the 
existing PV infrastructure in their location. 
Understanding transparency within pharmacovigilance 
There are many stakeholders that participate in PV environment. To allow PV systems to operate efficiently and 
effectively, these stakeholders (also referred to as partners in later discussions) must collaborate and ensure the 
success of PV systems. A collaboration of this scale is difficult, and is often burdened by the lack of 
communication. Communication is one of the most important aspects of collaboration in any industry, and serves 
as the foundation to basic business [23]. With communication comes transparency, which is also a crucial element 
of any collaboration. 
Transparency is defined as “the level of availability and accessibility of market information to its participants” 
[24]. In essence, transparency means that all relevant information is made public, and shared between the relevant 
stakeholders. In PV, and also in healthcare in general, transparency is crucial because the information being shared 
either directly or indirectly relates to patient and public health. 
One of the major challenges faced in PV is to ensure transparency between all stakeholders. There are many 
stakeholders that participate in PV (healthcare workers, non-governmental organisations, PV centres, 
governments, pharmaceutical manufacturers, academic institutions etc.). It is extremely difficult to ensure 
transparency between each of these stakeholders, since each has different priorities and expectations from a PV 
system. It is  essential that transparency between these stakeholders be improved in order to aggregate a 
disseminated PV system, which can ultimately be leveraged towards the benefit of PV. This can be achieved by 
improving communication, and developing policies that govern the way in which information is shared in PV. 
Partnerships 
PV is a collaborative endeavour [25]. Sustained collaboration and commitment are vital to attend to future 
challenges of PV ([2]; and [26]). However, ineffective partnership is a threat to PV [26]. Operating in a resource-
constrained environment, partners (also referred to as stakeholders in earlier discussions) in PV must sometimes 
provide expertise, training, political support, scientific infrastructure, and a capacity to accomplish comprehensive 
monitoring and investigations of the safety of medicines [25]. Failure in providing such resources, ineffective 
partnerships can lead to failed PV initiatives. In order to maintain a certain inventory of these resources, it is vital 
that PV organisations form lasting relationships with its partners. A publication by Management for Science [27] 
emphasises the importance of relationships between partners, and further states that failed relationships often lead 
to failures in business. 
Partnership success factors 
Characteristics of successful partnerships include common purpose and goals, high motivation, having the right 
people and the right leadership, maintaining balanced relationships, trust and respect, and good communication 
[28]. Moreover, literature often makes reference to success factors, and how these are essential to ensure effective 
and efficient partnerships. Casey [28] provides the following foundational success factors, stating that they are a 
requirement in any partnership: trust and value between partners, leadership and change management, a 
partnership framework, communication, equity and involvement in decision-making, and power distribution. 
These success factors constitute examples of best practice for partnership formation and, without effective 
management, these partnerships are likely to fail [28] 
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In conclusion, it is critical to those within PV systems to understand that the partners with whom they collaborate 
have different levels of power and interest. Naturally, it would be of value to PV systems to maintain sustainable 
collaborations with partners who show deep interest in PV, and who also have high levels of power that can have 
a beneficial influence on PV systems. 
Insufficient resources 
It is well-known that PV operate within a resource-constrained environment in several countries [29]. Especially 
in developing countries where other challenges such as drought and war are of high priority, PV organisations 
struggle to implement new PV systems [29]. In these countries the available resources are rather invested 
elsewhere, leaving little for the requirements of PV. 
Another challenge associated with insufficient resources is that the resources requirements of PV systems are 
unique in specific countries e.g. a country might have the necessary expertise and manpower to assist a PV system, 
but lack the governmental funding, whereas another country might have the necessary budget but lack the required 
manpower [25]. Countries experiencing this phenomena include Sub-Saharan African countries [29], India [30], 
and certain South-East Asian countries [31]. Common resources required by PV systems include monetary 
assistance, hardware and software infrastructure, expertise and training curricula amongst healthcare 
professionals, and common PV knowledge amongst both healthcare professionals and consumers ([29]; and [25]). 
PV systems are dependent on the combination of these resources and are not able to function properly without it 
[29]. 
Forasmuch as it is not feasible to conclude that the resource deficiencies burdening PV systems can be addressed 
by simply providing more resources to such systems, the focus should be towards the improved management of 
the existing resource portfolios. This type of resource management is made possible by assessing the value offered 
by the already used resources in PV. A model that embodies some aspects of resource management is the resource 
based view (RBV), able to assess organisation’s resource portfolios based on certain characteristics and attributes. 
Models such as this assess the value of resources, allowing PV organisations to better manage their resources.  
A resource-based view of pharmacovigilance 
PV is not necessarily a profit-gaining industry, therefore there is some limitation to the implementation of the 
RBV in PV. However, many of the characteristics and attributes on which RBV is based can be used to assess the 
value offered by resources in PV.  
First-off, reference can be made to the similarities of sustained competitive advantage between profit-gaining 
organisations and PV. In a business where much focus is on profit margins, sustained competitive advantage is a 
critical element as it allows for increased profits. Considering PV, a great deal of emphasis should be placed on 
the sustainability aspect sustained competitive advantage. With an increasing demand for healthcare, PV is more 
and more under severe pressure to monitor a wide range of medicines, while still giving attention to other activities 
such as causality and risk assessments. Since PV is so important in ensuring drug safety, it is even clearer that it 
should be able to do so, both now and in the future, under the difficult conditions just described.  
Secondly, the RBV states that resources should be heterogeneous. In the context of PV, large inventories of 
resources with disparate roles and capacities to address diverse activities in PV exist. These resource portfolios 
must be managed and maintained to ensure that PV goals are constantly achieved.  
Two resource attributes, value and organisation, on which the RBV is based, can be applied to the assessment of 
resources in PV. Firstly, the value posed by the resources in PV must be determined. Operating in a resource-
constrained environment, non-value adding resources must be identified, allowing for resource requirements to 
be identified. Once the exact resource requirements are identified, steps can be taken to either develop or acquire 
the required resources. The second resource attribute, the question of organisation, determines whether PV 
systems are organised and able to effectively and efficiently utilise the existing resources for exploitation and to 
capture value. Failure in being organised and utilising all available resources, PV systems will struggle to meet 
healthcare demands. 
Country-specific factors 
Country-specific factors refer to challenges faced by PV organisations outside the traditional resource architecture 
and are described by Edwards [35] and Härmark & Van Grootheest [36]. A number of factors, defined differently 
in various disciplines, affect PV. Disciplines such as sociology and social anthropology are receiving more 
attention and are included in the development and planning of not only PV systems, but also many other healthcare 
initiatives such as vaccination administration programmes. These disciplines, as well as a range of other 
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disciplines, are capable of identifying different factors such as human behavioural traits that might affect the 
implementation, operation, or maintenance of PV systems.  
Influential factors that might affect pharmacovigilance 
Often, the factors that are relevant to this section are defined differently in literature. Two categorisations of such 
factors exist, namely sociocultural factors and contextual – or systemic factors. Distinguishing between 
consortiums of factors, these categorisations make reference to a range of different factors that PV organisations 
should consider.  
Covering a wide range of things that might impact PV systems, sociocultural factors distinguish between social 
factors such as attitudes, ethical identities, linguistic differentiations, and power structures, as well as cultural 
factors such as cross-cultural differences, cultural identity, and religious beliefs.  
Other types of factors that might influence the operation of PV systems are contextual factors, also referred to as 
systemic factors. These refer to political, economic and social factors, both national and international. Contextual 
factors are categorised, according to Buse et al. [37], as follows:  
i. Situational factors: Transient or impermanent conditions such as drought and war. 
ii. Structural factors: The relatively unchanging elements of society such as the political system, health 
expenditure, gross domestic product (GDP) per capita, and the degree to which the public is allowed to participate 
in decision-making etc. 
iii. Cultural factors: Similar to sociocultural factors, cultural factors refer to aspects such as power 
hierarchies, linguistic differences, and religious beliefs. 
iv. International or exogenous factors: Closely related to partnerships, collaborations are often needed to aid 
in the implementation and operation of systems.  
Some of the categories of contextual factors are similar to that of sociocultural factors. Often used interchangeably, 
contextual – and sociocultural studies identify and assess similar influential factors. Identifying and assessing 
sociocultural and contextual – or systemic factors are not simple, requiring multiple, multi-disciplinary individuals 
or groups such as sociologists, anthropologists, and governmental agencies. Proving to challenge PV systems, 
these individuals and groups must be employed, saturating the already constrained resource portfolios of PV. 
Regardless, it is essential that these factors be identified and assessed to determine its possible effect on PV 
systems. 
Impact of sociocultural – and contextual factor: Case studies 
Many case studies that describe the impact of sociocultural – and contextual factors, particularly in healthcare, 
exist in literature. Subsequently, some case studies are provided to indicate the beneficial results delivered by the 
identification and assessment of sociocultural – and contextual factors, emphasising its importance in PV. 
In 2007, a study was conducted to determine the association between contextual factors and breast cancer 
screening amongst women in the United States. The study found that two factors led to the limited breast cancer 
screening. First, high unemployment rates gave way to poverty i.e. women could not afford regular breast cancer 
screenings. The second factor was the increased aged population. Elderly women tend to reject the need for breast 
cancer screening, feeling it is not of importance to them. The research allowed for American health authorities to 
develop new policies to improve access towards breast cancer screening to the women most affected by these two 
contextual factors [38].  
Assessing the contextual factors influencing resource utilisation in nursing, a study conducted in 2006 found that 
resource utilisation amongst nurses was influenced by several contextual factors. These factors are the role of 
nurses, multi-faceted access to resources, organisational culture, multi-faceted support systems, time for research 
activities, and provision of education. Though limited research exist in this regards, the authors suggested that the 
identification of these contextual factors would allow healthcare institutions to better manage its resources made 
available to nurses [40]. 
In 2013, a study was conducted by numerous healthcare researchers who aimed at advancing both internal – and 
external validity of healthcare research by delivering their opinions of the importance of reporting contextual 
factors. It was stated that contextual factors are rarely reported in healthcare research, leading to failed attempts 
in replicating such research. The efforts to translate research into practice fail because contextual factors which 
are important for understanding and knowledgably synthesising findings across studies are not known. The 
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opinions from all researchers were synthesised, where it was found that everyone suggested that the identification 
of contextual factors during healthcare research is an important stage that must be incorporated in future research 
[41]. 
Lastly, a study conducted in 2007 aimed at identifying the cultural factors that affected children’s oral healthcare 
amongst different ethnic groups (African-American, Chinese, Latino, and Filipino) in San Francisco, California. 
Lack of knowledge about primary teeth were barriers to early preventative care in all ethnic groups. In all groups, 
family carers, especially elders, influenced access to preventative care. Also, dental fear, whether derived from 
community beliefs or personal negative dental experiences, greatly influenced attitudes towards preventative 
dental care. The study concluded that many similarities and differences exist amongst the ethnic groups in how 
cultural beliefs and experiences influence children’s access to oral healthcare [42].  
These case studies show the importance of identifying and assessing contextual – and sociocultural factors, 
particularly in healthcare. Literature suggests that these factors are routinely left out of healthcare research [41], 
burdening the healthcare systems in many countries. It can be concluded that healthcare initiatives, such as PV, 
can be improved by focussing more on the identification and assessment of these factors. 
Adverse drug reaction under-reporting 
Under-reporting of ADRs occur when healthcare workers (general practitioners, nurses, surgeons, pharmacists 
etc.) fail to efficiently report new and existing ADRs [43]. In the interest of consumers and patients who 
experience ADRs, it is crucial that all ADRs be reported to the relevant authorities. This will give way to signal 
detection, leading to investigations into the specific ADR. Without ADR reports that generate signals of a 
problematic ADR, investigations that aim to address these problems cannot take place. 
Two prominent models that explain the causes of under-reporting are widely cited in literature namely Inman’s 
model of the seven deadly sins of under-reporting and the KAP (knowledge, attitude, and practice) model of 
under-reporting. Taken together, these two models provide a comprehensive overview of the causes of under-
reporting of ADRs. The KAP model is said to be the leading cause, in association with Inman’s model, of under-
reporting of ADRs [43]. 
Inman’s seven deadly sins of under-reporting 
In the 1990s Dr William Inman conducted research on PV with specific reference to the causes of under-reporting 
[44]. This study, known as Inman’s seven deadly sins of under-reporting, is widely cited in literature ([44]; [45]; 
[46]; and [47]). More recent studies ([44]; and [47]) have confirmed the findings, specifically highlighting the 
ignorance, insecurity and indifference aspects of the model. 
The so-called sins of Inman’s model are: 
i. Fear: Of litigation, 
ii. Indifference: About contributing to the general advancement of knowledge, 
iii. Ambition: To collect and publish a personal case series, 
iv. Guilt: At having caused an adverse effect, 
v. Complacency: The mistaken belief that only safe drugs are licensed, 
vi. Ignorance: Of the need for reporting, and 
vii. Diffidence: About reporting a mere suspicion. 
In 2014, a study was conducted amongst hospitals and physicians in Spain. The objective of the study was to 
identify the main causes for under-reporting of ADRs by health professionals in Spain. It was found that the main 
causes of under-reporting were ignorance, insecurity, and indifference, all associated with Inman’s model [44]. 
Also, Rodrigues & Khan [47] conducted research with the intention of identifying the cause of under-reporting 
amongst surgeons and surgical wards in an unknown context. The findings of the research correlated with Inman’s 
model. Rodrigues & Khan [47], Varallo et al. [44], and Hazell & Shakir [45] are all of opinion that Inman’s model 
is and will be applicable to future PV initiatives. 
Many of these so-called sins such as indifference, ambition, complacency, and diffidence strongly relate to the 
culture in PV and research in eliminating these sins is believed to improve the overall culture within PV. 
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KAP model 
The first aspect of the KAP model is knowledge, closely related to education [43]. The shortcomings of PV in the 
undergraduate and postgraduate syllabus of medical students is regularly referred to in literature ([48]; [49]; [50]; 
[51]; and [52]). These shortcomings are also not unique to specific countries. Studies in Nigeria [49], Malaysia 
[51], Portugal [43], Turkey [1], India [53], and China [54] all discuss the need for medical students’ curriculum 
to either include or improve PV education. 
The aforementioned country specific studies also highlight the lack of sufficient knowledge on the correct PV 
practices in practicing healthcare professionals. Toklu & Uysal [1] discuss the need for improved PV knowledge 
amongst community pharmacists in Turkey, Passier et al. [55] the need for improved PV knowledge amongst 
general practitioners in Netherlands, and Herdeiro et al. [43] the need for improved PV knowledge amongst 
pharmacists in Portugal. It is clear that thorough knowledge of PV is a challenge, hurdling several PV initiatives 
to be completely successful in many countries. 
Secondly, the KAP model refers to the general attitude of healthcare professionals towards PV. This element of 
the KAP model is closely related to the indifference and ignorance aspects of Inman’s model and also relates 
strongly to the culture aspects of the PV challenge landscape. Some examples of the role of attitude in under-
reporting are given in a recent study by Shamim et al. [56] who seek to build an understanding of the general 
attitude of physicians, pharmacists, and nurses towards PV in Pakistan. It was found that a large portion of these 
healthcare professionals are indifferent towards PV, with only 14.3% being aware that there was an ADR reporting 
organisation in Pakistan. Similarly, a study within a Spanish context also discuss the poor attitude of healthcare 
professionals towards PV [44]. The indifference found in the Spanish context is associated with the lack of interest 
of healthcare professionals to register for ADR reporting and a lack of time for the many activities in the clinical 
routine.  
Lastly, the lack of sufficient practice in PV is also a challenge faced in the PV industry. Closely associated with 
training, Varallo et al. [44] is of the opinion that the lack of sufficient practice has recently surfaced and is 
nowadays referred to as the eight sin of Inman’s model. The lack of practice in PV is regularly referred to in 
literature, including Aronson [57] discussing the need for increased, real-world PV practice amongst British 
healthcare professionals, and Beckmann et al. [58] who similarly emphasises this need in a general context. 
Synthesising Inman’s model and the KAP model in PV 
Under-reporting of ADRs is a burden to PV systems in many countries, limiting the extent to which action can be 
taken to improve medicine safety. There is a need for the culture surrounding ADR reporting to improve to a state 
where healthcare professionals, patients, and the public feel unthreatened and assured to report ADRs. Achieving 
such a culture is possible when especially healthcare professionals are sensitised and aware of the benefits posed 
by PV towards patient safety [23]. 
There is argument that ADR under-reporting can be improved by a range of solutions including standardised and 
universal reporting systems, simplified ADR reporting forms, decentralised PV systems, and electronic reporting 
forms. Regardless of the many possible solutions like those just mentioned, one must still consider that PV systems 
in different countries are unique, therefore requiring a comprehensive investigation to understand the attributes 
that affect ADR reporting (e.g. understanding how country-specific factors might affect ADR reporting). 
Technical capacity 
Technical capacity refers to the ability of a person conducting a specific action that is meant to achieve a specific 
outcome. Often categorised as an insufficient resource, Mehta [59] is of the opinion that it deserves to be 
independently categorised, because it is such an influential aspect that is lacking in many countries, especially 
developing countries Many factors contribute to the ability of an individual to exercise  a specific action, which 
includes past experience, personal skills, ability to utilise resources, and academic education.  
The only way in which experience, personal skills, and the ability to utilise resources can be achieved is by both 
theoretical – and practical training. Theoretical training closely relates to academic education, and plays an 
essential role in developing foundations and thinking patterns in individuals who enter practice. Practical training 
is often much more difficult to obtain, since training often clashes with the working schedules. However, Mehta 
[59] is of the opinion that it is of great importance that practical training is provided to those who fail to achieve 
the desired objectives.  
An improvement in technical capacity offer many benefits to PV, which includes: 
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i. PV personnel will be able to complete their work even quicker. 
ii. They will also be able to deliver work of much better quality standards. 
iii. Since many PV systems operate in resource saturated environments, improving the technical capacity of 
existing personnel eliminates the need to appoint more employees i.e. one individual will be able to do the work 
of two or more. 
iv. Improving technical capacity will also increase resource utilisation, which may convince investors to 
supply wider consortiums of resources. 
However, improving technical capacity is not as simple as one might think. Not even considering the cost 
implications of theoretical training in the form of academic education, practical training is often very difficult to 
provide as well. Training sessions in the form of workshops and brainstorming sessions require resources that are 
often not available. Also, individuals who have the desired technical capacities are needed to convey their skills 
and experiences onto those who are in need of it. Similar to the issues of gathering all the necessary resources, 
these individuals are not in abundance. 
Regardless of the challenges facing technical capacity, Mehta [59] is of the opinion that it is crucial that these 
challenges be overcome, because technical capacity is a challenge in many PV systems. 
Conclusion 
Increasing pressure  can be attributed to an increasing demand for healthcare services, as well as an unsteady and 
unpredictable supply of resources, is burdening many healthcare systems in several countries. Included in these 
healthcare systems is PV, a system that is clearly still experiencing several challenges when consulting literature. 
In order to alleviate some of the pressures by starting to address some of these challenges, prioritisation has 
become a critical stage that is impossible to overlook. Consequently, this forms the core argument of this paper. 
The importance of prioritising PV challenge landscape is advocated in this paper, and some evidence as to why it 
is necessary is provided, which includes resource deficiencies and improper resource rationing. In order to 
prioritise the PV challenge landscape, the results from two prioritisation techniques that have been developed are 
combined. 
Consequently, it can be concluded that there are seven challenges in PV that should be of priority, namely: culture, 
transparency, partnerships, insufficient resources, and country-specific factors, ADR under-reporting, and 
technical capacity.  
Many of these challenges are interrelated i.e. addressing one may affect another. For example, when ADR under-
reporting is advocated properly, it would contribute to the improvement of the culture of PV. Many of these 
challenges are, as per definition, severely challenging to address, especially in developing countries where 
resources are constrained. Regardless, it is an absolute necessity that more focus, especially from a research point 
of view, be diverted towards addressing these seven challenges in PV. These challenges represent a set of 
challenges that, when properly addressed, will have a large beneficial impact of PV systems, which will ultimately 
contribute to overall drug safety, which is the foundation of PV. 
Declaration 
Abbreviations 
PV: Pharmacovigilance 
WHO: World Health Organisation 
ADR: Adverse drug reaction 
RBV: Resource based view 
KAP: Knowledge, Attitude, and Practice 
Ethics approval and consent to participate 
Not applicable 
Consent for publication 
Not applicable 
Stellenbosch University  https://scholar.sun.ac.za
XXXI | P a g e  
 
Availability of data and material 
The data that support the findings of this study are available from the authors of this paper. 
Competing interests 
The authors declare that they have no competing interests. 
Funding 
No funding was provided for this research. 
Authors’ contributions 
IL made substantial contributions to the conception and design of the information in this paper. Both LB and IDK 
reviewed this paper in an attempt to make suggestions where changes to the content provided should be made, 
and gave final approval for this version to be published. All three authors are accountable for all of the work in 
ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated 
and resolved. 
Acknowledgements 
Not applicable 
References 
[1] H. Z. Toklu and M. K. Uysal, The knowledge and attitude of the Turkish community pharmacists toward 
pharmacovigilance in the Kadikoy district of Istanbul, Pharm. World Sci., vol. 30, pp. 556–562, 2008. 
[2] World Health Organization, The Importance of Pharmacovigilance - Safety Monitoring of medicinal 
products, 2002. 
[3] Strengthening Pharmaceutical Systems, Supporting Pharmacovigilance in Developing Countries The 
Systems Perspective, 2009. 
[4] I. V. B. Lamprecht, L. Bam, and I. H. de Kock, An investigation into the prospects of existing 
technologies to address the challenges faced by pharmacovigilance systems, in SAIIE28: Taking up Stewardship, 
2017, pp. 1–17. 
[5] L. Barnieh, C. Donaldson, and B. Manns, Health care prioritization : a clinician’s duty, Can. J. Kidney 
Heal. Dis., vol. 1, no. 27, pp. 1–5, 2014. 
[6] R. Newton, Six Symptoms of Poor Prioritisation, Corporate Geek, 2010. [Online]. Available: 
http://www.corporategeek.info/six-symptoms-poor-prioritisation. [Accessed: 09-Nov-2017]. 
[7] L. M. Sabik and R. K. Lie, Priority setting in health care: Lessons from the experiences of eight countries, 
Int. J. Equity Health, vol. 7, no. 1, p. 4, 2008. 
[8] R. Klein, Puzzling out Priorities: Why We Must Acknowledge That Rationing Is a Political Process, Br. 
Med. J., vol. 317, no. 7164, pp. 959–960, 1998. 
[9] R. Klein, Dimensions of rationing: who should do what?, Br. Med. J., vol. 307, pp. 309–131, 1993. 
[10] J. Calltorp, Priority setting in health policy in Sweden and a comparison with Norway, Heal. Policy 50, 
vol. 50, no. 1–2, pp. 1–22, 1999. 
[11] Coach Federation, The Action Priority Matrix, International Coach Federation, 2014. [Online]. 
Available: https://coachfederation.org/blog/index.php/3694/. [Accessed: 22-Nov-2017]. 
[12] Z. Song, Analysis on Satisfaction Degree of School-Enterprise Cooperation in Application-oriented 
Undergraduate Base on Two-dimensional Scale, Boletín Técnico, vol. 55, no. 7, pp. 92–97, 2017. 
[13] A. K. Olsen and M. D. Whalen, Public Perceptions of the Pharmaceutical Industry and Drug Safety and 
the Culture of Safety, Drug Saf., vol. 32, no. 10, pp. 805–810, 2009. 
[14] B. Edwards, M. Gold, A. K. Olsen, and M. D. Whalen, Guiding Principles of Safety as a Basis for 
Developing a Pharmaceutical Safety Culture, Curr. Drug Saf., vol. 2, pp. 135–139, 2015. 
[15] J. Bellot, Defining and assessing organizational culture., Nurs. Forum, vol. 46, no. 1, pp. 29–37, 2011. 
[16] P. Naidoo and N. Martins, The relationship between organizational culture and work engagement: A 
multilevel investigation, Probl. Perspect. Manag., vol. 12, no. 4, pp. 433–441, 2014. 
[17] B. Fortado and P. Fadil, The four faces of organizational culture, Compet. Rev. An Int. Bus. J., vol. 22, 
no. 4, pp. 283–298, 2012. 
[18] W. Alan, Understanding organisational culture and the implications for corporate marketing, Eur. J. 
Mark., vol. 35, no. 3/4, pp. 353–367, 2001. 
[19] A. I. Al‐Alawi, N. Y. Al‐Marzooqi, and Y. F. Mohammed, Organizational culture and knowledge 
sharing: critical success factors, J. Knowl. Manag., vol. 11, no. 2, pp. 22–42, 2007. 
Stellenbosch University  https://scholar.sun.ac.za
XXXII | P a g e  
 
[20] P. Pronovost and B. Sexton, Assessing safety culture: guidelines and recommendations, Br. Med. J., vol. 
14, pp. 231–233, 2005. 
[21] T. Scott, R. Mannion, H. Davies, and M. Marshall, The Quantitative Measurement of Organizational 
Culture in Health Care : A Review of the Available Instruments, HSR Heal. Serv. Res., vol. 38, no. 3, pp. 923–
945, 2003. 
[22] M. R. B. Rubel, D. M. H. Kee, N. N. Rimi, and Y. M. Yusoff, Adapting technology : effect of high-
involvement HRM and organisational trust, Behav. Inf. Technol., vol. 36, no. 1, pp. 281–293, 2017. 
[23] V. Jusot, Correspondence. 20 July, Stellenbosch. 2017. 
[24] N. Granados, A. Gupta, and R. J. Kauffman, Information Transparency in Tusiness-to-Consumer 
Markets: Concepts, Framework, and Research Agenda, Inf. Syst. Res., vol. 21, no. 2, pp. 207–226, 2010. 
[25] G. J. D. Pan, Ongoing Challenges in Pharmacovigilance, Drug Saf., vol. 37, pp. 1–8, 2014. 
[26] World Health Organization, Pharmacovigilance : ensuring the safe use of medicines, 2004. 
[27] Management for Science, Pharmacovigilance. p. 35.1-35.19, 2012. 
[28] M. Casey, Partnership - Success factors of interorganizational relationships, J. Nurs. Manag., vol. 16, no. 
1, pp. 72–83, 2008. 
[29] A. O. Isah, S. N. Pal, S. Olsson, A. Dodoo, and R. S. Bencheikh, Specific features of medicines safety 
and pharmacovigilance in Africa., Ther. Adv. drug Saf., vol. 3, no. 1, pp. 25–34, 2012. 
[30] P. Rama, P. A. Rodrigues, and A. Georgy, Asian Journal of Pharmaceutical and Clinical Research 
PHARMAOVIGILANCE : PERSPECTIVES AND FUTURE CHALLENGES IN INDIAN SCENARIO, Asain 
J. Pharm. Clin. Res., vol. 4, no. 4, pp. 1–4, 2011. 
[31] W. Suwankesawong, T. Dhippayom, C. Kongkaew, and W.-C. Tan-Koi, Pharmacovigilance activities in 
ASEAN countries. Pharmacoepidemiol. Drug Saf., vol. 25, pp. 1061–1069, 2016. 
[32] M. Heinrich, Quality and safety of herbal medical products : regulation and the need for quality assurance 
along the value chains, Br. J. Clin. Pharmacol., vol. 80, no. 1, pp. 62–66, 2015. 
[33] O. Jurevicius, Resource based view, Strategic Management Insight, 2013. [Online]. Available: 
https://www.strategicmanagementinsight.com/topics/resource-based-view.html. [Accessed: 28-Jun-2017]. 
[34] J. Kraaijenbrink, J. C. Spender, and A. J. Groen, The Resource-Based View : A Review and Assessment 
of Its Critiques, J. Manage., vol. 36, no. 1, pp. 349–372, 2010. 
[35] I. R. Edwards, Causality Assessment in Pharmacovigilance: Still a Challenge, Drug Saf., vol. 40, no. 5, 
pp. 365–372, 2017. 
[36] L. Härmark and A. C. Van Grootheest, Pharmacovigilance: Methods, recent developments and future 
perspectives, Eur. J. Clin. Pharmacol., vol. 64, no. 8, pp. 743–752, 2008. 
[37] K. Buse, N. Mays, and G. Walt, Making Health Policy. Berkshire, England: McGraw-Hill Education, 
2005. 
[38] D. Litaker and A. Tomolo, Association of Contextual Factors And Breast Cancer Screening: Finding 
New Targets to Promote Early Detection, J. Women’s Heal., vol. 16, no. 1, pp. 36–45, 2007. 
[39] D. K. Brazier, Influence of contextual factors on health-care leadership, Leadersh. Organ. Dev. J., vol. 
26, no. 2, pp. 128–140, 2005. 
[40] J. M. M. Meijers, M. A. P. Janssen, G. G. Cummings, L. Wallin, C. A. Estabrooks, and R. Y.G. Halfens, 
Assessing the relationships between contextual factors and research utilization in nursing: Systematic literature 
review, J. Adv. Nurs., vol. 55, no. 5, pp. 622–635, 2006. 
[41] A. Tomoaia-Cotisel et al., Context Matters : The Experience, Ann. Fam. Med., vol. 11, no. Supp 1, pp. 
115–123, 2013. 
[42] I. V. Hilton, S. Stephen, J. C. Barker, and J. A. Weintraub, Cultural factors and children’s oral health 
care: A qualitative study of carers of young children, Community Dent. Oral Epidemiol., vol. 35, no. 6, pp. 429–
438, 2007. 
[43] M. T. Herdeiro, A. Figueiras, J. Polonia, and J. Gestal-Otero, Influence of Pharmacists ’ Attitudes on 
Adverse Drug Reaction Reporting A Case-Control Study in Portugal, Drug Saf., vol. 29, no. 4, pp. 331–340, 2006. 
[44] F. R. Varallo, S. de O. P. Guimaraes, S. A. R. Abjaude, and P. de C. Mastroianni, Causes for the 
underreporting of adverse drug events by health professionals : a systematic review, Rev Esc Enferm USP, vol. 
48, no. 4, pp. 739–747, 2014. 
[45] L. Hazell and S. A. W. Shakir, Under-Reporting of Adverse A Systematic Review, Drug Saf., vol. 29, 
no. 5, pp. 385–396, 2006. 
[46] M. Irujo, G. Beitia, M. Bes-Rastrollo, A. Figueiras, S. Hernandez-Diaz, and B. Lasheras, Factors that 
Influence Under-Reporting of Suspected Adverse Drug Reactions among Community Pharmacists in a Spanish 
Region, Drug Saf., vol. 30, no. 11, pp. 1073–1082, 2007. 
[47] G. S. Rodrigues and S. A. Khan, Pharmacovigilance Among Surgeons and in Surgical Wards : 
Overlooked or Axiomatic ?, Indian J. Surg., vol. 73, no. 1, pp. 4–8, 2011. 
Stellenbosch University  https://scholar.sun.ac.za
XXXIII | P a g e  
 
[48] G. E. Schramm, P. P. Narayanan, D. S. Chutka, and W. T. Nicholson, Implementation of an 
interprofessional clinical pharmacology selective learning experience for pharmacy residents and medical 
students, Am. J. Heal. Pharm., vol. 74, no. 6, p. 397, 2017. 
[49] A. R. Abubakar, B. A. Chedi, K. G. Mohammed, and M. Haque, Perception of Nigerian medical students 
on adverse drug reaction reporting, J. Adv. Pharm. Technol. Res., vol. 6, no. 4, pp. 154–158, 2015. 
[50] A. R. Abubakar and M. Haque, Pharmacovigilance Practice : The Current Challenges and the Gaps in 
the Medical Students ’ Curriculum, J. Appl. Pharm. Sci., vol. 6, no. 5, pp. 210–215, 2016. 
[51] A. R. Abubakar, S. Ismail, N. I. A. Rahman, and M. Haque, Comparative study on drug safety 
surveillance between medical students of Malaysia and Nigeria, Ther. Clin. Risk Manag., pp. 1015–1025, 2015. 
[52] A. R. Abubakar, N. Bin Simbak, and M. Haque, Pharmacovigilance Study : Awareness among Medical 
Students of a New Medical School of Malaysia, Int. J. Pharm. Res., vol. 7, no. 1, pp. 83–88, 2015. 
[53] S. KC, P. Tragulpiankit, I. R. Edwards, and S. Gorsanan, Knowledge about adverse drug reactions 
reporting among healthcare professionals in Nepal, Int. J. Risk Saf. Med., vol. 25, pp. 1–16, 2013. 
[54] C. Su, H. Ji, and Y. Su, Hospital pharmacists ’ knowledge and opinions regarding adverse drug reaction 
reporting in Northern China, Pharmacoepidemiol. Drug Saf., vol. 19, pp. 217–222, 2010. 
[55] A. Passier, K. van Grootheest, M. ten Napel, and E. van Puijenbroek, Reporting of Adverse Drug 
Reactions by General Practitioners, Drug Saf., vol. 32, no. 10, pp. 851–858, 2009. 
[56] S. Shamim et al., Adverse drug reactions (ADRS) reporting : awareness and reasons of under‑reporting 
among health care professionals , a challenge for pharmacists, SpringerPlus (2016), vol. 5, pp. 1–8, 2016. 
[57] J. K. Aronson, Balanced prescribing – principles and challenges, Br. J. Clin. Pharmacol., vol. 74, no. 4, 
pp. 566–572, 2012. 
[58] J. Beckmann et al., Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive 
Modular Curriculum, Drug Saf., vol. 37, no. 10, pp. 743–759, 2014. 
[59] U. Mehta, Personal interview. 21 August, School of Public Health (UCT). 2017. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
XXXIV | P a g e  
 
Appendix C: Chapter 4 supporting content 
This appendix provides the supporting content of Chapter 4. In this appendix, two sections are 
provided, namely: 
 Section C.1: IAMOT2018 annual conference article – This section contains article that 
was produced from a large portion of the content in Chapter 4, and published in the 
IAMOT2018 annual conference proceedings. 
 Section C.2: Implementation of the 5Why method, illustrated by fishbone diagrams – 
This section contains the fishbone diagrams, referenced in Section 4.6, that illustrate 
the implementation of the 5Why method. These diagrams identify several possible root 
causes to specific PV challenges. 
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Section C.1: IAMOT2018 annual conference article  
Translating the pharmacovigilance challenge landscape to a lower level of abstraction: The 
implementation of a value chain analysis, the 5Why method, and fishbone diagrams 
IZAK LAMPRECHT  
Stellenbosch University, Industrial Engineering, Health Systems Engineering and Innovation Hub, South Africa 
izaklamp3@gmail.com 
LOUZANNE BAM & IMKE DE KOCK  
Stellenbosch University, Industrial Engineering, Health Systems Engineering and Innovation Hub, South Africa 
louzanne@sun.ac.za & imkedk@sun.ac.za 
ABSTRACT  
While substantial progress has been made over the last decade to address the prevalent challenges faced by 
pharmacovigilance (PV) systems, many such systems are still experiencing various challenges. Considering that 
PV challenges identified in literature are often described on a strategic level and that no PV system is the same, 
there is a failure to understand the influence of these challenges within their specific contexts. Moreover, there 
is a shortage of research that proposes appropriate methodologies to translate these strategically defined 
challenges to an operational level, where it would be much simpler to: (i) understand the effects these might 
have on a PV system, and (ii) realise the potential of leveraging existing technologies to address these challenges. 
Thus, the rationale as to why it is important to translate strategic level challenges to an operational level is 
discussed in this paper. The potential of existing methodologies that can assist and guide this translation process 
is also investigated. A selected set of methodologies are implemented as an example, describing the influence 
of strategically defined challenges on the functions in PV and identifying the root causes of these challenges. 
Lastly, the prospects of existing technologies that can address these challenges are discussed. 
Key words: Pharmacovigilance; challenge landscape; translation; value chain analysis; 5Why method; fishbone 
diagrams; technology landscape. 
INTRODUCTION: BACKGROUND 
In the 1960s, an international health disaster was experienced. A pharmaceutical company introduced 
Thalidomide, a drug which was marketed as a sedative and anti-emetic in pregnancy. Following the release of 
Thalidomide, reports of infants being born with severe birth defects flooded the healthcare system. Worldwide, 
it was reported that nearly 10 000 infants were born with such defects, which affected the development of 
extremities (Toklu & Uysal (2008) and Isah et al. (2012)). Following these events, it was clear that there was a 
dire need to develop a system where the effects of newly marketed and existing drugs were constantly 
monitored to prevent a similar tragedy such as that of the Thalidomide case (Wang et al. (2009); Stolk (2012); 
and Klausen & Parle (2015)). Subsequently, such a system was developed, and came to be known as 
pharmacovigilance (PV) (De Abajo 2005). 
PV is defined as the “science and activities relating to the detection, assessment, understanding and prevention 
of adverse effects or any other possible drug-related problems” (World Health Organization 2002). Ultimately, 
the goal of PV is to optimise benefits and minimise the risks, of newly marketed and existing drugs, at both the 
individual and population level. In the last decade, PV has been the recipient of a great deal of research and 
investment, and has grown to become an important facet of healthcare (World Health Organization 2002). This 
considerable growth, however, has led to PV becoming a ubiquitous system with an increasing scope. 
The expansion of activities have led to numerous challenges that burden modern PV systems (Pan 2014). 
Challenges from both a systems – and clinical perspective prevent optimal service delivery and resource 
utilisation within PV systems, and limits the extent to which PV can operate both effectively and efficiently 
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(Strengthening Pharmaceutical Systems (SPS) 2009). In an effort to identify these challenges, Lamprecht et al. 
(2017) conducted a systematic review, and prioritised the following challenges: unsupported culture of drug 
safety, lack of partnerships, lack of transparency, insufficient resources, country-specific factors serving as 
barriers, adverse drug reaction (ADR) under-reporting, and lack of technical capacity. 
An investigation of these challenges established that most are described on a high level of abstraction i.e. at a 
strategic level. In other words, literature tends to argue that these challenges burden PV systems in many 
countries, but fails to provide additional information as to the specific influences these challenges have on the 
different functions within PV. The root causes of these challenges in different contexts are also not identified in 
literature. The subsequent section argues the importance of translating the strategically defined challenges in 
PV to an operational level in order to realise the influence and root causes of these challenges. 
RATIONALE BEHIND THE IMPORTANCE OF TRANSLATING STRATEGICALLY DEFINED CHALLENGES 
Strategic management is often the so-called golden child of an organisation, receiving far greater attention than 
operational management. Executives and managers who have not moved through the ranks of operational 
management and as a consequence are not familiar with operations, frequently fail to consider the influence of 
operations on an organisation’s overall strategy (Hammer 2004). According to both Croxton et al. (2001) and 
Hammer (2004), being aware of both the opportunities posed and the limitations associated with various 
operational strategies will allow these previously mentioned executives and managers to add to their strategic 
arsenal to become influential market players.  
Provided that more effort needs to be shifted towards processes and activities related to operational 
management (Croxton et al. 2001), there is a need to define and investigate strategic level processes and 
activities at an operational level. Thus, strategies need to be translated to an operational level to understand 
how these influence the different functions within an organisation (Naghibi & Baban 2011). Considering this 
within the PV context, in order to propose actionable solutions to the strategic level challenges that have been 
identified in the PV landscape, these must be translated to an operational level. Formalising the operational 
level challenges in this manner will enable knowledge sharing and debate about these in literature, and will 
enable researchers and practitioners to differentiate between the effects these challenges have on the various 
functions in PV. 
Hewitt-Taylor (2012) argue that, in order for challenges to be described at an operational level, the root causes 
must be identified. It is argued that it is often more feasible to investigate these root causes, rather than 
addressing the challenges on an strategic level, because the root causes will deliver tangible problems that can 
be more easily addressed.  
Therefore, the rationale behind the proposition that the PV challenge landscape must be translated to a lower 
level of abstraction is (i) such a translation will make it clear how strategic challenges influence the different 
functions in an organisation, or in the case of PV, the stages of which PV systems are composed, and (ii) 
identifying the root causes of strategic challenges will make it increasingly easier to address such challenges at 
an operational level. 
Such a translation, however, is not always simple, and according to Chmutova (2015), business often struggle 
severely with this process, given that they fail to leverage existing methodologies in guiding the entire process. 
Some of the methodologies that have been developed for this translation process are considered in the 
subsequent section. 
TRANSLATION METHODOLOGY ASSESSMENT  
In order to identify the different methodologies that can be used to translate the PV challenge landscape, a 
literature review was conducted in two databases, namely Google Scholar and Scopus, as well as grey literature. 
Using the search terms “root cause analysis”, “translation methodologies and approaches”, and “problem 
solving”, the literature review uncovered some of the more widely used methodologies, namely root-cause 
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analyses (RCAs), the 5Why method and fishbone diagrams. Additionally, the 5W2H method, key performance 
indicators (KPIs), and value chain analyses, methods that are commonly used for analysing and defining systems 
in the Industrial Engineering profession, are added to the list of methodologies that are considered for 
application.  
Root cause analysis 
According to Jones & Despotou (2016), the RCA is by far the most widely used analysis tool for investigating 
problems, especially in the healthcare environment. RCAs focus on the root cause of problems, while avoiding 
emphasis on any mistakes made by specific individuals. Ideally, a team-based approach, where teams are 
composed of individuals from different backgrounds and contexts, is the best approach to conducting a RCA, as 
this will ensure that a range of root causes to the same problem be identified.  
There are different techniques that can be used to conduct a RCA, the most popular being the 5Why method 
and Fishbone diagrams. 
The 5Why method and fishbone diagrams 
The 5Why method was developed by Sakichi Toyoda, one of the fathers of the establishment of the car company 
Toyota in the late 1940s (Warner 2015). Adopted by the global market in the 1970s, the 5Why method became 
one of the most renowned methodologies, able to identify the root causes of specific problems. 
In essence, this form of RCA is completed by asking the Why question, on average, five times (Warner 2015), 
which will lead to the root cause of a given problem. Additionally, in order to capture the thinking processes 
during this exercise, a fishbone diagram can be developed, which will provide a visual representation of the 
possible root causes to a given problem (Pojasek (2000) and Jones & Despotou (2016)).  
The 5Why method, in combination with fishbone diagrams, offer several benefits to its users, including (Pojasek 
2000): (i) it is a very quick and simple tool to use; (ii) the nature of the Why question is highly relatable, since 
Why is so often asked in real-life; (iii) fishbone diagrams serve as visual representations to the 5Why method, 
providing a holistic view of the effects that stem from a certain root cause; (iv) the process initiates a thinking 
process in the individuals of the team, allowing them to come up with an answer more quickly; and (v) the one 
right answer syndrome is eliminated since the method is a team-based approach i.e. a broad range of answers 
from different departments are given. 
Regardless of the benefits offered by the 5Why method and fishbone diagrams, there are also some challenges 
associated with it, namely (Pojasek 2000): (i) facilitation is needed to optimise the results of the method, and 
the facilitator(s) should have some experience in the method; (ii) it is not always simple to answer the simple 
question of Why, since many environmental factors may affect the answer; and (iii) when used incorrectly, these 
methods can lead to finger pointing i.e. one individual or group can be blamed for a mistake. 
A number of studies (Pojasek (2000); Bulsuk (2009); Sonkiya (2014); Mpanza (2016); and Brundage et al. (2017)) 
have endorsed the efficacy of the 5Why method in combination with fishbone diagrams as a mechanism for 
translating problems that have been defined on a strategic level to a more tactical – or operational level where 
some of the root causes may exist. 
5W2H 
The 5W2H method is a highly efficient and simple management tool, constructed of well-defined stages which 
serve as structures to action planning (Veyrat 2016). The name of this method originates from the questions 
that are asked. These questions are: “What will be done?”, “Why will this be done?”, “Where will it be done?”, 
“When will it be done?”, “Who will do it?”, “How will this be done?”, and “How much will it cost?” Given that 
strategies constantly change within the competitive market, strategies must be continuously adjusted, and as a 
result new strategic challenges come to light. According to Veyrat (2016), going through the process of the 5W2H 
method will allow organisations to define their strategies, and determine how these goals will be achieved. 
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The 5W2H method offer many benefits, including (Bau et al. (2012) and Veyrat (2016)): (i) it is a simple method 
to implement since straightforward questions are asked; (ii) it enables businesses to comprehensively define the 
problem at hand, which in turn make it simpler to identify areas where improvements are necessary; (iii) the 
simple questions enables individuals from different backgrounds and experiences to provide their input; and (iv) 
the simplicity of the method allows it to be used in many different industries. 
As with any methodology, there are also some challenges that might burden businesses to effectively use the 
5W2H method, which includes: (i) the method is most beneficial when there is a facilitating individual or team 
who has experience with the method; and (ii) it is not always simple to answer the questions asked by the 
method, and there may be conflicting views on the correct answer. 
It is clear that there are pros and cons to this method, which must be weighed against one another. On balance, 
however, Veyrat (2016) is of the opinion that when used correctly, the 5W2H method can effectively help 
businesses translate their strategic goals. 
Key performance indicators 
Most businesses make use of KPIs to translate their strategy into some quantifiable and measurable objective 
(Baroudi 2014). For example, a manufacturing business’s strategy may be to increase overall productivity. 
Measuring a business’s overall productivity is most likely difficult or infeasible, therefore, operational level KPIs 
such as the total hours of machine downtime per day, or the total number of defective raw materials per month 
are used instead. These operational level KPIs can be measured in a direct and standardised manner and enable 
businesses to determine whether productivity has increased or decreased.  
The specific benefits that KPIs offer includes (Baroudi 2014): (i) increasing individual and team focus; (ii) 
encouraging departments to meet their goals; (iii) serving as a link between individual and departmental goals; 
(iv) allowing executives, managers, and employees to identify possible areas for improvement; and (v) defining 
and communicating both the expected and achieved performance levels. 
Some potential drawbacks associated with the use of KPIs include (Baroudi 2014): (i) unclear definitions of KPIs 
can negatively affect other KPIs that are crucial to the measurement of the success of a business; and (ii) 
employees may sometimes focus more on what is expected of them, rather than focus on how these 
expectations will be met, leading to possible health and safety risks. 
Developing KPIs is often a tedious and difficult process. To avoid this, it is essential that businesses consult the 
relevant stakeholders as they may have valuable inputs that have not been considered before (Baroudi 2014). 
Value chain analysis 
A value chain analysis is defined as “a process where a firm identifies its primary and support activities that add 
value to its final product [or service] and then analyse these activities to reduce costs or increase differentiation” 
(Jurevicius 2013b). It enables businesses to identify underperforming business processes and activities, allowing 
them to make necessary adjustments. It also highlights influential factors (environmental factors, participating 
actors etc.) that affect a value chain, delivering a comprehensive image of how a value chain and its components 
interact. 
Value chain analyses offer several benefits, which include (Simister 2011): (i) it is a flexible strategy tool, and can 
be adapted towards many different industries; (ii) it focusses on the activities needed to deliver value 
proposition, highlighting the processes and activities that contribute to delivering the customer demand; and 
(iii) it is a well-known strategic tool, and has delivered insight to many industries as to how and where they need 
to improve. 
It is also important to be aware of the limitations to using value chain analyses, which include (Simister 2011): 
(i) although the value chain analysis is flexible, it is not a plug and play instrument, therefore necessary changes 
must be made to adapt the analysis to a specific industry; (ii) knowing that value chain analysis was originally 
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designed for use in the manufacturing industry may deter other industries from using it; (iii) the scale and scope 
of a value chain analysis can be intimidating, since it considers a value chain in its entirety; and (iv) though many 
people are familiar with the concept of a value chain analysis, few are experts, and facilitation is therefore often 
needed to guide the development of such an analysis. 
A value chain analysis is a comprehensive strategic tool that offers many benefits, and when implemented 
properly and the limitations are considered and managed, it can assist businesses in making necessary 
improvements across its value chain in order to deliver a better value proposition. 
TRANSLATION METHODOLOGY SELECTION  
In order to select the most appropriate translation methodology for application to the PV system, the 
methodologies are compared to one another by evaluating their capability of meeting certain qualification 
criteria. These criteria were developed based on a set of indicators, developed by the World Health Organisation, 
used to evaluate the inputs, outputs, processes, and impacts of PV systems (World Health Organization 2014), 
and incorporates some conditions set by the authors of this paper. These qualifying criteria are: 
 Stakeholder identification: Does the methodology allow the user to identify the stakeholders that 
participate in the PV system? 
 Distinguishing: Does the methodology distinguish between the different stages in the PV system? 
 Flexibility: Does the methodology adapt well to different input data and structures? 
 Relationship identification: Does the methodology indicate the effect that different elements may 
have on the other? 
 Reproducible: Can the methodology be reproduced by anyone, regardless of their background? 
 Measurable outcome: Does the methodology deliver measurable outcomes? 
The sought after translation process consists of two stages, which, in unison, will contribute to the translation 
of the PV challenge landscape to a lower level of abstraction, where tangible problems can be defined and 
addressed. These stages are: (1) defining the influence of the PV challenge landscape by differentiating between 
the different functions, or stages, of a PV system; and (2) identifying the root causes of the differentiated PV 
challenges within a PV system. 
The comparison of the methodologies according to the set of qualifying criteria is shown in Table 1. Based on 
this analysis, the following two methodologies are selected to address the two stages of the desired translation 
process: 1) value chain analysis, and 2) the 5Why method and fishbone diagrams. The use of these 
methodologies are further advocated in the subsequent sections. 
Table 1: Comparing the different translation methodologies. 
Translation 
methodology 
Stakeholder 
identification 
Distinguishing Flexibility Relationship 
identification 
Reproducible Measurable 
outcomes 
5Why and 
Fishbone 
diagrams 
X  X  X  
Problem tree 
analysis  
  X X   
5W2H X  X  X  
KPIs      X 
Stellenbosch University  https://scholar.sun.ac.za
XL | P a g e  
 
Value chain 
analysis 
X X  X   
 
The value chain analysis 
A recent report by Franz et al. (2015) discusses a value chain analysis conducted in the energy market system in 
sub-Saharan African countries. This analysis allowed the developers to comprehensively understand the 
operation of the current energy market system in sub-Saharan African countries, which in turn allowed them to 
identify improvement initiatives with regards to specified inputs, services, finances, and enabling factors (Franz 
et al. 2015). Similarly, the United Nations also implemented a value chain analysis, which focussed on the living 
conditions of disabled persons. Several influential factors such as disabled rights, policies, and financial 
structures were identified, indicating problem areas where improvements or adjustments were necessary 
(United Nations 2012).  
The prospects of leveraging the value chain analysis for translating challenges in the PV system that have been 
defined at a strategic level to an operational level in a specific context is evidenced by these two cases. 
Moreover, with reference to the qualifying criteria in Table 1, value chain analyses enables the user to 
differentiate between the stakeholders in PV (“Stakeholder identification”), distinguishes between the different 
functions of a value chain or in this case a PV system (“Distinguishing), can be adapted towards the PV context 
(“Flexibility”), and enables the user to identify any possible relationships that might be shared between the 
different influences in a value chain (“Relationship identification”). The methodology therefore satisfies four of 
the six qualifying criteria defined in the previous section and this justifies the use of a value chain analysis for 
the first stage of the translation process i.e. defining the influence of the PV challenge landscape on the functions 
in a PV system. 
The 5Why method and fishbone diagrams 
There are many reported cases where the 5Why method and fishbone diagrams have enabled businesses to 
follow a systematic approach in identifying the root causes of challenges they are experiencing. Myszewski 
(2013) describes a case where an unknown company used these analyses to identify certain root causes with 
regards to quality deficiencies found in a product manufactured by this company. 
Another reported case of the successful application of the 5Why method and fishbone diagrams is described by 
Jones & Despotou (2016). A number of hospitals based in the United Kingdom reported numerous unintended 
consequences from the use of electronic health records. Though these consequences are not named in the 
article, Jones & Despotou (2016) described that through a combination of the 5Why method and fishbone 
diagrams, investigators were able to identify the root causes of these consequences, and were subsequently 
able to address the problems. 
These two cases support the rationale that these methodologies are suitable to support the translation of the 
PV challenge landscape to an operational level. Providing even further justification, the 5Why method, in 
combination with fishbone diagrams, allows the user to differentiate between the key role players in a PV system 
(“Stakeholder identification”), can be adapted towards a PV context (“Flexibility”), and can be easily reproduced 
by someone who might be lacking a certain degree of technical capacity (“Reproducible”). The methodology 
therefore satisfies three of the six qualifying criteria defined in the previous section and this justifies the use of 
the 5Why method in combination with fishbone diagrams for the second stage of the translation process i.e. 
identifying the root causes of the PV challenge landscape. 
Subsequently, an example of the application of the two stages of the translation of the PV challenge landscape 
is provided through a worked example. 
STAGE 1: IMPLEMENTATION OF THE VALUE CHAIN ANALYSIS 
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Following the argument that the value chain analysis can be used for the purpose of the first stage of the 
proposed translation process, a PV value chain analysis is developed in the subsequent section. 
The pharmacovigilance value chain analysis 
The PV value chain analysis is shown in Appendix 1. Many of the challenges identified in the analysis share 
relationships with others. Illustrated by double-headed arrows, these relationships indicate that when the one 
challenge is addressed, there will either be a direct or indirect effect on the other(s).  
The PV value chain analysis has been developed in a general context, taking no specific location into 
consideration. In order to further ensure that the analysis is even more accurate, it can be developed within a 
specific context where specific challenges to a specific context are investigated. 
Regardless, the PV value chain analysis has been validated by a subject matter expert who have sufficient 
experience in the PV industry, and endorsed the use of such an analysis.  
Key points highlighted by the pharmacovigilance value chain analysis 
By disseminating the PV challenge landscape in the PV value chain, the PV value chain analysis has highlighted 
several key points that would have been difficult to identify by simply considering the PV challenge landscape in 
isolation. The analysis also sheds some light on the relationships within the PV challenge landscape, as well as 
the actual meaning of the influence of challenges in PV. These key points are briefly described in subsequent 
subsections. 
Prominent role players 
Governmental bodies, also referred to as regulatory authorities, are key role players in PV. This is because, in 
most countries, regulatory authorities govern PV systems, developing the necessary policies and investing the 
required resources for PV systems to operate. Though some countries (e.g. South Africa) are trying to shift a 
portion of the power held by regulatory authorities outside their jurisdiction, these authorities will still play a 
major part in PV systems.  
Snowballing effect caused by adverse drug reaction under-reporting 
Within the ADR under-reporting lane, it is shown that many of the challenges in the downstream PV value chain 
share relationships with this phenomenon, emphasising the limitations caused by ADR under-reporting that are 
so often described in literature.  
Many challenges faced at the start of the pharmacovigilance value stream 
Many challenges are found at the start of the PV value chain i.e. within the data collection and ADR under-
reporting, and data collation stages, which highlights the limitations posed by a lack of robust qualitative and 
quantitative data. Data plays a major part in PV, and it is therefore of great importance that the efforts towards 
acquiring such data be made as efficient and effective as possible. 
 
Exchanges between country-specific factors and insufficient resources 
There are frequent exchanges between the challenges associated with country-specific factors and insufficient 
resources, therefore it is worthwhile exploring whether there is a causal relationship between these two 
strategically defined challenges. In other words, when it is found that there are insufficient resources within a 
certain country, it is possible that it is a unique case to that specific country i.e. another country may not 
experience the same problem. 
 
Role played by country-specific factors 
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Many challenges have been identified within the country-specific factors lane. This only highlights the rationale 
that globalisation and standardisation of PV systems on an international scale is not feasible, given that PV 
systems in different countries are unique, and are influenced by different factors. 
Failure to understand the effects of pharmacovigilance 
It is often the case that there is a failure amongst those within the PV spectrum, as well as those outside, to 
fathom the importance of PV, and the major influence it not only has on an individual level, but also the effect 
it has on the entire healthcare industry. 
Lack of access 
The lack of access to resources is regularly reported in the analysis. It is not necessarily the case that the 
expertise, experience, funding, training, technology, and other resources do not exist, but rather that PV systems 
are not given access to such resources. One of the main reasons for this can be attributed to the fact that PV is 
not classified as priority within a certain country. 
Adoption by the widespread healthcare industry 
Disseminating the PV challenge landscape, shows that PV is a large and complex system with much room for 
problems, and therefore needs to be adopted by the widespread healthcare industry i.e. it must be a priority 
not only to those actively involved in PV, but also to those outside the spectrum of PV, to aid PV in its activities. 
Lack of technical capacity 
The lack of training, knowledge, or practice, all of which are attributed to technical capacity, are often limiting 
factors in PV systems. This can be directly traced back to the pre-entering phase into the healthcare environment 
i.e. university, college, or any other form of tertiary education. Training needs to start on a tertiary level, where 
the basics of PV are taught.  
Concluding stage one of the translation process 
These key point all contribute to the initial translation process i.e. understanding that the PV challenge landscape 
affects the different stages in the PV value chain in different ways. It is critical to a system such as PV, where 
drug and patient safety are of primary concern, that researchers understand how the challenges affect a PV 
system, which will allow them to make the necessary improvements to the system.  
In order to identify the root causes of challenges in the PV landscape, the second stage of the translation process 
proposed in this paper is essential, an example of this second translation step is given in the following section. 
STAGE 2: IMPLEMENTATION OF THE 5WHY METHOD AND FISHBONE DIAGRAMS 
Up to this point, the translation of the strategically defined PV challenge landscape has reached an intermediate 
stage. To complete the translation, the root causes of these challenges must be identified, which will translate 
these challenges to tangible problems that can be addressed at an operational level. In order to do this, the 
5Why method, in combination with fishbone diagrams, can be used. To illustrate the implementation of these 
methodologies, the root causes of three of the challenges in the PV value chain analysis are identified, namely: 
(i) inadequate access to ADR reporting forms (spontaneous); (ii) failure to develop locally relevant and easily 
measurable indicators of performance of PV systems; and (iii) the lack of robust local data that limits the extent 
to which decision-making can be done. Appendix 2 contains a fishbone diagram illustrating the application of 
the 5Why method to each of these three challenges. The key findings are briefly discussed in the remainder of 
this section. 
In summary, the possible root causes that have been identified for the inadequate access to ADR reporting forms 
(spontaneous) are: 
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i) There is a lack of funding to access software technologies to assist the coordination of the deliveries 
of spontaneous ADR reporting forms. 
ii) There is no existing software technology that can assist the coordination of the deliveries of 
spontaneous ADR reporting forms. 
iii) The individuals responsible for coordinating the deliveries of spontaneous ADR reporting forms are 
not sufficiently trained in this regard.  
iv) There is no designated transportation service to distribute the ADR reporting forms. 
v) The person in charge of re-ordering the ADR reporting forms is not sufficiently trained in stock 
control. 
vi) The person in charge of re-ordering the ADR reporting forms is situated in remote location, and as a 
consequence, users of the forms struggle to notify the person. 
vii) The users of the forms have competing priorities, and simply do not have time to notify the person in 
charge of re-ordering the ADR reporting forms. 
The identified potential root causes for the failure to develop locally relevant and easily measurable indicators 
of performance of PV systems are: 
i) Key stakeholders are not aware of the health impact of PV. 
ii) There are only globally defined indicators of performance that may not include features of a unique, 
local PV system. 
The possible root causes of the lack of robust local data that limits the extent to which decision-making can be 
done have been identified as: 
i) PV is not sufficiently advocated to the necessary stakeholders. 
ii) PV is not included in the undergraduate syllabus of healthcare tertiary education. 
iii) The ADR reporting forms are overly complicated and takes too long to complete. 
iv) Key stakeholders are not aware of the health impact of PV. 
These examples show the systematic thinking process behind the identification of the root causes by using the 
5Why method in combination with fishbone diagrams. Subsequently, the key points that were highlighted during 
this process are discussed. 
Key points highlighted by the implementation of the 5Why method, in combination with fishbone diagrams 
Certain key points that can be concluded from these analyses, highlighting several distinct features that may not 
have been known before. 
Wide spectrum of possible root causes 
When conducting these types of analyses, it is possible to either identify numerous possible root causes of a 
specific problem, or only a few. This is evident from the wide spectrum of root causes identified in the examples 
provided. This phenomenon is a result of the nature of answering a simple “Why?” question, which may have 
more than one possible answer. 
Unclear association between root causes and the overall problem 
Some of the root causes identified may be deemed as far-fetched i.e. it may seem that the root cause and the 
overall problem may not have anything in common, and this may make stakeholders resistant to using the 5Why 
methodology. For example, a root cause for the inadequate access to ADR reporting forms is the lack of funding 
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to access software technologies. As Warner (Warner 2015) described, however, these types of analyses have 
delivered many positive results, and therefore one should at the very least put some effort into investigating the 
possible interactions these seemingly non-associated root causes and challenges may share. 
Shared root causes 
As indicated by the analysis of the failure to develop locally relevant and easily measurable indicators of 
performance of PV systems, and the lack of robust local data that limits the extent to which decision-making can 
be done, certain possible root causes may affect different problems. This is proof that the challenges in the PV 
challenge landscape share relationships, as illustrated in the PV value chain analysis. 
Concluding stage two of the translation process 
In combination with the initial translation process where the influence of the PV challenge landscape on the PV 
value chain is investigated, the root cause analysis identifies tangible problems that have not been previously 
known. Further investigations into these root causes can commence, and solutions can be developed in terms 
of technology, funding, or general managerial strategies.  
LEVERAGING THE TECHNOLOGY LANDSCAPE 
The translation of the PV challenge landscape has delivered tangible problems, many of which are described on 
an operational level. Some of these operational challenges offer investigators the opportunity to investigate the 
prospects of the technology landscape and determine how these technologies can be leveraged towards 
addressing some of these problems. Subsequently, examples of some of these technologies are provided. 
Online teaching services 
Already proven to deliver desirable outcomes within the educational environment (Lamprecht 2017), online 
teaching services have been successfully implemented to address the issue of the lack of technical capacity. 
Frequently found in PV, and emphasised in this paper, the lack of technical capacity refers to the lack of essential 
theoretical – and practical knowledge. Online teaching services are able to provide these essential skills to 
individuals in different contexts. 
Big data analysis 
As highlighted by second stage of the translation process, the lack of existing software to manage data in PV is 
a challenge affecting different areas in PV. In order to accommodate for the large amount of data circulating in 
PV, big data analysis software can be used to collect, synthesise, and analyse data. This will enable researchers 
and practitioners in PV to manage large amounts of data, and identify signals of adverse events much quicker. 
This will also eliminate the snowballing effect caused by ADR under-reporting, because the necessary data is 
readily available and analysed. 
Cloud technology 
Cloud technology, which is essentially an information sharing platform, can be implemented to address the issue 
of the lack of advocacy of PV systems. One component of this lack of advocacy is the challenge of sharing 
information with the necessary stakeholders. Cloud technology platforms such are easy-to-use software that 
can be used to share large amounts of data with many stakeholders, making them aware of the effects caused 
by PV and the importance of maintaining and supporting these systems. 
CONCLUSION AND FUTURE RESEARCH 
In this paper, the translation of the PV challenge landscape to a lower level of abstraction is the main focus point. 
It is concluded that this translation process is best achieved via two stages, which are (i) the identification of the 
influence of the PV challenge landscape in the PV value chain, and, (ii) the identification of the root causes of 
these challenges. In order to complete these stages, the prospects of several methodologies are investigated, 
and by making use of a set of qualification criteria, two candidate methodologies are chosen, namely the value 
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chain analysis (used for stage one of the translation process) and the 5Why method in combination with fishbone 
diagrams (used for stage two of the translation process). As an illustration of the implementation of these 
methodologies and the associated benefits they offer, examples are provided, followed by a summary of the key 
points that can be concluded from the application of each of these methodologies to the PV landscape. Finally, 
candidate technologies are identified that can be leveraged towards addressing the challenges in PV. 
Following the two stages of the translation process, is became clear that the methodologies that have been 
implemented highlighted several key points that may have been difficult, or even impossible, to conclude. As a 
result, the proposed approach to translating the PV challenge landscape can be used in future studies in an 
attempt to develop solutions to the many problems that burden PV systems. 
Both stages of the translation process of the PV challenge landscape identified several tangible problems and 
operational challenges that can be addressed with technology. The technologies identified in the paper 
represent only a portion of the technology landscape, and there are many other technologies that can be 
investigated. Regardless, the success already achieved by these technologies in other industries such as the 
educational industry increase the probability that these technologies can be used to address the PV challenge 
landscape. 
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APPENDIX 1: THE PHARMACOVIGILANCE VALUE CHAIN ANALYSIS 
 
Value chain analysis of the PV system – Illustration of the challenges faced within the confines of each stage in the PV system 
C
ou
nt
ry
 
sp
ec
if
ic
 
fa
ct
or
s
In
su
ff
ic
ie
nt
 
re
so
ur
ce
s
T
ra
ns
pa
re
nc
y
C
ul
tu
re
P
ar
tn
er
sh
ip
s
A
D
R
 u
nd
er
-
re
po
rt
in
g
T
ec
hn
ic
al
 c
ap
ac
ity
P
V
 V
al
ue
 c
ha
in
S
ta
ke
ho
ld
er
s
Evaluation of outcomesData collection and ADR Reporting Data collation Data analysis (Causality and Risk assessment) Decision making and Governance Appropriate action
Data collection 
and ADR 
reporting
Data collation
Data analysis 
(Causality and 
risk assessment)
Decision-
making and 
governance
Appropriate 
action
Evaluation of 
outcomes
 HCWs (GPs, specialists, 
pharmacists etc.)
 Public & patients
 Hardware and software 
manufacturers (H&S)
 Media
 Academics
 Government
 PV centres
 Government
 H&S
 Acamedics
 PV centres
 Non-profits (NPOs) (e.g. 
UMC, WHO)
 Specialists in C&R
 H&S
 Pharma companies
 Academics
 Government
 PV centres
 Government
 NPOs
 Non-governmental 
(NGOs)
 Public & patients
 HCWs
 PV centres
 Government
 Media
 NPOs
 H&S
 NGOs
 PV centres
 H&S
 Government
 HCWs
 Public & patients
Inadequate access  
to reporting tools 
Lack of central coordinat ion 
of data collection
Inadequate access  to ADR 
reporting forms 
(spontaneous  report ing)
Lack of access to electronic 
hardware and software to 
accommodate report ing 
systems
Lack of 
awareness of the 
importance of 
ADR reporting 
among healthcare 
workers and 
patients
Public unclear on 
existing ADR 
reporting facil ities 
and methods.
Lack of 
collaboration 
between 
healthcare and 
allied 
healthcare 
profession 
councils
Inman s seven 
deadly sins
Overly 
complicated 
reporting sys tems 
e.g. too much 
detai ls are 
required
HCWs don t 
know how to 
report ADRs – 
sometimes 
leading to poor 
quality
Public and patients don t 
know how to report – 
sometimes leading to poor 
quality
Lack of access to 
sufficiently trained 
personnel who can 
synthesise data
Lack of personnel 
who can do data 
collation
Lack of access to 
local ly developed 
or locally adapted 
data management 
systems
Disagreement on 
what  data is 
essential  during 
collation
Failure to 
understand 
importance of 
data collation
Limited data 
collated due to 
under-reporting
PV personnel 
don t know how 
to collate data
Existing resources 
used for data 
collation not 
util ised
Lack of  access to 
expertise who can 
conduct data 
analysis
Lack of expert ise 
who can conduct 
data analysis
Peers in data 
analysis fail to 
share relevant  
information 
with other in 
different  
locat ions
Pharma 
companies fai l 
to provide all  
information 
regarding data 
analysis
Lack of funding 
given by industry 
to PV systems to 
conduct 
independent data 
analyses
Data analys is not 
done due to 
under-reporting
Existing PV 
personnel don t 
always have 
sufficient 
knowledge to 
conduct data 
analysis
Failure to util ise 
existing resources  
available to C&R
Proposed solution 
not feasible to due 
a lack of access to 
expertise
Stakeholders 
unclear of the 
rationale and 
meaning of the 
problem on hand
Lack of overarching 
PV policy and 
platforms for 
information sharing 
between stakeholders
Lack of access to a 
broad spectrum of 
expertise required to 
oversee and conduct 
PV act ivities
Difficult ies in 
implementing the 
solut ion due to 
situational and 
environmental 
factors
Local users resist  
to using and 
exercising new 
policies regarding 
PV
Lack of access 
resources to 
implement 
init iat ive
Lack of funding, H&S, 
and personnel  to 
implement ini tiative
Resistance to 
change (e.g. have 
to use new 
technology all  of 
a sudden)
Lack of expert ise 
and experience to 
implement the 
init iat ive in a 
region
Failure to util ise 
existing resources  
during 
implementation
Difficult ies to 
evaluate PV 
init iat ives  e.g. in 
remote vil lages
Lack of access to 
personnel who are 
able to conduct 
evaluation
Lack of training 
in evaluation
Unclear 
instructions and 
lack of awareness 
of what is  
important during 
evaluation
Indifference of 
industry to 
support 
evaluation of PV 
systems
Lack of access to 
expertise and 
individuals  who 
have experience 
regarding 
evaluation
Failure to util ise 
existing resources  
during evaluation
Competing priorit ies of 
healthcare staff
Inadequate feedback 
(newsletters, emails 
etc.) given to ADR 
reporters and other 
stakeholders
The KAP 
(knowledge, 
attitude, and 
practice) model 
leading to under-
reporting
Lack of access to data 
management systems  that 
can synthesise and analyse 
existing electronic records
Non-adherence of 
industry 
(pharmaceutical 
companies) to 
reporting 
guidelines of 
regulatory agency
Lack of access to 
tools  such as 
signal analys is 
tools
Industry tends  to 
bias data analyses 
to ensure that the 
marketing of their 
product is not 
negatively 
influenced
Failure to develop 
local ly relevant  
indicators  to 
determine the 
success of a PV 
system
Unclear definition 
of the roles and 
ownership of 
stakeholders 
Lack of advocacy 
from industry 
towards the 
importance and 
awareness of 
ADR reporting
Cultural barriers preventing 
ADR reporting e.g. wrong 
advice given by community 
healers to address ADRs
Inabil ity or 
unwillingness of 
industry and PV 
systems to share 
information
Unwillingness to 
share information 
to relevant parties 
who are able to do 
necessary 
analyses (e.g. 
academic 
inst itutions)
Lack of 
regulatory 
capacity to 
enforce relevant 
PV guidelines by 
industry
Lack of a governance 
structure to guide and 
coordinate data analyses 
process to ensure best 
outcome and prevent biased 
outcomes
Lack of a governance 
structure to guide and 
coordinate data analyses 
process to ensure best 
outcome and prevent biased 
outcomes
Public not made aware of 
improvements – No feedback 
given
Lack of sustainable funding 
for expanding and 
improving effect iveness of 
survei llance systems
Lack of standardised training 
programme for ADR reporting at 
univers ities and healthcare 
facilites
Inadequate technical 
oversight of collation data 
management processes  as a 
whole
Lack of an overarching 
national PV policy that 
provides  a cohesive basis 
for interaction between 
stakeholders 
Failure of stakeholders to 
recognise the public health 
impact of PV
Lack of robust  
local  data limits 
the extent to 
which decision 
making can be 
done
Inadequate 
enforcement 
power by 
regulatory 
authori ties and 
con-compliance 
by manufacturers
Failure to develop 
local ly relevant  and 
easily measurable 
indicators  of 
performance of PV 
systems
Lack of funding for 
data collect ion via 
other surveillance 
systems
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APPENDIX 2: IMPLEMENTATION OF THE 5WHY METHOD, ILLUSTRATED BY FISHBONE DIAGRAMS 
1. Inadequate access to ADR reporting forms (spontaneous). 
 
2. Failure to develop locally relevant and easily measurable indicators of performance of PV systems. 
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3. Lack of robust local data limits the extent to which decision-making can be done 
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Section C.2: Implementation of the 5Why method, illustrated by fishbone 
diagrams. 
1. Inadequate access to ADR reporting forms (spontaneous) 
 
2. Failure to develop locally relevant and easily measurable indicators of performance of 
PV systems. 
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3. Lack of robust local data limits the extent to which decision-making can be done. 
 
4. Inadequate feedback (newsletters, emails etc.) given to ADR reporters and other 
stakeholders. 
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5. Inadequate access to data management systems that can synthesise and analyse existing 
electronic health records. 
6. Failure to utilise existing resources to conduct data collection, collation, and analysis. 
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7. Lack of overarching platforms for information sharing between stakeholders. 
8. Lack of sufficient knowledge of existing PV personnel to conduct necessary data 
analysis 
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Appendix D: Chapter 5 supporting content 
This appendix provides the supporting content of Chapter 5. In this appendix, one section is 
provided, namely: 
 Section D.1: Focus group session details – This section contains the information 
regarding the focus group referenced in Section 5.5.1. The document that was issued to 
the participants of the focus group session is shown, containing the relevant details 
discussed during the session. 
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Section D.1: Focus group session details 
Connecting technology to the pharmacovigilance challenge landscape – Focus group: Discussion and 
feedback (23 February 2018) 
Background 
This document constitutes research in the field of pharmacovigilance (PV). The purpose of the research is to determine where 
technology can be implemented in PV to address some of the challenges faced in the system. Taking no specific context into 
consideration, the research is conducted from a general lens. In other words, the research does not state that the Nokia 3310 
should be used to improve communication in the PV system that focusses on the malaria vaccine programme in Kenya, Nairobi. 
Instead, it is stated that mobile technology should be used to address the shortcomings in communication in the PV system. 
The more specified version where specific models of technologies are proposed will constitute an add-on project. 
At this stage in time, the PV challenge landscape, with the use of a systematic review, has been identified. It was found that 
the challenge landscape is incredibly vast, meaning there are numerous challenges with different degrees of impact on PV. 
Consequently, is was decided that the PV challenge landscape should be refined with the use of prioritisation. It was argued 
that this will reduce the research scope, and ensure that the challenges with the largest footprint in PV be addressed.  
Subsequently, the prioritised challenges are: culture, transparency, partnerships, insufficient resources, country-specific factors, 
technical capacity, and adverse drug reaction (ADR) under-reporting. A brief description of each is provided at the end of this 
document. 
Looking at the description of each of these challenges, it is clear that they are described on a high, strategic level. In other 
words, these challenges do not make specific reference to tangible problems that provide some clarification as to the true effect 
these challenges have on a PV system. Therefore, in order to clarify the true meaning and effect of the prioritised PV challenge 
landscape, a translation process was used.  
This translation process consisted of two stages. The first stage served as an interim stage, where the PV challenge landscape 
was disseminated into the PV system i.e. the meaning and effect of each challenge during each stage of a PV system were 
described. Using this stage as foundation, the second stage of the translation process made use of a 5Why analysis to identify 
possible root causes to these PV challenges. The results of both translation stages are shown in the end of this document. 
Purpose of the focus group 
As stated in the beginning of this document, this research is looking at the technology landscape, and determines which 
technologies can be used to address the PV challenge landscape i.e. the root causes identified by the translation process. In 
order to identify these technologies, two sources are used, namely: grey literature and a focus group. These two sources ensures 
that the process used to identify candidate technologies is credible. 
Therefore, the purpose of this focus group is to identify candidate technologies that can be used to address some of the root 
causes of the PV challenge landscape, as well as describe possible, real-world implementations of these candidate technologies 
into the PV system. The suggested technologies should not make reference to specific models, but rather high-level 
categorisations of the technologies. For example: this research will focus on the use of smartphone technologies, rather than 
the IPhone X.  
Agenda of focus group 
The agenda of the focus group is as follows: 
1. Welcoming 
2. Discussion of the background of the research 
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3. Discussion of the translation process described in the provided document 
4. Identification of candidate technologies and possible implementations 
Example of focus group output 
This is an example of the sought after output of this focus group. The two columns in Bold portray the intended output. 
Technology PV challenge Stage 1 challenge Root cause Real-world implementation 
Online teaching 
services 
Insufficient 
resources 
 
Inadequate access to data 
management systems that can 
synthesise and analyse existing 
electronic health records 
 
Lack of training provided 
those who report ADRs. 
 
Online teaching services can be used to 
provide several ADR reporters (practitioners, 
nurses, patients etc.) with the necessary know-
how of how and where an adverse drug 
reaction should be reported. 
Culture 
PV is based on the culture of safety, where PV professionals provide the foundation upon which the principles of this culture 
is built (Olsen & Whalen 2009). Literature, however, argues that there is a need to improve the culture in modern PV systems 
(Edwards et al. 2015). It is believed that the improvement of PV culture will give lead to the improvement of the other 
challenges in PV. It is often discussed that the improvement of PV culture requires participation across all disciplines in order 
to become a reality. 
The culture of PV is closely related to ADR under-reporting (Rodrigues & Khan 2011). To achieve this culture the challenges 
presented by these models should be investigated. This is also the opinion of Rodrigues & Khan (2011), who refer to the need 
to develop a safety culture, associated with the reporting of ADRs, amongst surgeons and surgical wards. The establishment of 
a culture of safety amongst healthcare professionals across the globe is time-sensitive (Edwards et al. 2015), emphasising the 
need for the timely establishment of such a culture. 
Transparency 
In close association with the culture found in PV, the lack of transparency amongst the stakeholders in PV may lead to failed 
PV initiatives (Rubel et al. 2017). It is essential that key stakeholders, especially those with the relevant experience in PV, 
share relevant information with their peers. This will enable participants in PV to learn of new ways in solving the problems 
they might be experiencing. Increasing the visibility of information in PV is critical (Rubel et al. 2017), as it will support an 
improved drug safety culture. 
It is also essential that the existence of PV systems in countries be publically unveiled. It is described in literature that HCWs 
in many countries do not contribute to PV, simply because they are not aware of the existing PV infrastructure in their location. 
Partnerships 
PV is a collaborative endeavour (Pan 2014). Sustained collaboration and commitment are vital to attend to future challenges 
of PV (World Health Organization (2002); and World Health Organization (2004)). However, ineffective partnership is a threat 
to PV (World Health Organization 2004). Operating in a resource constrained environment, partners in PV must sometimes 
provide expertise, training, political support, scientific infrastructure, and a capacity to accomplish comprehensive monitoring 
and investigations of the safety of medicines (Pan 2014). Failure in providing such resources, ineffective partnerships can lead 
to failed PV initiatives. In order to maintain a certain inventory of these resources, it is vital that PV organisations form lasting 
relationships with its partners. Management for Science (2012) emphasises the importance of relationships between partners 
and how failed relationships often lead to failures. 
Insufficient resources 
It is well-known that PV operate within a resource constrained environment (Isah et al. 2012). Especially in developing 
countries where other challenges such as drought and war are of high priority, PV organisations struggle to implement new PV 
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systems (Isah et al. 2012). In these countries the available resources are rather invested elsewhere, leaving little for the 
requirements of PV. 
The resources required by PV systems are unique in specific countries e.g. a country might have the necessary expertise and 
manpower to assist a PV system but lack the governmental funding, whereas another country might have the necessary budget 
but lack the required manpower (Pan 2014). Countries experiencing this phenomena include Sub-Saharan African countries 
(Isah et al. 2012), India (Rama et al. 2011), and certain South-East Asian countries (Suwankesawong et al. 2016). Common 
resources required by PV systems include monetary assistance, hardware and software infrastructure, expertise and training 
curricula amongst healthcare professionals, and common PV knowledge amongst both healthcare professionals and consumers 
(Isah et al. (2012); and Pan (2014)). PV systems are dependent on the combination of these resources and are not able to 
function properly without it (Isah et al. 2012). Heinrich (2015) make reference to effective resource management, a crucial 
element to the successful operation of a PV system. 
Country-specific factors 
Country-specific factors refer to challenges faced by PV organisations outside the traditional resource architecture and are 
described by Edwards (2017) and Härmark & Van Grootheest (2008). Closely related to the effect of the public on PV, the 
social factors of an area must be considered which includes the culture, religion, age groups, and sex groups of a specific region. 
It is often a burden to clearly identify these factors, since it requires manpower and funding that are not always available. 
Situational factors which refer to border regulations, policies for implementation, governmental budget constraints, conflict in 
countries, and environmental issues such as severe drought must also be considered. Often governments refuse to authorise and 
support the implementation of new PV systems since its priorities are elsewhere (World Health Organization 2002), delaying 
the implementation of PV systems. Similar to the social factors, the required resources needed to identify these factors are not 
always available, proving to contribute to the failed deployment of PV initiatives. 
Technical capacity 
Technical capacity refers to the ability of individuals and teams working in PV to conduct their work efficiently and effectively. 
Very closely associated with the country-specific factors, Mehta (2017) is of the opinion that it deserves to be independently 
categorised. The challenge faced here, especially in developing countries where there are limited resource capacities, is that 
the individuals or teams working within the PV systems often lack the necessary skills and experience to conduct their work 
effectively and efficiently.  
Over the years, PV has grown to be a large and complex system. The nature of PV has changed from a single oriented discipline 
to a cross-functional discipline. Individuals and teams from different background than that of healthcare (e.g. statisticians, 
programmers, and engineers) are more often being consulted and involved in PV, since they offer additional perspectives that 
may be of benefit to PV (Mehta 2017). 
Under-reporting of ADRs 
Under-reporting of ADRs occur when healthcare workers (HCWs) (general practitioners, nurses, surgeons, pharmacists etc.) 
fail to efficiently report new and existing ADRs (Herdeiro et al. 2006). In the interest of consumers and patients who experience 
ADRs, it is crucial that all ADRs be reported to the relevant authorities. This will give way to signal detection, leading to 
investigations into the specific ADR. Without ADR reports that generate signals of a problematic ADR, investigations that aim 
to address these problems cannot take place. 
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PV challenge Result from stage 1 Results from stage 2: Possible root causes 
Insufficient 
resources 
Inadequate access to 
ADR reporting forms 
(spontaneous) 
There is a lack of funding to access software technologies that can assist the coordination of the deliveries of spontaneous ADR reporting forms. 
There is no existing software technology that can assist the coordination of the deliveries of spontaneous ADR reporting forms. 
The individuals responsible for coordinating the deliveries of spontaneous ADR reporting forms are not sufficiently trained to execute the necessary 
tasks. 
There is no designated transportation service to distribute the ADR reporting forms. 
The person in charge of re-ordering the ADR reporting forms is not sufficiently trained in stock control. 
The person in charge of re-ordering the ADR reporting forms is situated in a remote location, and as a consequence, users of the forms struggle to 
make contact with this person. 
The users of the forms have competing priorities, and simply do not have time to notify the person in charge of re-ordering the ADR reporting forms. 
Country-
specific factors 
Failure to develop 
locally relevant and 
easily measurable 
indicators of 
performance of PV 
systems 
Key stakeholders are not aware of the health impact of PV. 
There are only globally defined performance indicators that may not include features of a unique, local PV system. 
ADR under-
reporting 
The lack of robust local 
data that limits the 
extent to which 
decision-making can be 
done 
PV is not sufficiently advocated to the necessary stakeholders. 
PV is not included in the undergraduate syllabus of healthcare tertiary education. 
The ADR reporting forms are overly complicated and are time-consuming. 
Key stakeholders are not aware of the health impact of PV. 
Transparency 
Inadequate feedback 
(newsletters, emails 
etc.) given to ADR 
reporters and other 
stakeholders 
There is no translation services that can prepare these reports for the specific context. 
Feedback is not deemed as a priority. 
The importance of feedback is not advocated sufficiently. 
Insufficient 
resources 
Inadequate access to 
data management 
There is a lack of ownership of managing this process. 
Lack of access to technology to simplify this process. 
Lack of training provided those who report ADRs. 
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systems that can 
synthesise and analyse 
existing electronic 
health records 
Difficulties in providing such training to all individuals in remote locations in a timely fashion. 
Insufficient 
resources 
Failure to utilise 
existing resources to 
conduct data collection, 
collation, and analysis 
There is no resource management system in place to manage the resource inventories. 
There is a lack of ownership taken to manage these resources. 
No training is provided to educate PV personnel on how to use these resources. 
Transparency 
Lack of overarching 
platforms for 
information sharing 
between stakeholders 
Lack of funding to access modern information sharing platforms. 
PV personnel are insufficiently trained in using existing platforms. 
There are no set regulations that governs the standardisation of data. 
It is unclear what data should be shared with which stakeholder. 
ADR reporters are not sufficiently trained in providing the sought after data. 
Technical 
capacity 
Lack of sufficient 
knowledge of existing 
PV personnel to 
conduct necessary data 
analysis 
Lack of sufficient knowledge of existing PV personnel to conduct necessary data analysis. 
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Appendix E: Chapter 6 supporting content 
This appendix provides the supporting content of Chapter 6. In this appendix, two sections are 
provided, namely: 
 Section E.1: IAMOT2019 annual conference article – This section contains the article 
that was produced from a large portion of the content in Chapter 6. At the time of this 
thesis hand-in date, this article is still in the process of being submitted to the 
IAMOT2019 conference. 
 Section E.2: Formal, structured validation document – This section contains the 
document that was sent to the various SMEs during the formal, structured validation 
process described in Section 6.9. In this document, some background to the validation 
request is provided, containing relevant information that the SMEs required to be able 
to provide the necessary feedback. The document also contains a summarised version 
of the research area where validation was required. 
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Section E.1: IAMOT2019 annual conference article 
An investigation into the prospects of the technology landscape to address challenges faced in 
pharmacovigilance systems 
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Stellenbosch University, Industrial Engineering, Health Systems Engineering and Innovation Hub, 
South Africa 
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ABSTRACT  
It is regularly reported that in many healthcare related activities in resource-limited settings are 
experiencing several challenges. Included in this range of struggling activities is pharmacovigilance 
(PV). In PV systems, a consortium of challenges are experienced, especially from a systems perspective 
i.e. challenges faced by the daily operations of PV systems. When consulting literature, it is clear that 
PV systems in resource-limited settings are struggling to operate both efficiently and effectively, while 
maintaining high standards of drug safety associated with a wide range of activities included in its 
scope. There is a wide range of research that investigates several solutions that can be implemented 
to assist and improve PV systems in resource-limited settings. Included in this research is a growing 
interest in the role of technology in PV. Provided that there has been profound developments 
experienced in the technology landscape, many of which have been developed with resource-limited 
settings in mind, there is a growing degree of interest in the role these technological developments 
can have in PV. 
Consequently, the prospects of the technology landscape are investigated in this paper, and it is argued 
how several of these technologies can be leveraged towards the benefit of PV systems in resource-
limited settings. Firstly, several root causes associated with the challenges experienced within PV 
systems are identified and described. This is followed by an investigation into the technology landscape 
where a consortium of technologies are identified which have the potential to be implemented within 
PV. Lastly, and in conclusion, the previously identified root causes of the PV challenge landscape are 
linked to the aforementioned technology landscape, where it is discussed how these technologies can 
possibly be leveraged towards addressing these challenges, and contribute towards the improvement 
of PV systems in resource-limited settings. 
Key words: pharmacovigilance; technology landscape; resource-limited settings 
INTRODUCTION: BACKGROUND 
Pharmacovigilance (PV) was introduced in the late 1960s, following the well-known Thalidomide 
tragedy which severely affected thousands of new-born infants across the world (Toklu & Uysal (2008) 
and Isah et al. (2012)). According to the World Health Organisation, PV can be defined as the “science 
and activities relating to the detection, assessment, understanding and prevention of adverse effects 
or any other possible drug-related problems” (World Health Organization 2002). Essentially, PV was 
developed with the purpose of ensuring universal drug safety, ultimately contributing to a healthier 
population. 
In recent years, the development and increase of pharmaceutical products, as well as the several 
delivery mechanisms of these products, PV systems have started to experience and increasing number 
of challenges (Pan 2014), both from a systems – and clinical perspective (Strengthening Pharmaceutical 
Systems 2009). The latter has been the recipient of many investigations and research, and has 
experienced considerate improvements. However, when shifting focus towards the challenges faced 
from a systems perspective, Lamprecht et al. (2017) found that there are still many challenges 
burdening PV systems from operating both effectively and efficiently, which include minimal 
investment from PV stakeholders in supporting PV culture, the lack of transparency amongst several 
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role players, and the lack of technical capacity. Especially in resource-limited settings, PV systems are 
burdened by these types of challenges (Pan 2014), and are in need of an innovative solution that can 
address these challenges in not only the short – to medium-term, but also sustainable solutions that 
will address these challenges in the long-term. 
Consulting literature, Lamprecht et al. (2017) that there are and have been research that addresses 
some of these challenges, however, failed to find research that approaches these challenges from (i) a 
technology perspective and (ii) a general perspective (not developed with a specific context or setting 
in mind). With this in mind, this research paper addresses the challenges found in PV systems on a 
general scale through a technology lens.  
TECHNOLOGY IN PHARMACOVIGILANCE 
It is well known that the technology landscape is exceedingly broad, with a range of technologies being 
invented, developed, and improved for many industries. PV systems in several countries have reaped 
the benefits offered by these technologies, and have managed to leverage these technologies to 
address the challenges it faces on a daily basis. For instance, a mobile application that can be used for 
adverse drug reaction (ADR) reporting, which was developed by the Web-RADR consortium, have 
contributed significantly towards the increase and simplification of ADR reporting in several European 
countries (De Vries et al. 2016). However, as the researchers if this paper argue, the PV systems in 
countries such as the United Kingdom and the United States of America, are much better equipped for 
the large-scale adoption of technologies to address the challenges it faces when compared to PV 
systems that operate in resource-limited countries, such as many sub-Saharan African countries.  
Considering the previously mentioned Web-RADR mobile application used for ADR reporting; this 
technology was only recently piloted in a sub-Saharan African country (Uppsala Monitoring Centre 
2017). Also, as pointed out by Mehta (2017), South Africa has also only recently introduced a mobile 
application based ADR reporting system. It is evident that in resource-limited settings, it can be argued 
that it significantly more challenging to implement and adopt a technology in PV systems compared to 
that of more developed countries, since there is not a readily-available, broad range of resources. 
Provided that there is an opportunity for research to be conducted in investigating the effect 
technology can have on PV systems, the primary aim of this paper is the following: Identify different 
technologies that can be used to address challenges faced in PV systems, especially those within 
resource-limited settings. Subsequently, the PV challenge landscape is identified, as well as several 
root causes of these challenges. 
THE ROOT CAUSES OF THE PHARMACOVIGILANCE CHALLENGE LANDSCAPE  
In order to identify the PV challenge landscape, the research conducted by Lamprecht et al. (2018) is 
used. Lamprecht et al. (2018) conducted a literature review in order to identify, in general, the PV 
challenge landscape. Realising that it would be more beneficial towards PV systems, Lamprecht et al. 
(2018) prioritised the PV challenge landscape, ending up with the following challenges which were 
regarded as priority in PV: culture, transparency, partnerships, insufficient resources, country-specific 
factors, ADR-under reporting, and technical capacity. Additionally, in order to identify the root causes 
of these challenges, Lamprecht et al. (2018) implemented an innovative translation strategy, and 
managed to identify numerous root causes.  
In order to focus primarily on the root causes that would have a significant effect on PV, the root causes 
identified by Lamprecht et al. (2018) were prioritised. Firstly, two subject matter experts (SMEs) were 
consulted in order to prioritise the root causes identified by Lamprecht et al. (2018), based on their 
personal experience and knowledge. Secondly, an exclusion criterion was also used to further filter 
root causes, which is: if the root cause cannot be addressed with the implementation of a technology, 
but rather with other interventions such as additional funding or business process restructuring, it was 
excluded from the research. 
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Consequently, 13 root causes were identified as priority, and therefore forms the primary focus of this 
research paper. These 13 root causes are identified and described within the clinical domain of PV in 
Table 1. Subsequently, the technology landscape is investigated in order to identify several potential 
technologies that can be leveraged towards the benefit of PV systems by addressing the root causes 
in Table 1. 
THE TECHNOLOGY LANDSCAPE 
In order to identify technologies that can be used to address the root causes of the prioritised PV 
challenge landscape, two sources were used, namely: grey literature, and a focus group. The search 
terms used to identify technologies in grey literature were: “Technologies used to address …” and 
“Emerging technologies used to address …” The prioritised challenges in PV, as identified by Lamprecht 
et al. (2018), namely: culture, transparency, partnerships, insufficient resources, country-specific 
factors, ADR-under reporting, and technical capacity were used in the place of the ellipses in each 
search term.  
To ensure additional credibility, a focus group was held to further populate the technology landscape 
investigated in this research. The participants of the focus group originate from an Industrial 
Engineering background, and therefore have an understanding of the role technologies play in the 
modern world. Subsequently, the technologies identified with the use of the previously mentioned 
sources (grey literature and the focus group) are described, along with some benefits and drawbacks.  
Resource management systems 
Resource management systems (RMSs) are used for the planning and control of resources (Spacey 
2015). These systems manage several different types of resources, including human resources, natural 
resources, financial resources, tangible and intangible infrastructures, and information technologies. 
According to Smith (2014) it is vital to have a balance between these different resources, because any 
system relies on a combination of many interacting resources. RMSs are able to provide a global view 
on the available resources (Smith 2014), and facilitate the management of these resources to ensure 
both efficiency and effectiveness. Some of the more widely used RMSs are known as SAP (Systems 
Applications and Products) models, developed by the SAP Company. These management systems 
provide organisations with the ability to improve their resource management efforts, and allows them 
to predict their resource requirements in future business. 
Regardless of the many benefits mentioned earlier, there are some drawbacks to RMSs as well. These 
include high initial acquisition and installation costs of the system (software) itself, resistance of 
employees in integrating such a system into their everyday routine, and the need for training 
employees in operating these systems. 
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Table 1: The prioritised root causes of the PV challenge landscape. 
Root cause Clinical domain 
1 The users of the forms 
have competing priorities, 
and do not have time to 
notify the person in charge 
of re-ordering the ADR 
reporting forms when 
stock is depleted. 
Due to severe workloads, especially in sub-Saharan African countries where the healthcare system is under-resourced, 
healthcare practitioners forget or for other reasons fail to request that the stock of ADR reporting forms be replenished. As a 
result, stock-outs of ADR reporting forms within healthcare facilities are frequently experienced. This leads to frustration on 
the part of the healthcare workers that are responsible for reporting ADRs and ultimately results in ADRs not being reported. 
It is possible that, in some cases, the person in charge of managing the ADR reporting form stock is not situated in the same 
healthcare facility in which healthcare practitioners reside, meaning calls must be placed to request that depleted form stocks 
be replenished. 
2 The individuals 
responsible for 
coordinating the deliveries 
of spontaneous ADR 
reporting forms are not 
sufficiently trained to 
execute these tasks. 
It has been validated that in some cases, the lack of technical expertise with regards to ADR reporting form delivery 
management is an issue. As a result, healthcare facilities that need the reporting forms are not receiving sufficient stock. 
Consequently, a snowballing effect takes place where ADR reporting form stock is not replenished in time, which leads to ADR 
under-reporting, putting further pressure on the overall healthcare system since patients experiencing ADRs re-enter the 
healthcare system. Therefore, there is a need to address the lack of technical expertise with regards to the management of the 
delivery of ADR reporting forms. 
3 Key stakeholders are not 
aware of the health impact 
of PV on the healthcare 
system. 
Key stakeholders are not aware of the impact of PV not only on PV itself, but also the impact it has on the entire healthcare 
system—when a PV system is not functioning properly, the healthcare system will experience increasing pressure. The key 
stakeholders among which PV awareness should be increased are patients, healthcare practitioners, nurses, and pharmacists. 
These stakeholders represent a group that are most exposed to ADR reporting. The obstacle that surfaces during the creation 
of awareness amongst these stakeholders is that existing awareness programmes struggle to reach a wide audience, especially 
audiences in remote locations.   
4 PV is not included in the 
undergraduate syllabus of 
tertiary healthcare 
education. 
In some undergraduate healthcare syllabuses, PV is not deemed a priority, and therefore does not receive the necessary 
attention. According to Mehta (2017), it is not a simple process to change existing syllabuses to focus more attention towards 
PV. As a result of the lack of PV education, increasing pressure is faced in the PV system where PV related activities, especially 
ADR reporting, are not executed properly. Healthcare practitioners frequently do not know how or where to report ADRs, and 
when they do, the quality of the data they provide is poor. As many of the graduates of these programmes are currently 
employed in the healthcare system, the definition of this root cause within the clinical domain should be expanded to also 
include a lack of PV education amongst current healthcare system workers. A lack of training on ADR reporting is defined as a 
separate root cause in this table, the scope of training referred to here, however, extends beyond the scope of ADR reporting 
only to encompass an understanding of the PV system as a whole and ties in with the previous root cause to also include an 
understanding of the role of PV within the broader healthcare system. Similarly to the previous root cause, the obstacle that 
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one would expect to surface when attempting to provide PV education to the current healthcare workforce include reaching a 
wide audience, including audiences in strategic locations throughout a country. 
5 The ADR reporting forms 
are overly complicated 
and are time-consuming. 
As reported in a study by Khan (2013), in many countries patients and healthcare workers are deterred from reporting ADRs 
due to overly complicated ADR reporting forms, as well as the great effort required to complete each of the fields in these 
forms. This is a phenomenon that is especially experienced in areas where spontaneous ADR reporting forms are used. 
Healthcare workers do not want to fill in these long documents, and would rather divert their attention and time to attending 
to patients, especially when they are remunerated on a patient-basis10. This issue is closely related to the lack of technical 
capacity discussed in the third and fifth root cause discussed in this table. Each of these three root causes ties back to the lack 
of technical capacity.  
6 The importance of 
feedback is not sufficiently 
advocated. 
The feedback referred to here is the feedback given to ADR reporters. These reporters include both patients and healthcare 
workers. In some countries, feedback is not regarded as a priority, which is a mind-set that should be changed. Some of the PV 
systems have some form of feedback system in place, however, these systems are severely limited in capabilities. The only 
form of feedback is in the form of a once-off, automated response once an ADR report is submitted. Thereafter, no form of 
feedback is provided. It is argued in this research that feedback should be regarded as a priority. As shown in a study by Al 
Dweik et al. (2016), the lack of feedback is a barrier to ADR reporting in several countries. 
7 There is a lack of 
ownership of managing 
the process of data 
management. 
 
The data management systems referred to here are the systems within local healthcare facilities. Since many of the staff in 
these facilities already have an overloaded schedule (similar to the second and sixth root causes discussed in this table), there 
may be a lack of ownership of managing the PV system, or in this case, the PV data management system (e.g. ensuring ADRs 
are reported, all the reports are collected, and the forms are captured on a computer). As a result, the PV systems in these 
facilities are of poor quality. It is therefore necessary to improve these PV systems, or rather PV data management systems. 
8 There is a lack of training 
provided to those who 
report ADRs. 
ADR under-reporting, as described numerous times in this research, is one of the major challenges in PV. Since ADR reporting 
is the front-end of PV, it is critical that all possible ADRs are reported. It is often reported in there is a lack of training provided 
to the public, patients, and healthcare workers on ADR reporting. 
9 There are difficulties in 
providing the necessary 
training to individuals in 
remote locations in a 
timely manner. 
This issue is closely related to the previously discussed root cause. Existing training initiatives struggle to provide the necessary 
ADR reporting (and broader PV related activities) training to the public, patients, and healthcare workers in remote locations. 
It is severely important that individuals in these remote locations be aware of ADR reporting, since they might be the ones 
who, unknowingly, are experiencing ADRs. 
                                                 
10 This phenomenon is usually experienced in healthcare facilities where the healthcare worker to patient ratio is low i.e. there are only a small number of healthcare workers 
compared to the large number of patients. In these facilities, remuneration for healthcare workers is usually based on a patient-basis, meaning the healthcare workers (mostly 
doctors and specialists) are payed according to the number of patients they attend to. This is very closely related to the second root cause discussed in this table, which also relates 
to the competing priorities of healthcare workers. 
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10 There is a lack of 
ownership to manage 
existing PV-related 
resources. 
The resources referred to here are those intended for PV activities in local healthcare facilities, such as ADR reporting forms, 
computers, smartphones, tablets, and human resources. Resources form the cornerstone of any system, and should be 
efficiently managed. Since in many cases existing healthcare staff already have an overloaded schedule, there may be no one 
who is willing to take ownership of managing PV resources, and in turn, manage the PV system. It is therefore essential to 
intervene in these cases, by ensuring PV does not interfere with the schedules of the staff, but also ensuring that PV is regarded 
as a priority and receives the necessary attention. This issue is closely related to the second and sixth root cause discussed in 
this table, which also relates to the overloaded schedules of healthcare workers, especially in resource-limited settings. 
11 Lack of training to educate 
PV personnel on how the 
available resources should 
be used. 
Closely affiliated with the lack of ADR reporting training previously discussed, the lack of training provided to healthcare staff 
in local facilities on how PV resources should be used is proving to burden the PV system in those facilities. It is essential that 
staff be trained on how to manage PV resources, such as ensuring the availability of ADR reporting forms, filling in ADR reporting 
forms, and capturing the data on a computer. This training should not only be provided to healthcare facilities in major cities 
or towns, but also to facilities in remote locations. 
12 There is no resource 
management system in 
place to manage existing 
resource inventories. 
This is closely related to the two previously discussed issues that refer to the management of PV resources. It is incredibly 
challenging to manage these resources without some sort of system that is able to track and monitor inventories. It is not 
unexpected that, in healthcare facilities where PV is not regarded as a priority, there are no initiatives taken to implement such 
a resource management system.  
13 PV personnel are not 
sufficiently trained in using 
existing platforms. 
The platforms referred to here are those used between healthcare workers to share information with their peers, which can 
be in the form of emails, online chatrooms, blogs, or cloud technologies (e.g. Google Drive). These technologies are available, 
however, are still unfamiliar to some of the staff. There is a need for some sort of training to be provided to these individuals 
in order to ensure that each member of a healthcare facility know how information can be shared with the relevant parties.  
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Cloud technology 
Cloud technology refers to the online space that can be used to store and share data (Harris 2017). 
Examples of cloud technologies include Dropbox, Google Drive, Amazon Drive, and Apple iCloud. These 
platforms can be used for two purposes; data storage, and data sharing (Harris 2017). This eliminates 
the need to store and share data on external data storage devices such as external hard-drives or flash 
drives that can easily be corrupted, stolen, damaged, or lost.  
Many cloud technology platforms are open source software (i.e. are freely available to the public). 
These platforms are simple to use, and can be accessed by anyone in any location, provided that they 
have access to the internet, both simplifying and speeding up the sharing of information with relevant 
parties (Baiju 2017). There are also some drawbacks to cloud technology, the first of which is that one 
can only access a limited storage capacity. When this predefined capacity is exceeded, a fee must be 
paid to access further storage capacity. Another drawback is that cloud technology can only be 
accessed with an internet connection (Baiju 2017). 
Online teaching services 
Online teaching services are popular platforms used to replace the need to physically attend a lecture 
(Palloff & Pratt 2001). These platforms are delivered through the internet i.e. lectures can be accessed 
online. There are many forms of online teaching services, such as online classes (courses that are 
delivered on the Internet), or hybrid courses (a combination of traditional, face-to-face classes and 
online courses) (Tallent-Runnels et al. 2006). In some cases, online teaching services are regarded as a 
form of cloud technology, however, in this research, these services are classified outside the 
jurisdiction of cloud technology. 
Online teaching services offer several benefits, the first of which is the fact that individuals in remote 
locations can access the necessary materials at their own discretion. The costs associated with online 
teaching is also less than that of a traditional, face-to-face lectures. There is no need for a classroom, 
lecturer, or transportation to and from a venue (Armstrong 2013). Online teaching also enables users 
to learn at their own pace, without a constant pressure to learn a large portion of work in a short time 
period (Norman 2016). There are also some drawbacks to online teaching services. These platforms 
cannot accommodate human interaction, which is in many cases a critical element of teaching. Also, 
these platforms can only be accessed with internet connectivity (Armstrong 2013).  
Remote internet accessibility  
Remote internet accessibility is defined as “the ability to access a network from a remote distance” 
(Rouse 2005). The context of this definition, however, only refers to one part of the intended meaning 
of remote internet accessibility. The intended meaning refers in large part to accessing internet in 
severe remote locations where there is not necessarily sufficient electricity and network 
infrastructures. Since many PV systems’ scope include activities in these locations, it is necessary for 
the inhabitants of these locations to have access to some sort of network in order to share and access 
relevant information.  
Remote internet accessibility technologies offer several benefits, which include providing access to 
important information, increasing economic growth of local businesses and entrepreneurs, and 
reducing the incidence of diseases through improved information sharing between patients and 
healthcare practitioners (Booth (2003) and Deloitte (2014)). There are also some drawbacks to these 
technologies, which include high initial acquisition costs, maintenance costs, and providing training for 
operating certain devices.  
Mobile technology 
Mobile technology refers to technologies that are used for cellular communication and other related 
aspects (Macwan 2017). Gaining increasing popularity and injection into new markets (Kendrick 2013), 
mobile technologies have been one of the most successful technological developments (Macwan 
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2017). There are many different technologies that are categorised under mobile technology, such as 
cellular phones, smartphones, portable computers, tablets, PDAs (personal digital assistant) and GPS 
devices. Many of these technologies are used in combination, and interact to connect people in 
different locations and allow them to share many different types of information.  
There are several benefits offered by mobile technologies. By definition, these technologies are 
mobile, and can be used in nearly any location. In the healthcare industry, sharing of information 
enabled by mobile technology has allowed for distant healthcare monitoring. Also, these technologies 
are able to transmit information much quicker, and enable individuals in remote locations to stay in 
contact with other communities (Kendrick 2013). One should also consider the drawbacks of mobile 
technologies. There are both acquisition and maintenance costs that should be considered. Integration 
of mobile technologies into an existing infrastructure might also pose a problem, since compatibility 
of devices may be a challenge. Another drawback is that the tangible devices might either get stolen, 
damaged, or lost, and must therefore be closely monitored (Kendrick 2013). 
User videos 
User videos are particularly used for the purpose of training and education. Videos are created by 
individuals or teams who are knowledgeable about a certain topic, and shared with others to train or 
educate them in the specific field, or guide them through a certain process. These videos are often 
used in education departments to train and educate both teachers and students in remote locations 
where it is difficult to gain physical access (Lamprecht 2017). There are also some drawbacks to these 
types of videos. The videos cannot be accessed without the necessary hardware, such as computers or 
tablet devices. The planning and creation of these videos must also be done meticulously, because 
missing or wrong information may cause complications.  
Mobile applications 
Mobile applications, better known as mobile apps, are software programmes designed for mobile 
devices to enable a wide array of functionalities. Mobile apps are used for a number of purposes, which 
include navigation, entertainment, sport, fitness, and productivity (Viswanathan 2017). These apps can 
be accessed on many different platforms, such as Google Play or Apple App Store. The use of mobile 
apps have grown exponentially over the last decade, with an estimated 197 billion apps forecasted to 
be downloaded in 2017 (Viswanathan 2017).  
Mobile apps are relatively easily maintained (depending on the degree of complexity of the 
functionalities enabled by the app), easily modifiable for different requirements and platforms, and 
relatively simple to develop for nearly any function. There are, however, also some drawbacks to 
consider. These include a limited scope of functions that can be executed, and the need for a 
smartphone or tablet device to access these apps (Singh 2017). 
Educational television and radio programmes 
Educational television programmes refer to programmes that incorporate different elements of 
education. These programmes are aired across a television network, with a wide target market. Many 
shows are aimed at children within a low age range (1-5 years), whereas other programmes are aimed 
at adults (Western Governers University 2017). The latter may incorporate different social elements 
and provide essential educational aspects, such as safe sex practices and anti-drug initiatives. 
There are several benefits associated with these educational television programmes. These 
programmes allow for a large audience to be reached, even in remote locations. It also eliminates the 
need for a physical presence of educators or trainers. One potential drawback is that the intended 
message of these types of programmes can be misinterpreted, which might lead to unintended 
behaviours. According to Ostrov et al. (2013), another potential drawback is that some of these 
programmes can lead to aggravated behaviours and attitudes, especially amongst the younger 
population. 
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Radio programmes, similar to educational television programmes, are educational programmes 
intended to convey a certain message of a particular subject to a certain target audience. However, 
instead of using the television, educational radio programmes are delivered across radio broadcasts. 
The benefits and drawbacks of these types of educational programmes are similar to educational 
television programmes. However, there is one additional drawback to consider, namely that radio 
programmes allow only for audible communication, which limits the amount of information that can 
be shared.  
Wireless Application Protocol based messaging 
Wireless Application Protocol (WAP) is a “specification for a set of communication protocols to 
standardise the way that wireless devices, such as cellular telephones…can be used for Internet access, 
including e-mail, the World Wide Web, newsgroups, and instant messaging” (Rouse 2010). In 
particular, WAP based messaging refers to messaging platforms that are based on WAP technology, 
such as Mxit, and Blackberry messenger. For the purpose of this research, the well-known application, 
WhatsApp, is not included in these messenger platforms, since it can only be accessed with more 
advanced smartphones, compared to the other platforms. WAP based messaging does not require 
advanced smartphones, but rather less expensive mobile technologies. It also allows for information 
to be shared in real-time. On the other hand, WAP based messaging can only be used within an area 
where there is access to a mobile network, which may be an obstacle to use in some areas. 
Routine assessments 
Routine assessments can be done in many different ways, such as examinations, interviews, projects, 
or surveys. These assessments are used to assess the knowledge and experience of employees, and 
determines whether a specified threshold is met (Lamprecht 2017). These assessments are used in 
many disciplines, such as healthcare and education. Often, it is seen as a type of incentive scheme, 
since some form of incentive (e.g. funding or promotions) is given to those who excel in these 
assessments.  
Routine assessments allow for a routine check-up on the level of expertise, which enables those in 
management positions to intervene where necessary. These types of assessments also eliminate the 
need for the physical presence of a SME, since the assessments are mostly done on computers. There 
are also some drawbacks to these assessments. It is possible for those being assessed to cheat i.e. get 
information from colleagues. Also, in some areas where there is not access to computers and internet 
networks, these assessments cannot be used (Lamprecht 2017). 
Game-based learning 
Game-based learning is a method of incorporating educational content or learning principles into 
videos games (Coffey 2007). In essence, game-based learning is the use of educational games to teach 
the user certain aspects of the real world. Many of these games are developed as mobile apps 
(described in an earlier section), and are widely available.  
Game-based learning engages and motivates students with a custom learning experience, and 
promotes long-term memory. It also contributes to the development of certain computer skills, which 
is a necessity in modern society. An important criticism is that this type of learning may be more 
distracting than more traditional teaching methods. Additionally, game-based learning can also be 
resource intensive, since it requires a computer, tablet, or smartphone to be accessed. 
Concluding the technology landscape 
It is clear that there are several technologies that can potentially be leveraged towards addressing the 
prioritised root causes identified in Table 1. Many of these technologies can be used in conjunction 
with one another in order to maximise the benefits to PV. For example, remote internet accessibility 
technologies can be used to supplement online teaching services and cloud technologies by providing 
an internet or intranet network. Thus, there are several different possible solutions to the root causes 
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in Table 1. Subsequently, the potential implementations of the technologies to address the root causes 
in Table 1 are discussed. 
ADRESSING THE ROOT CAUSES OF THE PHARMACOVIGILANCE CHALLENGE LANDSCAPE 
It should be made clear that the discussions that follow are non-exhaustive, and in no way is it implied 
that these potential implementations of the technologies are the only solutions to the root causes of 
the PV challenge landscape. Subsequently, a guiding overview is provided where it is explained how 
each of the prioritised root causes in Table 1 can potentially be addressed with the use of the 
technologies identified in the previous section. 
Root cause #1: The users of the form have competing priorities, and simply do not have time to 
notify the person in charge of re-ordering the ADR reporting forms when stock is depleted 
Envisaged technologies: RMS, remote internet accessibility, mobile technologies, mobile 
applications, and WAP-based messaging. 
Firstly, RMSs can be implemented to maintain a record of the movement of ADR reporting forms. If 
maintained, these systems can keep track of the number of ADR reporting forms used, as well as the 
left-over stock. Such a system will allow anyone to be aware of the ADR reporting form stock levels, 
enabling them to reorder new forms in time. In areas where there is not a reliable internet network, 
remote internet accessibility technologies can be used to provide access to internet, which will allow 
individuals in different locations to access the same RMS.  
The second option is using mobile applications, in combination with mobile technologies. Mobile 
applications can be used in the same way as RMS, except with the use of mobile technologies. RMSs, 
as described in the earlier section, are accessed via a computer or tablet, whereas mobile applications 
can be accessed via smartphones. This allows the user to have constant and immediate access to the 
ADR reporting form stock levels. Mobile applications can also be accessed by anyone, which is 
beneficial in the case where the individual in charge of managing the ADR reporting form stock may be 
situated in a remote location where healthcare facilities may have difficulties to communicate. 
Lastly, WAP-based messaging can be used to partially address this issue. Regardless that WAP-based 
messaging cannot be used as a RMS, it can be used to address the issue of communication. By making 
use of these communication platforms, healthcare facilities can constantly communicate with their 
ADR reporting form supplier. 
Root cause #2: The individuals responsible for coordinating the deliveries of spontaneous ADR 
reporting forms are not sufficiently trained to execute these tasks 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, and 
game-based learning, routine assessments. 
Firstly, online teaching services can be used to provide essential training to these individuals. These 
teaching services replace the need for a physical representation of an expert in a remote location who 
provides face-to-face training. Rather, training videos can be accessed via the internet, at any time and 
in any location. This is beneficial since the individuals who need the training can access these videos in 
their own time, and complete any necessary assessments in the comfort of their own workplace. 
Remote internet accessibility technologies can be used in support of online teaching services to 
provide access to internet in areas where it might be lacking. The second option is similar to online 
teaching services, except that it does not require access to an internet connection. Physical copies of 
user videos can simply be distributed to different locations and accessed by those who might need the 
necessary training.  
The final option is with the use of game-based learning, where individuals are provided with the 
necessary training in a gaming format. These types of learning platforms allows the user to learn 
several real-world processes in a virtual world, and allows them to understand the implications their 
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actions might have on an overall system. In the end, individuals will be equipped with key skills that 
they can leverage in their daily tasks of ADR reporting form management.  
In support of all three of these possible solutions are routine assessments, which allows for periodic 
evaluation to be done in order to determine whether the individuals who are coordinating the delivery 
of spontaneous reporting forms have gained the necessary experience in managing ADR reporting 
forms. 
Root cause #3: Key stakeholders are not aware of the health impact of PV on the healthcare system 
Envisaged technologies: Online teaching services, remote internet accessibility, routine 
assessments, user videos, and educational television and radio programmes. 
Firstly, online teaching services can be used to provide healthcare workers with the necessary 
knowledge and awareness of the health impact of PV. If this method is used, it should be made 
mandatory for healthcare workers to access and review these online learning materials, in order to 
ensure that they actually do read through the necessary materials. Additionally, in areas where there 
is a lack of access to internet networks, remote internet accessibility technologies can be used to 
provide access to such networks. Routine assessments or assignments can be used to ensure that all 
healthcare workers put in the time and effort to access online teaching services. In order to further 
motivate these workers, an incentive programme can be implemented whereby healthcare workers 
receive a certain number of points which will contribute to the yearly, mandatory points they must 
gather in order to remain registered as professional healthcare workers. The continual professional 
development (CPD) programme, used in the engineering realm, is an example of such an incentive 
scheme. 
The second option is similar to online teaching services, however, it does not require access to an 
internet network. Physical copies of user videos are simply distributed to different locations, and 
viewed by certain parties. Similar to online teaching services, these training videos do not only remove 
the need for the physical presence of a person knowledgeable within a specific field, but also creates 
awareness amongst healthcare workers of the impact of ADRs, which motivates them to support PV. 
The third option is largely aimed at public awareness. Since many people in several locations have 
access to either televisions or radios, educational television and radio programmes can be used to 
promote PV, and create awareness amongst the public. This will not only motivate the public to 
support and contribute to PV, but will provide them with the necessary knowledge on key aspects such 
as the source of ADRs, where ADRs should be reported, as well as when to know that an ADR is 
experienced. 
Root cause #4: PV is not included in the undergraduate syllabus of tertiary healthcare education 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, routine 
assessments, and game-based learning. 
As indicated by Mehta (2017), it is a difficult to change a healthcare syllabus, because there are 
numerous important aspects of healthcare that deserve attention. Ideally, the solution would be to 
include PV training in the syllabus of healthcare training, however, this can be difficult and time-
consuming. Therefore, in order to provide the necessary PV education to healthcare workers who have 
been minimally exposed to PV in their undergraduate training, some focus should be shifted towards 
providing this training in their workplace. In this instance, online teaching services can be used. These 
services, as described in earlier sections, removes the need for healthcare workers to take time away 
from their overloaded schedules to physically attend training sessions. In areas with poor internet 
networks, remote internet accessibility technologies can be implemented to create access to such 
networks.  
Similar to online teaching services, the second option provides healthcare workers with the necessary 
PV knowledge in their workplace, however, does not require access to internet. User videos can be 
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accessed on a computer or smartphone at any time and in any location. This reduces the pressure on 
healthcare workers, since they can consult these materials at their own discretion. In order to ensure 
that healthcare workers do put in the time and effort to access either online teaching services or user 
videos, routine assessments can be used to assess whether the workers have gained the necessary PV 
knowledge such as ADR reporting. A similar point system as that discussed under the previous root 
cause, where healthcare workers are obligated to obtain a certain number of points to maintain 
registered as professional healthcare workers, can also be used. 
Lastly, PV knowledge can be conveyed via game-based learning platforms. These platforms will provide 
its users with the necessary knowledge in a virtual world, such as ADR reporting, which can then be 
implemented within the real world.  
Root cause #5: The ADR reporting forms are overly complicated and are time-consuming 
Envisaged technologies: Mobile applications and mobile technologies. 
Two possible solutions to this issue are envisaged. As indicated in the study by Khan (2013), the time 
required of healthcare workers to complete overly complicated ADR reporting forms is a major barrier 
to ADR reporting. It is therefore important that, in order to motivate healthcare workers to 
continuously support PV and contribute towards the improvement of ADR reporting, any initiatives 
should ideally be minimally invasive, and disrupt daily routines of healthcare workers minimally. In this 
instance, mobile applications, in combination with mobile technology, can be used. ADR reporting 
forms can be changed into electronic reporting forms, which can be accessed via mobile applications. 
Such mobile application based ADR reporting forms are already being used, including a recent 
development, named WEB-RADR, which has been released in Burkina Faso in 2017 (Uppsala 
Monitoring Centre 2017).  
These forms should also be made up of as little as possible data entries, and should only serve as an 
initial ADR report. In order to reduce complexity during ADR analyses that takes place during a later 
stage in the PV system, these initial ADR reports should be identical in different countries (i.e. a 
standardised reporting form). Once a signal has been detected (a number of ADRs have been reported 
in the same location), a second stage of ADR reporting can commence, where supporting information, 
related to the already supplied information, is submitted, resulting in a growing ADR report which 
contains only the relevant information.  
Root cause #6: The importance of feedback is not sufficiently advocated 
Envisaged technologies: Educational television and radio programmes, mobile applications, and 
mobile technologies, WAP-based messaging. 
Three possible solutions to this issue are envisaged. In order to provide feedback to the public 
regarding ADR reporting, educational television and radio programmes can be used. Instead of printing 
and distributing tangible reports, these programmes are able to reach a large audience in many 
different locations. These types of feedback can be done on a monthly or quarterly basis. It is just 
important that periodic feedback be provided in order to reassure the public that any ADRs they might 
have reported are being investigated.  
An electronic ADR reporting system can also be investigated, with the use of mobile application, in 
combination with mobile technologies. Not only may such a system reduce the time and effort 
required for ADR reporting, but it will also enable feedback to be provided through the application, 
which can be viewed by the reporter at any time. 
Another form of feedback, aimed at both the public and healthcare workers, is in the form of WAP 
based messaging. These messaging platforms can be used to provide feedback to ADR reporters during 
strategic stages in the PV system, such as a notification when the ADR report is received, and when it 
is being investigated, and finally if certain steps are being taken to address the particular ADR. WAP 
based messaging is specifically aimed at resource-limited healthcare facilities who might not have 
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access to online reports. A simple SMS might reassure healthcare workers that their voices are heard 
(their ADR report is being investigated), which may motivate them to regularly report ADRs. 
Root cause #7: There is a lack of ownership of managing the process of data management 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, RMS, 
mobile applications, and mobile technologies. 
Firstly, two major causes of concern can be concluded from the seeming lack of ownership. It can either 
be the case that there is a lack of personnel with the necessary skills and appropriate training to 
maintain the data management system, or it can be that there is significant time constraints, thus 
individuals with the necessary and appropriate skills are not able to add PV data management to their 
schedule. Either way, both of these possible causes must be accounted for. Considering the first case, 
two possible technologies are envisaged to be possibly implemented to address the issue of a lack of 
training. Firstly, online teaching services can be used to provide an individual or team with the 
necessary knowledge and skills to maintain PV data management, which in turn will motivate them to 
take complete ownership of that system. In areas where there is not access to internet (in order to 
access online teaching services), remote internet accessibility technologies can be used to provide such 
networks.  
Secondly, similar to online teaching services, user videos can be used to provide training with regards 
to data management. User videos may be more practical online teaching services in certain settings, 
since they do not require access to internet. However, they are limited with regards to the degree of 
interaction there is between the host and the viewer.  
In order to address the second cause of the lack of ownership, the issue of limited capacities for clinical 
activities and responsibilities, two technologies are envisaged to be possible implemented. Firstly, 
RMSs can be implemented. These systems maintains not only records of resources, but it also allows 
for data management to be done. With a system that automatically does data management, requiring 
minimal interaction, individuals will be less deterred from PV data management, and will feel more 
obliged and comfortable to take ownership of data management. 
Another candidate technology are mobile applications, in combination with mobile technologies. 
Providing someone with anywhere, anytime access to PV data management systems will simplify their 
responsibilities and activities since they are not limited with regards to their location from where they 
are supposed to work, and they will be able to notice any possible warnings or mistakes much quicker. 
Root cause #8: There is a lack of training provided to those who report ADRs 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, and 
game-based learning, and educational television and radio programmes. 
Three possible solutions to this issue are envisaged. With specific aim at healthcare workers, online 
teaching services can be used to provide them with the necessary knowledge and skills of ADR 
reporting, such as how to know when a patient is experiencing an ADR, which essential data to submit 
on ADR reports, and where to report ADRs. These services are more user-friendly when it comes to 
interference with the schedules of healthcare workers since they can view these materials at their own 
discretion and according to their own schedule. In areas where there is no access to internet networks, 
remote internet accessibility technologies can be used to provide access to such networks. The second 
option, similar to online teaching services, are user videos. These videos are minimally invasive on the 
schedules of healthcare workers, since it can be viewed at any time. Also, user videos does not require 
access to internet networks, which in some settings is advantageous. Lastly, game-based learning 
initiatives can be used to provide healthcare workers with the necessary skills on how to report ADRs. 
These virtual platforms can teach them key aspects of ADR reporting which they can implement in the 
real-world.  
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Focussing on the public and the patients who can also report ADRs, educational television and radio 
programmes can be used to educate the public on PV related activities, such as when to know an ADR 
is experienced and where ADRs can be reported. Since many people have access to either a television 
or radio, these educational programmes will be able to reach a large audience in remote locations.  
Root cause #9: There are difficulties in providing the necessary training to individuals in remote 
locations in a timely manner 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, mobile 
applications, and mobile technologies. 
Four possible solutions to this issue are envisaged. This root cause is similar to the one described in 
the previous section, however, focusses on the barrier of providing training to the public and 
healthcare workers in remote locations. In this case, online teaching services, in combination with 
remote internet accessibility technologies, user videos, and game-based learning can be applied in the 
same manner as the case previously discussed. The fourth technology that is added to this list are 
mobile applications, in combination with mobile technologies. Given the widespread adoption of 
mobile technologies (not smartphone technology) in sub-Saharan African countries (Data Team 2017), 
mobile applications can be used to provide training to those residing in remote locations. By making 
use of a technology they are already familiar and comfortable with, mobile application based training 
can be used to supply both the public and healthcare workers with the necessary knowledge regarding 
ADR reporting. 
Root cause #10: There is a lack of ownership to manage existing PV-related resources 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, mobile 
applications, mobile technologies, game-based learning, and RMS. 
Similar to the eighth root cause described, the lack of ownership can be contributed to two possible 
causes. It can either be that there is a lack of personnel who has the necessary knowledge and skills to 
manage PV resources, or it is possible that there is simply no one who can add PV resource 
management to their existing portfolios. As described under the discussion of the eighth root cause, 
the first cause can be addressed with the implementation of either online teaching services (in 
combination with remote internet accessibility technologies), user videos, mobile applications (in 
combination with mobile technologies), or game-based learning. Each of these technologies offer 
different ways of teaching which can be used to provide essential resource management training.  
Another technology that has great potential with regards to adding PV resource management to the 
schedule of an individual or team, is a RMS. These systems maintains electronic records of all the 
resources available to PV activities, and also tracks their movements, and therefore requires a minimal 
degree of intervention. Therefore, if RMSs are well maintained and updated, resource management 
would be made much simpler, and is therefore minimally invasive to the overloaded schedules of 
healthcare workers. 
Root cause #11: Lack of training to educate PV personnel on how available resources should be used 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, mobile 
applications, mobile technologies, game-based learning, and routine assessments. 
There are several different forms of training that can be provided to individuals in order to provide 
them with the necessary knowledge on how to fully utilise PV resources such as ADR reporting forms, 
computers, and smartphones. Online teaching services (in combination with remote internet 
accessibility technologies), user videos, mobile applications (in combination with mobile technologies), 
or game-based learning are all technologies that remove the need for face-to-face interaction, by 
providing training which can be accessed through computers, smartphones, or tablets. All these 
technologies are minimally invasive i.e. slightly interferes with the daily routine of healthcare workers. 
Additionally, and in support of these training platforms, routine assessments, which can either be 
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paper– or computer based, can be used to assess whether or not healthcare workers have put in the 
time and effort to learn from the aforementioned learning technologies. 
Root cause #12: There is no resource management system in place to manage existing resource 
inventories 
Envisaged technologies: RMS and remote internet accessibility. 
One possible solution to this issue is envisaged, namely RMSs. These systems, if well maintained, 
simplify the process of PV resource management by monitoring the available resources, as well as 
keeping track of the movement of resources. These types of systems can also be accessed by anyone 
in any location, provided that there is access to an internet network, which can be provided by remote 
internet accessibility technologies. This can be beneficial in several ways. For example, the distribution 
centre for ADR reporting forms can simply log on to the RMS of a healthcare facility, check their 
available ADR reporting form stock, and start distributing more forms to the facility if necessary. 
Another example is where the system keeps track of the available PV resources. For example, the 
system keeps record of who might be using a smartphone intended for ADR reporting. If something 
where to happen, such as vandalism or the item is lost, the individual who last used the smartphone 
can be tracked down. 
Root cause #13: PV personnel are not sufficiently trained in using existing platforms 
Envisaged technologies: Online teaching services, remote internet accessibility, user videos, mobile 
applications, mobile technologies, game-based learning, and cloud technologies. 
The platforms referred to in this case are information sharing platforms such as emails, chatrooms, or 
blogs. Each of these platforms allow for different parties to communicate with one another, and share 
relevant information. In order to provide training to healthcare workers, especially in areas where they 
are not familiar with these platforms, three different technologies can be used, namely: online 
teaching services (in combination with remote internet accessibility technologies), user videos, or 
game-based learning. Each of these technologies, as mentioned in earlier sections, removes the need 
for face-to-face interaction. It also reduces the degree of interference in the daily routine of healthcare 
workers, since they can access these training materials at their own discretion. The one technology 
that can also, to a certain extent, be used to simplify the process of information sharing is cloud 
technology. These technologies are freely available to the public, and can be used to share large 
amounts of data, such as ADR reports.  
CONCLUDING REMARKS 
From the discussions in the previous section, it is clear that there are indeed numerous technologies 
that can potentially be implemented in PV systems that operate in resource-limited settings. In many 
instances, there are several technologies that can be either individually, or in supplement of another, 
implemented to address a specific root cause. For instance, remote internet accessibility technologies 
can be used to provide internet or intranet networks on which other technologies rely, such as online 
teaching services and cloud technologies. Additionally, routine assessments can also be used to 
supplement user videos and online teaching services, by providing a platform where the target 
audiences can be assessed whether or not they are gaining the necessary skills and knowledge. 
Consequently, it is clear that there is value in investigating the technology landscape, and determine 
how it can be leveraged to address the challenges faced in PV systems. 
CONCLUSION 
In this paper, the potential effects that the technology landscape can have on struggling PV systems 
are explained. Firstly, several root causes of the PV challenge landscape is identified, representing a 
set of prioritised root causes that are believed to have a significant effect on the PV challenge 
landscape. Secondly, the technology landscape is investigated, identifying several technologies that 
can potentially be leveraged towards the benefit of PV. Lastly, a guiding overview is provided, where 
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it is explained how each of the prioritised root causes can be addressed with the technologies 
identified in this paper.  
Subsequently, it is clear from the discussions in this paper that there are several opportunity areas 
where the role of technology in PV can be investigated. Many of these technologies offer several 
benefits that can be leveraged towards the benefit of PV in the short –, medium –, and long-term. 
Provided with the increasing attention being diverted towards sustainability, there are also additional 
technologies that have not been mentioned in this paper that can be used to address the challenges 
in PV in the long-term. Technologies such as block chain, Internet of Things, and big data analytics are 
all exciting technologies that are creating waves of enthusiasm in the modern world, and have the 
potential to significantly benefit PV systems in resource-limited settings in the long-term.  
It is not a secret that technology has completely changed the modern world, and that nearly all 
industries have benefitted significantly from its investments in technology. In order to ensure that PV 
systems, especially those in resource-limited settings, become sustainable systems that are able to 
maintain and ensure universal drug safety, there should be an increasing amount of investment and 
research devoted towards adopting new, innovative technologies in PV systems across the globe. 
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Section E.2: Formal, structured validation document 
An investigation into the prospects of technologies in order to address the challenges 
faced in PV 
After almost 18 months of research, I have finally reached a conclusion, or rather 
recommendation to my research. It is absolutely critical that these recommendations be 
validated by subject matter experts in order to determine whether or not they are feasible and 
credible within PV. Therefore, I would like to ask for your assistance in this process.  
Brief summary of research 
Given that I have completed a very large portion of my research and have conducted a great 
deal of work, I would like to provide a brief summary of the work I completed in order to reach 
this stage. This will provide some context to the research I would like you to review. 
1. Starting the research, I investigated the PV system, where I consulted literature and 
subject matters experts in order to understand PV and the PV system. 
2. Following this, I conducted a systematic literature review to identify the PV challenge 
landscape, which included challenges related to PV culture, insufficient resources, and 
technical capacity. 
3. Realising that the PV challenge landscape is too large, I decided to prioritise the 
landscape in an effort to divert my focus towards the challenges that have the largest 
impact on PV. 
4. Following the prioritisation of the PV challenge landscape, I induced a translation 
process in order to translate the prioritised PV challenge landscape to a lower level of 
abstraction. This was done because the initially defined PV challenges, identified via 
literature, were all described on a strategic level (or high level of abstraction), which 
made it particularly difficult to understand the true effect these challenges have on PV. 
5. Following the translation process, I found that there are several tangible problems (or 
root causes) that made it clear what are the effects of the initially defined PV challenge 
landscape on PV.  
6. Similar to the first prioritisation exercise in number three, I prioritised these root causes 
in order to divert my research focus on the most important root causes. 
7. The nature of my research is to draw a link between the technology landscape and the 
PV challenge landscape. Therefore, I identified several technologies that can be 
leveraged towards PV.  
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8. Using a technology selection framework, I determined that there are some technologies 
that are not feasible for implementation in PV, and have accordingly excluded these 
from my research. The remaining technologies were each assessed with regards to 
setting, workforce, delivery mechanisms, communication modalities, and in some cases, 
interface. 
9. Using the root causes of the prioritised PV challenge landscape and the technologies 
identified, I was able to draw a link between the PV challenge landscape and the 
technology landscape. In other words, I identified and discussed which technologies can 
be used to address which root cause. 
Subsequently, I require validation for the last (number 9) stage of this research.  
What I need from you 
I need you to read through the research that I am providing below, and give some form of 
feedback (notes, email correspondence, or phone call) where you mention whether or not you 
think the recommendations are feasible, both presently and in the future of PV (with specific 
focus on Section 3 of the provided research). If there are sections where you do not agree, or 
where you think there are additional areas for opportunities, you are welcome to make 
suggestions.  
If you need any further clarification, please feel free to contact me via email 
(17574846@sun.ac.za) or by phone (+27714182564). 
Research summary 
In order to reduce the demand for reading through too much information, I am only providing 
you with a certain portion of the research, which includes: 
1. The prioritised root causes described within the clinical domain, in a table format. 
2. A matrix showing which technology can be used to address which root cause. 
3. The discussion of each root cause where the different candidate technologies are 
identified – You can mainly focus on this section. 
Section 1 
For the purpose of reducing the number of pages of this document, Section 1 of this document 
contains the exact same table as Table 20 on p.98 of this research document. 
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Section 2: 
For the purpose of reducing the number of pages of this document, Section 2 of this document 
contains the exact same table as Table 25 on p.126 of this research document. 
Section 3: 
For the purpose of reducing the number of pages of this document, Section 3 of this document 
contains the exact same information found in Section 6.6 on p.127 of this research document. 
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